WBPaper ID,WBGene,Gene,Mutation,Transcript,Gene Sentence,Mutation Sentence,Result
WBPaper00000779,WBGene00006742,unc-2,G118R,T02C5.5p,Line 1979: These mutations were obtained as dominant suppressors of unc-22(s12).,"Line 2093: The genetic localization of s74, s77 and s95 to the myosin head region suggested that these mutations altered myosin enzymatic activity but not thick filament assembly. In the mutation s95, glycine-118 is replaced by an arginine.",False Positive
WBPaper00000779,WBGene00006742,unc-2,M856K,T02C5.5f,Line 1979: These mutations were obtained as dominant suppressors of unc-22(s12).,"Line 2075: Consequently, the subs titution of methionine for lysine-856 in the c position of the myosin rod removes the neutralizing salt-bridge normally found in this position, and would be expected to create a local distortion.",False Positive
WBPaper00000779,WBGene00006742,unc-2,M856K,T02C5.5g,Line 1979: These mutations were obtained as dominant suppressors of unc-22(s12).,"Line 2075: Consequently, the subs titution of methionine for lysine-856 in the c position of the myosin rod removes the neutralizing salt-bridge normally found in this position, and would be expected to create a local distortion.",False Positive
WBPaper00000779,WBGene00006742,unc-2,M856K,T02C5.5h,Line 1979: These mutations were obtained as dominant suppressors of unc-22(s12).,"Line 2075: Consequently, the subs titution of methionine for lysine-856 in the c position of the myosin rod removes the neutralizing salt-bridge normally found in this position, and would be expected to create a local distortion.",False Positive
WBPaper00000779,WBGene00006742,unc-2,M856K,T02C5.5i,Line 1979: These mutations were obtained as dominant suppressors of unc-22(s12).,"Line 2075: Consequently, the subs titution of methionine for lysine-856 in the c position of the myosin rod removes the neutralizing salt-bridge normally found in this position, and would be expected to create a local distortion.",False Positive
WBPaper00000779,WBGene00006789,"unc-54, myo-4",R273C,F11C3.3,"Line 1843: We have sequenced 11 representative mutations of the unc-54 myosin heavy chain gene of Caenorhabditis elegans that affect the synthesis, assembly or enzymatic activity of the encoded myosin heavy chain.",Line 2007: The DNA sequencing studies predict that this change is due to the conversion of arginine-273 to a cysteine.,False Positive
WBPaper00001234,WBGene00003090,lys-1,R107C,Y22F5A.4,"Line 3226: We have not recovered mutations affecting Lys-183, an invariant residue of the nucleotide binding consensus sequence.","Line 3233: r380 (Glu-87- Lys), r342 (Arg-107-Cys), and the r381-r424-r445 muta- tional cluster (Pro-126-Leu) alter residues within a con- served, hydrophobic region that likely contributes to ATP- ase activity.",False Positive
WBPaper00001234,WBGene00006745,unc-5,P685L,B0273.4a,Line 3218: aunc-54(e1420) has been sequenced independently by J. Kiff.,Line 3244: r383 and f474 (Thr-675lle) and the r372-r434-r444 mutational cluster (Pro-685-Leu) are all located within this actin binding site.,False Positive
WBPaper00001234,WBGene00006745,unc-5,Q631AMBER,B0273.4a,Line 3218: aunc-54(e1420) has been sequenced independently by J. Kiff.,"Line 3217: The crystal structures of EFTu and human ras, both of which bind GTP, demonstrate that the Table 1 B. uric-54(O) Mutant Sequences Nucleotide Base Codon Amino Acid Allele Affected Change Change Change r316 3325 C-T CAG-UAG Gin-420-amber r619 3504 G-A UGG+UGA Trp-479-opal e7420a 3960 C-T CAA-UAA Gin-614-ochre e1419 4011 C-T CAG-UAG Gln-631-amber r818 4308 C-T CAA-UAA Gln-730-ochre r308 4619 G-A UGG-UGA Trp-833-opal r315 5907 C-T CAG-UAG Gin-1263-amber r820 6075 C-T CAG-UAG Gln-1319-amber r318 6264 C-T cAA+uAA Gln-1382-ochre r310 6777 C-T CAA-UAA Gln-1553+ochre A09 6840 C-T CAG-UAG Gln-1574-amber r306 2936 to 2939 deleted (out-of-frame deletion) r621 7087 to 7469 deleted (out-of-frame deletion) Nucleotide coordinates are those of Karn et al.",False Positive
WBPaper00001234,WBGene00010259,ric-7,R107C,F58E10.1c,"Line 3260: Although we have not found significant numbers of misplaced thick filaments (such as those found in the muscle arms of uric-75 mutants) (Waterston et al., 1977) or other filamentous aggregates, the exact lo- cations of the wild-type myosins within these cells are presently unknown.","Line 3233: r380 (Glu-87- Lys), r342 (Arg-107-Cys), and the r381-r424-r445 muta- tional cluster (Pro-126-Leu) alter residues within a con- served, hydrophobic region that likely contributes to ATP- ase activity.",False Positive
WBPaper00001366,WBGene00023497,lin-15,K132E,ZK662.4,"Line 20460: Although n1981 does not cause a dominant Vul phenotype, this allele is like the dominant Vul alleles in that it causes a dominant suppression of the Muv phenotype caused by the lin-15(n765) mutation.","Line 20457: The s1155 mutant strain contains two mutations, an A- T transversion that causes the substitution of cysteine for serine at codon 131 and a G- A transition that causes the substitution of lysine for glutamic acid at codon 132; we do not know whether one or both of these DNA changes is responsible for the phenotype of s1155 strains.",False Positive
WBPaper00001677,WBGene00001063,dpy-1,A1034T,M01E10.2b,"Line 16623: The mutations used are LGI, smg-l(r861), LGIII, glp-l (q46, q50, q158, q172, q175, q224, q231, q415, bnl8, e2072, e2141, e2142, e2144, oz25 and sy56), dpy-17 (el64), dpy-19 (el259), unc-32 (e189), unc-69 (e587), and LGV, him-5 (el490).",Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",A1034T,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",C126S,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",C560Y,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",G1043E,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",G1057E,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",G137E,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001677,WBGene00001609,"glp-1, emb-33",G226E,F02A9.6,Line 16558: The glp-1 gene encodes a membrane protein required for inductive cell interactions during development of the nematode Caenorhabditis elegans.,Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,True Positive
WBPaper00001677,WBGene00006743,unc-3,G226E,Y16B4A.1,"Line 16623: The mutations used are LGI, smg-l(r861), LGIII, glp-l (q46, q50, q158, q172, q175, q224, q231, q415, bnl8, e2072, e2141, e2142, e2144, oz25 and sy56), dpy-17 (el64), dpy-19 (el259), unc-32 (e189), unc-69 (e587), and LGV, him-5 (el490).",Line 16801: Molecular lesions in glp-1(lf) mutants Nucleotide Base Allele affecteda change Codon change Amino acid change glp-1(O) q46 6745 C - T CAA - UAA Gln 537 - ochre q158 6815 G A UGU UAU Cys 560 Tyr q172 6709-6969 In-Frame Deletion Asp 524 to Thr 611 deleted q175 5102 C - T CGA UGA Arg 191 - opal oz25 5538 G - A UGU - UAU Cys 336 - Tyr glp-1(ts) q224 8721 G A GGA - GAA Gly 1043 Glu q231 8763 G A GGA GAA Gly 1057 Glu bnl8 8693 G - A GCA ACA Ala 1034 Thr e2141 8378 C - T CUU UUU Leu 929 -Phe e2144 8378 C T CUU - UUU Leu 929 - Phe sy56 8678 C T CGG UGG Arg 1029 -aTrp glp-1(lf) q415 5208 G A GGA GAA Gly 226 Glu q50 4907 T A UGC AGC Cys 126 Ser e2072 4941 G - A GGA GAA Gly 137 Glu e2142 2609 G A GGA AGA Gly 33 -Arg a Nucleotide coordinates from Yochem and Greenwald (1989).,False Positive
WBPaper00001691,WBGene00004747,"sdc-3, dpy-29",R1508Q,C25D7.3,Line 21635: sdc-3 is an early-acting regulatory gene that controls both sex determination and X chromosome dosage compensation in C. elegans.,"Line 21898: The weaker sex determination allele, yl3iTra, causes an arginine to glutamine change at amino acid 1508.",True Positive
WBPaper00001768,WBGene00001864,him-5,E183K,D1086.4a,"Line 12291: In experiments analyzing male phenotypes, we in- cluded him-8 or him-5 mutations in the strains; these mutations in- creasethefrequencyof male(XO)progenyarisingfromXchromosome nondisjunction (Hodgkin et al., 1979).","Line 12208: Sequences of /in-39 Mutations Allele Wild-Type Sequence Mutant Sequence Substitution or Splice Site Change n7OQts cactccag/ATG cactccaATG Exon 2 acceptor n2547 ATG ATA Ml1 GGA Gi G88E n2689 CAA IM Q87ochre nl880 CAG TAG OlOOamber n1064 UtttcagXA tttttcaa/TCA Exon 3 acceptor n149Ms, n1872is CAGlgttagtca CAGlattagtca Exon 3 donor n2110, n2684 GAG AAG El 79K n1491, n2512 GAA AAA E183K n1488, n1874, n2008, n2009 CAAJgtgagaat Cmgtgagaat Exon 4 donor n1532, n2010 tgtttcag/GTC tgntcagGTC Exon 5 acceptor n1760 AAA LM K2lOochre n1115 TGG TAG WZlPamber For each mutation, the codon altered and the expected substitution are shown.",False Positive
WBPaper00001768,WBGene00001867,him-8,G88E,T07G12.12a,"Line 12080: Pn.aap cell fates in /in-39 males are shown based on lineage observations of 5 /in-39(n7760); him-8 males and 3 /in-392010); him-8 males followed during L3, and 4 /in-3Q(n7760); him-8 males in which P lineages were followed from Lt.","Line 12208: Sequences of /in-39 Mutations Allele Wild-Type Sequence Mutant Sequence Substitution or Splice Site Change n7OQts cactccag/ATG cactccaATG Exon 2 acceptor n2547 ATG ATA Ml1 GGA Gi G88E n2689 CAA IM Q87ochre nl880 CAG TAG OlOOamber n1064 UtttcagXA tttttcaa/TCA Exon 3 acceptor n149Ms, n1872is CAGlgttagtca CAGlattagtca Exon 3 donor n2110, n2684 GAG AAG El 79K n1491, n2512 GAA AAA E183K n1488, n1874, n2008, n2009 CAAJgtgagaat Cmgtgagaat Exon 4 donor n1532, n2010 tgtttcag/GTC tgntcagGTC Exon 5 acceptor n1760 AAA LM K2lOochre n1115 TGG TAG WZlPamber For each mutation, the codon altered and the expected substitution are shown.",False Positive
WBPaper00001768,WBGene00002990,"lin-1, elk-1",G88E,C37F5.1a,"Line 12321: From heterozy- gotes of genotype /in-39/sma-3 /in-73 uric-36,ll of 16 Sma non-Lin-I 3 recombinants segregated Lin-39 animals, and 5 of 5 Uric non-Lin-13 recombinants segregated Lin-39 animals.","Line 12208: Sequences of /in-39 Mutations Allele Wild-Type Sequence Mutant Sequence Substitution or Splice Site Change n7OQts cactccag/ATG cactccaATG Exon 2 acceptor n2547 ATG ATA Ml1 GGA Gi G88E n2689 CAA IM Q87ochre nl880 CAG TAG OlOOamber n1064 UtttcagXA tttttcaa/TCA Exon 3 acceptor n149Ms, n1872is CAGlgttagtca CAGlattagtca Exon 3 donor n2110, n2684 GAG AAG El 79K n1491, n2512 GAA AAA E183K n1488, n1874, n2008, n2009 CAAJgtgagaat Cmgtgagaat Exon 4 donor n1532, n2010 tgtttcag/GTC tgntcagGTC Exon 5 acceptor n1760 AAA LM K2lOochre n1115 TGG TAG WZlPamber For each mutation, the codon altered and the expected substitution are shown.",False Positive
WBPaper00001768,WBGene00002992,"lin-3, let-94, sli-4",E183K,F36H1.4e,Line 11983: The gene lin-39 is required for mid-body region-specific development.,"Line 12208: Sequences of /in-39 Mutations Allele Wild-Type Sequence Mutant Sequence Substitution or Splice Site Change n7OQts cactccag/ATG cactccaATG Exon 2 acceptor n2547 ATG ATA Ml1 GGA Gi G88E n2689 CAA IM Q87ochre nl880 CAG TAG OlOOamber n1064 UtttcagXA tttttcaa/TCA Exon 3 acceptor n149Ms, n1872is CAGlgttagtca CAGlattagtca Exon 3 donor n2110, n2684 GAG AAG El 79K n1491, n2512 GAA AAA E183K n1488, n1874, n2008, n2009 CAAJgtgagaat Cmgtgagaat Exon 4 donor n1532, n2010 tgtttcag/GTC tgntcagGTC Exon 5 acceptor n1760 AAA LM K2lOochre n1115 TGG TAG WZlPamber For each mutation, the codon altered and the expected substitution are shown.",False Positive
WBPaper00001835,WBGene00000596,"col-7, col7",G258A,C15A11.5,"Line 18140: All of the C. eleguns cuticle collagens characterized have two cysteine residues in 1038 J. M. Kramer and Homology Block A Gene Location Sequence dPY-7 col-7 COl-8 col- 19 col- 1 dpy- 13 col-2 col- 14 COl-6 COI- 12,13 COI-36 col-40 dpy- 10 dPY-2 sqt- 1 rol-6 -32 -23 -23 -23 -27 -32 -30 -47 -65 -30 -42 -30 -40 -33 -62 -85 G'R I K R Q'Y G FGRRRQKK TR'KARQAY ARTARQAG NRTTRQAY NRTARAVR TRVARQAY KRDTLQDF HRMKRAWL RKARRQSY TRSRRDAG TRSRRGGY NRTARGAY NVTKRAAG K'R v R R Q'Y E NRVRRQQY Consensus NRTRRQAY A FIGURE 2.-Homology Block A sequences of 17 C. elegans cuticle collagens.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000597,"col-8, col8",G258A,F11H8.3,"Line 18140: All of the C. eleguns cuticle collagens characterized have two cysteine residues in 1038 J. M. Kramer and Homology Block A Gene Location Sequence dPY-7 col-7 COl-8 col- 19 col- 1 dpy- 13 col-2 col- 14 COl-6 COI- 12,13 COI-36 col-40 dpy- 10 dPY-2 sqt- 1 rol-6 -32 -23 -23 -23 -27 -32 -30 -47 -65 -30 -42 -30 -40 -33 -62 -85 G'R I K R Q'Y G FGRRRQKK TR'KARQAY ARTARQAG NRTTRQAY NRTARAVR TRVARQAY KRDTLQDF HRMKRAWL RKARRQSY TRSRRDAG TRSRRGGY NRTARGAY NVTKRAAG K'R v R R Q'Y E NRVRRQQY Consensus NRTRRQAY A FIGURE 2.-Homology Block A sequences of 17 C. elegans cuticle collagens.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000617,col-40,G258A,T13B5.4,"Line 18140: All of the C. eleguns cuticle collagens characterized have two cysteine residues in 1038 J. M. Kramer and Homology Block A Gene Location Sequence dPY-7 col-7 COl-8 col- 19 col- 1 dpy- 13 col-2 col- 14 COl-6 COI- 12,13 COI-36 col-40 dpy- 10 dPY-2 sqt- 1 rol-6 -32 -23 -23 -23 -27 -32 -30 -47 -65 -30 -42 -30 -40 -33 -62 -85 G'R I K R Q'Y G FGRRRQKK TR'KARQAY ARTARQAG NRTTRQAY NRTARAVR TRVARQAY KRDTLQDF HRMKRAWL RKARRQSY TRSRRDAG TRSRRGGY NRTARGAY NVTKRAAG K'R v R R Q'Y E NRVRRQQY Consensus NRTRRQAY A FIGURE 2.-Homology Block A sequences of 17 C. elegans cuticle collagens.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000898,daf-2,C413T,Y55D5A.5a,"Line 18319: We suggest that the C. elegans suppressor mutant collagens cause a physiological stress which induces chmerones that can partially rescue the ts mutant glp-1, mup-1 or daf-2 proteins.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000898,daf-2,C413T,Y55D5A.5c,"Line 18319: We suggest that the C. elegans suppressor mutant collagens cause a physiological stress which induces chmerones that can partially rescue the ts mutant glp-1, mup-1 or daf-2 proteins.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000898,daf-2,G1105A,Y55D5A.5a,"Line 18319: We suggest that the C. elegans suppressor mutant collagens cause a physiological stress which induces chmerones that can partially rescue the ts mutant glp-1, mup-1 or daf-2 proteins.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000898,daf-2,G1105C,Y55D5A.5a,"Line 18319: We suggest that the C. elegans suppressor mutant collagens cause a physiological stress which induces chmerones that can partially rescue the ts mutant glp-1, mup-1 or daf-2 proteins.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000898,daf-2,G604A,Y55D5A.5a,"Line 18319: We suggest that the C. elegans suppressor mutant collagens cause a physiological stress which induces chmerones that can partially rescue the ts mutant glp-1, mup-1 or daf-2 proteins.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00000898,daf-2,G604A,Y55D5A.5c,"Line 18319: We suggest that the C. elegans suppressor mutant collagens cause a physiological stress which induces chmerones that can partially rescue the ts mutant glp-1, mup-1 or daf-2 proteins.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00001069,dpy-7,G258A,F46C8.6,"Line 18081: 1990), dpy-7 (JOHNSTONE, SHAFI and BARRY 1992), dpp2 and dpy-10 (LEVY, YANG and KRAMER 1993).","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00001263,"emb-9, clb-2, zyg-6",G258A,K04H4.1a,"Line 18242: 1993) collagen chains, and the C. elegans emb-9 (Guo, JOHNSON and KRAMER 1991), dpy-7 (JOHNSTONE, SHAFI and BARRY 1992), dpy-2 and dpy-10 (LEVY, YANG and KRAMER 1993) collagen chains cause severe phenotypes.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00001263,"emb-9, clb-2, zyg-6",G258A,K04H4.1b,"Line 18242: 1993) collagen chains, and the C. elegans emb-9 (Guo, JOHNSON and KRAMER 1991), dpy-7 (JOHNSTONE, SHAFI and BARRY 1992), dpy-2 and dpy-10 (LEVY, YANG and KRAMER 1993) collagen chains cause severe phenotypes.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00001263,"emb-9, clb-2, zyg-6",G943A,K04H4.1a,"Line 18242: 1993) collagen chains, and the C. elegans emb-9 (Guo, JOHNSON and KRAMER 1991), dpy-7 (JOHNSTONE, SHAFI and BARRY 1992), dpy-2 and dpy-10 (LEVY, YANG and KRAMER 1993) collagen chains cause severe phenotypes.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00001263,"emb-9, clb-2, zyg-6",G943A,K04H4.1b,"Line 18242: 1993) collagen chains, and the C. elegans emb-9 (Guo, JOHNSON and KRAMER 1991), dpy-7 (JOHNSTONE, SHAFI and BARRY 1992), dpy-2 and dpy-10 (LEVY, YANG and KRAMER 1993) collagen chains cause severe phenotypes.","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00001609,"glp-1, emb-33",G604A,F02A9.6,"Line 18301: Mutations in the sqt-I, dpy-2 and dpy-IO collagen genes have been found to suppress a temperature- sensitive (ts) mutation in the glp-1 gene (MAINE and KIMBLE 1989).","Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00001835,WBGene00005016,"sqt-1, rol-5",G258A,B0491.2,Line 18049: Different mutations in the sqt-1 and rol-6 collagen genes of Caenorhabditis elegans can cause diverse changes in body morphology and display different genetic attributes.,"Line 18123: wLRol 604 G>A 136 Gly > Glu sc99 Tal, wLon 649 G>A 151 Gly > Glu SClOl Lon, Tal 943 G>A 249 Gly > Glu scl12 sLRol, Tal 1105 G>A 303 Cys > Tyr scl3 sLRol, Tal 1105 G>A 303 Cys > Tyr scl13 sLRol, Tal 1105 G>C 303 Cys > Ser 01-6 n1268 WDPY 258 G>A 36 Trp > Opa n1270 WDPY 258 G>A 36 Trp > Opa su I006 Semidominant RRol 413 C>T 71 Arg > Cys e187 RRol 414 G>A 71 Arg > His n1178 WDPY 1034 C>T 278 Gln > Amb a Phenotypes are: Dpy, dumpy; Lon, long; LRol, left roller; RRol, right roller; Tal, abnormal tail; WT, wild type.",False Positive
WBPaper00002018,WBGene00003171,mec-7,A393T,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,A97V,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,C303Y,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,D249N,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,E407K,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",False Positive
WBPaper00002018,WBGene00003171,mec-7,F317I,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,G109E,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,G148R,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.",Line 4083: Summary of analysis of mec-7 mutants  Process Allele Amino acid Nucleotide mRNA* Cell body Process length  Antigen  intensity  Severe RECESSIVE: e1506 met(1) G(341)A - - - NA u9 trp(101)stop G(817)A - - - NA u80 ND ND - - - NA u88 arg(318)stop C(1513)T - - - NA u142 gln(279)stop C(1349)T - - - NA u176 ND ND ND ++ +  u178 gln(280)stop C(1352)T - - - NA u275 gly(148)arg G(956)A + +  ?,True Positive
WBPaper00002018,WBGene00003171,mec-7,G244S,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,G269D,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",False Positive
WBPaper00002018,WBGene00003171,mec-7,G34S,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",False Positive
WBPaper00002018,WBGene00003171,mec-7,G369R,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,G402R,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,M300T,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,M300V,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,N226Y,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,N247I,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,P171L,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,P243L,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,P61L,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,P61S,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",False Positive
WBPaper00002018,WBGene00003171,mec-7,Q279*,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.",Line 4083: Summary of analysis of mec-7 mutants  Process Allele Amino acid Nucleotide mRNA* Cell body Process length  Antigen  intensity  Severe RECESSIVE: e1506 met(1) G(341)A - - - NA u9 trp(101)stop G(817)A - - - NA u80 ND ND - - - NA u88 arg(318)stop C(1513)T - - - NA u142 gln(279)stop C(1349)T - - - NA u176 ND ND ND ++ +  u178 gln(280)stop C(1352)T - - - NA u275 gly(148)arg G(956)A + +  ?,False Positive
WBPaper00002018,WBGene00003171,mec-7,Q280*,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.",Line 4083: Summary of analysis of mec-7 mutants  Process Allele Amino acid Nucleotide mRNA* Cell body Process length  Antigen  intensity  Severe RECESSIVE: e1506 met(1) G(341)A - - - NA u9 trp(101)stop G(817)A - - - NA u80 ND ND - - - NA u88 arg(318)stop C(1513)T - - - NA u142 gln(279)stop C(1349)T - - - NA u176 ND ND ND ++ +  u178 gln(280)stop C(1352)T - - - NA u275 gly(148)arg G(956)A + +  ?,False Positive
WBPaper00002018,WBGene00003171,mec-7,Q292P,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,R318*,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.",Line 4083: Summary of analysis of mec-7 mutants  Process Allele Amino acid Nucleotide mRNA* Cell body Process length  Antigen  intensity  Severe RECESSIVE: e1506 met(1) G(341)A - - - NA u9 trp(101)stop G(817)A - - - NA u80 ND ND - - - NA u88 arg(318)stop C(1513)T - - - NA u142 gln(279)stop C(1349)T - - - NA u176 ND ND ND ++ +  u178 gln(280)stop C(1352)T - - - NA u275 gly(148)arg G(956)A + +  ?,False Positive
WBPaper00002018,WBGene00003171,mec-7,R318Q,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,S176F,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,S188F,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,S25F,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,T214P,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,V179A,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,V255M,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,V286D,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",True Positive
WBPaper00002018,WBGene00003171,mec-7,W101*,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.",Line 4083: Summary of analysis of mec-7 mutants  Process Allele Amino acid Nucleotide mRNA* Cell body Process length  Antigen  intensity  Severe RECESSIVE: e1506 met(1) G(341)A - - - NA u9 trp(101)stop G(817)A - - - NA u80 ND ND - - - NA u88 arg(318)stop C(1513)T - - - NA u142 gln(279)stop C(1349)T - - - NA u176 ND ND ND ++ +  u178 gln(280)stop C(1352)T - - - NA u275 gly(148)arg G(956)A + +  ?,False Positive
WBPaper00002018,WBGene00003171,mec-7,W344*,ZK154.3,"Line 3992: Journal of Cell Science 107, 2165-2175 (1994) Printed in Great Britain  The Company of Biologists Limited 1994  2165  Mutations in the   Caenorhabditis elegans b -tubulin gene mec-7: effects on  microtubule assembly and stability and on tubulin autoregulation  Cathy Savage1,*, Yingzi Xue1, Shohei Mitani , David Hall2, Randa Zakhary1 and Martin Chalﬁe1,  1Department of Biological Sciences, 1012 Sherman Fairchild Center, Columbia University, New York, NY 10027, USA 2Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA  *Present address: Waksman Institute, PO Box 759, Piscataway, NJ 08855-0759, USA On leave from the Department of Neurobiology, Institute of Brain Research, School of Medicine, University of Tokyo, Tokyo, 113, Japan Present address: Department of Physiology, Tokyo Women’s Medical College, Tokyo, 162, Japan Author for correspondence  SUMMARY  mec-7, a b -tubulin gene We have sequenced 45 mutations in  required  for  the  production  of  15-protoﬁlament  micro- tubules in the nematode Caenorhabditis elegans, and have correlated  sequence  alterations  with  mutant  phenotypes.","Line 4084: u440 trp(101)stop G(817)A - - - NA u443 deletion ND - - NA u448 deletion ND ND ND ND u453 deletion ND ND ND ND   Mild RECESSIVE: u170 glu(407)lys G(1827)A ND + + ++ u173 gly(402)arg G(1812)A  + + + u305 gly(34)ser G(493)A - + + + u430 ala(97)val C(804)T  + +   DOMINANT: e1527 val(286)asp T(1418)A - + + + n434 asn(247)ile A(1254)T  + +  u18 ala(393)thr G(1785)A - + +  u129 gly(244)ser G(1244)A - + +  u162 asp(249)asn G(1259)A - + +  u283 pro(243)leu C(1242)T  + +   Severe SEMIDOMINANT: e1343 pro(171)leu C(1026)T  + + + e1505 gly(269)asp G(1320)A - +  + e1522 phe(317)ile T(1510)A - + + + u10 ser(188)phe C(1077)T    + u48 ser(176)phe C(1041)T  + +  u58 pro(61)leu C(575)T ND + + + u98 met(300)thr T(1460)C  + + + u127 pro(171)leu C(1026)T  + + + u136 ND ND - - - NA u143 gly(369)arg G(1666)A  + + + u222 gly(109)glu G(840)A - + + + u223 pro(61)leu C(575)T  + + + u225 thr(214)pro A(1154)C  + + + u234 arg(318)gln G(1514)A - + + + u249 pro(61)ser C(574)T - + + + u445 met(300)val A(1459)G - + +  u449 val(179)ala T(1050)C  + +  u451 gln(292)pro A(1433)C - + + +  Mild SEMIDOMINANT: u156 trp(344)stop G(1593)A - - - NA u262 asn(226)tyr A(1190)T  +   u278 cys(303)tyr G(1469)A - + + ++ u319 ser(25)phe C(467)T  + + + u427 val(255)met G(1277)A  + + +   *Symbols used: ++ or +++, greater than wild-type levels or length; +, wild-type  levels or length; , less than wild-type levels or length; -, undetectable; ND, not determined; and NA, not able to be determined (because no antigen was present).",False Positive
WBPaper00002034,WBGene00001412,"fem-2, isx-2",P50L,T19C3.8,Line 1257: Signal .................. Transduction .................. ..... : Regulation ; Transcriptional ..... : Regulation j Transcriptional -9 XA 4 xol-1 4 sdc-2 4 her-1 1 4 fem-2 1 tra-l SdC- 1 fem- 1 sdc-3 fem-3 xx 1.0 Off ON Off ON Off ON x0 0.5 ON Off ON Off ON Off (3 FIGURE 1.-The genetic regulatory pathway governing somatic sex determination in C. elegans.,"Line 1367: The third ts mutation, e2296 (P50L), causes only slight morphological sexual transformation of X0 animals at permissive temperature (15-16), but these males cannot mate; at higher temperatures, phenotypes range from clearly intersexual animals to completely transformed self-fertile hermaphrodites (J. HODGKIN, personal communication).",False Positive
WBPaper00002034,WBGene00001413,fem-3,E154K,C01F6.4a,Line 1257: Signal .................. Transduction .................. ..... : Regulation ; Transcriptional ..... : Regulation j Transcriptional -9 XA 4 xol-1 4 sdc-2 4 her-1 1 4 fem-2 1 tra-l SdC- 1 fem- 1 sdc-3 fem-3 xx 1.0 Off ON Off ON Off ON x0 0.5 ON Off ON Off ON Off (3 FIGURE 1.-The genetic regulatory pathway governing somatic sex determination in C. elegans.,Line 1365: The very weak mutations q428 (E77K) and n830 (E154K) both cause slight X0 femi- nization at the nonpermissive temperature (25) ; n830 males have variable tail abnormalities which substan- tially reduce mating efficiency (TRENT et al.,False Positive
WBPaper00002034,WBGene00001842,her-1,E154K,ZK287.8a,"Line 1223: In the control of Caenorhabditis elegans sex determination, the her-1 gene must normally be activated to allow male development of XO animals and deactivated to allow hermaphrodite development of XX animals.",Line 1365: The very weak mutations q428 (E77K) and n830 (E154K) both cause slight X0 femi- nization at the nonpermissive temperature (25) ; n830 males have variable tail abnormalities which substan- tially reduce mating efficiency (TRENT et al.,False Positive
WBPaper00002034,WBGene00001842,her-1,E77K,ZK287.8a,"Line 1223: In the control of Caenorhabditis elegans sex determination, the her-1 gene must normally be activated to allow male development of XO animals and deactivated to allow hermaphrodite development of XX animals.",Line 1365: The very weak mutations q428 (E77K) and n830 (E154K) both cause slight X0 femi- nization at the nonpermissive temperature (25) ; n830 males have variable tail abnormalities which substan- tially reduce mating efficiency (TRENT et al.,True Positive
WBPaper00002034,WBGene00001842,her-1,P50L,ZK287.8a,"Line 1223: In the control of Caenorhabditis elegans sex determination, the her-1 gene must normally be activated to allow male development of XO animals and deactivated to allow hermaphrodite development of XX animals.","Line 1367: The third ts mutation, e2296 (P50L), causes only slight morphological sexual transformation of X0 animals at permissive temperature (15-16), but these males cannot mate; at higher temperatures, phenotypes range from clearly intersexual animals to completely transformed self-fertile hermaphrodites (J. HODGKIN, personal communication).",True Positive
WBPaper00002034,WBGene00001867,him-8,E154K,T07G12.12a,Line 1285: The him-5 and him-8 alleles were described by HODGKIN et al.,Line 1365: The very weak mutations q428 (E77K) and n830 (E154K) both cause slight X0 femi- nization at the nonpermissive temperature (25) ; n830 males have variable tail abnormalities which substan- tially reduce mating efficiency (TRENT et al.,False Positive
WBPaper00002034,WBGene00006605,tra-2,E77K,C15F1.3c,"Line 1244: Genetic analysis of her-1 mutations alone and in combination with mutations in other sex- determining genes predicted that her-1 expression should be high in X0 and low in XX animals, and that its product should directly or indirectly negatively regu- late the tra-2 gene or its product (HODGKIN 1980).",Line 1365: The very weak mutations q428 (E77K) and n830 (E154K) both cause slight X0 femi- nization at the nonpermissive temperature (25) ; n830 males have variable tail abnormalities which substan- tially reduce mating efficiency (TRENT et al.,False Positive
WBPaper00002207,WBGene00001411,"fem-1, isx-1",G227S,F35D6.1a,"Line 21447: 1987] and female develop- ment [fem-1(hc17); Hodgkin 19861, consistent with the sex-nonspecific role of gld-1 in premeiotic proliferation (Francis et al.","Line 21357: Of particular interest is that three of the class A missense mutations (oz89, q93oz55, and q361) affect a single residue (Gly-227 Ser or Asp) in the gld-1 KH motif.",False Positive
WBPaper00002207,WBGene00001481,"fog-1, cpb-4",G248R,Y54E10A.4c,"Line 21253: gld-1 is not required for sperm formation in either sex, however, and its role in promoting hermaphrodite spermatogenesis may be limited to assisting the set of genes (fog-1, fog-3, and the fem genes) that act to specify the male fate (Francis et al.","Line 21427: All class C1 mutations (q93, q62, oz17, oz34, and oz35) result in Gly-248 Arg, and all class C2 mutations (oz30, oz16, oz29, oz33, and oz70) result in Gly-250 Arg.",False Positive
WBPaper00002207,WBGene00001513,"gad-1, tag-86",P335S,T05H4.14,Line 21586: This sequence was used to make primers for 5'-RACE analysis as described above for gad-1.,Line 21436: The oz10 allele contains two muta- tions: a missense mutation (Pro-335 Ser) and a 515-bp deletion within the 3' UTR of the gene.,False Positive
WBPaper00002207,WBGene00001595,gld-1,G227S,T23G11.3,Line 21216: The gld-1 gene of Caenorhabditis elegans is a germ-line-specific tumor suppressor gene that is essential for oogenesis.,"Line 21357: Of particular interest is that three of the class A missense mutations (oz89, q93oz55, and q361) affect a single residue (Gly-227 Ser or Asp) in the gld-1 KH motif.",False Positive
WBPaper00002207,WBGene00001595,gld-1,G248R,T23G11.3,Line 21216: The gld-1 gene of Caenorhabditis elegans is a germ-line-specific tumor suppressor gene that is essential for oogenesis.,"Line 21427: All class C1 mutations (q93, q62, oz17, oz34, and oz35) result in Gly-248 Arg, and all class C2 mutations (oz30, oz16, oz29, oz33, and oz70) result in Gly-250 Arg.",False Positive
WBPaper00002207,WBGene00001595,gld-1,G250R,T23G11.3,Line 21216: The gld-1 gene of Caenorhabditis elegans is a germ-line-specific tumor suppressor gene that is essential for oogenesis.,"Line 21427: All class C1 mutations (q93, q62, oz17, oz34, and oz35) result in Gly-248 Arg, and all class C2 mutations (oz30, oz16, oz29, oz33, and oz70) result in Gly-250 Arg.",True Positive
WBPaper00002207,WBGene00001595,gld-1,G308E,T23G11.3,Line 21216: The gld-1 gene of Caenorhabditis elegans is a germ-line-specific tumor suppressor gene that is essential for oogenesis.,Line 21417: ing males to make oocytes (Francis et al. The two class D mutations (q126 and oz142) contain identical nucleotide changes resulting in Gly-308 Glu.,False Positive
WBPaper00002207,WBGene00001595,gld-1,P335S,T23G11.3,Line 21216: The gld-1 gene of Caenorhabditis elegans is a germ-line-specific tumor suppressor gene that is essential for oogenesis.,Line 21436: The oz10 allele contains two muta- tions: a missense mutation (Pro-335 Ser) and a 515-bp deletion within the 3' UTR of the gene.,False Positive
WBPaper00002207,WBGene00001628,gly-3,G250R,ZK688.8,"Line 21490: 4): An intragenic mutation in Glu-310 suppresses the class C1 mutant defect, with the resulting double mutant having a tumorous phenotype (phenotypic class A2); mutation of Gly-308 results in a gf defect leading to a feminization of the germ-line (Fog) phenotype in both the hermaphrodite and male but does not disrupt oocyte differentiation (class D); finally, dele- tion of the last 4 amino acids of the CGA region results in a defect in oogenesis as well as a gf defect that results in a hermaphrodite-specific Fog phenotype (class E).","Line 21427: All class C1 mutations (q93, q62, oz17, oz34, and oz35) result in Gly-248 Arg, and all class C2 mutations (oz30, oz16, oz29, oz33, and oz70) result in Gly-250 Arg.",False Positive
WBPaper00002207,WBGene00006741,"unc-1, unc-102",G227S,K03E6.5a,"Line 21393: RNA from a balanced q343 strain [unc13(e51) gld-1(q343) / unc-15(e1214)] did not show aberrant-sized gld-1 transcripts on Northern blots (data not shown), suggesting that the element may be spliced out of gld-1 mRNA (e.g., Benian et al.","Line 21357: Of particular interest is that three of the class A missense mutations (oz89, q93oz55, and q361) affect a single residue (Gly-227 Ser or Asp) in the gld-1 KH motif.",False Positive
WBPaper00002379,WBGene00000897,daf-1,G359A,F29C4.1a,"Line 6172: Linkage group V: unc-42 (e270), daf-11 (m84), and mec-9 (ethyl methanesulfonate alleles: e1494, u27, u30, u34, u42, u73, u86, physical forces across the cell surface and is a critical u93, u148, u151, u258, and u321; g ray alleles: u368, u369, and component in some mechanosensory organs (reviewed u437;mut-2(r459)-derived allele: u364 [the mut-2 mutationincreases by Ingber, 1991).",Line 6054: This suggestion is sup- u87 122 G359A G112R ported by b-galactosidase expression studies.,False Positive
WBPaper00002379,WBGene00000897,daf-1,G359A,F29C4.1b,"Line 6172: Linkage group V: unc-42 (e270), daf-11 (m84), and mec-9 (ethyl methanesulfonate alleles: e1494, u27, u30, u34, u42, u73, u86, physical forces across the cell surface and is a critical u93, u148, u151, u258, and u321; g ray alleles: u368, u369, and component in some mechanosensory organs (reviewed u437;mut-2(r459)-derived allele: u364 [the mut-2 mutationincreases by Ingber, 1991).",Line 6054: This suggestion is sup- u87 122 G359A G112R ported by b-galactosidase expression studies.,False Positive
WBPaper00002379,WBGene00000897,daf-1,R631G,F29C4.1a,"Line 6172: Linkage group V: unc-42 (e270), daf-11 (m84), and mec-9 (ethyl methanesulfonate alleles: e1494, u27, u30, u34, u42, u73, u86, physical forces across the cell surface and is a critical u93, u148, u151, u258, and u321; g ray alleles: u368, u369, and component in some mechanosensory organs (reviewed u437;mut-2(r459)-derived allele: u364 [the mut-2 mutationincreases by Ingber, 1991).",Line 6125: We did not find any u148 G315R G958A egf4 mutation in the RGD sequence in the first Ca 2 1 -binding u151 R631G A1906G egf6 EGF repeat and so used site-directed mutagenesis to u258 W54AMB G176A ku1 change the RGD sequence in the second EGF repeat u321 W215OPA G660A egf2 to RGE or AGD.,False Positive
WBPaper00002379,WBGene00001063,dpy-1,G250E,M01E10.2a,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00001063,dpy-1,G602A,M01E10.2b,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",False Positive
WBPaper00002379,WBGene00001063,dpy-1,G650A,M01E10.2b,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",False Positive
WBPaper00002379,WBGene00001063,dpy-1,G768A,M01E10.2b,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00001063,dpy-1,G809A,M01E10.2b,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6052: This temporal expression is consistent u12 222 NF with the temperature-sensitive periods of mec-5 ani- u22 222 NF mals, which occur between stages L2 and L3 (Chalfie u23 222 NF u62 222 G783A G253E and Sulston, 1981; Chalfie and Au, 1989; M. C., unpub- u65 112 G809A G262S lished data).",False Positive
WBPaper00002379,WBGene00001063,dpy-1,G959A,M01E10.2b,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",False Positive
WBPaper00002379,WBGene00001063,dpy-1,P209L,M01E10.2b,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6141: ization of the protein, since fusion TU#246 (equivalent Two mutations, both producing a temperature-sensi- to TU#240in Figure 5withthis region deleted)expressed tive phenotype, affect the Y position of the Gly-X-Y re- active enzyme without the inclusion of a synthetic trans- peats (P264L and P209L).",False Positive
WBPaper00002379,WBGene00001063,dpy-1,P69L,M01E10.2a,Line 6170: in Mechanosensation Linkage group III: dpy-17(e164).,"Line 6044: This conclusion is also supported by the adventitious finding of a point mutation, u753 (and its duplication by in vitro mutagenesis), P69L, that does not produce a mutant phenotype.",False Positive
WBPaper00002379,WBGene00003167,mec-3,G176A,F01D4.6c,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",Line 6125: We did not find any u148 G315R G958A egf4 mutation in the RGD sequence in the first Ca 2 1 -binding u151 R631G A1906G egf6 EGF repeat and so used site-directed mutagenesis to u258 W54AMB G176A ku1 change the RGD sequence in the second EGF repeat u321 W215OPA G660A egf2 to RGE or AGD.,False Positive
WBPaper00002379,WBGene00003167,mec-3,G196R,F01D4.6a,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00003167,mec-3,G238R,F01D4.6d,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00003167,mec-3,P249L,F01D4.6c,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).","Line 6045: Two mec-5 mutations that resulted in touch insensitivity did occur in other positions ( u213: P267L; u248: P249L), but both give weaker phenotypes in the sense that the phenotypes are temperature sensitive.",False Positive
WBPaper00002379,WBGene00003168,"mec-4, mec-13",G313E,T01C8.7,"Line 5991: In particular, mec-4 and mec-10 encode ho- mologous membrane proteins, called degenerins, that The mec-5 and mec-9 genes encode putative extracel- are expressed in the touchneurons (Driscolland Chalfie, lular proteins that allow a set of six touch receptor 1991; Mitani et al., 1993;Huang andChalfie, 1994).","Line 6124: Since the missense mutations u73 G313E G953A egf4 alter the 2 Ca 2 1 -binding EGF repeats, the sixth EGF u86 W359OPA G1092A ku3 u93 C203Y G623A egf2 repeat, and the third Kunitz domain, these repeats ap- u97 D323 plus/minus 351 D983 plus/minus 1066 ku3 pear critical for mec-9 function.",False Positive
WBPaper00002379,WBGene00003168,"mec-4, mec-13",P209L,T01C8.7,"Line 5991: In particular, mec-4 and mec-10 encode ho- mologous membrane proteins, called degenerins, that The mec-5 and mec-9 genes encode putative extracel- are expressed in the touchneurons (Driscolland Chalfie, lular proteins that allow a set of six touch receptor 1991; Mitani et al., 1993;Huang andChalfie, 1994).","Line 6141: ization of the protein, since fusion TU#246 (equivalent Two mutations, both producing a temperature-sensi- to TU#240in Figure 5withthis region deleted)expressed tive phenotype, affect the Y position of the Gly-X-Y re- active enzyme without the inclusion of a synthetic trans- peats (P264L and P209L).",False Positive
WBPaper00002379,WBGene00003169,mec-5,G109E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,Line 6053: u66 112 NF The presence of the putative signal peptide suggests u77 112 G351A G109E that MEC-5 may be secreted.,True Positive
WBPaper00002379,WBGene00003169,mec-5,G112R,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,Line 6054: This suggestion is sup- u87 122 G359A G112R ported by b-galactosidase expression studies.,True Positive
WBPaper00002379,WBGene00003169,mec-5,G154E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G184E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G193R,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G196R,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",True Positive
WBPaper00002379,WBGene00003169,mec-5,G208E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",False Positive
WBPaper00002379,WBGene00003169,mec-5,G232R,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G235R,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",True Positive
WBPaper00002379,WBGene00003169,mec-5,G238R,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G247E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",True Positive
WBPaper00002379,WBGene00003169,mec-5,G250E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",True Positive
WBPaper00002379,WBGene00003169,mec-5,G253A,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6058: ( mec-3 is ex- u461 112 G783A G253A pressed in the touch cells and two other neuronal pairs, Touch sensitivity: 1, virtually all (,95%) of the animals are sensitive the PVD and FLP cells [Way and Chalfie, 1989].)",False Positive
WBPaper00002379,WBGene00003169,mec-5,G253E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6052: This temporal expression is consistent u12 222 NF with the temperature-sensitive periods of mec-5 ani- u22 222 NF mals, which occur between stages L2 and L3 (Chalfie u23 222 NF u62 222 G783A G253E and Sulston, 1981; Chalfie and Au, 1989; M. C., unpub- u65 112 G809A G262S lished data).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G262D,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00003169,mec-5,G262S,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6052: This temporal expression is consistent u12 222 NF with the temperature-sensitive periods of mec-5 ani- u22 222 NF mals, which occur between stages L2 and L3 (Chalfie u23 222 NF u62 222 G783A G253E and Sulston, 1981; Chalfie and Au, 1989; M. C., unpub- u65 112 G809A G262S lished data).",True Positive
WBPaper00002379,WBGene00003169,mec-5,G313E,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6124: Since the missense mutations u73 G313E G953A egf4 alter the 2 Ca 2 1 -binding EGF repeats, the sixth EGF u86 W359OPA G1092A ku3 u93 C203Y G623A egf2 repeat, and the third Kunitz domain, these repeats ap- u97 D323 plus/minus 351 D983 plus/minus 1066 ku3 pear critical for mec-9 function.",False Positive
WBPaper00002379,WBGene00003169,mec-5,P249L,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6045: Two mec-5 mutations that resulted in touch insensitivity did occur in other positions ( u213: P267L; u248: P249L), but both give weaker phenotypes in the sense that the phenotypes are temperature sensitive.",True Positive
WBPaper00002379,WBGene00003169,mec-5,P264L,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",True Positive
WBPaper00002379,WBGene00003169,mec-5,P69L,E03G2.3,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6044: This conclusion is also supported by the adventitious finding of a point mutation, u753 (and its duplication by in vitro mutagenesis), P69L, that does not produce a mutant phenotype.",False Positive
WBPaper00002379,WBGene00003173,mec-9,C203Y,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6124: Since the missense mutations u73 G313E G953A egf4 alter the 2 Ca 2 1 -binding EGF repeats, the sixth EGF u86 W359OPA G1092A ku3 u93 C203Y G623A egf2 repeat, and the third Kunitz domain, these repeats ap- u97 D323 plus/minus 351 D983 plus/minus 1066 ku3 pear critical for mec-9 function.",True Positive
WBPaper00002379,WBGene00003173,mec-9,C381Y,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",True Positive
WBPaper00002379,WBGene00003173,mec-9,G154E,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",False Positive
WBPaper00002379,WBGene00003173,mec-9,G235R,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00003173,mec-9,G247E,C50H2.3b,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00003173,mec-9,G262D,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00003173,mec-9,G262S,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6052: This temporal expression is consistent u12 222 NF with the temperature-sensitive periods of mec-5 ani- u22 222 NF mals, which occur between stages L2 and L3 (Chalfie u23 222 NF u62 222 G783A G253E and Sulston, 1981; Chalfie and Au, 1989; M. C., unpub- u65 112 G809A G262S lished data).",False Positive
WBPaper00002379,WBGene00003173,mec-9,G313E,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6124: Since the missense mutations u73 G313E G953A egf4 alter the 2 Ca 2 1 -binding EGF repeats, the sixth EGF u86 W359OPA G1092A ku3 u93 C203Y G623A egf2 repeat, and the third Kunitz domain, these repeats ap- u97 D323 plus/minus 351 D983 plus/minus 1066 ku3 pear critical for mec-9 function.",True Positive
WBPaper00002379,WBGene00003173,mec-9,G315E,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",True Positive
WBPaper00002379,WBGene00003173,mec-9,G315R,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,Line 6125: We did not find any u148 G315R G958A egf4 mutation in the RGD sequence in the first Ca 2 1 -binding u151 R631G A1906G egf6 EGF repeat and so used site-directed mutagenesis to u258 W54AMB G176A ku1 change the RGD sequence in the second EGF repeat u321 W215OPA G660A egf2 to RGE or AGD.,True Positive
WBPaper00002379,WBGene00003173,mec-9,G359A,C50H2.3b,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,Line 6054: This suggestion is sup- u87 122 G359A G112R ported by b-galactosidase expression studies.,False Positive
WBPaper00002379,WBGene00003173,mec-9,G365A,C50H2.3a,Line 5980: The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch.,"Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",False Positive
WBPaper00002379,WBGene00003174,"mec-10, deg-2",P264L,F16F9.5,"Line 5991: In particular, mec-4 and mec-10 encode ho- mologous membrane proteins, called degenerins, that The mec-5 and mec-9 genes encode putative extracel- are expressed in the touchneurons (Driscolland Chalfie, lular proteins that allow a set of six touch receptor 1991; Mitani et al., 1993;Huang andChalfie, 1994).","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00003499,"mut-2, rde-3",P264L,K04F10.6a,"Line 6172: Linkage group V: unc-42 (e270), daf-11 (m84), and mec-9 (ethyl methanesulfonate alleles: e1494, u27, u30, u34, u42, u73, u86, physical forces across the cell surface and is a critical u93, u148, u151, u258, and u321; g ray alleles: u368, u369, and component in some mechanosensory organs (reviewed u437;mut-2(r459)-derived allele: u364 [the mut-2 mutationincreases by Ingber, 1991).","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00003499,"mut-2, rde-3",P264L,K04F10.6b,"Line 6172: Linkage group V: unc-42 (e270), daf-11 (m84), and mec-9 (ethyl methanesulfonate alleles: e1494, u27, u30, u34, u42, u73, u86, physical forces across the cell surface and is a critical u93, u148, u151, u258, and u321; g ray alleles: u368, u369, and component in some mechanosensory organs (reviewed u437;mut-2(r459)-derived allele: u364 [the mut-2 mutationincreases by Ingber, 1991).","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00004397,rol-6,G109E,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.",Line 6053: u66 112 NF The presence of the putative signal peptide suggests u77 112 G351A G109E that MEC-5 may be secreted.,False Positive
WBPaper00002379,WBGene00004397,rol-6,G170A,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",False Positive
WBPaper00002379,WBGene00004397,rol-6,G176A,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.",Line 6125: We did not find any u148 G315R G958A egf4 mutation in the RGD sequence in the first Ca 2 1 -binding u151 R631G A1906G egf6 EGF repeat and so used site-directed mutagenesis to u258 W54AMB G176A ku1 change the RGD sequence in the second EGF repeat u321 W215OPA G660A egf2 to RGE or AGD.,False Positive
WBPaper00002379,WBGene00004397,rol-6,G196R,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00004397,rol-6,G208E,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6057: u281 222 G485A G154E As expected from the hypodermal localization of the u327 222 G650A G208E fusion products, mec-5 expression was not dependent u373 222 Deletion Deletion on mec-3, a gene encoding a LIM-type homeodomain u439 222 G602A G193R protein needed for the development of the touch recep- u444 222 Deletion Deletion tor neurons (Way and Chalfie, 1988).",False Positive
WBPaper00002379,WBGene00004397,rol-6,G232R,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00004397,rol-6,G235R,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00004397,rol-6,G238R,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00004397,rol-6,G247E,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00004397,rol-6,G250E,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00004397,rol-6,G253A,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6058: ( mec-3 is ex- u461 112 G783A G253A pressed in the touch cells and two other neuronal pairs, Touch sensitivity: 1, virtually all (,95%) of the animals are sensitive the PVD and FLP cells [Way and Chalfie, 1989].)",False Positive
WBPaper00002379,WBGene00004397,rol-6,G253E,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6052: This temporal expression is consistent u12 222 NF with the temperature-sensitive periods of mec-5 ani- u22 222 NF mals, which occur between stages L2 and L3 (Chalfie u23 222 NF u62 222 G783A G253E and Sulston, 1981; Chalfie and Au, 1989; M. C., unpub- u65 112 G809A G262S lished data).",False Positive
WBPaper00002379,WBGene00004397,rol-6,G315E,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",False Positive
WBPaper00002379,WBGene00004397,rol-6,G315R,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.",Line 6125: We did not find any u148 G315R G958A egf4 mutation in the RGD sequence in the first Ca 2 1 -binding u151 R631G A1906G egf6 EGF repeat and so used site-directed mutagenesis to u258 W54AMB G176A ku1 change the RGD sequence in the second EGF repeat u321 W215OPA G660A egf2 to RGE or AGD.,False Positive
WBPaper00002379,WBGene00004397,rol-6,P249L,T01B7.7,"Line 6220: (1991): 50 ng/ ml cosmid or 20 ng/ml plasmid plus 100 ng/ml rol-6 DNA (su1006)fromplasmid pRF4(Mello et al.,1991)was solubi- from TU#263 in the PstI plus/minus SmaI site of pPD34.110, which includes sequences encoding a synthetic transmembrane domain.","Line 6045: Two mec-5 mutations that resulted in touch insensitivity did occur in other positions ( u213: P267L; u248: P249L), but both give weaker phenotypes in the sense that the phenotypes are temperature sensitive.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G109E,R07D5.1f,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.",Line 6053: u66 112 NF The presence of the putative signal peptide suggests u77 112 G351A G109E that MEC-5 may be secreted.,False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G109E,R07D5.1g,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.",Line 6053: u66 112 NF The presence of the putative signal peptide suggests u77 112 G351A G109E that MEC-5 may be secreted.,False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G112R,R07D5.1a,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.",Line 6054: This suggestion is sup- u87 122 G359A G112R ported by b-galactosidase expression studies.,False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G112R,R07D5.1j,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.",Line 6054: This suggestion is sup- u87 122 G359A G112R ported by b-galactosidase expression studies.,False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G184E,R07D5.1f,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G184E,R07D5.1g,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G196R,R07D5.1f,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G196R,R07D5.1g,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G232R,R07D5.1c,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G247E,R07D5.1b,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G247E,R07D5.1i,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G250E,R07D5.1a,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G250E,R07D5.1g,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G250E,R07D5.1j,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6050: e1504 622 G810A G262D In early L2 larvae, staining is also seen in the cells of e1790 222 G671A G250E the ventral hypodermis.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G313E,R07D5.1j,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6124: Since the missense mutations u73 G313E G953A egf4 alter the 2 Ca 2 1 -binding EGF repeats, the sixth EGF u86 W359OPA G1092A ku3 u93 C203Y G623A egf2 repeat, and the third Kunitz domain, these repeats ap- u97 D323 plus/minus 351 D983 plus/minus 1066 ku3 pear critical for mec-9 function.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G315E,R07D5.1a,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6123: Table 2. mec-9 Mutations Allele Amino Acid Nucleotide Domain MEC-9L Is Needed for Touch Sensitivity e1494 G315E G959A egf4 We have identified the positions of 18 mec-9 mutations u27 W52AMB G170A ku1 (see Figure 5B; Table 2): 7 nonsense mutations, 2 dele- u30 R232OPA C709T egf2 tions that change the open reading frame, an insertion u34 C381Y G1157A ku3 of the Tc1 transposon into the second EGF repeat, and u42 W117AMB G365A ku2 8 missense mutations.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",G315R,R07D5.1a,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.",Line 6125: We did not find any u148 G315R G958A egf4 mutation in the RGD sequence in the first Ca 2 1 -binding u151 R631G A1906G egf6 EGF repeat and so used site-directed mutagenesis to u258 W54AMB G176A ku1 change the RGD sequence in the second EGF repeat u321 W215OPA G660A egf2 to RGE or AGD.,False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",P69L,R07D5.1d,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6044: This conclusion is also supported by the adventitious finding of a point mutation, u753 (and its duplication by in vitro mutagenesis), P69L, that does not produce a mutant phenotype.",False Positive
WBPaper00002379,WBGene00006747,"unc-7, unc-12, unc-124",P69L,R07D5.1e,"Line 6179: In Alport syndrome, mutations Genetic and Phenotypic Characterization in a type IV collagen subunit of the basal membrane mec-5 was mapped 0.2 map units to the right of lin-15 by examining the Unc and Mec progeny from 1 lin-15(n765) 1/unc-7(e5) 1 cause neuron-based hearing loss (Barker et al., 1990; mec-5(e1340) heterozygotes.","Line 6044: This conclusion is also supported by the adventitious finding of a point mutation, u753 (and its duplication by in vitro mutagenesis), P69L, that does not produce a mutant phenotype.",False Positive
WBPaper00002379,WBGene00006778,unc-42,G184E,F58E6.10b,"Line 6172: Linkage group V: unc-42 (e270), daf-11 (m84), and mec-9 (ethyl methanesulfonate alleles: e1494, u27, u30, u34, u42, u73, u86, physical forces across the cell surface and is a critical u93, u148, u151, u258, and u321; g ray alleles: u368, u369, and component in some mechanosensory organs (reviewed u437;mut-2(r459)-derived allele: u364 [the mut-2 mutationincreases by Ingber, 1991).","Line 6056: A lac-Z fusion, TU#302,which was identi- u201 112 NF cal to TU#235 except that it lacked the synthetic trans- u205 222 G745A G238R membrane domain, and should therefore express the u210 112 C719T G232R enzyme extracellularly, produced immunoassayable u213 112 G816A P264L protein (in the hypodermal cells) but no measureable u248 162 G768A P249L u263 222 G576A G184E b-galactosidase activity (data not shown).",False Positive
WBPaper00002379,WBGene00023497,lin-15,G313E,ZK662.4,"Line 6174: Linkage group X: unc- lular tip links are thought to be needed for mechanosen- 7(e5), lin-15(n765), and mec-5 (ethyl methanesulfonate alleles: sory transduction (Osborne et al., 1984; Pickles et al., e1504, e1790, u4, u12, u22, u23, u62, u65, u77, u87, u92, u100, u146, 1984; Hudspeth, 1989; Assad et al., 1991).","Line 6124: Since the missense mutations u73 G313E G953A egf4 alter the 2 Ca 2 1 -binding EGF repeats, the sixth EGF u86 W359OPA G1092A ku3 u93 C203Y G623A egf2 repeat, and the third Kunitz domain, these repeats ap- u97 D323 plus/minus 351 D983 plus/minus 1066 ku3 pear critical for mec-9 function.",False Positive
WBPaper00002379,WBGene00023497,lin-15,G765A,ZK662.4,"Line 6174: Linkage group X: unc- lular tip links are thought to be needed for mechanosen- 7(e5), lin-15(n765), and mec-5 (ethyl methanesulfonate alleles: sory transduction (Osborne et al., 1984; Pickles et al., e1504, e1790, u4, u12, u22, u23, u62, u65, u77, u87, u92, u100, u146, 1984; Hudspeth, 1989; Assad et al., 1991).","Line 6055: In gen- u92 112 G728A G235R eral, b-galactosidase is not active in E. coli (Manoil, u100 222 G(before 819)A Splice junction u146 622 G765A G247E 1990) or C. elegans (Fire et al., 1990) when it is localized u161 222 G611A G196R extracellularly.",False Positive
WBPaper00002379,WBGene00023497,lin-15,G809A,ZK662.4,"Line 6174: Linkage group X: unc- lular tip links are thought to be needed for mechanosen- 7(e5), lin-15(n765), and mec-5 (ethyl methanesulfonate alleles: sory transduction (Osborne et al., 1984; Pickles et al., e1504, e1790, u4, u12, u22, u23, u62, u65, u77, u87, u92, u100, u146, 1984; Hudspeth, 1989; Assad et al., 1991).","Line 6052: This temporal expression is consistent u12 222 NF with the temperature-sensitive periods of mec-5 ani- u22 222 NF mals, which occur between stages L2 and L3 (Chalfie u23 222 NF u62 222 G783A G253E and Sulston, 1981; Chalfie and Au, 1989; M. C., unpub- u65 112 G809A G262S lished data).",False Positive
WBPaper00002379,WBGene00023497,lin-15,P69L,ZK662.4,"Line 6174: Linkage group X: unc- lular tip links are thought to be needed for mechanosen- 7(e5), lin-15(n765), and mec-5 (ethyl methanesulfonate alleles: sory transduction (Osborne et al., 1984; Pickles et al., e1504, e1790, u4, u12, u22, u23, u62, u65, u77, u87, u92, u100, u146, 1984; Hudspeth, 1989; Assad et al., 1991).","Line 6044: This conclusion is also supported by the adventitious finding of a point mutation, u753 (and its duplication by in vitro mutagenesis), P69L, that does not produce a mutant phenotype.",False Positive
WBPaper00003021,WBGene00003214,mel-32,G313E,C05D11.11a,"Line 16125: RESULTS AND DISCUSSION Identification of a C. elegans Homolog of SHMT A search of the ACeDB program revealed one SHMT homolog, C05D11.11, located on chromosome III within the area defined by the cosmid C05D11.","Line 16177: Alleles t1456 and t1474 both contain the same base pair mutation, which changes glycine 313 to glutamic acid.",True Positive
WBPaper00003021,WBGene00004777,ser-2,G313E,C02D4.2e,Line 16286: Two sequenced alleles of par-2 introduce stop codons that trun- T ABLE II mel-32 mutant alleles Allele Codon mutation Amino acid mutation 1 t1456 GGA 3 GAA Gly-313 3 Glu 2 t1473 GCT 3 GTT Ala-63 3 Val CTT 3 TTT Leu-146 3 Phe 3 t1474 GGA 3 GAA Gly-313 3 Glu 4 t1520 TCT 3 TTT Ser-251 3 Phe 5 t1552 GGA 3 GAA Gly-204 3 Glu 6 t1555 AGA 3 AAA Arg-102 3 Lys 7 t1576 GGA 3 AGA Gly-372 3 Arg 8 t1597 CGG 3 CAG Arg-84 3 Gln 9 t1607 CAC 3 TAC His-259 3 Tyr 10 t1616 GCT 3 ACT Ala-268 3 Thr 11 t1631 CAG 3 TAG Gln-171 3 Stop 12 t1632 GGA 3 GAA Gly-406 3 Glu 13 t1665 GGA 3 GAA Gly-149 3 Glu 14 t1666 GCT 3 GTT Ala-103 3 Val 15 t1671 TCT 3 TTT Ser-251 3 Phe 16 t1679 GGC 3 GAC Gly-143 3 Asp 17 s2518 GCC 3 GTC Ala-126 3 Val F IG .4.,"Line 16177: Alleles t1456 and t1474 both contain the same base pair mutation, which changes glycine 313 to glutamic acid.",False Positive
WBPaper00003350,WBGene00004397,rol-6,G217D,T01B7.7,"Line 23917: pRF4, which contains the dominant mutation rol-6(su1006) (Kramer et al., 1990), was used as a coinjection marker when either N2 or unc-25 animals were used as the host for transformation.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00004397,rol-6,G294R,T01B7.7,"Line 23917: pRF4, which contains the dominant mutation rol-6(su1006) (Kramer et al., 1990), was used as a coinjection marker when either N2 or unc-25 animals were used as the host for transformation.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006750,"unc-10, rim-1",G1177A,T10A3.1a,"Line 24005: To evaluate whether the synaptic localization of UNC-25::GFP is caused by an association with synaptic vesicles, we examined the expression of this transgene in unc-104 mutant animals, which accumulate synaptic vesicles in cell bodies because of defects in a kinesin-like molecule (Hall and Hedgecock, 1991; Otsuka et al., 1991).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006750,"unc-10, rim-1",G1397A,T10A3.1c,"Line 24005: To evaluate whether the synaptic localization of UNC-25::GFP is caused by an association with synaptic vesicles, we examined the expression of this transgene in unc-104 mutant animals, which accumulate synaptic vesicles in cell bodies because of defects in a kinesin-like molecule (Hall and Hedgecock, 1991; Otsuka et al., 1991).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006750,"unc-10, rim-1",G659A,T10A3.1a,"Line 24005: To evaluate whether the synaptic localization of UNC-25::GFP is caused by an association with synaptic vesicles, we examined the expression of this transgene in unc-104 mutant animals, which accumulate synaptic vesicles in cell bodies because of defects in a kinesin-like molecule (Hall and Hedgecock, 1991; Otsuka et al., 1991).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006750,"unc-10, rim-1",G659A,T10A3.1b,"Line 24005: To evaluate whether the synaptic localization of UNC-25::GFP is caused by an association with synaptic vesicles, we examined the expression of this transgene in unc-104 mutant animals, which accumulate synaptic vesicles in cell bodies because of defects in a kinesin-like molecule (Hall and Hedgecock, 1991; Otsuka et al., 1991).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006750,"unc-10, rim-1",G659A,T10A3.1d,"Line 24005: To evaluate whether the synaptic localization of UNC-25::GFP is caused by an association with synaptic vesicles, we examined the expression of this transgene in unc-104 mutant animals, which accumulate synaptic vesicles in cell bodies because of defects in a kinesin-like molecule (Hall and Hedgecock, 1991; Otsuka et al., 1991).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006750,"unc-10, rim-1",G659A,T10A3.1f,"Line 24005: To evaluate whether the synaptic localization of UNC-25::GFP is caused by an association with synaptic vesicles, we examined the expression of this transgene in unc-104 mutant animals, which accumulate synaptic vesicles in cell bodies because of defects in a kinesin-like molecule (Hall and Hedgecock, 1991; Otsuka et al., 1991).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006762,unc-25,G217D,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G217D,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G217D,Y37D8A.23c,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G292D,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G292D,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G294R,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G294R,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G323E,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G323E,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G364E,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G364E,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G387E,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G387E,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G387R,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G387R,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G390R,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G390R,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,G463D,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,L321F,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,L321F,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",True Positive
WBPaper00003350,WBGene00006762,unc-25,M322I,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006762,unc-25,M322I,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00006762,unc-25,W291AMBER,Y37D8A.23a,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23968: The nonsense mutation n2324 changes Trp291 to an amber stop codon and is likely to result in a premature protein that lacks the C-terminal half of the protein, including the NPHK tetrapeptide, the cofactor binding site.",True Positive
WBPaper00003350,WBGene00006762,unc-25,W291AMBER,Y37D8A.23b,"Line 23844: We show that the Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase (GAD), the GABA biosynthetic enzyme.","Line 23968: The nonsense mutation n2324 changes Trp291 to an amber stop codon and is likely to result in a premature protein that lacks the C-terminal half of the protein, including the NPHK tetrapeptide, the cofactor binding site.",True Positive
WBPaper00003350,WBGene00006784,unc-49,L321F,T21C12.1f,"Line 24125: Fifth, in unc-49 mutant animals, which are defective in a GABA receptor (B. Bamber and E. J., unpublished obser- vations) and hence likely to be defective in GABA function, the axonal morphology of GABAergic neurons (McIntire et al., 1993a) and the presynaptic termini of the DD and VD GABA neuromuscular junctions as revealed by a synapse-specic GFP marker are normal (Y. J., unpublished results).","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00007024,"plin-1, mdt-28",G323E,W01A8.1a,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00007024,"plin-1, mdt-28",G323E,W01A8.1b,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00007024,"plin-1, mdt-28",G364E,W01A8.1a,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00007024,"plin-1, mdt-28",G364E,W01A8.1b,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00023497,lin-15,G1169A,ZK662.4,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00023497,lin-15,G977A,ZK662.4,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23987: Table 1. unc-25 alleles and molecular lesions Allele Nucleotide change Amino acid change Mutant phenotype n2638 C136A L43 M Strong n2323 G659A G217D Strong n2324 G881A W291amber Strong n2380 G884A G292D Strong n2381 G889A G294R Strong n2569 C970T L321F Weak, ts sa94 G975A M322I Weak, ts n2379 G977A G323E Weak, ts n2384 G1100A G364E Strong e156 G1157A W383amber Strong e265 G1168A G387E Strong n2385 G1169A G387R Strong e591 G1177A G390R Strong n2383 G1397A G463D Strong n2328 C1465T Q486amber Strong Jin et al.GAD in C. elegans J.",False Positive
WBPaper00003350,WBGene00023497,lin-15,W291AMBER,ZK662.4,"Line 23918: plin-15EK, which contains the entire gene for lin-15 (Clark et al., 1994), was used as a coinjection marker when lin-15(n765) was used as the host.","Line 23968: The nonsense mutation n2324 changes Trp291 to an amber stop codon and is likely to result in a premature protein that lacks the C-terminal half of the protein, including the NPHK tetrapeptide, the cofactor binding site.",False Positive
WBPaper00003632,WBGene00001174,"egl-5, ceh-11",S65C,C08C3.1a,Line 23644: We mapped lin-36 under nDf20 and between egl-5 and unc-36 (Fig.,"Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",False Positive
WBPaper00003632,WBGene00001174,"egl-5, ceh-11",S65C,C08C3.1b,Line 23644: We mapped lin-36 under nDf20 and between egl-5 and unc-36 (Fig.,"Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",False Positive
WBPaper00003632,WBGene00002299,"let-23, kin-7",G324E,ZK1067.1c,"Line 23559: lin- 2 , lin-7 and lin-10 appear to act to localize the LET-23 receptor to the basolateral membrane of the P(3-8).p cells, thereby upregulating the activity of the receptor tyrosine kinase pathway (Ferguson et al., 1987; Hoskins et al., 1996; Simske et al., 1996).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002299,"let-23, kin-7",H284Y,ZK1067.1b,"Line 23559: lin- 2 , lin-7 and lin-10 appear to act to localize the LET-23 receptor to the basolateral membrane of the P(3-8).p cells, thereby upregulating the activity of the receptor tyrosine kinase pathway (Ferguson et al., 1987; Hoskins et al., 1996; Simske et al., 1996).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002990,"lin-1, elk-1",G324E,C37F5.1b,"Line 23643: Cloning of lin-36 Previous data placed lin-36 between lin-13 and unc-36 on linkage group III (Ferguson and Horvitz, 1989).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002990,"lin-1, elk-1",P246L,C37F5.1b,"Line 23643: Cloning of lin-36 Previous data placed lin-36 between lin-13 and unc-36 on linkage group III (Ferguson and Horvitz, 1989).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002991,lin-2,S65C,F17E5.1b,"Line 23558: Mutations in the genes lin-2 , lin-7 and lin-10 produce a Vul phenotype similar to that produced by reduction-of- function mutations in components of the let-60 ras pathway.","Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",False Positive
WBPaper00003632,WBGene00002992,"lin-3, let-94, sli-4",H284Y,F36H1.4b,Line 23794: The lin-3 ligand stimulates the let- 23 receptor.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002992,"lin-3, let-94, sli-4",H284Y,F36H1.4e,Line 23794: The lin-3 ligand stimulates the let- 23 receptor.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002992,"lin-3, let-94, sli-4",R189Q,F36H1.4e,Line 23794: The lin-3 ligand stimulates the let- 23 receptor.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002992,"lin-3, let-94, sli-4",S65C,F36H1.4e,Line 23794: The lin-3 ligand stimulates the let- 23 receptor.,"Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",False Positive
WBPaper00003632,WBGene00002996,lin-7,R189Q,Y54G11A.10b,"Line 23558: Mutations in the genes lin-2 , lin-7 and lin-10 produce a Vul phenotype similar to that produced by reduction-of- function mutations in components of the let-60 ras pathway.",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00002998,lin-9,G324E,ZK637.7b,"Line 23566: Four class A genes ( lin-8 , lin-15 A, lin-38 and lin-56 ) and ten class B genes ( lin-9 , lin-15 B, lin-35 , lin-36 , lin-37 , lin-51 , lin-52 , lin-53 , lin-54 , lin-55 ) have been identified (Horvitz and Sulston, 1980; Ferguson and Horvitz, 1989; J. H. Thomas and H. R. Horvitz, unpublished observations).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00003020,lin-35,G324E,C32F10.2,"Line 23566: Four class A genes ( lin-8 , lin-15 A, lin-38 and lin-56 ) and ten class B genes ( lin-9 , lin-15 B, lin-35 , lin-36 , lin-37 , lin-51 , lin-52 , lin-53 , lin-54 , lin-55 ) have been identified (Horvitz and Sulston, 1980; Ferguson and Horvitz, 1989; J. H. Thomas and H. R. Horvitz, unpublished observations).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00003021,lin-36,E241K,F44B9.6,Line 23546: The Caenorhabditis elegans gene lin-36 acts to antagonize Ras-mediated vulval induction in a pathway that includes genes with products similar to the mammalian retinoblastoma (Rb) protein and the Rb-binding protein p48.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,True Positive
WBPaper00003632,WBGene00003021,lin-36,G324E,F44B9.6,Line 23546: The Caenorhabditis elegans gene lin-36 acts to antagonize Ras-mediated vulval induction in a pathway that includes genes with products similar to the mammalian retinoblastoma (Rb) protein and the Rb-binding protein p48.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,True Positive
WBPaper00003632,WBGene00003021,lin-36,H284Y,F44B9.6,Line 23546: The Caenorhabditis elegans gene lin-36 acts to antagonize Ras-mediated vulval induction in a pathway that includes genes with products similar to the mammalian retinoblastoma (Rb) protein and the Rb-binding protein p48.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,True Positive
WBPaper00003632,WBGene00003021,lin-36,P246L,F44B9.6,Line 23546: The Caenorhabditis elegans gene lin-36 acts to antagonize Ras-mediated vulval induction in a pathway that includes genes with products similar to the mammalian retinoblastoma (Rb) protein and the Rb-binding protein p48.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,True Positive
WBPaper00003632,WBGene00003021,lin-36,R189Q,F44B9.6,Line 23546: The Caenorhabditis elegans gene lin-36 acts to antagonize Ras-mediated vulval induction in a pathway that includes genes with products similar to the mammalian retinoblastoma (Rb) protein and the Rb-binding protein p48.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00003021,lin-36,Y325N,F44B9.6,Line 23546: The Caenorhabditis elegans gene lin-36 acts to antagonize Ras-mediated vulval induction in a pathway that includes genes with products similar to the mammalian retinoblastoma (Rb) protein and the Rb-binding protein p48.,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,True Positive
WBPaper00003632,WBGene00003037,lin-54,G324E,JC8.6a,"Line 23566: Four class A genes ( lin-8 , lin-15 A, lin-38 and lin-56 ) and ten class B genes ( lin-9 , lin-15 B, lin-35 , lin-36 , lin-37 , lin-51 , lin-52 , lin-53 , lin-54 , lin-55 ) have been identified (Horvitz and Sulston, 1980; Ferguson and Horvitz, 1989; J. H. Thomas and H. R. Horvitz, unpublished observations).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00003559,ncl-1,G324E,ZK112.2c,Line 23600: Two strategies were adopted to find mosaic animals using a strain of genotype lin-8(n111); dpy-17(e164) ncl-1(e1865) lin-36(n766) unc-36(e251); sDp3[dpy-17(+) ncl-1(+) lin-36(+) unc-36(+)] .,Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00006745,unc-5,G324E,B0273.4d,"Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00006745,unc-5,S65C,B0273.4a,"Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.","Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",False Positive
WBPaper00003632,WBGene00006745,unc-5,S65C,B0273.4b,"Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.","Line 23612: Construction of a lin-36::GFP repor ter A lin-36::GFP reporter was constructed by ligating a 4.4 kb Sal I Sac I fragment from pJHT16 to a linker fragment and Sal I Xma I double- digested pPD95.79, a vector containing a green uorescent protein (GFP) coding region with a C. elegans unc-54 3 end and a uorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al., 1994, 1995; A.",False Positive
WBPaper00003632,WBGene00013006,lin-38,R189Q,Y48E1B.7,"Line 23566: Four class A genes ( lin-8 , lin-15 A, lin-38 and lin-56 ) and ten class B genes ( lin-9 , lin-15 B, lin-35 , lin-36 , lin-37 , lin-51 , lin-52 , lin-53 , lin-54 , lin-55 ) have been identified (Horvitz and Sulston, 1980; Ferguson and Horvitz, 1989; J. H. Thomas and H. R. Horvitz, unpublished observations).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003632,WBGene00023497,lin-15,R189Q,ZK662.4,"Line 23566: Four class A genes ( lin-8 , lin-15 A, lin-38 and lin-56 ) and ten class B genes ( lin-9 , lin-15 B, lin-35 , lin-36 , lin-37 , lin-51 , lin-52 , lin-53 , lin-54 , lin-55 ) have been identified (Horvitz and Sulston, 1980; Ferguson and Horvitz, 1989; J. H. Thomas and H. R. Horvitz, unpublished observations).",Line 23714: Sequences of lin-36 mutations Substitution or AlleleWild-type sequenceMutant sequencesplice-site change n747 G AA A AA E241K n750 CC TC T T P246L GGC GGT G103G (silent) n766 TAT TA A Y796ochre n772 CG CC A C R189Q n2235 C AA T AA Q898ochre n2240 CC TC T T P246L n2243 GG AG A A G324E n3090 T AT A AT Y325N n3093 C AG T AG Q579amber n3094 atttttag /GAT a tttttaa /GATExon 2 acceptor n3095 C AA T AA Q569ochre n3096 C AA T AA Q442ochre n3097 C AT T AT H284Y Exon sequences are shown in uppercase letters and intron sequences are shown in lowercase letters.,False Positive
WBPaper00003757,WBGene00000952,del-1,G188D,E02H4.1a,Line 471: (A ) Adjacent VA and VB motor neurons are visualized in this transgenic animal with neuron-specific promoters driving ex- pression of the cyan GFP variant in VA motor neurons ( unc- 4 ::CFP) and the yellow GFP mutant protein in VB motor neu- rons ( del-1::YFP ) (Miller et al.,"Line 521: Interestingly, the two GLY188 point mutations in the UNC-4 eh1 domain, G188D and G188S, are not suppressed by UNC-37(E580K).",False Positive
WBPaper00003757,WBGene00000952,del-1,G188S,E02H4.1a,Line 471: (A ) Adjacent VA and VB motor neurons are visualized in this transgenic animal with neuron-specific promoters driving ex- pression of the cyan GFP variant in VA motor neurons ( unc- 4 ::CFP) and the yellow GFP mutant protein in VB motor neu- rons ( del-1::YFP ) (Miller et al.,"Line 521: Interestingly, the two GLY188 point mutations in the UNC-4 eh1 domain, G188D and G188S, are not suppressed by UNC-37(E580K).",False Positive
WBPaper00003757,WBGene00000952,del-1,L121F,E02H4.1c,Line 471: (A ) Adjacent VA and VB motor neurons are visualized in this transgenic animal with neuron-specific promoters driving ex- pression of the cyan GFP variant in VA motor neurons ( unc- 4 ::CFP) and the yellow GFP mutant protein in VB motor neu- rons ( del-1::YFP ) (Miller et al.,Line 498: Amino acid substitutions in the UNC-4 homeodomain and in the UNC-4 eh1 repressor domain perturb unc-4 function The temperature-sensitive mutation unc-4(e2322ts) changes a conserved leucine to a phenylalanine (L121F) Figure 2.,False Positive
WBPaper00003757,WBGene00000952,del-1,R190Q,E02H4.1a,Line 471: (A ) Adjacent VA and VB motor neurons are visualized in this transgenic animal with neuron-specific promoters driving ex- pression of the cyan GFP variant in VA motor neurons ( unc- 4 ::CFP) and the yellow GFP mutant protein in VB motor neu- rons ( del-1::YFP ) (Miller et al.,Line 520: The UNC-37(E580K) mutation also suppresses specific unc-4 missense muta- tions in the eh1 region (Table 1); wild-type movement is restored to mutants bearing the amino acid substitutions R190Q or R197K.,False Positive
WBPaper00003757,WBGene00003168,"mec-4, mec-13",E580K,T01C8.7,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).",Line 519: Sequence analysis revealed that all four of these unc-37(d) mutations correspond to an E580K missense mutation in the sixth WD40 repeat of UNC-37 (Pflugrad et al.,False Positive
WBPaper00003757,WBGene00003168,"mec-4, mec-13",G188D,T01C8.7,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).","Line 521: Interestingly, the two GLY188 point mutations in the UNC-4 eh1 domain, G188D and G188S, are not suppressed by UNC-37(E580K).",False Positive
WBPaper00003757,WBGene00003168,"mec-4, mec-13",G188S,T01C8.7,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).","Line 521: Interestingly, the two GLY188 point mutations in the UNC-4 eh1 domain, G188D and G188S, are not suppressed by UNC-37(E580K).",False Positive
WBPaper00003757,WBGene00003168,"mec-4, mec-13",R197K,T01C8.7,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).",Line 520: The UNC-37(E580K) mutation also suppresses specific unc-4 missense muta- tions in the eh1 region (Table 1); wild-type movement is restored to mutants bearing the amino acid substitutions R190Q or R197K.,False Positive
WBPaper00003757,WBGene00003174,"mec-10, deg-2",E580K,F16F9.5,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).",Line 519: Sequence analysis revealed that all four of these unc-37(d) mutations correspond to an E580K missense mutation in the sixth WD40 repeat of UNC-37 (Pflugrad et al.,False Positive
WBPaper00003757,WBGene00006744,"unc-4, ceh-4",F174E,F26C11.2,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,Line 522: The movement defect of animals expressing an UNC-4 eh1 F174E mutant transgene is also not suppressed by UNC- 37(E580K) (Table 1; data not shown).,False Positive
WBPaper00003757,WBGene00006744,"unc-4, ceh-4",G188D,F26C11.2,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,"Line 521: Interestingly, the two GLY188 point mutations in the UNC-4 eh1 domain, G188D and G188S, are not suppressed by UNC-37(E580K).",False Positive
WBPaper00003757,WBGene00006744,"unc-4, ceh-4",G188S,F26C11.2,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,"Line 521: Interestingly, the two GLY188 point mutations in the UNC-4 eh1 domain, G188D and G188S, are not suppressed by UNC-37(E580K).",True Positive
WBPaper00003757,WBGene00006744,"unc-4, ceh-4",L121F,F26C11.2,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,Line 498: Amino acid substitutions in the UNC-4 homeodomain and in the UNC-4 eh1 repressor domain perturb unc-4 function The temperature-sensitive mutation unc-4(e2322ts) changes a conserved leucine to a phenylalanine (L121F) Figure 2.,False Positive
WBPaper00003757,WBGene00006744,"unc-4, ceh-4",R190Q,F26C11.2,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,Line 520: The UNC-37(E580K) mutation also suppresses specific unc-4 missense muta- tions in the eh1 region (Table 1); wild-type movement is restored to mutants bearing the amino acid substitutions R190Q or R197K.,True Positive
WBPaper00003757,WBGene00006744,"unc-4, ceh-4",R197K,F26C11.2,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,Line 520: The UNC-37(E580K) mutation also suppresses specific unc-4 missense muta- tions in the eh1 region (Table 1); wild-type movement is restored to mutants bearing the amino acid substitutions R190Q or R197K.,True Positive
WBPaper00003757,WBGene00006748,"unc-8, unc-28",E580K,R13A1.4a,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).",Line 519: Sequence analysis revealed that all four of these unc-37(d) mutations correspond to an E580K missense mutation in the sixth WD40 repeat of UNC-37 (Pflugrad et al.,False Positive
WBPaper00003757,WBGene00006748,"unc-8, unc-28",E580K,R13A1.4c,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).",Line 519: Sequence analysis revealed that all four of these unc-37(d) mutations correspond to an E580K missense mutation in the sixth WD40 repeat of UNC-37 (Pflugrad et al.,False Positive
WBPaper00003757,WBGene00006748,"unc-8, unc-28",E580K,R13A1.4d,"Line 698: Ge- netic studies of the degenerin family members, UNC-8, MEC-4, and MEC-10, have led to proposals that these proteins are components of mechano-transducing so- dium channels (for reviews, see Chalfie 1995; Corey and Garcia-Anoveros 1996; Garcia-Anoveros and Corey 1996).",Line 519: Sequence analysis revealed that all four of these unc-37(d) mutations correspond to an E580K missense mutation in the sixth WD40 repeat of UNC-37 (Pflugrad et al.,False Positive
WBPaper00003757,WBGene00006773,"unc-37, let-76",E580K,W02D3.9,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,Line 519: Sequence analysis revealed that all four of these unc-37(d) mutations correspond to an E580K missense mutation in the sixth WD40 repeat of UNC-37 (Pflugrad et al.,False Positive
WBPaper00003757,WBGene00006773,"unc-37, let-76",H539Y,W02D3.9,Line 423: The UNC-4 homeoprotein and the Groucho-like corepressor UNC-37 specify synaptic choice in the Caenorhabditis elegans motor neuron circuit.,Line 588: Genotypes for each row are indicated at left . unc-37(e262) corresponds to UNC-37(H539Y); unc-4(e2321) corresponds to UNC-4(R197K).,False Positive
WBPaper00003815,WBGene00000215,asp-2,G277D,T18H9.2,"Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000216,asp-3,S314L,H22K11.1,"Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",Line 2049: The alleles n2429 and n2883 (S314L and 1660 S. Shaham et al.,False Positive
WBPaper00003815,WBGene00000216,asp-3,S314P,H22K11.1,"Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00000415,ced-1,G360S,Y47H9C.4a,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00000415,ced-1,G360S,Y47H9C.4b,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00000415,ced-1,G360S,Y47H9C.4c,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00000415,ced-1,L27F,Y47H9C.4a,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000415,ced-1,L27F,Y47H9C.4b,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000415,ced-1,L27F,Y47H9C.4c,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000417,ced-3,A347V,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",True Positive
WBPaper00003815,WBGene00000417,ced-3,C358A,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1996: Expression was detected both in cells that normally die and in those that normally live (data not shown), 2 4/13 consistent with previous experiments suggesting that ced-3 ac- 3 5/12 tivity is present both in cells that do and in cells that do not P mec-7 ced-3 (C358A) 1 18/18 die (Shaham and Horvitz 1996a).",False Positive
WBPaper00003815,WBGene00000417,ced-3,C358S,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1997: Because the expression 2 24/24 patterns we observed were somewhat variable from strain to 3 17/17 strain, perhaps because the expression constructs were present P mec-7 ced-3 (C358S) 1 22/25 on unstable extrachromosomal arrays, we did not pursue a 2 25/26 detailed characterization of these patterns.",False Positive
WBPaper00003815,WBGene00000417,ced-3,D131A,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00000417,ced-3,D221E,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.",Line 2000: 1989); such overex- P mec-7 ced-3 (D221E) 1 21/22 pression of a wild-type ced-3 cDNA results in the pro- 2 20/20 grammed deaths of these cells ( Shaham and Horvitz 3 20/20 1996a).,False Positive
WBPaper00003815,WBGene00000417,ced-3,D371A,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00000417,ced-3,D374A,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00000417,ced-3,E318K,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",True Positive
WBPaper00003815,WBGene00000417,ced-3,G277D,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",True Positive
WBPaper00003815,WBGene00000417,ced-3,G360S,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",True Positive
WBPaper00003815,WBGene00000417,ced-3,G474R,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2042: AT transition, the mutation in- to have a similar role in CED-3 function. Specically, the alleles n2427, n2438, and n2830 (G474R) alter a duced most often by EMS ( Coulondre and Miller 1977; Anderson 1995).",False Positive
WBPaper00003815,WBGene00000417,ced-3,H315Y,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",True Positive
WBPaper00003815,WBGene00000417,ced-3,L27F,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000417,ced-3,L30F,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",True Positive
WBPaper00003815,WBGene00000417,ced-3,L30F,C48D1.2b,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000417,ced-3,R242C,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",True Positive
WBPaper00003815,WBGene00000417,ced-3,R359Q,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",True Positive
WBPaper00003815,WBGene00000417,ced-3,R429K,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",True Positive
WBPaper00003815,WBGene00000417,ced-3,S314L,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.",Line 2049: The alleles n2429 and n2883 (S314L and 1660 S. Shaham et al.,True Positive
WBPaper00003815,WBGene00000417,ced-3,S314P,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",True Positive
WBPaper00003815,WBGene00000417,ced-3,S486F,C48D1.2a,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",True Positive
WBPaper00003815,WBGene00000418,ced-4,L27F,C35D10.9a,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000418,ced-4,L27F,C35D10.9b,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000418,ced-4,L30F,C35D10.9a,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000418,ced-4,L30F,C35D10.9b,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000418,ced-4,R242C,C35D10.9a,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000418,ced-4,S314L,C35D10.9b,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.",Line 2049: The alleles n2429 and n2883 (S314L and 1660 S. Shaham et al.,False Positive
WBPaper00003815,WBGene00000418,ced-4,S314P,C35D10.9b,"Line 1890: ced-3 appears to act downstream of both ced-4S, a positive protease, granzyme B/fragmentin 2, which is thought to function in cell death mediated by cytotoxic T cells regulator of cell death ( Ellis and Horvitz 1986; Sha- ham and Horvitz 1996a,b) that encodes a protein simi- ( Shi et al.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00000419,ced-5,L27F,C02F4.1,"Line 1911: abnormal corpse morphology of ced-5 or ced-11 mutants, re- programmed cell death.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00000425,ced-11,D371A,ZK512.3,"Line 1911: abnormal corpse morphology of ced-5 or ced-11 mutants, re- programmed cell death.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00000425,ced-11,S314L,ZK512.3,"Line 1911: abnormal corpse morphology of ced-5 or ced-11 mutants, re- programmed cell death.",Line 2049: The alleles n2429 and n2883 (S314L and 1660 S. Shaham et al.,False Positive
WBPaper00003815,WBGene00000425,ced-11,S314P,ZK512.3,"Line 1911: abnormal corpse morphology of ced-5 or ced-11 mutants, re- programmed cell death.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00002189,kin-1,A347V,ZK909.2i,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00002189,kin-1,A347V,ZK909.2k,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00002189,kin-1,A347V,ZK909.2m,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00002189,kin-1,D371A,ZK909.2e,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00002189,kin-1,D374A,ZK909.2n,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00002189,kin-1,E318K,ZK909.2d,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00002189,kin-1,G360S,ZK909.2e,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00002189,kin-1,G360S,ZK909.2l,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00002189,kin-1,R242C,ZK909.2n,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00002189,kin-1,R359Q,ZK909.2k,"Line 1878: Mutations in the gene ced-3, which encodes a protease similar to interleukin-1beta converting enzyme and related proteins termed caspases, prevent programmed cell death in the nematode Caenorhabditis elegans.","Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00003171,mec-7,G360S,ZK154.3,Line 1967: ced-3 cDNAs were digested with Spe I and Sma I and ligated to the P mec-7 -containing vector pPD52.102 ( Mello and Fire 1995) Frozen bacteria were added to the culture as a food source.,"Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00003171,mec-7,R359Q,ZK154.3,Line 1967: ced-3 cDNAs were digested with Spe I and Sma I and ligated to the P mec-7 -containing vector pPD52.102 ( Mello and Fire 1995) Frozen bacteria were added to the culture as a food source.,"Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00003906,paf-1,S314L,W03G9.6,Line 1891: Several observations indicate roles for mammalian lar to the human cell-death protein Apaf-1 ( Zou et al.,Line 2049: The alleles n2429 and n2883 (S314L and 1660 S. Shaham et al.,False Positive
WBPaper00003815,WBGene00003906,paf-1,S314P,W03G9.6,Line 1891: Several observations indicate roles for mammalian lar to the human cell-death protein Apaf-1 ( Zou et al.,"Line 2050: S314P, respectively), n2870 (R429K), n2721 and n2720 These results suggest that the ced-3 alleles n2447 and n2443 are less defective in ced-3 function (i.e., allow (H315Y), n2871 (R359Q), and n2433 (G360S) all alter residues with equivalents in caspase-1 located within 4 A more cell death to occur) than is the allele n717, consis- tent with the results presented in Tables 3 and 4. of the bound substrate, suggesting that these residues might be important for the CED-3 active site.",False Positive
WBPaper00003815,WBGene00004773,sem-4,S360G,F15C11.1,"Line 1938: Spe- cically, primers SHA2 and PCR2 were used to amplify exons Linkage Group (LG) I: sem-4 (n1378 ), ced-1 (e1735 ) 1 plus/minus 3, primers PCR3 and PCR4 were used to amplify exon 4, LGIII: ced-9 (n1950 n2077 , n1950 n2161 ), ced-11 (n2744 ), ced- primers PCR5 and 650 were used to amplify exons 5 plus/minus 7, and 5(n2098 ) primers BD1 and 1200 were used to amplify exon 8.","Line 2200: 1996) abolished the killing activity of CED-3 in vivo. The processing of the ( n2433) mutation, which substitutes a serine for glycine at codon 360 ( Shaham and Horvitz 1996a).",False Positive
WBPaper00003815,WBGene00006743,unc-3,S486F,Y16B4A.1,"Line 1953: using the ced-3 (n717 ) allele, followed by mapping to establish DNA anking the ced-3 (n2452 ) deletion site was isolated linkage to unc-30 (e191 ) on chromosome IV.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003815,WBGene00010241,,D374A,F58D2.2,"Line 2075: 1992), whereas ced-9(n1950 n2077 ); ced-3(n717) animals were deletion also removes two other putative genes (C48D1.1 and F58D2.2) and disrupts a third putative egg-laying competent.","Line 1998: 3 14/14 P mec-7 ced-3 (D374A) 1 22/23 2 18/20 RESULTS 3 15/18 P mec-7 ced-3 (D371A) 1 10/20 Cys-358, asp-221, and asp-374 are important for CED- 2 13/20 3-induced cell death: To determine whether CED-3 pro- 3 13/20 tease activity is required for programmed cell death, we P mec-7 ced-3 (D371A, D374A) 1 25/26 used site-directed mutagenesis to generate mutant ced-3 2 23/23 cDNAs that should lack either CED-3 protease activity 3 25/25 P mec-7 ced-3 (D131A) 1 7/20 or the CED-3 precursor cleavage sites.",False Positive
WBPaper00003815,WBGene00010241,,G277D,F58D2.2,"Line 2075: 1992), whereas ced-9(n1950 n2077 ); ced-3(n717) animals were deletion also removes two other putative genes (C48D1.1 and F58D2.2) and disrupts a third putative egg-laying competent.","Line 2056: Specically, as shown in Figure 3A, both a 1.7-kb XhoI fragment internal caspases: n1040(L27F), n2439(L30F), n3001(R242C), n2425-(G277D), n2889 (E318K), n2924 (E318K), to the ced-3 gene and an adjacent 20.2-kb XhoI fragment present in wild-type animals were absent in ced-3(n2452) n2923 (A347V), n2870(R429K), and n1163(S486F).",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",A321T,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",A420V,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",A713D,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",A713V,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.",Line 4284: mec-4 alleles used in this work were described by Chale and Sulston (1981) and Chale and Au (1989). The dominant death-inducing mec-4(d) allele encoding the A713V substitution was u231 .,False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",C595Y,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",D599N,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",D714A,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4542: It is noteworthy, however, that substitution D714A, affecting a highly conserved amino acid, does not disrupt channel activity.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",E397K,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",E445K,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",E732K,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G117E,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G230E,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G533S,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G539E,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G598E,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G716D,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",G95E,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",K72*,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",P395L,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",Q664*,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",R108*,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",R601C,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",S542F,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",S726F,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",S92F,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",T729I,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",T91I,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",True Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",W273*,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",W338*,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",W722*,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003168,"mec-4, mec-13",Y89R,T01C8.7,"Line 4234: We report a genetically based structure-function analysis of the candidate mechanotransducing channel subunit MEC-4, a core component of a touch-sensing complex in Caenorhabditis elegans and a member of the DEG/ENaC superfamily.","Line 4369: Note that not all substitutions in the conserved region disrupt MEC-4 function; for example, the Y89R mutant behaves as does the wild type in all assays.",False Positive
WBPaper00003969,WBGene00003173,mec-9,C595Y,C50H2.3a,"Line 4501: The subdomain high- lighted by CRDIII mutations might interact with the specialized extracellular matrix proteins needed for appropriate gating [for example, matrix protein MEC-9, which itself includes many venom toxin-related Kunitz domains (Du et al., 1996)].","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003173,mec-9,G716D,C50H2.3a,"Line 4501: The subdomain high- lighted by CRDIII mutations might interact with the specialized extracellular matrix proteins needed for appropriate gating [for example, matrix protein MEC-9, which itself includes many venom toxin-related Kunitz domains (Du et al., 1996)].","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00003174,"mec-10, deg-2",Y89R,F16F9.5,"Line 4256: The core mole- cules in the complex, MEC-4 (Driscoll and Chale, 1991; Lai et al., 1996) and the homologous MEC-10 (Huang and Chale, 1994), are postulated to be subunits of a mechanically gated touch-transducing channel.","Line 4369: Note that not all substitutions in the conserved region disrupt MEC-4 function; for example, the Y89R mutant behaves as does the wild type in all assays.",False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",A321T,R13A1.4c,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",A713D,R13A1.4a,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",A713V,R13A1.4a,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).",Line 4284: mec-4 alleles used in this work were described by Chale and Sulston (1981) and Chale and Au (1989). The dominant death-inducing mec-4(d) allele encoding the A713V substitution was u231 .,False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",C595Y,R13A1.4c,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",E445K,R13A1.4d,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",G533S,R13A1.4c,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006748,"unc-8, unc-28",S726F,R13A1.4d,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",G539E,T10A3.1a,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",G539E,T10A3.1b,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",G539E,T10A3.1d,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",G539E,T10A3.1f,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",G598E,T10A3.1d,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",G598E,T10A3.1f,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",Q664*,T10A3.1d,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",Q664*,T10A3.1f,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",S726F,T10A3.1a,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003969,WBGene00006750,"unc-10, rim-1",S726F,T10A3.1b,"Line 4260: Two additional degenerins, unc-8 and unc-105 , have been impli- cated in mechanical signaling (Liu et al., 1996; Tavernarakis et al., 1997; Garca-Anoveros et al., 1998).","Line 4353: EMS-induced mec-4(r) mutations mec-4(r) allele a Site of mutation b Base change c Amino acid change Type of mutation Exon u167 601 A plus/minus T K72Stop Nonsense 2 u25 659 C plus/minus T T91I Missense 2 u339 662 C plus/minus T S92F Missense 2 e1818 671 G plus/minus A G95E Missense 2 u335 709 C plus/minus T R108Stop Nonsense 2 u45(ts) 737 G plus/minus A G117E Missense 2 u316 1123 G plus/minus A G230E Missense 3 u175 1304 G plus/minus A W273Stop Nonsense 4 u19 1661 G plus/minus A A321T Missense 5 u46 1715 G plus/minus A W338Stop Nonsense 5 u424 1778 G plus/minus A Splicing 5/6 u51 1983 C plus/minus T P395L Missense 6 u45(ts) 1988 G plus/minus A E397K Missense 6 u126 2070 G plus/minus A Splicing 6/7 u219 2105 C plus/minus T A420V Missense 7 u89 2179 G plus/minus A E445K Missense 7 u51 2452 G plus/minus A Splicing 8/9 u342 2578 G plus/minus A G533S Missense 9 u242(ts) 2597 G plus/minus A G539E Missense 9 u209 2606 C plus/minus T S542F Missense 9 e1601 2939 G plus/minus A C595Y Missense 11 u273 2939 G plus/minus A C595Y Missense 11 u128 2939 G plus/minus A C595Y Missense 11 u340 2939 G plus/minus A C595Y Missense 11 u221 2948 G plus/minus A G598E Missense 11 u315 2950 G plus/minus A D599N Missense 11 u56 d 2956 C plus/minus T R601C Missense 11 u140 3054 G plus/minus A Splicing 11/12 u72 3246 C plus/minus T Q664Stop Nonsense 14 u441 e 3246 C plus/minus T Q664Stop Nonsense 14 u56 3581 C plus/minus T A713D Missense 15 u2 3590 G plus/minus A G716D Missense 15 u260 3608 G plus/minus A W722Stop Nonsense 15 e1789 f 3620 C plus/minus T S726F Missense 15 u35 3620 C plus/minus T S726F Missense 15 u246 3629 C plus/minus T T729I Missense 15 u238 3629 C plus/minus T T729I Missense 15 u29 3637 G plus/minus A E732K Missense 15 Rearrangements u229, u308 insertion of 4 nucleotides (GCTT) at position 6, 11 bases before initiation codon which creates an out-of-frame ini- tiation codon u85 deletion of 7 nucleotides at starting position 1157 creating frame shift in exon 3 u253, u423 deletion in exon 3 e1497 deletion and insertion in exon 13 which creates a termination codon Alleles that do not include coding region mutations: u32, u230, u330, u331, u207, u133, u183, u302, e1851 a In a touch assay, all alleles except ts u45 and u242 confer the same touch-insensitive phenotype.",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4a,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4b,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4c,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4d,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4e,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4f,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4g,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4h,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4i,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000254,"bli-4, let-77, kpc-4",L46W,K04F10.4j,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00000421,ced-7,A223V,C48B4.4d,"Line 22714: Golden, NIDDK, NIH, Bethesda, MD), emb-30(g53 ts), emb-30(tn) alleles (this paper), sod-4(pk68::Tc1) (provided by L. Speliotes, MIT, Cambridge, MA), ced-7(n1892) , sqv- 3(n2823) , unc-69(e587) ; LGIV: fem-3(q20 gf, ts ); LGV: fog-2(q71) , unc- 46(e177) , mdf-1(gk2) (Kitagawa and Rose, 1999); LGX: ceh-18.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00000421,ced-7,G224D,C48B4.4d,"Line 22714: Golden, NIDDK, NIH, Bethesda, MD), emb-30(g53 ts), emb-30(tn) alleles (this paper), sod-4(pk68::Tc1) (provided by L. Speliotes, MIT, Cambridge, MA), ced-7(n1892) , sqv- 3(n2823) , unc-69(e587) ; LGIV: fem-3(q20 gf, ts ); LGV: fog-2(q71) , unc- 46(e177) , mdf-1(gk2) (Kitagawa and Rose, 1999); LGX: ceh-18.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00000441,ceh-18,A223V,ZC64.3b,"Line 22714: Golden, NIDDK, NIH, Bethesda, MD), emb-30(g53 ts), emb-30(tn) alleles (this paper), sod-4(pk68::Tc1) (provided by L. Speliotes, MIT, Cambridge, MA), ced-7(n1892) , sqv- 3(n2823) , unc-69(e587) ; LGIV: fem-3(q20 gf, ts ); LGV: fog-2(q71) , unc- 46(e177) , mdf-1(gk2) (Kitagawa and Rose, 1999); LGX: ceh-18.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00000441,ceh-18,G224D,ZC64.3a,"Line 22714: Golden, NIDDK, NIH, Bethesda, MD), emb-30(g53 ts), emb-30(tn) alleles (this paper), sod-4(pk68::Tc1) (provided by L. Speliotes, MIT, Cambridge, MA), ced-7(n1892) , sqv- 3(n2823) , unc-69(e587) ; LGIV: fem-3(q20 gf, ts ); LGV: fog-2(q71) , unc- 46(e177) , mdf-1(gk2) (Kitagawa and Rose, 1999); LGX: ceh-18.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00001063,dpy-1,G224D,M01E10.2a,"Line 22715: Rear- rangements, duplications, and deciencies were as follows: hT2 [bli-4(e937)]I ; hT2 [dpy-18(h662)]III ; hT1(I, V), mnC1[dpy-10(e128) unc- 52(e444)]II ; eT1(III, V) , tnDf2 (this work).","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00001263,"emb-9, clb-2, zyg-6",G224D,K04H4.1a,"Line 22713: The following C. elegans genes, mutations, deciencies, rearrangements, and extrachromosomal arrays were used (see Hodgkin [1997] for references or as cited): LGI: smg- 1(r861), gld-1(q485) , fog-3(q443) , glp-4(bn2 ts), unc-54(r293) ; LGII: rol- 6(su1006 d), let-23(sy10) ; LGIII: fem-2(b245 ts), unc-36(e251) , dpy- 19(e1259 ts, mat ), sma-2(e502) , unc-32(e189) , glp-1(q46) , emb-9(hc70 sd, ts), emb-30(ax69 ts) (provided by A.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00001263,"emb-9, clb-2, zyg-6",G224D,K04H4.1b,"Line 22713: The following C. elegans genes, mutations, deciencies, rearrangements, and extrachromosomal arrays were used (see Hodgkin [1997] for references or as cited): LGI: smg- 1(r861), gld-1(q485) , fog-3(q443) , glp-4(bn2 ts), unc-54(r293) ; LGII: rol- 6(su1006 d), let-23(sy10) ; LGIII: fem-2(b245 ts), unc-36(e251) , dpy- 19(e1259 ts, mat ), sma-2(e502) , unc-32(e189) , glp-1(q46) , emb-9(hc70 sd, ts), emb-30(ax69 ts) (provided by A.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00001284,"emb-30, apc-4",A223V,F54C8.3,"Line 22788: This change has been submitted to ACEDB; however, we mention it here so that others may avoid difculties that can arise with the use of the incorrect F54C8.3 prediction.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00001284,"emb-30, apc-4",G224D,F54C8.3,"Line 22788: This change has been submitted to ACEDB; however, we mention it here so that others may avoid difculties that can arise with the use of the incorrect F54C8.3 prediction.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00001284,"emb-30, apc-4",L46W,F54C8.3,"Line 22788: This change has been submitted to ACEDB; however, we mention it here so that others may avoid difculties that can arise with the use of the incorrect F54C8.3 prediction.","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",True Positive
WBPaper00003989,WBGene00002299,"let-23, kin-7",A223V,ZK1067.1c,"Line 22713: The following C. elegans genes, mutations, deciencies, rearrangements, and extrachromosomal arrays were used (see Hodgkin [1997] for references or as cited): LGI: smg- 1(r861), gld-1(q485) , fog-3(q443) , glp-4(bn2 ts), unc-54(r293) ; LGII: rol- 6(su1006 d), let-23(sy10) ; LGIII: fem-2(b245 ts), unc-36(e251) , dpy- 19(e1259 ts, mat ), sma-2(e502) , unc-32(e189) , glp-1(q46) , emb-9(hc70 sd, ts), emb-30(ax69 ts) (provided by A.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00002299,"let-23, kin-7",L46W,ZK1067.1d,"Line 22713: The following C. elegans genes, mutations, deciencies, rearrangements, and extrachromosomal arrays were used (see Hodgkin [1997] for references or as cited): LGI: smg- 1(r861), gld-1(q485) , fog-3(q443) , glp-4(bn2 ts), unc-54(r293) ; LGII: rol- 6(su1006 d), let-23(sy10) ; LGIII: fem-2(b245 ts), unc-36(e251) , dpy- 19(e1259 ts, mat ), sma-2(e502) , unc-32(e189) , glp-1(q46) , emb-9(hc70 sd, ts), emb-30(ax69 ts) (provided by A.","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00004856,"sma-2, cem-1",A223V,ZK370.2a,"Line 22713: The following C. elegans genes, mutations, deciencies, rearrangements, and extrachromosomal arrays were used (see Hodgkin [1997] for references or as cited): LGI: smg- 1(r861), gld-1(q485) , fog-3(q443) , glp-4(bn2 ts), unc-54(r293) ; LGII: rol- 6(su1006 d), let-23(sy10) ; LGIII: fem-2(b245 ts), unc-36(e251) , dpy- 19(e1259 ts, mat ), sma-2(e502) , unc-32(e189) , glp-1(q46) , emb-9(hc70 sd, ts), emb-30(ax69 ts) (provided by A.","Line 23102: The two strongest missense mutations, found in the class I alleles tn478 and tn479 , result in amino acid changes (A223V and G224D, respectively) in WD5.",False Positive
WBPaper00003989,WBGene00004879,"smg-1, mab-1",L46W,C48B6.6a,"Line 23120: Impor- tantly, both emb-30(tn477) and emb-30(tn474) are smg sup- pressible: smg-1(r861); emb-30(tn477) and smg-1(r861); emb- 30(tn474)/emb-30(tn377 ts) hermaphrodites are fertile.","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00004879,"smg-1, mab-1",L46W,C48B6.6b,"Line 23120: Impor- tantly, both emb-30(tn477) and emb-30(tn474) are smg sup- pressible: smg-1(r861); emb-30(tn477) and smg-1(r861); emb- 30(tn474)/emb-30(tn377 ts) hermaphrodites are fertile.","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00003989,WBGene00005021,"sqv-3, svh-10",L46W,R10E11.4,"Line 22745: tnDf2 fails to complement all tested emb-30 mutant alleles (tn377ts, tn471, tn472, tn474, tn477, tn479, tn481, tn494), ced-7(n1892) , and sqv-3(n2823) .","Line 23103: These amino acids are not shared with hAPC4 or Lid1 (Figure 8). The viable weak allele, tn481 , results in an amino acid substitution (L46W) at a position conserved in hAPC4 (Figure 8).",False Positive
WBPaper00004181,WBGene00000897,daf-1,M562I,F29C4.1a,Line 8609: 1997) and this extension depends on the daf-16 (+) forkhead/AFX transcription factor (Kenyon et al.,"Line 8728: Missense al- lele m25 (M562I) is within the LBD itself, and gives rise to partial (Vowels and Thomas 1992) or mosaic dauer larvae (Fig.",False Positive
WBPaper00004181,WBGene00000897,daf-1,Q618*,F29C4.1a,Line 8609: 1997) and this extension depends on the daf-16 (+) forkhead/AFX transcription factor (Kenyon et al.,"Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000898,daf-2,L147*,Y55D5A.5d,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000898,daf-2,L147*,Y55D5A.5e,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000898,daf-2,M562I,Y55D5A.5a,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.","Line 8728: Missense al- lele m25 (M562I) is within the LBD itself, and gives rise to partial (Vowels and Thomas 1992) or mosaic dauer larvae (Fig.",False Positive
WBPaper00004181,WBGene00000898,daf-2,M562I,Y55D5A.5c,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.","Line 8728: Missense al- lele m25 (M562I) is within the LBD itself, and gives rise to partial (Vowels and Thomas 1992) or mosaic dauer larvae (Fig.",False Positive
WBPaper00004181,WBGene00000898,daf-2,R564C,Y55D5A.5a,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000898,daf-2,R564C,Y55D5A.5c,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000898,daf-2,R564H,Y55D5A.5a,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000898,daf-2,R564H,Y55D5A.5c,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000898,daf-2,S137F,Y55D5A.5e,"Line 8608: For example, mutations in the daf-2 insulin/IGF-I-like receptor and the age-1 PI3 kinase extend life span twofold or more (Friedman and Johnson 1988; Kenyon et al.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",False Positive
WBPaper00004181,WBGene00000900,daf-4,C154*,C05D2.1b,"Line 8644: Notably, however, this property differs from wild type, or daf-2 and daf-4 genotypic mosaics in which all cells express either dauer or non-dauer programs (Apfeld and Kenyon 1998; Inoue and Thomas 2000).","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000900,daf-4,M562I,C05D2.1c,"Line 8644: Notably, however, this property differs from wild type, or daf-2 and daf-4 genotypic mosaics in which all cells express either dauer or non-dauer programs (Apfeld and Kenyon 1998; Inoue and Thomas 2000).","Line 8728: Missense al- lele m25 (M562I) is within the LBD itself, and gives rise to partial (Vowels and Thomas 1992) or mosaic dauer larvae (Fig.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",A125V,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",A125V,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",C121Y,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",C121Y,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",C154*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",C154*,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",C461Y,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",G582K,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",L147*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",L147*,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",M562I,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8728: Missense al- lele m25 (M562I) is within the LBD itself, and gives rise to partial (Vowels and Thomas 1992) or mosaic dauer larvae (Fig.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",P746S,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",Q501*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.",Line 8726: daf-12 nuclear receptor regulates nematode life history GENES  DEVELOPMENT 1517 Two exceptional class 3 mutations are not in the DBD. Dauer-defective nonsense allele m419 (Q501stop) affects the amino-terminal boundary of the LBD.,False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",Q59*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",Q59*,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",Q618*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",Q707*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R143K,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R143K,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R197K,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R197K,F11A1.3c,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R197K,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R564C,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R564C,F11A1.3d,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R564H,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R564H,F11A1.3d,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.",Line 8736: Independent isolates rh62 and rh274 both generate an R564C substitution and rh273 generates an R564H substitution.,False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R688*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",R688*,F11A1.3f,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",S137F,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",S137F,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",True Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",S70*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",S70*,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",W187*,F11A1.3a,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00000908,"daf-12, mig-7, daf-20",W187*,F11A1.3g,"Line 8570: The daf-12 gene acts at the convergence of pathways regulating larval diapause, developmental age, and adult longevity in Caenorhabditis elegans.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00002991,lin-2,Q618*,F17E5.1a,"Line 8618: Genetic epistasis tests with other heterochronic regulators place daf-12 downstream of lin-14 , but up- stream of lin-28 .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003003,lin-14,S137F,T25C12.1a,"Line 8618: Genetic epistasis tests with other heterochronic regulators place daf-12 downstream of lin-14 , but up- stream of lin-28 .","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",False Positive
WBPaper00004181,WBGene00003499,"mut-2, rde-3",Q59*,K04F10.6a,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003499,"mut-2, rde-3",Q59*,K04F10.6b,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003607,nhr-8,L147*,F33D4.1a,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003607,nhr-8,L147*,F33D4.1b,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003607,nhr-8,Q501*,F33D4.1a,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.",Line 8726: daf-12 nuclear receptor regulates nematode life history GENES  DEVELOPMENT 1517 Two exceptional class 3 mutations are not in the DBD. Dauer-defective nonsense allele m419 (Q501stop) affects the amino-terminal boundary of the LBD.,False Positive
WBPaper00004181,WBGene00003638,nhr-48,R197K,ZK662.3a,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003638,nhr-48,R197K,ZK662.3b,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003638,nhr-48,R197K,ZK662.3c,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00003638,nhr-48,R197K,ZK662.3d,"Line 8571: It encodes a nuclear receptor most closely related to two C. elegans receptors, NHR-8 and NHR-48, Drosophila DHR96, and vertebrate vitamin D and pregnane-X receptors.","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00006759,"unc-22, twitchin",C461Y,ZK617.1e,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00006759,"unc-22, twitchin",Q707*,ZK617.1b,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00006759,"unc-22, twitchin",Q707*,ZK617.1h,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00006759,"unc-22, twitchin",Q707*,ZK617.1i,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00006759,"unc-22, twitchin",S70*,ZK617.1e,"Line 8942: Alleles used in this study were wild- type N2, daf-12 (m20 , m25 , m116 , m419 , m420 , m421 , m422 , m423 , m424 , m425 , m524 , m545 , m524m570 , m545m571 , rh61 , rh61rh411 , rh61rh412 , rh62 , rh62rh157 , rh84 , rh193 , rh257 , rh258 , rh273 , rh274 , rh284 , rh285 , rh286 , sa156)X ; lin- 15(n765)X ; daf-1(m40)IV ; mut-6(st702)IV ; unc-22(st192st527)IV ; daf-2(m41 or e1370)III ; daf-4(e1364)III ; mut-2(r459)I .","Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004181,WBGene00018880,acc-3,S137F,F55D10.5,"Line 8981: The 3 8 ends of nhr-48 were amplified as above using the primer pairs 5 8-GCATGTGCGGACGCTATCCACC-3 8 / external adaptor-dT 18 and 5 8-GCTGAAAATGAGTCTCGG- GAAT-3 8 /external adaptor for first- and second-round PCR, re- spectively.","Line 8708: For example, S137F ( m421 ) and R143K ( m116 and m423 ) affect predicted contact resi- dues in the DNA-binding helix itself, and C121Y ( sa156 ) affects one of four conserved Zn coordinating cysteines in the first Zn finger.",False Positive
WBPaper00004181,WBGene00023497,lin-15,M562I,ZK662.4,Line 8997: Cosmid F11A1 con- taining daf-12::GFP (10 plus/minus 20 ng/l) and lin-15 (+) pL15.EK coin- jectible marker (75 ng/l) (Clark et al.,"Line 8728: Missense al- lele m25 (M562I) is within the LBD itself, and gives rise to partial (Vowels and Thomas 1992) or mosaic dauer larvae (Fig.",False Positive
WBPaper00004181,WBGene00023497,lin-15,Q59*,ZK662.4,Line 8997: Cosmid F11A1 con- taining daf-12::GFP (10 plus/minus 20 ng/l) and lin-15 (+) pL15.EK coin- jectible marker (75 ng/l) (Clark et al.,"Line 8742: Sites of mutations, and summary of dauer and heterochronic phenotypes of daf-12 alleles Class Allele Mutation Location Dauer phenotype Heterochronic phenotypes Extra-gonadal (L3 seam) a Gonadal (L4 distal tip) b WT + Normal ++++ ++++ Class 1 rh61 Q618stop LBD beta turn Defective + + rh84 R688stop LBD H9 ++ rh257 Y699splice acceptor LBD H9 + Class 2 rh62rh157 S70stop, R564C before DBD, LBD, H3 Defective + ++++ Class 3 m583 Q59stop before DBD Defective +++ ++++ sa156 C121Y DBD Zn1 m421 S137F DBD Zn1 m116/m423 R143K DBD Zn1 rh61rh411 L147stop, Q618stop DBD after Zn1, LBD beta turn m422 C154stop DBD Zn2 m20/m425 W187stop DBD after Zn2 rh61rh412 R195frameshift,Q618stop DBD after Zn2, LBD beta turn m524::Tc1 Y239insertion DBD after Zn2 m419 Q501stop LBD before H1 rh258 n.d. c m420 A125V DBD Zn1 ++++ ++++ m424 R197K DBD Zn1 m25 M562I LBD H3 Class 4 rh193 G582K LBD H4 Normal d ++ ++ rh285 Q707stop LBD after H9 + Class 5 rh284 P746S LBD H12 Normal ++++ + rh286 C461Y Hinge +++ +++ Class 6 rh62/rh274 R564C LBD H3 Constitutive ++++ + rh273 R564H LBD H3 +++ (+) 0% plus/minus 33% wild type; (++) 34% plus/minus 66% wild type; (+++) 67% plus/minus 99% wild type; (++++) 100% wild type.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",D722N,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",True Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",D825N,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",True Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",E623*,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",G662E,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",True Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",G721R,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",True Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",R709T,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",R799*,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",W796*,JC8.10a,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",W796*,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",W802*,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004275,WBGene00006763,"unc-26, unc-48",W903*,JC8.10b,"Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.","Line 893: Table I. Sequence of unc-26 Alleles DNA change AlleleMutagenWild-typeMutantAmino acid changeDomainPhenotypic strength e176 EMS Gat Aat D722N Phosphatase Strong e205 EMS tGg tAg W903stop Phosphatase Strong e314 EMS gGa gAa G662E Phosphatase Weak e345Spontaneous415-bp deletionIn-frame deletion of aa183-280Sac1Strong e429 EMS Gat Aat D825N Phosphatase Weak e446 (1 st site)EMS Gag Tag E623stop Phosphatase Strong e446 (2 nd site)EMS aGa aCa R709T Phosphatase Strong e568 EMS Cga Tga R799stop Phosphatase Moderate e1048sd EMS Gga Aga G721R Phosphatase Strong e1196 ICR gat gGa Frameshift at 732, stop at 733PhosphataseStrong m2 ICR tgG tgA W796stop Phosphatase Strong n1307 Spontaneous z650-bp tandem duplication in 1 st intronSac1Strong ox1 EMS tgG tgA W802stop Phosphatase Strong s1710mut-4 mutator gAT GCG ttcgtt caa aac Frameshift at 309, stop at 328Sac1Strong Harris et al.",False Positive
WBPaper00004282,WBGene00000897,daf-1,C90Y,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,Line 19010: The daf-1(m138) mutation changes the fourth cysteine to tyrosine (C90Y).,True Positive
WBPaper00004282,WBGene00000897,daf-1,C90Y,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,Line 19010: The daf-1(m138) mutation changes the fourth cysteine to tyrosine (C90Y).,True Positive
WBPaper00004282,WBGene00000897,daf-1,E105A,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,True Positive
WBPaper00004282,WBGene00000897,daf-1,E105A,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,True Positive
WBPaper00004282,WBGene00000897,daf-1,G110E,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000897,daf-1,G110E,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000897,daf-1,G352E,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19033: In daf-1(n690) , a glycine conserved in other type I receptors is changed to glutamic acid (G352E).",True Positive
WBPaper00004282,WBGene00000897,daf-1,G352E,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19033: In daf-1(n690) , a glycine conserved in other type I receptors is changed to glutamic acid (G352E).",True Positive
WBPaper00004282,WBGene00000897,daf-1,G465D,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19038: In the C lobe of the DAF-1 kinase, daf-1(m575) mutates a glycine conserved in the activation sequence of all type I and type II receptors to aspartic acid (G465D).",True Positive
WBPaper00004282,WBGene00000897,daf-1,G465D,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19038: In the C lobe of the DAF-1 kinase, daf-1(m575) mutates a glycine conserved in the activation sequence of all type I and type II receptors to aspartic acid (G465D).",True Positive
WBPaper00004282,WBGene00000897,daf-1,G70R,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19009: In daf-1(p168) , a glycine-to-arginine substitution (G70R) is positioned between the third and fourth cysteines (C64 and C90).",True Positive
WBPaper00004282,WBGene00000897,daf-1,G70R,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19009: In daf-1(p168) , a glycine-to-arginine substitution (G70R) is positioned between the third and fourth cysteines (C64 and C90).",True Positive
WBPaper00004282,WBGene00000897,daf-1,P546S,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19040: In daf-1(m213) , a proline invariant in all type I and II receptors, but not other kinases, is changed to serine (P546S).",False Positive
WBPaper00004282,WBGene00000897,daf-1,R349K,F29C4.1a,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19034: We predict that the longer side chain of the glutamic acid could disrupt the packing of the b sheet. In daf-1(sa40) , the effect of the arginine-to-lysine (R349K) substitution is difficult to predict.",True Positive
WBPaper00004282,WBGene00000897,daf-1,R349K,F29C4.1b,Line 18870: The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1.,"Line 19034: We predict that the longer side chain of the glutamic acid could disrupt the packing of the b sheet. In daf-1(sa40) , the effect of the arginine-to-lysine (R349K) substitution is difficult to predict.",True Positive
WBPaper00004282,WBGene00000899,daf-3,E105A,F25E2.5a,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000899,daf-3,E105A,F25E2.5c,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000899,daf-3,E105A,F25E2.5d,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000899,daf-3,G352E,F25E2.5g,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).","Line 19033: In daf-1(n690) , a glycine conserved in other type I receptors is changed to glutamic acid (G352E).",False Positive
WBPaper00004282,WBGene00000899,daf-3,G352E,F25E2.5h,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).","Line 19033: In daf-1(n690) , a glycine conserved in other type I receptors is changed to glutamic acid (G352E).",False Positive
WBPaper00004282,WBGene00000899,daf-3,G465D,F25E2.5h,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).","Line 19038: In the C lobe of the DAF-1 kinase, daf-1(m575) mutates a glycine conserved in the activation sequence of all type I and type II receptors to aspartic acid (G465D).",False Positive
WBPaper00004282,WBGene00000899,daf-3,P546S,F25E2.5a,"Line 18886: The DAF-7 growth signal is received and transduced by two transmembrane receptor kinases, DAF-1 (Georgi et al., 1990) and DAF-4 (Estevez et al., 1993), and three SMAD [SMA (Small)/MAD (Mothers Against Decapentaplegic)-related] proteins, DAF-8 (Estevez, 1997), DAF-14 (Inoue and Thomas, 2000) and DAF-3 (Patterson et al., 1997).","Line 19040: In daf-1(m213) , a proline invariant in all type I and II receptors, but not other kinases, is changed to serine (P546S).",False Positive
WBPaper00004282,WBGene00000900,daf-4,C90Y,C05D2.1a,"Line 18869: The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning.",Line 19010: The daf-1(m138) mutation changes the fourth cysteine to tyrosine (C90Y).,False Positive
WBPaper00004282,WBGene00000900,daf-4,C90Y,C05D2.1d,"Line 18869: The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning.",Line 19010: The daf-1(m138) mutation changes the fourth cysteine to tyrosine (C90Y).,False Positive
WBPaper00004282,WBGene00000900,daf-4,C90Y,C05D2.1e,"Line 18869: The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning.",Line 19010: The daf-1(m138) mutation changes the fourth cysteine to tyrosine (C90Y).,False Positive
WBPaper00004282,WBGene00000900,daf-4,E105A,C05D2.1a,"Line 18869: The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning.",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000900,daf-4,E105A,C05D2.1d,"Line 18869: The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning.",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00000900,daf-4,E105A,C05D2.1e,"Line 18869: The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning.",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00004856,"sma-2, cem-1",E105A,ZK370.2a,"Line 18892: Mutations in dbl-1/cet-1 , which encodes a bone morphogenetic protein (BMP)-like ligand(Morita et al., 1999; Suzuki et al., 1999), daf-4 , the type I receptor sma-6 (Krishna et al., 1999), and three SMAD genes, sma-2 , sma-3 and sma-4 (Savage et al., 1996), all result in small adult body size (Sma) and abnormal male tail structures (Mab).",Line 19011: daf-1(m122) carries two mutations that result in substitutions in a glutamic acid (E105A) and glycine (G110E) proximal to the sixth cysteine (C111).,False Positive
WBPaper00004282,WBGene00004856,"sma-2, cem-1",G352E,ZK370.2a,"Line 18892: Mutations in dbl-1/cet-1 , which encodes a bone morphogenetic protein (BMP)-like ligand(Morita et al., 1999; Suzuki et al., 1999), daf-4 , the type I receptor sma-6 (Krishna et al., 1999), and three SMAD genes, sma-2 , sma-3 and sma-4 (Savage et al., 1996), all result in small adult body size (Sma) and abnormal male tail structures (Mab).","Line 19033: In daf-1(n690) , a glycine conserved in other type I receptors is changed to glutamic acid (G352E).",False Positive
WBPaper00004282,WBGene00004857,sma-3,C90Y,R13F6.9,"Line 18892: Mutations in dbl-1/cet-1 , which encodes a bone morphogenetic protein (BMP)-like ligand(Morita et al., 1999; Suzuki et al., 1999), daf-4 , the type I receptor sma-6 (Krishna et al., 1999), and three SMAD genes, sma-2 , sma-3 and sma-4 (Savage et al., 1996), all result in small adult body size (Sma) and abnormal male tail structures (Mab).",Line 19010: The daf-1(m138) mutation changes the fourth cysteine to tyrosine (C90Y).,False Positive
WBPaper00004282,WBGene00004860,sma-6,P546S,C32D5.2,"Line 18892: Mutations in dbl-1/cet-1 , which encodes a bone morphogenetic protein (BMP)-like ligand(Morita et al., 1999; Suzuki et al., 1999), daf-4 , the type I receptor sma-6 (Krishna et al., 1999), and three SMAD genes, sma-2 , sma-3 and sma-4 (Savage et al., 1996), all result in small adult body size (Sma) and abnormal male tail structures (Mab).","Line 19040: In daf-1(m213) , a proline invariant in all type I and II receptors, but not other kinases, is changed to serine (P546S).",False Positive
WBPaper00004442,WBGene00002990,"lin-1, elk-1",R108AMBER,C37F5.1a,Line 1081: Mutant strains were scored as positive for the L2 division phenotype if at least one animal with the LIN-1 Ets transcription factor that is disrupted displayed L2 divisions.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00003017,lin-31,N68I,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",True Positive
WBPaper00004442,WBGene00003017,lin-31,Q58OCHRE,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00003017,lin-31,R108AMBER,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00003017,lin-31,R62AMBER,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00003017,lin-31,R62Q,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00003017,lin-31,W57AMBER,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00003017,lin-31,W87AMBER,K10G6.1,Line 1038: The lin-31 gene is required for the proper specification of vulval cell fates in the nematode Caenorhabditis elegans and encodes a member of the winged-helix family of transcription factors.,"Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004442,WBGene00004013,"pha-4, fkh-1",N68I,F38A6.1a,"Line 1157: 1996), and several winged- helix DNA-binding domains from C. elegans : PHA-4 ( Azzaria et al.","Line 1144: TABLE 1 Molecular analysis of lin-31 mutations Type of DNA Amino acid Allele a Mutagen mutation change change Position in protein or gene b ,c n301 EMS Missense G to A Arg 62 to Gln 62 Middle of helix 3 in DBD ga57 EMS Missense A to T Asn 68 to Ile 68 End of helix 3 in DBD n1053 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as e1750 ) e1750 EMS Nonsense G to A Trp 57 to amber Middle of DBD (same as n1053 ) n435 EMS Nonsense C to T Gln 58 to ochre Middle of DBD n1048 EMS Nonsense C to T Arg 62 to amber Middle of DBD n762 EMS Nonsense G to A Trp 87 to amber Near end of DBD ga70 EMS Nonsense C to T Arg 108 to amber End of DBD ga37 d Mutator Insertion Just before start codon ( 2 29 bp) n1282 d Mutator Insertion Near 5 9 end of gene n1290 d Mutator Insertion Unknown n1291 d,e Mutator Insertion Near 5 9 end of gene n1049 EMS Deletion 69 bp Removes last third of DBD (1216 plus/minus 1285) n376 EMS Deletion 535 bp Removes last splice site (2960 plus/minus 3495) ga10 EMS Deletion 956 bp Deletes all but DBD (3025 plus/minus 3981) ga9 d Mutator Frameshift 1 bp lost End of DBD (1292) DBD, DNA-binding domain.",False Positive
WBPaper00004503,WBGene00000415,ced-1,N962A,Y47H9C.4a,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,N962A,Y47H9C.4b,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,N962A,Y47H9C.4c,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,Y1019A,Y47H9C.4a,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,Y1019A,Y47H9C.4b,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,Y965A,Y47H9C.4a,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,Y965A,Y47H9C.4b,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004503,WBGene00000415,ced-1,Y965A,Y47H9C.4c,"Line 17709: We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death.","Line 17909: The N962A, Y965A, and P ced-1 ced-1::gfp 11.8 6 3.1 (n 5 12) 18.2 6 2.3 (n 5 12) Y1019A mutations resulted in 85%, 71%, and 54% loss P col-10 ced-1::gfp 6.2 6 3.0 (n 5 10) 17.5 6 1.4 (n 5 10) of CED-1 activity, respectively (Table 5), indicating each P ced-1 NLS-gfp 0.9 6 0.9 (n 5 12) 17.8 6 2.0 (n 5 12) of these three residues is necessary for the full en- P hsp ced-1::gfp b 10.7 6 3.3 (n 5 11) 17.9 6 4.4 (n 5 11) gulfment activity of CED-1 and that the NPXY motif plays P hsp gfp 2 0(n 5 12) 17.5 6 1.6 (n 5 12) a more major role.",False Positive
WBPaper00004943,WBGene00000548,clr-1,G60R,F56D1.4a,Line 20530: 8104 CLR-1 receptor tyrosine phosphatase that normally attenuates EGL-15 signaling (23).,"Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00000548,clr-1,G60R,F56D1.4b,Line 20530: 8104 CLR-1 receptor tyrosine phosphatase that normally attenuates EGL-15 signaling (23).,"Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00000548,clr-1,G60R,F56D1.4e,Line 20530: 8104 CLR-1 receptor tyrosine phosphatase that normally attenuates EGL-15 signaling (23).,"Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00001063,dpy-1,P49L,M01E10.2a,"Line 20587: mIn1 is homozy- gous viable and contains a mutation in dpy-10 that confers a Dpy phenotype in mIn1 homozygotes (M. Edgley, personal communication).","Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00001064,"dpy-2, rol-2",R87Q,T14B4.6,Line 20552: Sub- sequent multifactor mapping showed that ay75 mapped between lin-3 and unc-22 and was inseparable from dpy-20 (data available from ACEDB [http://www .sanger.ac.uk/Projects/C_elegans/webace_front_end.shtml]).,"Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00002299,"let-23, kin-7",C518S,ZK1067.1c,"Line 20650: gests that RAS has an important function in EGL-15 FGFR signaling in addition to its well-characterized role in C. elegans LET-23 EGF receptor signaling (4, 15).","Line 20614: Mutagenic primers include (mutant codons are under- lined) N-SH2 (R36E) (5 fl-GGA GAT TTT CTT CTT GAA TAC AGC GAA TCA AAT CCG-3fl), C-SH2 (R159E) (5fl-T TAC GAG AGC TCC TGG TAT GTGTTGACTTGCTTCTAGAAGATACGTTCCATTCTTTTC-3 fl), and PTP (C518S) (5 fl-C AAG TAC GGT ACC TGT TCT ACC AAT TCC AGC ACT AGA ATG AAC AAC GAT CGG-3 fl).",False Positive
WBPaper00004943,WBGene00002299,"let-23, kin-7",P49L,ZK1067.1d,"Line 20650: gests that RAS has an important function in EGL-15 FGFR signaling in addition to its well-characterized role in C. elegans LET-23 EGF receptor signaling (4, 15).","Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00002299,"let-23, kin-7",R87Q,ZK1067.1a,"Line 20650: gests that RAS has an important function in EGL-15 FGFR signaling in addition to its well-characterized role in C. elegans LET-23 EGF receptor signaling (4, 15).","Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00002990,"lin-1, elk-1",R159E,C37F5.1b,"Line 20657: To circum- vent this problem, an allele of lin-1 was used to suppress the FIG.","Line 20614: Mutagenic primers include (mutant codons are under- lined) N-SH2 (R36E) (5 fl-GGA GAT TTT CTT CTT GAA TAC AGC GAA TCA AAT CCG-3fl), C-SH2 (R159E) (5fl-T TAC GAG AGC TCC TGG TAT GTGTTGACTTGCTTCTAGAAGATACGTTCCATTCTTTTC-3 fl), and PTP (C518S) (5 fl-C AAG TAC GGT ACC TGT TCT ACC AAT TCC AGC ACT AGA ATG AAC AAC GAT CGG-3 fl).",False Positive
WBPaper00004943,WBGene00002990,"lin-1, elk-1",R87Q,C37F5.1a,"Line 20657: To circum- vent this problem, an allele of lin-1 was used to suppress the FIG.","Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00002992,"lin-3, let-94, sli-4",G60R,F36H1.4e,Line 20552: Sub- sequent multifactor mapping showed that ay75 mapped between lin-3 and unc-22 and was inseparable from dpy-20 (data available from ACEDB [http://www .sanger.ac.uk/Projects/C_elegans/webace_front_end.shtml]).,"Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00002992,"lin-3, let-94, sli-4",Y408F,F36H1.4g,Line 20552: Sub- sequent multifactor mapping showed that ay75 mapped between lin-3 and unc-22 and was inseparable from dpy-20 (data available from ACEDB [http://www .sanger.ac.uk/Projects/C_elegans/webace_front_end.shtml]).,Line 20608: The PTP-2 fragment fused to SOC-1(Y408F) contained the entire C-terminal portion of PTP-2 from alanine 123 just upstream of the C-terminal SH2 domain to the C terminus of PTP-2.,False Positive
WBPaper00004943,WBGene00003030,"lin-45, raf-1",G60R,Y73B6A.5f,"Line 20673: Many functions of LET-60 RAS are mediated by the MAPK cascade, which consists of the serine/threonine kinases LIN-45 RAF, MEK-2 MAPKK, and MPK-1 MAPK (17, 24, 26, 56).","Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00003030,"lin-45, raf-1",R87Q,Y73B6A.5c,"Line 20673: Many functions of LET-60 RAS are mediated by the MAPK cascade, which consists of the serine/threonine kinases LIN-45 RAF, MEK-2 MAPKK, and MPK-1 MAPK (17, 24, 26, 56).","Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00004214,"ptp-2, stp-1",C518S,F59G1.5,"Line 20494: Similarly, the C. elegans CSW ortholog PTP-2 was found to be involved in EGL-15 signaling.","Line 20614: Mutagenic primers include (mutant codons are under- lined) N-SH2 (R36E) (5 fl-GGA GAT TTT CTT CTT GAA TAC AGC GAA TCA AAT CCG-3fl), C-SH2 (R159E) (5fl-T TAC GAG AGC TCC TGG TAT GTGTTGACTTGCTTCTAGAAGATACGTTCCATTCTTTTC-3 fl), and PTP (C518S) (5 fl-C AAG TAC GGT ACC TGT TCT ACC AAT TCC AGC ACT AGA ATG AAC AAC GAT CGG-3 fl).",False Positive
WBPaper00004943,WBGene00004214,"ptp-2, stp-1",R159E,F59G1.5,"Line 20494: Similarly, the C. elegans CSW ortholog PTP-2 was found to be involved in EGL-15 signaling.","Line 20614: Mutagenic primers include (mutant codons are under- lined) N-SH2 (R36E) (5 fl-GGA GAT TTT CTT CTT GAA TAC AGC GAA TCA AAT CCG-3fl), C-SH2 (R159E) (5fl-T TAC GAG AGC TCC TGG TAT GTGTTGACTTGCTTCTAGAAGATACGTTCCATTCTTTTC-3 fl), and PTP (C518S) (5 fl-C AAG TAC GGT ACC TGT TCT ACC AAT TCC AGC ACT AGA ATG AAC AAC GAT CGG-3 fl).",False Positive
WBPaper00004943,WBGene00004214,"ptp-2, stp-1",R36E,F59G1.5,"Line 20494: Similarly, the C. elegans CSW ortholog PTP-2 was found to be involved in EGL-15 signaling.","Line 20614: Mutagenic primers include (mutant codons are under- lined) N-SH2 (R36E) (5 fl-GGA GAT TTT CTT CTT GAA TAC AGC GAA TCA AAT CCG-3fl), C-SH2 (R159E) (5fl-T TAC GAG AGC TCC TGG TAT GTGTTGACTTGCTTCTAGAAGATACGTTCCATTCTTTTC-3 fl), and PTP (C518S) (5 fl-C AAG TAC GGT ACC TGT TCT ACC AAT TCC AGC ACT AGA ATG AAC AAC GAT CGG-3 fl).",False Positive
WBPaper00004943,WBGene00004774,sem-5,P49L,C14F5.5,Line 20495: Structure-function analysis of SOC-1 and phenotypic analysis of single and double mutants are consistent with a model in which SOC-1 and PTP-2 act together in a pathway downstream of EGL-15 and the Src homology domain 2 (SH2)/SH3-adaptor protein SEM-5/GRB2 contributes to SOC-1-independent activities of EGL-15.,"Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00004774,sem-5,R87Q,C14F5.5,Line 20495: Structure-function analysis of SOC-1 and phenotypic analysis of single and double mutants are consistent with a model in which SOC-1 and PTP-2 act together in a pathway downstream of EGL-15 and the Src homology domain 2 (SH2)/SH3-adaptor protein SEM-5/GRB2 contributes to SOC-1-independent activities of EGL-15.,"Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004943,WBGene00004928,soc-1,W124A,F41F3.2,Line 20491: Epistasis analysis indicates that the gene soc-1 functions in EGL-15 signaling by acting either upstream of or independently of LET-60 RAS.,"Line 20735: To investigate whether the PH domain of SOC-1 is impor- tant for function in vivo, we used site-directed mutagenesis to change the invariant tryptophan found in all PH domains to alanine (W124A) (33).",False Positive
WBPaper00004943,WBGene00004928,soc-1,Y408F,F41F3.2,Line 20491: Epistasis analysis indicates that the gene soc-1 functions in EGL-15 signaling by acting either upstream of or independently of LET-60 RAS.,Line 20608: The PTP-2 fragment fused to SOC-1(Y408F) contained the entire C-terminal portion of PTP-2 from alanine 123 just upstream of the C-terminal SH2 domain to the C terminus of PTP-2.,False Positive
WBPaper00004943,WBGene00004929,"soc-2, sur-8",G60R,AC7.2c,"Line 20538: These suppressor mutations include multiple al- leles of four genes ( egl-15 , sem-5 , soc-1 , and soc-2/sur-8 ) as well as a single allele of let-341/sos-1 (11).","Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00006759,"unc-22, twitchin",G60R,ZK617.1d,Line 20552: Sub- sequent multifactor mapping showed that ay75 mapped between lin-3 and unc-22 and was inseparable from dpy-20 (data available from ACEDB [http://www .sanger.ac.uk/Projects/C_elegans/webace_front_end.shtml]).,"Line 20635: Sequence analysis of the let-60 ras gene in ay75/ay75 homozy- gotes revealed a G 178 -to-A transition which results in a G60R alteration, demonstrating that ay75 is an allele of let-60 .",False Positive
WBPaper00004943,WBGene00006761,unc-24,P49L,F57H12.2,Line 20571: Gravid unc-24(e138) let-60(ay75) unc-22(e66)/dpy-20(e1362) adult hermaphro- dites were allowed to lay eggs fo r1hat15 degree C and transferred to 25 degree C for approximately 48 h until the progeny reached the L4 stage.,"Line 20626: Sequence determination revealed that ay53 cor- responds to a molecular lesion that is identical to that found in the n1619 allele (P49L), ay73 corresponds to a nonsense mutation at Q10, and ay74 corresponds to a mutation in the SH2 domain (R87Q).",False Positive
WBPaper00004985,WBGene00004777,ser-2,S252A,C02D4.2b,"Line 14654: However, a direct interaction (hydrogen bonding) between the hydroxyl group of Ser-252 in TMD VI and the ester group of acetylcholine is unlikely because the S252A mutation did not affect the initial velocity of acetylcholine transport.","Line 14583: Similarly, replacement of these mutated hydrophobic residues with alanine (G233A, S252A, and C391A) did not affect the binding of vesamicol.",False Positive
WBPaper00004985,WBGene00004777,ser-2,S252F,C02D4.2b,"Line 14654: However, a direct interaction (hydrogen bonding) between the hydroxyl group of Ser-252 in TMD VI and the ester group of acetylcholine is unlikely because the S252A mutation did not affect the initial velocity of acetylcholine transport.","Line 14575: All tested VAChT-specific mutants examined displayed altered affinities for acetylcholine (Fig. 5; Table I), with K m values of 3m M (C391Y), 6 m M (A228V), and 8 m M (S252F).",False Positive
WBPaper00005045,WBGene00001063,dpy-1,E408K,M01E10.2b,Line 5908: Homozygosity for the smg-4(ma116) allele was scored by assaying for the linked mutation in dpy-11.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00001063,dpy-1,Q354*,M01E10.2a,Line 5908: Homozygosity for the smg-4(ma116) allele was scored by assaying for the linked mutation in dpy-11.,Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",C122*,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",C409Y,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",C580Y,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",E408K,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",G343E,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",G343R,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",G361R,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",K238N,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",P327L,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",Q354*,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",Q83*,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",S204F,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,True Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",T366I,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",W10*,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",W235*,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00001481,"fog-1, cpb-4",Y579D,Y54E10A.4b,Line 5663: FOG-1 controls germ cell fates in the nematode Caenorhabditis elegans.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00001595,gld-1,S204F,T23G11.3,Line 5692: Biochemical studies in Xenopus have shown sage is translationally repressed by GLD-1 in hermaphro- that the RRM domains and the C-H domain are both dites to allow them to produce sperm during larval needed for CPEB proteins to bind target messenger RNAs (Hake et al.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00003392,mog-4,E408K,C04H5.6a,"Line 5710: 1999), and the products of mog-1 , mog-4 , promote the cytoplasmic polyadenylation of specific tar- and mog-5 are DEAH box proteins that are likely to bind to gets, and this activity appears to increase the rate at messages and perhaps regulate their translation ( Puoti and which the targets are translated ( Hake and Richter Kimble 1999 , 2000).",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00003785,"nos-3, syt-1, pqn-86",G361R,Y53C12B.3a,"Line 5675: However, it has long been clear that many processes are controlled proteins and NOS-3 to prevent spermatogenesis from continuing into adulthood ( Ahringer et al.",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00003785,"nos-3, syt-1, pqn-86",G361R,Y53C12B.3b,"Line 5675: However, it has long been clear that many processes are controlled proteins and NOS-3 to prevent spermatogenesis from continuing into adulthood ( Ahringer et al.",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00003785,"nos-3, syt-1, pqn-86",P327L,Y53C12B.3a,"Line 5675: However, it has long been clear that many processes are controlled proteins and NOS-3 to prevent spermatogenesis from continuing into adulthood ( Ahringer et al.",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00003785,"nos-3, syt-1, pqn-86",P327L,Y53C12B.3b,"Line 5675: However, it has long been clear that many processes are controlled proteins and NOS-3 to prevent spermatogenesis from continuing into adulthood ( Ahringer et al.",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00004882,"smg-4, mab-14",K238N,F46B6.3a,Line 5908: Homozygosity for the smg-4(ma116) allele was scored by assaying for the linked mutation in dpy-11.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00004882,"smg-4, mab-14",K238N,F46B6.3b,Line 5908: Homozygosity for the smg-4(ma116) allele was scored by assaying for the linked mutation in dpy-11.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00004882,"smg-4, mab-14",P327L,F46B6.3a,Line 5908: Homozygosity for the smg-4(ma116) allele was scored by assaying for the linked mutation in dpy-11.,Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00006604,"tra-1, her-2",Q83*,Y47D3A.6a,"Line 5708: In addition, the Third, CPEB proteins appear to regulate translation tra-1 product functions in part to regulate localization of RNA by a variety of mechanisms.",Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00006604,"tra-1, her-2",Q83*,Y47D3A.6b,"Line 5708: In addition, the Third, CPEB proteins appear to regulate translation tra-1 product functions in part to regulate localization of RNA by a variety of mechanisms.",Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00006743,unc-3,P327L,Y16B4A.1,"Line 5751: for unc-37 , and RE119 and RE120 for tra-1.",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005045,WBGene00006743,unc-3,Q83*,Y16B4A.1,"Line 5751: for unc-37 , and RE119 and RE120 for tra-1.",Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00006745,unc-5,Q83*,B0273.4a,"Line 5917: By contrast, smg mutations can cause a 10-fold increase in the levels of stable transcripts from genes like unc-54 (Pulak and Anderson 1993).",Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00006745,unc-5,Q83*,B0273.4b,"Line 5917: By contrast, smg mutations can cause a 10-fold increase in the levels of stable transcripts from genes like unc-54 (Pulak and Anderson 1993).",Line 5769: Nonsense mutations and frameshifting mutations q250 EMS G63 A Trp10 STOP G748 T q372 EMS C281 T Gln83 STOP q273 TR403 C400 A Cys122 STOP q242 Gamma ray G738 A Trp235 STOP G748 T q219 TR403 G738 A Trp235 STOP q155 EMS C1094 T Gln354 STOP e2121 EMS C1688 T Glu552 STOP q218 TR403 C inserted at 618 Frameshift of 1 q272 TR403 G inserted at 1063 Frameshift of 1 q325 Gamma ray Delete (1210 to 1216) Frameshift of 2 q243 TR403 G inserted at 1646 Frameshift of 1 q271 TR403 G inserted at 1646 Frameshift of 1 molecular lesions associated with 33 independent fog-1 and four lesions altered the C-H domain.,False Positive
WBPaper00005045,WBGene00006745,unc-5,S204F,B0273.4c,"Line 5917: By contrast, smg mutations can cause a 10-fold increase in the levels of stable transcripts from genes like unc-54 (Pulak and Anderson 1993).",Line 5768: TABLE 2 Molecular lesions associated with mutations Allele Mutagen Molecular lesion Effect on FOG-1 A. Missense mutations and in-frame deletions e1959 EMS C645 T Ser204 Phe q181 EMS C645 T Ser204 Phe q380 EMS G748 T Lys238 Asn q229 EMS G748 T Lys238 Asn q311 EMS C1014 T Pro327 Leu q382 EMS G1062 A Gly343 Glu oz95 Spontaneous G1062 A Gly343 Glu q180 EMS G1062 A Gly343 Glu e2122 EMS G1115 A Gly361 Arg q253ts EMS C1131 T Thr366 Ile q254 EMS G1256 A Glu408 Lys q255 EMS G1260 A Cys409 Tyr q493 UV/TMP T1769 G Tyr579 Asp q187 EMS G1773 A Cys580 Tyr q507 UV Delete (633 to 659) (Gln200Val209) Leu q492 UV/TMP Delete (844 to 933) (Met270Tyr270) Ile q182 EMS Delete (1160 to 1210) (Ala376Thr392) deleted q379 EMS G748 T Lys238 Asn G1062 A Gly343 Glu q248 EMS G748 T Lys238 Asn G1061 A Gly343 Arg oz15ts Spontaneous G748 T Lys238 Asn C1131 T Thr366 Ile B.,False Positive
WBPaper00005096,WBGene00003132,"mat-1, apc-3, cdc-27, pod-5, let-364",E164K,Y110A7A.17a,"Line 11858: phase-to-anaphase transition defective): mat-1, mat-2, and Although the role of APC/C in separating sister chroma- mat-3 (Golden et al 2000).","Line 11892: ax143, or224 L367F Molecular identiﬁcation of additional APC/C genes in C. elegans: As it became apparent that mat genes could ax148 A531T encode APC/C subunits (Table 1), we asked whether or172, or180, or187 S505F additional APC/C subunits function during the meta- ax68 E164K phase-to-anaphase transition of C. elegans meiosis I.",False Positive
WBPaper00005096,WBGene00003132,"mat-1, apc-3, cdc-27, pod-5, let-364",E164K,Y110A7A.17b,"Line 11858: phase-to-anaphase transition defective): mat-1, mat-2, and Although the role of APC/C in separating sister chroma- mat-3 (Golden et al 2000).","Line 11892: ax143, or224 L367F Molecular identiﬁcation of additional APC/C genes in C. elegans: As it became apparent that mat genes could ax148 A531T encode APC/C subunits (Table 1), we asked whether or172, or180, or187 S505F additional APC/C subunits function during the meta- ax68 E164K phase-to-anaphase transition of C. elegans meiosis I.",False Positive
WBPaper00005096,WBGene00004333,rec-8,A454V,W02A2.6a,"Line 11861: In addition, we different APC/C subunits in Caenorhabditis elegans re- use rec-8 RNAi to demonstrate that the loss of sister vealed a requirement for APC/C in the meiosis I segre- chromatid cohesion is insufﬁcient to bypass a require- gation of chromosomal homologs (Golden et al 2000; ment for APC/C during meiosis I chromosome segrega- Furuta et al 2000).","Line 11893: Of ax70 A454V the 8–12 known APC/C subunits in yeast and verte- ax71 G535D brates, orthologs of several have been predicted on the ax77 A342L basis of C. elegans genomic sequence data (Table 1).",False Positive
WBPaper00005096,WBGene00004333,rec-8,E73K,W02A2.6b,"Line 11861: In addition, we different APC/C subunits in Caenorhabditis elegans re- use rec-8 RNAi to demonstrate that the loss of sister vealed a requirement for APC/C in the meiosis I segre- chromatid cohesion is insufﬁcient to bypass a require- gation of chromosomal homologs (Golden et al 2000; ment for APC/C during meiosis I chromosome segrega- Furuta et al 2000).","Line 11894: In ax79, ax136 E404K particular, K06H7.6 and F35G12.9 were predicted as ax82 E240K orthologs of the subunits APC-2 (Yu et al 1998; Zacha- or192 E73K riae et al 1998) and APC-11 (Ohta et al 1999), respec- For each mutation, the ﬁrst letter refers to the amino acid tively.",False Positive
WBPaper00005135,WBGene00000996,dif-1,E238K,F49E8.5,Line 1600: (1993) molecularly char- the left ( pat-8 ) and right ( dif-1 )of lin-45 (Riddle et al.,"Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00000996,dif-1,R175*,F49E8.5,Line 1600: (1993) molecularly char- the left ( pat-8 ) and right ( dif-1 )of lin-45 (Riddle et al.,"Line 1587: lin-1(e1275 R175Stop) appears to depend on relieving the interaction between is a recessive, heat-sensitive, partial loss-of-function allele that truncates LIN-1 downstream of the ETS DNA-binding domain the N-terminal regulatory domain and the C-terminal (Beitel et al.",False Positive
WBPaper00005135,WBGene00001063,dpy-1,G13E,M01E10.2b,"Line 1579: (1997): LGI, sup-11(n403) ; dpy-5(e61) ; LGIII, unc- analyzed extensively using purified Raf protein and Raf 79(e1068) ; dpy-17(e164) ; and LGIV, unc-24(e138) ; unc-5(e53) ; expressed in vertebrate cultured cells.",Line 1584: let-60(n1046 G13E) 1994; Finney and Herrera 1995; Marais et al.,False Positive
WBPaper00005135,WBGene00001067,dpy-5,G13E,F27C1.8,"Line 1579: (1997): LGI, sup-11(n403) ; dpy-5(e61) ; LGIII, unc- analyzed extensively using purified Raf protein and Raf 79(e1068) ; dpy-17(e164) ; and LGIV, unc-24(e138) ; unc-5(e53) ; expressed in vertebrate cultured cells.",Line 1584: let-60(n1046 G13E) 1994; Finney and Herrera 1995; Marais et al.,False Positive
WBPaper00005135,WBGene00001651,gon-2,D213N,T01H8.5d,"Line 1581: Standard techniques were used to stimulation, Raf is catalytically inactive and localized to mutagenize animals and screen for mutants, separate the lin- 45 mutations from the let-60 , lin-15 ,or gon-2 unc-29 mutations, the cytoplasm in a multiprotein complex.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00001651,gon-2,R175*,T01H8.5c,"Line 1581: Standard techniques were used to stimulation, Raf is catalytically inactive and localized to mutagenize animals and screen for mutants, separate the lin- 45 mutations from the let-60 , lin-15 ,or gon-2 unc-29 mutations, the cytoplasm in a multiprotein complex.","Line 1587: lin-1(e1275 R175Stop) appears to depend on relieving the interaction between is a recessive, heat-sensitive, partial loss-of-function allele that truncates LIN-1 downstream of the ETS DNA-binding domain the N-terminal regulatory domain and the C-terminal (Beitel et al.",False Positive
WBPaper00005135,WBGene00002299,"let-23, kin-7",S872P,ZK1067.1c,"Line 1568: The strong The anchor cell and P6.p communicate using a highly conserved signal transduction pathway that includes the loss-of-function or null alleles demonstrate that Raf is required for Ras-mediated signaling during larval devel- lin-3 ligand, which is similar to EGF; the let-23 RTK; the sem-5 adapter protein; let-341 guanine nucleotide opment, oocyte maturation, and vulval induction.","Line 1590: Activated Raf phosphorylates MEK on two serine 12(n137 S872P) is a dominant gain-of-function allele that af- residues, which greatly stimulates MEK kinase activity fects the extracellular domain of the LIN-12 Notch receptor (Alessi et al.",False Positive
WBPaper00005135,WBGene00002990,"lin-1, elk-1",D213N,C37F5.1a,"Line 1561: kinase that phosphorylates and activates a mitogen-acti- P6.p signals P5.p and P7.p to adopt the 2 fate by activat- vated protein (MAP) kinase kinase named MEK, which ing lin-12, which is similar to the receptor Notch.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00002990,"lin-1, elk-1",R108W,C37F5.1a,"Line 1561: kinase that phosphorylates and activates a mitogen-acti- P6.p signals P5.p and P7.p to adopt the 2 fate by activat- vated protein (MAP) kinase kinase named MEK, which ing lin-12, which is similar to the receptor Notch.","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",False Positive
WBPaper00005135,WBGene00002990,"lin-1, elk-1",R175*,C37F5.1a,"Line 1561: kinase that phosphorylates and activates a mitogen-acti- P6.p signals P5.p and P7.p to adopt the 2 fate by activat- vated protein (MAP) kinase kinase named MEK, which ing lin-12, which is similar to the receptor Notch.","Line 1587: lin-1(e1275 R175Stop) appears to depend on relieving the interaction between is a recessive, heat-sensitive, partial loss-of-function allele that truncates LIN-1 downstream of the ETS DNA-binding domain the N-terminal regulatory domain and the C-terminal (Beitel et al.",False Positive
WBPaper00005135,WBGene00002990,"lin-1, elk-1",R217L,C37F5.1b,"Line 1561: kinase that phosphorylates and activates a mitogen-acti- P6.p signals P5.p and P7.p to adopt the 2 fate by activat- vated protein (MAP) kinase kinase named MEK, which ing lin-12, which is similar to the receptor Notch.","Line 1830: changes the homologous arginine 217 to leucine was discovered as an intermediate loss-of-function allele, The interaction of Raf and Ras initiates Raf activation.",False Positive
WBPaper00005135,WBGene00002992,"lin-3, let-94, sli-4",E238K,F36H1.4g,"Line 1568: The strong The anchor cell and P6.p communicate using a highly conserved signal transduction pathway that includes the loss-of-function or null alleles demonstrate that Raf is required for Ras-mediated signaling during larval devel- lin-3 ligand, which is similar to EGF; the let-23 RTK; the sem-5 adapter protein; let-341 guanine nucleotide opment, oocyte maturation, and vulval induction.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00002997,lin-8,E238K,B0454.1,"Line 1610: 1990), lin-8(n111); let-60(gf) hermaphrodites were mutagenized with EMS and non-Muv F 1 self-progeny CAATGATAGCACCC-3 fi) were used to amplify a DNA frag- were picked to separate petri dishes at 25 .","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00002997,lin-8,P92S,B0454.1,"Line 1610: 1990), lin-8(n111); let-60(gf) hermaphrodites were mutagenized with EMS and non-Muv F 1 self-progeny CAATGATAGCACCC-3 fi) were used to amplify a DNA frag- were picked to separate petri dishes at 25 .","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",False Positive
WBPaper00005135,WBGene00003017,lin-31,R108W,K10G6.1,"Line 1588: lin-31(n1053 Trp57Stop) is a recessive, kinase domain ( Stanton et al.","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",False Positive
WBPaper00005135,WBGene00003017,lin-31,W57*,K10G6.1,"Line 1588: lin-31(n1053 Trp57Stop) is a recessive, kinase domain ( Stanton et al.","Line 1588: lin-31(n1053 Trp57Stop) is a recessive, kinase domain ( Stanton et al.",False Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",D213N,Y73B6A.5c,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",P92S,Y73B6A.5a,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",False Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",R108W,Y73B6A.5a,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",True Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",R118W,Y73B6A.5a,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",True Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",R118W,Y73B6A.5e,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1835: The lin-45(n2018 P92S) mu- tation, which causes a moderate loss of function, and lin-45(n2506 R118W) affects a highly conserved arginine at the terminus of -helix 1 that directly contacts Ras the lin-45(n1925 R108W) mutation, which causes a weak loss of function, affect residues in the Ras-binding do- by hydrogen bonding to aspartic acid 38 and serine 39 of Ras (Figure 2).",False Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",R175*,Y73B6A.5a,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1587: lin-1(e1275 R175Stop) appears to depend on relieving the interaction between is a recessive, heat-sensitive, partial loss-of-function allele that truncates LIN-1 downstream of the ETS DNA-binding domain the N-terminal regulatory domain and the C-terminal (Beitel et al.",False Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",R175*,Y73B6A.5d,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1587: lin-1(e1275 R175Stop) appears to depend on relieving the interaction between is a recessive, heat-sensitive, partial loss-of-function allele that truncates LIN-1 downstream of the ETS DNA-binding domain the N-terminal regulatory domain and the C-terminal (Beitel et al.",False Positive
WBPaper00005135,WBGene00003030,"lin-45, raf-1",R217L,Y73B6A.5b,"Line 1532: Raf activation is initiated by an interaction with GTP-bound Ras, and Raf functions in signal transmission by phosphorylating and activating a mitogen-activated protein (MAP) kinase kinase named MEK We identified 13 mutations in the Caenorhabditis elegans lin-45 raf gene by screening for hermaphrodites with abnormal vulval formation or germline function.","Line 1830: changes the homologous arginine 217 to leucine was discovered as an intermediate loss-of-function allele, The interaction of Raf and Ras initiates Raf activation.",False Positive
WBPaper00005135,WBGene00003186,"mek-2, let-537, glv-1",D213N,Y54E10BL.6,"Line 1535: The lin-45(null) phenotype is similar to the mek-2(null) and mpk-l(null) phenotypes, indicating that LIN-45, MEK-2, and MPK-1 ERR MAP kinase function in a predominantly linear signaling pathway.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00003186,"mek-2, let-537, glv-1",E238K,Y54E10BL.6,"Line 1535: The lin-45(null) phenotype is similar to the mek-2(null) and mpk-l(null) phenotypes, indicating that LIN-45, MEK-2, and MPK-1 ERR MAP kinase function in a predominantly linear signaling pathway.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00003401,"mpk-1, sur-1",D213N,F43C1.2a,"Line 1535: The lin-45(null) phenotype is similar to the mek-2(null) and mpk-l(null) phenotypes, indicating that LIN-45, MEK-2, and MPK-1 ERR MAP kinase function in a predominantly linear signaling pathway.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00003401,"mpk-1, sur-1",R175*,F43C1.2a,"Line 1535: The lin-45(null) phenotype is similar to the mek-2(null) and mpk-l(null) phenotypes, indicating that LIN-45, MEK-2, and MPK-1 ERR MAP kinase function in a predominantly linear signaling pathway.","Line 1587: lin-1(e1275 R175Stop) appears to depend on relieving the interaction between is a recessive, heat-sensitive, partial loss-of-function allele that truncates LIN-1 downstream of the ETS DNA-binding domain the N-terminal regulatory domain and the C-terminal (Beitel et al.",False Positive
WBPaper00005135,WBGene00006745,unc-5,G13E,B0273.4a,"Line 1579: (1997): LGI, sup-11(n403) ; dpy-5(e61) ; LGIII, unc- analyzed extensively using purified Raf protein and Raf 79(e1068) ; dpy-17(e164) ; and LGIV, unc-24(e138) ; unc-5(e53) ; expressed in vertebrate cultured cells.",Line 1584: let-60(n1046 G13E) 1994; Finney and Herrera 1995; Marais et al.,False Positive
WBPaper00005135,WBGene00006745,unc-5,G13E,B0273.4b,"Line 1579: (1997): LGI, sup-11(n403) ; dpy-5(e61) ; LGIII, unc- analyzed extensively using purified Raf protein and Raf 79(e1068) ; dpy-17(e164) ; and LGIV, unc-24(e138) ; unc-5(e53) ; expressed in vertebrate cultured cells.",Line 1584: let-60(n1046 G13E) 1994; Finney and Herrera 1995; Marais et al.,False Positive
WBPaper00005135,WBGene00006745,unc-5,G13E,B0273.4f,"Line 1579: (1997): LGI, sup-11(n403) ; dpy-5(e61) ; LGIII, unc- analyzed extensively using purified Raf protein and Raf 79(e1068) ; dpy-17(e164) ; and LGIV, unc-24(e138) ; unc-5(e53) ; expressed in vertebrate cultured cells.",Line 1584: let-60(n1046 G13E) 1994; Finney and Herrera 1995; Marais et al.,False Positive
WBPaper00005135,WBGene00006761,unc-24,D213N,F57H12.2,"Line 1579: (1997): LGI, sup-11(n403) ; dpy-5(e61) ; LGIII, unc- analyzed extensively using purified Raf protein and Raf 79(e1068) ; dpy-17(e164) ; and LGIV, unc-24(e138) ; unc-5(e53) ; expressed in vertebrate cultured cells.","Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00006765,"unc-29, tmr-4, unc-21, unc-56",R217L,T08G11.5,"Line 1581: Standard techniques were used to stimulation, Raf is catalytically inactive and localized to mutagenize animals and screen for mutants, separate the lin- 45 mutations from the let-60 , lin-15 ,or gon-2 unc-29 mutations, the cytoplasm in a multiprotein complex.","Line 1830: changes the homologous arginine 217 to leucine was discovered as an intermediate loss-of-function allele, The interaction of Raf and Ras initiates Raf activation.",False Positive
WBPaper00005135,WBGene00021922,atg-3,D213N,Y55F3AM.4a,Line 1620: dx84 was gener- RESULTS ated by mutagenizing N2 hermaphrodites and identified by screening for deletions in the lin-45 locus using the outer Isolation and molecular characterization of fi primers 5 fi-GACATATTTTGTCAGGTAATCG-3 fi and 5 fi-GTC alleles: We identified 12 alleles of lin-45 raf by conduct- TAAGTGAAGAACATTCGG-3 fi and the inner primers 5 fi-TCT ing several different genetic screens (see materials CAATTATTCAGGAGCTCG-3 fi and 5 fi-GAGTCAATTTTGGA AGAATTATG-3 fi according to the method described by Den- and methods ).,"Line 1591: 1994; Zheng and (Greenwald and Seydoux 1990). mek-2(n2516 E238K ) and mek-2(n2678 D213N ) are recessive, strong loss-of-function or Guan 1994).",False Positive
WBPaper00005135,WBGene00021922,atg-3,R217L,Y55F3AM.4a,Line 1620: dx84 was gener- RESULTS ated by mutagenizing N2 hermaphrodites and identified by screening for deletions in the lin-45 locus using the outer Isolation and molecular characterization of fi primers 5 fi-GACATATTTTGTCAGGTAATCG-3 fi and 5 fi-GTC alleles: We identified 12 alleles of lin-45 raf by conduct- TAAGTGAAGAACATTCGG-3 fi and the inner primers 5 fi-TCT ing several different genetic screens (see materials CAATTATTCAGGAGCTCG-3 fi and 5 fi-GAGTCAATTTTGGA AGAATTATG-3 fi according to the method described by Den- and methods ).,"Line 1830: changes the homologous arginine 217 to leucine was discovered as an intermediate loss-of-function allele, The interaction of Raf and Ras initiates Raf activation.",False Positive
WBPaper00005177,WBGene00001069,dpy-7,G76E,F46C8.6,"Line 18853: A large number of cuticular collagen molecules, such as those encoded by dpy-2, dpy-7, dpy-10 and dpy-13 genes, are made, modified upon maturation and secreted by the hypodermal tissues (Gilleard et al., 1997; Johnstone, 2000).",Line 18660: A G76E mutant version of the thioredoxin-like domain with glycine 76 changed to glutamic acid was engineered by mutagenesis with primer KC369 (5 -GGAATCAAGGTT GAAGAAGTCGATG-3 ) and KC370 (5 -CATCGACTTCTTCAA C CTTGATTCC-3 ) and was designated pG2TG76E.,False Positive
WBPaper00005177,WBGene00001073,dpy-11,G187E,F46E10.9,Line 18703: The p72WCP fragment contained the F46E10.9 gene and a truncated F46E10.8 ORF.,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,True Positive
WBPaper00005177,WBGene00001073,dpy-11,G191R,F46E10.9,Line 18703: The p72WCP fragment contained the F46E10.9 gene and a truncated F46E10.8 ORF.,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,False Positive
WBPaper00005177,WBGene00001073,dpy-11,G76E,F46E10.9,Line 18703: The p72WCP fragment contained the F46E10.9 gene and a truncated F46E10.8 ORF.,Line 18660: A G76E mutant version of the thioredoxin-like domain with glycine 76 changed to glutamic acid was engineered by mutagenesis with primer KC369 (5 -GGAATCAAGGTT GAAGAAGTCGATG-3 ) and KC370 (5 -CATCGACTTCTTCAA C CTTGATTCC-3 ) and was designated pG2TG76E.,True Positive
WBPaper00005177,WBGene00001073,dpy-11,W173OPAL,F46E10.9,Line 18703: The p72WCP fragment contained the F46E10.9 gene and a truncated F46E10.8 ORF.,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,True Positive
WBPaper00005177,WBGene00001073,dpy-11,W34AMBER,F46E10.9,Line 18703: The p72WCP fragment contained the F46E10.9 gene and a truncated F46E10.8 ORF.,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,True Positive
WBPaper00005177,WBGene00001073,dpy-11,W50AMBER,F46E10.9,Line 18703: The p72WCP fragment contained the F46E10.9 gene and a truncated F46E10.8 ORF.,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,True Positive
WBPaper00005177,WBGene00001173,"egl-4, cgk-1, odr-9, eat-7, chb-1, pkg-1",G187E,F55A8.2a,Line 18626: Mapping the dpy-11 and lesions in mutant alleles dpy-11 was mapped between gad-1 and egl-46 .,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,False Positive
WBPaper00005177,WBGene00001173,"egl-4, cgk-1, odr-9, eat-7, chb-1, pkg-1",G187E,F55A8.2h,Line 18626: Mapping the dpy-11 and lesions in mutant alleles dpy-11 was mapped between gad-1 and egl-46 .,Line 18696: The phenotypes of dpy-11 mutant alleles Mutation Male tail Ram Male body Allele(amino acid changes)Index (0-5)length (mm)* him-8(e1489) 0.0 0.88 plus/minus 0.04 e33 W173 Opal 4.3 0.41 plus/minus 0.03 e207 R4 Opal 4.5 0.46 plus/minus 0.03 e504 W34 Amber 4.6 0.38 plus/minus 0.03 e752 W50 Amber 4.7 0.38 plus/minus 0.04 e794 P20 4.8 0.41 plus/minus 0.02 e1180 P20 4.7 0.45 plus/minus 0.06 s261 H100 3.5 0.42 plus/minus 0.02 e224 G76E 1.9 0.63 plus/minus 0.02 e390 G76E 1.9 0.66 plus/minus 0.04 e455 G76E 2.3 0.60 plus/minus 0.04 e733 G76E 2.1 0.64 plus/minus 0.03 e395 G187E 0.0 0.65 plus/minus 0.04 e431 G187E 0.1 0.65 plus/minus 0.03 s10 G191R 0.5 0.43 plus/minus 0.05 s360 D 195-197aa 0.0 0.49 plus/minus 0.02 e207/e224 2.7 0.48 plus/minus 0.03 *Thirty worms were measured and the value averaged for each allele.,False Positive
WBPaper00005177,WBGene00001173,"egl-4, cgk-1, odr-9, eat-7, chb-1, pkg-1",G76E,F55A8.2g,Line 18626: Mapping the dpy-11 and lesions in mutant alleles dpy-11 was mapped between gad-1 and egl-46 .,Line 18660: A G76E mutant version of the thioredoxin-like domain with glycine 76 changed to glutamic acid was engineered by mutagenesis with primer KC369 (5 -GGAATCAAGGTT GAAGAAGTCGATG-3 ) and KC370 (5 -CATCGACTTCTTCAA C CTTGATTCC-3 ) and was designated pG2TG76E.,False Positive
WBPaper00005177,WBGene00001579,gex-2,G76E,F56A11.1,"Line 18659: After a Sma I site was introduced after the TRX domain by site-directed mutagenesis with primer KC299 as described above, the Sma I fragment encompassing aa 19-133 was subcloned into the pGEX-2T vector to generate pG2TD11T (wild type).",Line 18660: A G76E mutant version of the thioredoxin-like domain with glycine 76 changed to glutamic acid was engineered by mutagenesis with primer KC369 (5 -GGAATCAAGGTT GAAGAAGTCGATG-3 ) and KC370 (5 -CATCGACTTCTTCAA C CTTGATTCC-3 ) and was designated pG2TG76E.,False Positive
WBPaper00005177,WBGene00004397,rol-6,G76E,T01B7.7,Line 18644: These constructs were injected with markerspRF4 ( rol-6 d ) into wild- type animals or with p d11 cDNA into dpy-11 mutants for expression pattern examination.,Line 18660: A G76E mutant version of the thioredoxin-like domain with glycine 76 changed to glutamic acid was engineered by mutagenesis with primer KC369 (5 -GGAATCAAGGTT GAAGAAGTCGATG-3 ) and KC370 (5 -CATCGACTTCTTCAA C CTTGATTCC-3 ) and was designated pG2TG76E.,False Positive
WBPaper00005208,WBGene00000875,cyk-4,S15L,K08E3.6,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2542: The N-terminal 34 amino acids of Microtubule Bundling by the CYK-4/ZEN-4 Complex 43 CYK-4 are poorly conserved and are followed by an 90 S15L, was engineered into the CYK-4 expression con- struct (c4) and used for ZEN-4 binding assays.",True Positive
WBPaper00005208,WBGene00002245,lag-1,E502K,K08B4.1b,"Line 2782: Cells were washed twice with cold PBS, frozen in 44(e1260) , lag-1(q385) , and mIs11 IV.","Line 2566: This substitution allele, E502K, binding domain (z7) consisting of 169 amino acids was does not cause a detectable phenotype on its own.",False Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",E340K,M03D4.1a,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2626: The nature of 11 alleles are shown in the figure; two additional substitution mutations in ZEN-4 were iso- lated, E340K and G454E.",False Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",E340K,M03D4.1b,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2626: The nature of 11 alleles are shown in the figure; two additional substitution mutations in ZEN-4 were iso- lated, E340K and G454E.",False Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",E340K,M03D4.1f,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2626: The nature of 11 alleles are shown in the figure; two additional substitution mutations in ZEN-4 were iso- lated, E340K and G454E.",False Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",E502K,M03D4.1a,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2566: This substitution allele, E502K, binding domain (z7) consisting of 169 amino acids was does not cause a detectable phenotype on its own.",True Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",E502K,M03D4.1b,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2566: This substitution allele, E502K, binding domain (z7) consisting of 169 amino acids was does not cause a detectable phenotype on its own.",True Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",E502K,M03D4.1f,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2566: This substitution allele, E502K, binding domain (z7) consisting of 169 amino acids was does not cause a detectable phenotype on its own.",True Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",G454E,M03D4.1a,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2626: The nature of 11 alleles are shown in the figure; two additional substitution mutations in ZEN-4 were iso- lated, E340K and G454E.",False Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",G454E,M03D4.1b,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2626: The nature of 11 alleles are shown in the figure; two additional substitution mutations in ZEN-4 were iso- lated, E340K and G454E.",False Positive
WBPaper00005208,WBGene00006974,"zen-4, klp-9",G454E,M03D4.1f,"Line 2478: Microtubule bundling and completion of cytokinesis require ZEN-4/CeMKLP-1, a kinesin-like protein, and CYK-4, which contains a RhoGAP domain.","Line 2626: The nature of 11 alleles are shown in the figure; two additional substitution mutations in ZEN-4 were iso- lated, E340K and G454E.",False Positive
WBPaper00005275,WBGene00000070,acy-3,E992K,C44F1.5,"Line 10434: Two additional genes encode adenylyl cyclases in the C. elegans genome, acy-3 (located on chro- mosome V, our unpublished observation) and acy-4 (lo- cated on chromosome III, C44F1.5; C. elegans Se- quencing Consortium 1998).","Line 10378: We conclude from this result that a 137 sgs-1 Is an Essential Gene TABLE 1 Properties of the fifl mutants Suppression of neural Growth in trans Allele Mutation Change Domain degeneration (%) to pk1279 pk862 caacgtc caatgtc Upstream of ATG 100 pk393 a gga aga G69R M1 100 ND pk884 cca tca P152A M1 72 pk363 a gga gaa G181E M1 100 ND pk863 gga gaa G181E M1 ND ND pk866 gga gaa G181E M1 100 pk487 ctc ttc L314F C1a 100 pk485 ctt ttt L347F C1a ND ND pk886 ctt ttt L347F C1a 100 pk880 gct gtt A374V C1a 100 pk867 atg ata M411I C1a 87 pk927 cac tac H455Y C1a 100 pk301 a tcc ttc S457F C1a 100 / pk311 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk474 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk871 gtaactt ataactt Splice donor, site C1a 100 intron 7 pk907 gaa aaa E992K M2-C2a 100 pk384 a ggg agg G1068R C2a 93 pk904 aga aaa R1074K C2a 100 pk484 agt aat S1109N C2a 100 pk874 agt aat S1109N C2a ND ND pk875 cgc cac R1216H C2a 100 pk310 a Unknown 100 ND pk1279 Deletion C1b-M2-C2 100 pk1279 / Deletion/wild type 9 Neuronal degeneration induced by activated G s under heat-shock promoter control as described in materials and methods .",False Positive
WBPaper00005275,WBGene00000070,acy-3,S457F,C44F1.5,"Line 10434: Two additional genes encode adenylyl cyclases in the C. elegans genome, acy-3 (located on chro- mosome V, our unpublished observation) and acy-4 (lo- cated on chromosome III, C44F1.5; C. elegans Se- quencing Consortium 1998).","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00000071,acy-4,L314F,T01C2.1,"Line 10434: Two additional genes encode adenylyl cyclases in the C. elegans genome, acy-3 (located on chro- mosome V, our unpublished observation) and acy-4 (lo- cated on chromosome III, C44F1.5; C. elegans Se- quencing Consortium 1998).","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00001063,dpy-1,G1068R,M01E10.2a,"Line 10281: 1998), dpy-17(e164) males were crossed with Bristol N2 hermaphro- NL1250 ( mut-2(r459) I; sgs-1(pk450::Tc1) III) ( Korswagen et dites and with homozygous sgs-1 mutants.",Line 10354: This suggests that in the mutants G1068R and R1074K suppression of the during development and that the ability to develop into larva is not the result of the presence of maternal sgs-1 neuronal degeneration is the result of decreased bind- ing to G s .,False Positive
WBPaper00005275,WBGene00001063,dpy-1,G181E,M01E10.2a,"Line 10281: 1998), dpy-17(e164) males were crossed with Bristol N2 hermaphro- NL1250 ( mut-2(r459) I; sgs-1(pk450::Tc1) III) ( Korswagen et dites and with homozygous sgs-1 mutants.","Line 10378: We conclude from this result that a 137 sgs-1 Is an Essential Gene TABLE 1 Properties of the fifl mutants Suppression of neural Growth in trans Allele Mutation Change Domain degeneration (%) to pk1279 pk862 caacgtc caatgtc Upstream of ATG 100 pk393 a gga aga G69R M1 100 ND pk884 cca tca P152A M1 72 pk363 a gga gaa G181E M1 100 ND pk863 gga gaa G181E M1 ND ND pk866 gga gaa G181E M1 100 pk487 ctc ttc L314F C1a 100 pk485 ctt ttt L347F C1a ND ND pk886 ctt ttt L347F C1a 100 pk880 gct gtt A374V C1a 100 pk867 atg ata M411I C1a 87 pk927 cac tac H455Y C1a 100 pk301 a tcc ttc S457F C1a 100 / pk311 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk474 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk871 gtaactt ataactt Splice donor, site C1a 100 intron 7 pk907 gaa aaa E992K M2-C2a 100 pk384 a ggg agg G1068R C2a 93 pk904 aga aaa R1074K C2a 100 pk484 agt aat S1109N C2a 100 pk874 agt aat S1109N C2a ND ND pk875 cgc cac R1216H C2a 100 pk310 a Unknown 100 ND pk1279 Deletion C1b-M2-C2 100 pk1279 / Deletion/wild type 9 Neuronal degeneration induced by activated G s under heat-shock promoter control as described in materials and methods .",False Positive
WBPaper00005275,WBGene00001680,"gpb-2, eat-11, gbp-2",L314F,F52A8.2a,"Line 10293: 1990) and of pk450::Tc1 , sgs-1(pk1279) , was isolated and could not be pRP2017 ( gpb-2::gfp ;50 g/ml; van der Linden et al.","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00001680,"gpb-2, eat-11, gbp-2",L347F,F52A8.2a,"Line 10293: 1990) and of pk450::Tc1 , sgs-1(pk1279) , was isolated and could not be pRP2017 ( gpb-2::gfp ;50 g/ml; van der Linden et al.","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00006752,unc-13,E992K,ZK524.2a,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10378: We conclude from this result that a 137 sgs-1 Is an Essential Gene TABLE 1 Properties of the fifl mutants Suppression of neural Growth in trans Allele Mutation Change Domain degeneration (%) to pk1279 pk862 caacgtc caatgtc Upstream of ATG 100 pk393 a gga aga G69R M1 100 ND pk884 cca tca P152A M1 72 pk363 a gga gaa G181E M1 100 ND pk863 gga gaa G181E M1 ND ND pk866 gga gaa G181E M1 100 pk487 ctc ttc L314F C1a 100 pk485 ctt ttt L347F C1a ND ND pk886 ctt ttt L347F C1a 100 pk880 gct gtt A374V C1a 100 pk867 atg ata M411I C1a 87 pk927 cac tac H455Y C1a 100 pk301 a tcc ttc S457F C1a 100 / pk311 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk474 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk871 gtaactt ataactt Splice donor, site C1a 100 intron 7 pk907 gaa aaa E992K M2-C2a 100 pk384 a ggg agg G1068R C2a 93 pk904 aga aaa R1074K C2a 100 pk484 agt aat S1109N C2a 100 pk874 agt aat S1109N C2a ND ND pk875 cgc cac R1216H C2a 100 pk310 a Unknown 100 ND pk1279 Deletion C1b-M2-C2 100 pk1279 / Deletion/wild type 9 Neuronal degeneration induced by activated G s under heat-shock promoter control as described in materials and methods .",False Positive
WBPaper00005275,WBGene00006752,unc-13,G1068R,ZK524.2e,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.",Line 10354: This suggests that in the mutants G1068R and R1074K suppression of the during development and that the ability to develop into larva is not the result of the presence of maternal sgs-1 neuronal degeneration is the result of decreased bind- ing to G s .,False Positive
WBPaper00005275,WBGene00006752,unc-13,G1068R,ZK524.2i,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.",Line 10354: This suggests that in the mutants G1068R and R1074K suppression of the during development and that the ability to develop into larva is not the result of the presence of maternal sgs-1 neuronal degeneration is the result of decreased bind- ing to G s .,False Positive
WBPaper00005275,WBGene00006752,unc-13,L347F,ZK524.2a,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00006752,unc-13,L347F,ZK524.2d,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00006752,unc-13,L347F,ZK524.2e,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005275,WBGene00006752,unc-13,P152A,ZK524.2b,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10378: We conclude from this result that a 137 sgs-1 Is an Essential Gene TABLE 1 Properties of the fifl mutants Suppression of neural Growth in trans Allele Mutation Change Domain degeneration (%) to pk1279 pk862 caacgtc caatgtc Upstream of ATG 100 pk393 a gga aga G69R M1 100 ND pk884 cca tca P152A M1 72 pk363 a gga gaa G181E M1 100 ND pk863 gga gaa G181E M1 ND ND pk866 gga gaa G181E M1 100 pk487 ctc ttc L314F C1a 100 pk485 ctt ttt L347F C1a ND ND pk886 ctt ttt L347F C1a 100 pk880 gct gtt A374V C1a 100 pk867 atg ata M411I C1a 87 pk927 cac tac H455Y C1a 100 pk301 a tcc ttc S457F C1a 100 / pk311 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk474 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk871 gtaactt ataactt Splice donor, site C1a 100 intron 7 pk907 gaa aaa E992K M2-C2a 100 pk384 a ggg agg G1068R C2a 93 pk904 aga aaa R1074K C2a 100 pk484 agt aat S1109N C2a 100 pk874 agt aat S1109N C2a ND ND pk875 cgc cac R1216H C2a 100 pk310 a Unknown 100 ND pk1279 Deletion C1b-M2-C2 100 pk1279 / Deletion/wild type 9 Neuronal degeneration induced by activated G s under heat-shock promoter control as described in materials and methods .",False Positive
WBPaper00005275,WBGene00006752,unc-13,P152A,ZK524.2g,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10378: We conclude from this result that a 137 sgs-1 Is an Essential Gene TABLE 1 Properties of the fifl mutants Suppression of neural Growth in trans Allele Mutation Change Domain degeneration (%) to pk1279 pk862 caacgtc caatgtc Upstream of ATG 100 pk393 a gga aga G69R M1 100 ND pk884 cca tca P152A M1 72 pk363 a gga gaa G181E M1 100 ND pk863 gga gaa G181E M1 ND ND pk866 gga gaa G181E M1 100 pk487 ctc ttc L314F C1a 100 pk485 ctt ttt L347F C1a ND ND pk886 ctt ttt L347F C1a 100 pk880 gct gtt A374V C1a 100 pk867 atg ata M411I C1a 87 pk927 cac tac H455Y C1a 100 pk301 a tcc ttc S457F C1a 100 / pk311 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk474 a gtaactt ataactt Splice donor, site C1a 100 ND intron 7 pk871 gtaactt ataactt Splice donor, site C1a 100 intron 7 pk907 gaa aaa E992K M2-C2a 100 pk384 a ggg agg G1068R C2a 93 pk904 aga aaa R1074K C2a 100 pk484 agt aat S1109N C2a 100 pk874 agt aat S1109N C2a ND ND pk875 cgc cac R1216H C2a 100 pk310 a Unknown 100 ND pk1279 Deletion C1b-M2-C2 100 pk1279 / Deletion/wild type 9 Neuronal degeneration induced by activated G s under heat-shock promoter control as described in materials and methods .",False Positive
WBPaper00005275,WBGene00006752,unc-13,P152S,ZK524.2b,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10397: However, three alleles, pk384 (G1068R), pk867 (M411I), and pk884 (P152S), showed 100% suppres- that in these animals, sgs-1 activity is reduced due to the 138 C. Moorman and R. H. A. Plasterk Figure 2.Structural representation of the residues that are changed in sgs-1 mutants.",False Positive
WBPaper00005275,WBGene00006752,unc-13,P152S,ZK524.2g,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10397: However, three alleles, pk384 (G1068R), pk867 (M411I), and pk884 (P152S), showed 100% suppres- that in these animals, sgs-1 activity is reduced due to the 138 C. Moorman and R. H. A. Plasterk Figure 2.Structural representation of the residues that are changed in sgs-1 mutants.",False Positive
WBPaper00005275,WBGene00006752,unc-13,R1074K,ZK524.2f,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.",Line 10354: This suggests that in the mutants G1068R and R1074K suppression of the during development and that the ability to develop into larva is not the result of the presence of maternal sgs-1 neuronal degeneration is the result of decreased bind- ing to G s .,False Positive
WBPaper00005275,WBGene00006752,unc-13,R1216H,ZK524.2h,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10357: The neuronal degeneration phenotype is already S1109N, and R1216H).",False Positive
WBPaper00005275,WBGene00006752,unc-13,S1109N,ZK524.2k,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10357: The neuronal degeneration phenotype is already S1109N, and R1216H).",False Positive
WBPaper00005275,WBGene00006752,unc-13,S457F,ZK524.2g,"Line 10478: 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo- line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain UNC-13.","Line 10356: fifl mutants are suppressors of activated G s -induced were distributed over the structure and were changed to larger residues (L314F, L347F, A374V, H455Y, and neuronal degeneration: sgs-1 mutants were initially se- lected as suppressors of activated G s -induced neuronal S457F) or to residues that no longer make contact with the backbone or side chain of other amino acids (M411I, degeneration ( Berger et al.",False Positive
WBPaper00005276,WBGene00001063,dpy-1,S24P,M01E10.2a,Line 10683: Bristol was the wild-type parent spe-27(it132); hc163 dpy-18(e364) hermaphrodites were mated of all mutant strains.,"Line 10832: Beside region [ e.g., hc167(S24P)] and the catalytic cleft [e.g., hc164, hc176, hc187 (all G133E), and hc168 (L135F)].",False Positive
WBPaper00005276,WBGene00004960,spe-6,L135F,Y66D12A.20,"Line 10636: Eighteen of the suppressor mutations are new alleles of spe-6, a previously identified gene required for an early stage of spermatogenesis.","Line 10832: Beside region [ e.g., hc167(S24P)] and the catalytic cleft [e.g., hc164, hc176, hc187 (all G133E), and hc168 (L135F)].",False Positive
WBPaper00005276,WBGene00004960,spe-6,T194I,Y66D12A.20,"Line 10636: Eighteen of the suppressor mutations are new alleles of spe-6, a previously identified gene required for an early stage of spermatogenesis.",Line 10843: The T194I mutation in sterile alleles hc92 and hc143 alters a threonine that normally H-bonds to the catalytic aspartic acid.,True Positive
WBPaper00005276,WBGene00004962,spe-8,L135F,F53G12.6,"Line 10635: The suppressors bypass the requirement for spe-27, as well as three other genes that act in this pathway, spe-8, spe-12, and spe-29.","Line 10832: Beside region [ e.g., hc167(S24P)] and the catalytic cleft [e.g., hc164, hc176, hc187 (all G133E), and hc168 (L135F)].",False Positive
WBPaper00005276,WBGene00004966,spe-12,S24P,T02E1.1,"Line 10635: The suppressors bypass the requirement for spe-27, as well as three other genes that act in this pathway, spe-8, spe-12, and spe-29.","Line 10832: Beside region [ e.g., hc167(S24P)] and the catalytic cleft [e.g., hc164, hc176, hc187 (all G133E), and hc168 (L135F)].",False Positive
WBPaper00005276,WBGene00006759,"unc-22, twitchin",G133E,ZK617.1c,"Line 10667: We show that 18 of independently from unc-22(e66) , which is itself closely linked these suppressor mutations are alleles of spe-6 .","Line 10832: Beside region [ e.g., hc167(S24P)] and the catalytic cleft [e.g., hc164, hc176, hc187 (all G133E), and hc168 (L135F)].",False Positive
WBPaper00005276,WBGene00006759,"unc-22, twitchin",T176I,ZK617.1d,"Line 10667: We show that 18 of independently from unc-22(e66) , which is itself closely linked these suppressor mutations are alleles of spe-6 .","Line 10820: cally reduced kinase activity, has an identical substitu- As shown in Figure 4, SPE-6 mutations that lead to the spermiogenesis-defect suppression phenotype are tion of the corresponding residue (T176I; Murakami et al.",False Positive
WBPaper00005374,WBGene00000148,aph-2,R51*,ZC434.6a,"Line 2108: A C. elegans genetic screen revealed two genes, aph-1 and pen-2, encoding multipass transmembrane proteins, that interact strongly with sel-12/presenilin and aph-2/nicastrin.","Line 2218: Alleles used in these tests were: aph-1(ep140) , pen-2(ep220) , sel-12(ep6) , and aph-2(ep335) . aph-2(ep335) , which carries a R51 stop mutation, confers 100% penetrant Egl and Mel/Aph phenotypes.",False Positive
WBPaper00005374,WBGene00000148,aph-2,R51*,ZC434.6b,"Line 2108: A C. elegans genetic screen revealed two genes, aph-1 and pen-2, encoding multipass transmembrane proteins, that interact strongly with sel-12/presenilin and aph-2/nicastrin.","Line 2218: Alleles used in these tests were: aph-1(ep140) , pen-2(ep220) , sel-12(ep6) , and aph-2(ep335) . aph-2(ep335) , which carries a R51 stop mutation, confers 100% penetrant Egl and Mel/Aph phenotypes.",False Positive
WBPaper00005374,WBGene00003975,pen-2,R51*,T28D6.9,"Line 2108: A C. elegans genetic screen revealed two genes, aph-1 and pen-2, encoding multipass transmembrane proteins, that interact strongly with sel-12/presenilin and aph-2/nicastrin.","Line 2218: Alleles used in these tests were: aph-1(ep140) , pen-2(ep220) , sel-12(ep6) , and aph-2(ep335) . aph-2(ep335) , which carries a R51 stop mutation, confers 100% penetrant Egl and Mel/Aph phenotypes.",False Positive
WBPaper00005374,WBGene00006747,"unc-7, unc-12, unc-124",R51*,R07D5.1d,"Line 2221: Complete genotypes were as follows: a, unc-29 aph-1 ;b, aph-1(RNAi) ;c, pen-2 and pen-2 dpy-18 ;d, pen-2(RNAi) ; e, unc-29 aph-2 ;f, aph-2(RNAi) and unc74 aph-2(RNAi) ;g, sel-12 ;h, hop-1(ep90 , ep168 ,or ep171); i, hop-1(ep168 or ep171) unc-74 ; sel-12; j, unc-29 aph-1 ; sel-12 ;k, pen-2 dpy-18 ; sel-12 ;l, unc-29 aph-2 ; sel-12 ;m, aph-2(RNAi) ; sel-12 ;n, hop-1(ep90 or ep168) unc-74 aph-1 ;o, hop-1(ep168) unc-74 ; pen-2 ;p, hop-1(ep171) unc-74 ; pen-2(RNAi) ;q, hop-1(ep171) unc-74 aph-2 ;r, hop-1(ep168) unc-74 aph-2(RNAi) ;s, hop-1(ep171) unc-74 aph-2(RNAi) ;t, unc-29 aph-1 ; pen-2 ;u, unc-29 aph-1 ; pen-2(RNAi) ;v, unc-29 aph-1 aph-2(RNAi) ;w, aph-2(RNAi) ; pen-2 dpy-18 ;x, hop-1(ep171) unc-74 aph-2 ; pen-2 dpy-18 .","Line 2218: Alleles used in these tests were: aph-1(ep140) , pen-2(ep220) , sel-12(ep6) , and aph-2(ep335) . aph-2(ep335) , which carries a R51 stop mutation, confers 100% penetrant Egl and Mel/Aph phenotypes.",False Positive
WBPaper00005374,WBGene00006747,"unc-7, unc-12, unc-124",R51*,R07D5.1e,"Line 2221: Complete genotypes were as follows: a, unc-29 aph-1 ;b, aph-1(RNAi) ;c, pen-2 and pen-2 dpy-18 ;d, pen-2(RNAi) ; e, unc-29 aph-2 ;f, aph-2(RNAi) and unc74 aph-2(RNAi) ;g, sel-12 ;h, hop-1(ep90 , ep168 ,or ep171); i, hop-1(ep168 or ep171) unc-74 ; sel-12; j, unc-29 aph-1 ; sel-12 ;k, pen-2 dpy-18 ; sel-12 ;l, unc-29 aph-2 ; sel-12 ;m, aph-2(RNAi) ; sel-12 ;n, hop-1(ep90 or ep168) unc-74 aph-1 ;o, hop-1(ep168) unc-74 ; pen-2 ;p, hop-1(ep171) unc-74 ; pen-2(RNAi) ;q, hop-1(ep171) unc-74 aph-2 ;r, hop-1(ep168) unc-74 aph-2(RNAi) ;s, hop-1(ep171) unc-74 aph-2(RNAi) ;t, unc-29 aph-1 ; pen-2 ;u, unc-29 aph-1 ; pen-2(RNAi) ;v, unc-29 aph-1 aph-2(RNAi) ;w, aph-2(RNAi) ; pen-2 dpy-18 ;x, hop-1(ep171) unc-74 aph-2 ; pen-2 dpy-18 .","Line 2218: Alleles used in these tests were: aph-1(ep140) , pen-2(ep220) , sel-12(ep6) , and aph-2(ep335) . aph-2(ep335) , which carries a R51 stop mutation, confers 100% penetrant Egl and Mel/Aph phenotypes.",False Positive
WBPaper00005504,WBGene00001413,fem-3,F103I,C01F6.4c,"Line 17230: Northern hybridization experiments reveal that the wee-1.3 -encoded 2.4 kb mRNA was found in fem- 1(hc17lf) hermaphrodites, which do not make sperm, as well as fem-3(q23gf) hermaphrodites, which make sperm but no oocytes (data not shown).",Line 17212: The eb94 suppressor mutation allows hermaphrodites to produce broods of 72. The eb94 F103I missense mutation affects a residue that is conserved among Myt1 orthologs (Fig.,False Positive
WBPaper00005504,WBGene00001413,fem-3,I160N,C01F6.4c,"Line 17230: Northern hybridization experiments reveal that the wee-1.3 -encoded 2.4 kb mRNA was found in fem- 1(hc17lf) hermaphrodites, which do not make sperm, as well as fem-3(q23gf) hermaphrodites, which make sperm but no oocytes (data not shown).",Line 17211: eb62 is an I160N missense mutation in an amino acid that shows weak conservation between wee-1.3 and its vertebrate orthologs (Fig.,False Positive
WBPaper00005504,WBGene00001414,fer-1,G1957A,F43G9.6a,"Line 17030: wee-1.3(eb104) was isolated in a F 1 non- complementation screen for new recessive fer-14 alleles (T. Kroft and S. W. L., unpublished).","Line 17200: Three of these dominant alleles ( q89 , e1947 and eb104 ) contained the same G1957A mutation that changes the encoded glycine at position 560 to an arginine.",False Positive
WBPaper00005504,WBGene00001414,fer-1,G558R,F43G9.6b,"Line 17030: wee-1.3(eb104) was isolated in a F 1 non- complementation screen for new recessive fer-14 alleles (T. Kroft and S. W. L., unpublished).","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005504,WBGene00004884,"smg-6, mab-16, est-1, spr-8",G560E,Y54F10AL.2a,"Line 17023: LG III: dpy-1(e1) (Brenner, 1974) and smg-6(r896) (Hodgkin et al., 1989).","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005504,WBGene00004884,"smg-6, mab-16, est-1, spr-8",G560E,Y54F10AL.2c,"Line 17023: LG III: dpy-1(e1) (Brenner, 1974) and smg-6(r896) (Hodgkin et al., 1989).","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005504,WBGene00004884,"smg-6, mab-16, est-1, spr-8",G560R,Y54F10AL.2a,"Line 17023: LG III: dpy-1(e1) (Brenner, 1974) and smg-6(r896) (Hodgkin et al., 1989).","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005504,WBGene00004884,"smg-6, mab-16, est-1, spr-8",G560R,Y54F10AL.2c,"Line 17023: LG III: dpy-1(e1) (Brenner, 1974) and smg-6(r896) (Hodgkin et al., 1989).","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",D561N,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",F103I,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.",Line 17212: The eb94 suppressor mutation allows hermaphrodites to produce broods of 72. The eb94 F103I missense mutation affects a residue that is conserved among Myt1 orthologs (Fig.,True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",G245E,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.",Line 17223: The eb88 suppressor results in a G245E missense mutation and eb90 results in a H163P missense mutation; each of these mutations affects an amino acid that is within a strongly conserved region (Fig.,True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",G558R,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",G560E,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",G560R,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",H163P,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.",Line 17223: The eb88 suppressor results in a G245E missense mutation and eb90 results in a H163P missense mutation; each of these mutations affects an amino acid that is within a strongly conserved region (Fig.,True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",I160N,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.",Line 17211: eb62 is an I160N missense mutation in an amino acid that shows weak conservation between wee-1.3 and its vertebrate orthologs (Fig.,True Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",L590*,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005504,WBGene00006940,"wee-1.3, spe-37",Q588*,Y53C12A.1,"Line 16985: The Caenorhabditis elegans Myt1 ortholog is encoded by the wee-1.3 gene, and six dominant missense mutants prevent primary spermatocytes from entering M phase but do not affect either oocyte meiosis or any mitotic division.","Line 17236: DISCUSSION wee-1.3(gf) has allowed a genetic analysis of the Myt1 kinase family We have analyzed a series of six dominant mutations in wee- 1.3 that affect the G/M transition during spermatogenesis but do not affect either the somatic cell cycle, germline eb62 I160N tttcg g ..... S I I S F STOP wild type spliced wee-1.3 mRNA q89 eb87 spliced wee-1.3 mRNA eb93 Q588stop eb60 L590stop eb87 eb91 deletion (545 bp) SL1 G590R 3' UTR spe-37(gf) q89 , e1947 and eb104 G560R eb95 G558R hc144 G560E hc145 D561N TCA ATT ATA AGT ...TTT TGA eb88 G245E eb90 H163P eb94 F103I ATP kinase A B TM TM eb61 S I TCA ATT gtaa....tttcag gtaa....tttcag Fig.",False Positive
WBPaper00005533,WBGene00000951,deg-3,E112K,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,G170E,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,G170R,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,G305E,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,I314N,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1835: RESULTS deg-3(u662)isamissensemutationinthepore-forming domainoftheacetylcholinereceptorsubunitDEG-3.This mutation(I314N)causesderegulatedreceptoractivityleading to degeneration of neurons expressing this receptor and concomitantly to uncoordinated movement and mechano- sensorydefects( 9,10).Wescreenedformutationswhich suppressedthebehavioraldefectscausedbythe deg-3(u662) mutation.Forthispurposewemutated deg-3(u662)homozy- gous animals and screened for F2 progeny that regained normal behavior.",False Positive
WBPaper00005533,WBGene00000951,deg-3,L309F,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",False Positive
WBPaper00005533,WBGene00000951,deg-3,P137L,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,P137S,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,S205N,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000951,deg-3,Y337D,K03B8.9,Line 1804: The deg-3 (u662) mutation is a degeneration-causing mutation in a Caenorhabditis elegans nicotinic acetylcholine receptor.,"Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",True Positive
WBPaper00005533,WBGene00000955,"des-2, acr-4",I314N,T26H10.1a,Line 1823: Mutations in deg-3were identifiedfollowingoutcrossofthemutantstrainsidentified inthesescreenswithN2males.Mutationsin deg-3itself suppress the appearance of the dominant deg-3(u662) phenotypeinallF1andF2progenyofthesecrosses(atleast 1000F2progenywereexamined).The des-2(hm71)mutation was identified in a noncomplementation screen for des-2 This research was supported by the Israel Science Foundation (Grant 493/01-16.6).,"Line 1835: RESULTS deg-3(u662)isamissensemutationinthepore-forming domainoftheacetylcholinereceptorsubunitDEG-3.This mutation(I314N)causesderegulatedreceptoractivityleading to degeneration of neurons expressing this receptor and concomitantly to uncoordinated movement and mechano- sensorydefects( 9,10).Wescreenedformutationswhich suppressedthebehavioraldefectscausedbythe deg-3(u662) mutation.Forthispurposewemutated deg-3(u662)homozy- gous animals and screened for F2 progeny that regained normal behavior.",False Positive
WBPaper00005533,WBGene00000955,"des-2, acr-4",I314N,T26H10.1b,Line 1823: Mutations in deg-3were identifiedfollowingoutcrossofthemutantstrainsidentified inthesescreenswithN2males.Mutationsin deg-3itself suppress the appearance of the dominant deg-3(u662) phenotypeinallF1andF2progenyofthesecrosses(atleast 1000F2progenywereexamined).The des-2(hm71)mutation was identified in a noncomplementation screen for des-2 This research was supported by the Israel Science Foundation (Grant 493/01-16.6).,"Line 1835: RESULTS deg-3(u662)isamissensemutationinthepore-forming domainoftheacetylcholinereceptorsubunitDEG-3.This mutation(I314N)causesderegulatedreceptoractivityleading to degeneration of neurons expressing this receptor and concomitantly to uncoordinated movement and mechano- sensorydefects( 9,10).Wescreenedformutationswhich suppressedthebehavioraldefectscausedbythe deg-3(u662) mutation.Forthispurposewemutated deg-3(u662)homozy- gous animals and screened for F2 progeny that regained normal behavior.",False Positive
WBPaper00005533,WBGene00003168,"mec-4, mec-13",C586T,T01C8.7,"Line 1873: Alternatively, deg- 3 ( u662 )-induced degenerations are similar to what is seen in degenerin [ mec-4d and deg-3 ( u38 )] induced degenerations ( 9 ); thus it is also possible that the deg-3 ( u662 )-induced degeneration process interferes with extension of axons, as was seen in mec-4d -induced degenerations, leading to type B like staining ( 19 ).","Line 1841: Allofthemissensemutationsarestrongsuppressorsof the degeneration process, as seen by their effect on the numberofswollencells,thehallmarkofthedegeneration F IGURE 1: Genomicmapof deg-3showingpositionsofmutations identifiedinthisstudy: blackboxes,codingregion;emptyboxes, membrane-spanningdomain;lines,introns;circles,missensemuta- tions;triangles,nonsensemutations.Theresultsofsequenceanalysis ofthemutationsareasfollows,includingthepositionandnature oftheaminoacidsubstitution,thepositionandnatureofthebase change (using the first A of the first ATG in the cDNA as reference),andthenumberofidenticalalleles(whenmorethan one): missensemutations,E112K:G334A,P137S:C409T,P137L: C410T, G170R:G508A, G170E:G509A (two alleles), S205N: G614A, G305E:G914A (two alleles), L309F:C925T, Y337D: T1009G;nonsensemutations,W104:G315A(fivealleles),W109: G326A,W135:G405A(threealleles),R196:C586T(twoalleles), W253:G758A,Q323:C967A,W395:G1184A,Q449:C1345T(three alleles),W479:G1436A(twoalleles),W517:G1551A(twoalleles).",False Positive
WBPaper00005783,WBGene00001663,gpa-1,S247P,T19C4.6a,"Line 3296: We characterized a C. elegans Galpha subunit gene, gpa-12, which is a homolog of mammalian G(12)/G(13)alpha, and found that animals defective in gpa-12 are viable.",Line 3444: (pk1478 ) contains a S247P amino acid substitution in the first C1A Proc.,False Positive
WBPaper00005783,WBGene00006599,"tpa-1, nipi-1",S247P,B0545.1a,"Line 3299: We isolated 50 suppressors that contain mutations in tpa-1, which encodes two protein kinase C isoforms, TPA-1A and TPA-1B, most similar to PKCtheta/delta.",Line 3444: (pk1478 ) contains a S247P amino acid substitution in the first C1A Proc.,True Positive
WBPaper00005955,WBGene00000074,adm-2,D461N,C04A11.4a,"Line 10959: The nematode C. elegans has four ADAM genes ( adm-1 , adm-2 , adm-4 and sup-17 ), and one secreted ADAM-like gene ( mig-17 ) (The C. elegans Genome Consortium, 1998).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00000074,adm-2,D461N,C04A11.4b,"Line 10959: The nematode C. elegans has four ADAM genes ( adm-1 , adm-2 , adm-4 and sup-17 ), and one secreted ADAM-like gene ( mig-17 ) (The C. elegans Genome Consortium, 1998).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00000075,adm-4,C477Y,ZK154.7,"Line 10959: The nematode C. elegans has four ADAM genes ( adm-1 , adm-2 , adm-4 and sup-17 ), and one secreted ADAM-like gene ( mig-17 ) (The C. elegans Genome Consortium, 1998).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00000075,adm-4,D461N,ZK154.7,"Line 10959: The nematode C. elegans has four ADAM genes ( adm-1 , adm-2 , adm-4 and sup-17 ), and one secreted ADAM-like gene ( mig-17 ) (The C. elegans Genome Consortium, 1998).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00001612,"glr-1, not-3",C477Y,C06E1.4,"Line 11164: (I,J) Ventral view of wild-type and unc- 71 animals expressing nuIs25[P glr-1 GFP] in the interneurons.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00003143,"max-1, frm-6",C477Y,C34B4.1b,"Line 11226: The signal transduction pathway downstream of the receptors is in part mediated by unc-34/Ena and max-1 (Colavita and Culotti, 1998; Huang et al., 2002).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00003143,"max-1, frm-6",L471P,C34B4.1a,"Line 11226: The signal transduction pathway downstream of the receptors is in part mediated by unc-34/Ena and max-1 (Colavita and Culotti, 1998; Huang et al., 2002).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00003248,mig-17,C477Y,F57B7.4,"Line 10959: The nematode C. elegans has four ADAM genes ( adm-1 , adm-2 , adm-4 and sup-17 ), and one secreted ADAM-like gene ( mig-17 ) (The C. elegans Genome Consortium, 1998).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00003929,"pat-2, vab-20",L471P,F54F2.1,"Line 11194: unc-71 acts in parallel to ina-1 / pat-3 integrins in motor axon guidance It is generally thought that a major function of ADAM proteins is to regulate the extracellular matrix, and that the integrin receptors are important targets of ADAM proteins (Wolfsberg et al., 1995; Evans, 2001).The C. elegans genome has two inte grin- a subunits, ina-1 and pat-2 ;one integrin- b sub unit, pat-3 ; and one integrin- b subunit, inb-1 (Hutter et al., 2000).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00003930,"pat-3, epi-2",D461N,ZK1058.2,"Line 11194: unc-71 acts in parallel to ina-1 / pat-3 integrins in motor axon guidance It is generally thought that a major function of ADAM proteins is to regulate the extracellular matrix, and that the integrin receptors are important targets of ADAM proteins (Wolfsberg et al., 1995; Evans, 2001).The C. elegans genome has two inte grin- a subunits, ina-1 and pat-2 ;one integrin- b sub unit, pat-3 ; and one integrin- b subunit, inb-1 (Hutter et al., 2000).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00003930,"pat-3, epi-2",L471P,ZK1058.2,"Line 11194: unc-71 acts in parallel to ina-1 / pat-3 integrins in motor axon guidance It is generally thought that a major function of ADAM proteins is to regulate the extracellular matrix, and that the integrin receptors are important targets of ADAM proteins (Wolfsberg et al., 1995; Evans, 2001).The C. elegans genome has two inte grin- a subunits, ina-1 and pat-2 ;one integrin- b sub unit, pat-3 ; and one integrin- b subunit, inb-1 (Hutter et al., 2000).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00006070,str-2,G149R,C50C10.7,"Line 11166: (K,L) Schematics of VD 13 neuron morphology viewed using juIs76 marker (K) and AWC neuron morphology viewed by kyIs136[P str-2 GFP] marker (L) in wild-type and unc-71 animals.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00006351,sur-5,D504N,K03A1.5,"Line 11141: unc-71 acts cell non-autonomously to regulate D motor neuron axon guidance To address where UNC-71 function is required for Dneuron axon guidance, we first performed geneticmosaic analysis with unc-71(ju156); juIs76[P unc-25 GFP] animals that also carried an extrachromosomal array containing the unc-71 rescuing DNA pool and SUR-5::GFP, a cell-autonomous nuclear GFP marker (Yochem et al., 1998).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00006745,unc-5,G149R,B0273.4a,"Line 11225: UNC-6 acts upon the UNC-5 receptor and the UNC-5 and UNC- 40/DCC co-receptor (Wadsworth, 2002).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00006745,unc-5,G149R,B0273.4b,"Line 11225: UNC-6 acts upon the UNC-5 receptor and the UNC-5 and UNC- 40/DCC co-receptor (Wadsworth, 2002).","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",D461N,T19B4.7,"Line 11236: Similar enhancement was also observed for double mutants between unc-71 with unc-40 ,or unc-34 ,or max-1 (Fig.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",C477Y,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",C509Y,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",D461N,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",D504N,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",G149R,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",L471P,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",P902L,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",True Positive
WBPaper00005955,WBGene00006804,"unc-71, max-3, adm-1",R990K,Y37D8A.13,Line 10928: WE report that the C. elegans gene unc-71 encodes a unique ADAM with an inactive metalloprotease domain.,"Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00009100,rgef-1,C509Y,F25B3.3a,"Line 10996: Tissue-specific expression of unc-71 The P unc-115 , P jam-1 , P unc-119 , P unc-33 , P F25B3.3 , P unc-25 , P unc-30 and P glr -1 promoters (Jin et al., 1994; Hart et al., 1995; Maduro and Pilgrim, 1995; Lundquist et al., 1998; Jin et al., 1999; Altun-Gultekin et al., 2001; Koppen et al., 2001) were inserted upstream of the unc-71 mini-gene in pCZ418.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00009100,rgef-1,C509Y,F25B3.3b,"Line 10996: Tissue-specific expression of unc-71 The P unc-115 , P jam-1 , P unc-119 , P unc-33 , P F25B3.3 , P unc-25 , P unc-30 and P glr -1 promoters (Jin et al., 1994; Hart et al., 1995; Maduro and Pilgrim, 1995; Lundquist et al., 1998; Jin et al., 1999; Altun-Gultekin et al., 2001; Koppen et al., 2001) were inserted upstream of the unc-71 mini-gene in pCZ418.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00009100,rgef-1,D461N,F25B3.3a,"Line 10996: Tissue-specific expression of unc-71 The P unc-115 , P jam-1 , P unc-119 , P unc-33 , P F25B3.3 , P unc-25 , P unc-30 and P glr -1 promoters (Jin et al., 1994; Hart et al., 1995; Maduro and Pilgrim, 1995; Lundquist et al., 1998; Jin et al., 1999; Altun-Gultekin et al., 2001; Koppen et al., 2001) were inserted upstream of the unc-71 mini-gene in pCZ418.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00005955,WBGene00009100,rgef-1,D461N,F25B3.3b,"Line 10996: Tissue-specific expression of unc-71 The P unc-115 , P jam-1 , P unc-119 , P unc-33 , P F25B3.3 , P unc-25 , P unc-30 and P glr -1 promoters (Jin et al., 1994; Hart et al., 1995; Maduro and Pilgrim, 1995; Lundquist et al., 1998; Jin et al., 1999; Altun-Gultekin et al., 2001; Koppen et al., 2001) were inserted upstream of the unc-71 mini-gene in pCZ418.","Line 11075: Molecular lesions of unc-71 mutants Amino acid AlleleNucleotide changechangeDomains ju161 G GA A GA G149R Prodomain ju156 170 bp deletionG149Prodomain ay64 G AT A AT D461N Disintegrin ay46, ay51 CT C CC C L471P Disintegrin ay17, ad48 7TG T TA T C477Y Disintegrin ay49 C GA T GA R490opal Disintegrin ju160 G AC A AC D504N Disintegrin ju159 TG T TA T C509Y Disintegrin ay45, ay50 C AA T AAQ533ochreCys rich ay52 TGG TGA W550opalCys rich ju194 G GA T GAG551opalCys rich e541 G CG A CGA557TCys rich ju157 GG A GA AG594ECys rich ay7 C AA T AAQ623ochreCys rich ay47 TC G TT GS628LCys rich ay44 T GT A GTC687SEGF like ay48 CC A CT A P902L Cytoplasmic C AA T AA Q948opal Cytoplasmic ju255 AG A AA A R990K Cytoplasmic ju mutations were isolated in the screen for axon guidance mutants using juIs76 [P unc-25 GFP] marker (Huang et al., 2002).",False Positive
WBPaper00006135,WBGene00000440,"ceh-17, ceh-42",E181K,D1007.1,"Line 11400: We confirmed this identification by immunostaining SUP-9::GFP-expressing animals and UNC-93::GFP- expressing animals with antisera raised against the homeodomain transcrip- tionfactorCEH-17,whichisexpressedinthefourSIAneuronsandtheALA neuron (Pujol et al., 2000).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001068,dpy-6,A236T,F16F9.2,"Line 11363: The following mutations were used in this study: linkage group (LG) II: lin- 42(n1089 ), sup-9(e2655gf , e2661gf , lr1, lr100 , lr11, lr129 , lr142 , lr30, lr35, lr38, lr45, lr57, lr73, n180 , n186 , n188 , n189 , n190 , n191 , n213 , n219 , n222 , n223 , n229 , n233 , n241 , n264 , n266 , n271 , n292 , n345 , n350 , n508 , n659 , n688 , n1009 , n1012 , n1016 , n1020 , n1023 , n1025 , n1026 , n1028 , n1037 , n1428 , n1435 , n1469 , n1472 , n1549 , n1550gf , n1553 , n1557 , n1913 , n1914 , n2174 , n2175 , n2176 , n2276 , n2278 , n2279 , n2281 , n2282 , n2283 , n2284 , n2285 , n2286 , n2287 , n2288 , n2291 , n2292 , n2294 , n2296 , n2343 , n2344 , n2345 , n2346 , n2347 , n2348 , n2349 , n2350 , n2351 , n2352 , n2353 , n2354 , n2355 , n2356 , n2357 , n2358 , n2359 , n2360 , n2361 , n3310gf , nP136 , lin- 31(n301 ); LGIII: unc-93(e1500gf , lr12, n234 ), nIs124 , sup-18(n1030 ); LGX: dpy-6(e14 ), sup-10(e2127 , n983gf , n183 , n240 , n247 , n250 , n251 , n342 , n619 , n1007 , n1008 , n1017 , n1468 , n1626 , n1906 , n2297 , n3558 , n3564 ), lin-15(n765ts ).",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00001068,dpy-6,T103I,F16F9.2,"Line 11363: The following mutations were used in this study: linkage group (LG) II: lin- 42(n1089 ), sup-9(e2655gf , e2661gf , lr1, lr100 , lr11, lr129 , lr142 , lr30, lr35, lr38, lr45, lr57, lr73, n180 , n186 , n188 , n189 , n190 , n191 , n213 , n219 , n222 , n223 , n229 , n233 , n241 , n264 , n266 , n271 , n292 , n345 , n350 , n508 , n659 , n688 , n1009 , n1012 , n1016 , n1020 , n1023 , n1025 , n1026 , n1028 , n1037 , n1428 , n1435 , n1469 , n1472 , n1549 , n1550gf , n1553 , n1557 , n1913 , n1914 , n2174 , n2175 , n2176 , n2276 , n2278 , n2279 , n2281 , n2282 , n2283 , n2284 , n2285 , n2286 , n2287 , n2288 , n2291 , n2292 , n2294 , n2296 , n2343 , n2344 , n2345 , n2346 , n2347 , n2348 , n2349 , n2350 , n2351 , n2352 , n2353 , n2354 , n2355 , n2356 , n2357 , n2358 , n2359 , n2360 , n2361 , n3310gf , nP136 , lin- 31(n301 ); LGIII: unc-93(e1500gf , lr12, n234 ), nIs124 , sup-18(n1030 ); LGX: dpy-6(e14 ), sup-10(e2127 , n983gf , n183 , n240 , n247 , n250 , n251 , n342 , n619 , n1007 , n1008 , n1017 , n1468 , n1626 , n1906 , n2297 , n3558 , n3564 ), lin-15(n765ts ).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001171,egl-2,E88K,F16B3.1a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00001171,egl-2,E88K,F16B3.1b,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00001171,egl-2,K170OPAL,F16B3.1a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00001171,egl-2,K170OPAL,F16B3.1b,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00001374,exp-2,A74V,F12F3.1b,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00001374,exp-2,D58V,F12F3.1a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00001374,exp-2,E181K,F12F3.1d,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,F226S,F12F3.1b,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,G202D,F12F3.1a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,G202S,F12F3.1a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,Q216OPAL,F12F3.1d,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,Q42AMBER,F12F3.1d,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,Q77AMBER,F12F3.1c,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,T195I,F12F3.1b,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,V242M,F12F3.1a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001374,exp-2,V44E,F12F3.1c,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00001579,gex-2,L122F,F56A11.1,"Line 11388: Codons 1-118 of sup-9 were fused to the glutathione S-transferase (GST) gene in the vector pGEX-2T (Amer- sham Biosciences, Piscataway, NJ), and codons 1-110 were fused to the maltose-binding protein (MBP) gene in the vector pMal-c2 (NEB).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001579,gex-2,L20OCHRE,F56A11.1,"Line 11388: Codons 1-118 of sup-9 were fused to the glutathione S-transferase (GST) gene in the vector pGEX-2T (Amer- sham Biosciences, Piscataway, NJ), and codons 1-110 were fused to the maltose-binding protein (MBP) gene in the vector pMal-c2 (NEB).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001579,gex-2,Q208OPAL,F56A11.1,"Line 11388: Codons 1-118 of sup-9 were fused to the glutathione S-transferase (GST) gene in the vector pGEX-2T (Amer- sham Biosciences, Piscataway, NJ), and codons 1-110 were fused to the maltose-binding protein (MBP) gene in the vector pMal-c2 (NEB).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00001579,gex-2,V242M,F56A11.1,"Line 11388: Codons 1-118 of sup-9 were fused to the glutathione S-transferase (GST) gene in the vector pGEX-2T (Amer- sham Biosciences, Piscataway, NJ), and codons 1-110 were fused to the maltose-binding protein (MBP) gene in the vector pMal-c2 (NEB).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003055,lon-1,A236T,F48E8.1b,"Line 11399: The paralysis caused by sup-9 , sup-10 , and unc-93 gf mutations is suppressed by lf mutations in any of the three genes Genotype Locomotion rate (bends per min SEM) Animals assayed Wild-type 26.3 0.6 n16 sup-9(n1550) Inviable sup-9(n1550)/ 1.3 0.4 n16 sup-10(n983) 5.1 0.5 n16 unc-93(e1500) 0.2 0.1 n32 sup-9(n1550n2287) 26.5 0.7 n16 sup-10(n983n1017) 23.5 0.5 n16 unc-93(e1500lr12) 24.6 0.6 n16 sup-9(n1550); sup-10(n983n1017) 19.2 0.4 n16 sup-9(n1550); unc-93(e1500lr12) 22.7 0.5 n16 sup-9(n1550n2287); unc-93(e1500) 24.3 0.6 n16 unc-93(e1500); sup-10(n1017) 23.5 0.5 n16 sup-9(n1550n2287); sup-10(n983) 24.7 0.7 n16 unc-93(lr12); sup-10(n983) 24.8 0.5 n16 lon-1 sup-10(n983) 5.2 0.5 n20 lon-1(e185) sup-5(e1464sd) sup-10(n983) 9.9 0.5 n20 Young adult hermaphrodites were assayed for the number of bends they make while moving on a bacterial lawn during a 1 min interval.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00003055,lon-1,G200E,F48E8.1a,"Line 11399: The paralysis caused by sup-9 , sup-10 , and unc-93 gf mutations is suppressed by lf mutations in any of the three genes Genotype Locomotion rate (bends per min SEM) Animals assayed Wild-type 26.3 0.6 n16 sup-9(n1550) Inviable sup-9(n1550)/ 1.3 0.4 n16 sup-10(n983) 5.1 0.5 n16 unc-93(e1500) 0.2 0.1 n32 sup-9(n1550n2287) 26.5 0.7 n16 sup-10(n983n1017) 23.5 0.5 n16 unc-93(e1500lr12) 24.6 0.6 n16 sup-9(n1550); sup-10(n983n1017) 19.2 0.4 n16 sup-9(n1550); unc-93(e1500lr12) 22.7 0.5 n16 sup-9(n1550n2287); unc-93(e1500) 24.3 0.6 n16 unc-93(e1500); sup-10(n1017) 23.5 0.5 n16 sup-9(n1550n2287); sup-10(n983) 24.7 0.7 n16 unc-93(lr12); sup-10(n983) 24.8 0.5 n16 lon-1 sup-10(n983) 5.2 0.5 n20 lon-1(e185) sup-5(e1464sd) sup-10(n983) 9.9 0.5 n20 Young adult hermaphrodites were assayed for the number of bends they make while moving on a bacterial lawn during a 1 min interval.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003055,lon-1,G200E,F48E8.1b,"Line 11399: The paralysis caused by sup-9 , sup-10 , and unc-93 gf mutations is suppressed by lf mutations in any of the three genes Genotype Locomotion rate (bends per min SEM) Animals assayed Wild-type 26.3 0.6 n16 sup-9(n1550) Inviable sup-9(n1550)/ 1.3 0.4 n16 sup-10(n983) 5.1 0.5 n16 unc-93(e1500) 0.2 0.1 n32 sup-9(n1550n2287) 26.5 0.7 n16 sup-10(n983n1017) 23.5 0.5 n16 unc-93(e1500lr12) 24.6 0.6 n16 sup-9(n1550); sup-10(n983n1017) 19.2 0.4 n16 sup-9(n1550); unc-93(e1500lr12) 22.7 0.5 n16 sup-9(n1550n2287); unc-93(e1500) 24.3 0.6 n16 unc-93(e1500); sup-10(n1017) 23.5 0.5 n16 sup-9(n1550n2287); sup-10(n983) 24.7 0.7 n16 unc-93(lr12); sup-10(n983) 24.8 0.5 n16 lon-1 sup-10(n983) 5.2 0.5 n20 lon-1(e185) sup-5(e1464sd) sup-10(n983) 9.9 0.5 n20 Young adult hermaphrodites were assayed for the number of bends they make while moving on a bacterial lawn during a 1 min interval.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003055,lon-1,G200E,F48E8.1c,"Line 11399: The paralysis caused by sup-9 , sup-10 , and unc-93 gf mutations is suppressed by lf mutations in any of the three genes Genotype Locomotion rate (bends per min SEM) Animals assayed Wild-type 26.3 0.6 n16 sup-9(n1550) Inviable sup-9(n1550)/ 1.3 0.4 n16 sup-10(n983) 5.1 0.5 n16 unc-93(e1500) 0.2 0.1 n32 sup-9(n1550n2287) 26.5 0.7 n16 sup-10(n983n1017) 23.5 0.5 n16 unc-93(e1500lr12) 24.6 0.6 n16 sup-9(n1550); sup-10(n983n1017) 19.2 0.4 n16 sup-9(n1550); unc-93(e1500lr12) 22.7 0.5 n16 sup-9(n1550n2287); unc-93(e1500) 24.3 0.6 n16 unc-93(e1500); sup-10(n1017) 23.5 0.5 n16 sup-9(n1550n2287); sup-10(n983) 24.7 0.7 n16 unc-93(lr12); sup-10(n983) 24.8 0.5 n16 lon-1 sup-10(n983) 5.2 0.5 n20 lon-1(e185) sup-5(e1464sd) sup-10(n983) 9.9 0.5 n20 Young adult hermaphrodites were assayed for the number of bends they make while moving on a bacterial lawn during a 1 min interval.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003168,"mec-4, mec-13",F226S,T01C8.7,"Line 11440: sup-10 encodes a novel putative transmembrane protein sup-10 was previously mapped to the right end of LGX near mec-4 (Greenwald and Horvitz, 1980; A. Villenevue, personal commu- nication to all).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003168,"mec-4, mec-13",G230E,T01C8.7,"Line 11440: sup-10 encodes a novel putative transmembrane protein sup-10 was previously mapped to the right end of LGX near mec-4 (Greenwald and Horvitz, 1980; A. Villenevue, personal commu- nication to all).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003168,"mec-4, mec-13",G230R,T01C8.7,"Line 11440: sup-10 encodes a novel putative transmembrane protein sup-10 was previously mapped to the right end of LGX near mec-4 (Greenwald and Horvitz, 1980; A. Villenevue, personal commu- nication to all).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003168,"mec-4, mec-13",G95D,T01C8.7,"Line 11440: sup-10 encodes a novel putative transmembrane protein sup-10 was previously mapped to the right end of LGX near mec-4 (Greenwald and Horvitz, 1980; A. Villenevue, personal commu- nication to all).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003168,"mec-4, mec-13",L122F,T01C8.7,"Line 11440: sup-10 encodes a novel putative transmembrane protein sup-10 was previously mapped to the right end of LGX near mec-4 (Greenwald and Horvitz, 1980; A. Villenevue, personal commu- nication to all).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003369,mlc-1,L122F,C36E6.3,"Line 11443: Neurosci., October 8, 2003 23(27):91339145 Perez de la Cruz et al.Putative C. elegans Two-Pore Channel Regulatory Subunits son mutagenesis using cosmid ZK54, which we found in unrelated studies to contain the mlc-1 gene ( mlc-1 encodes a myosin light chain, and we regarded this gene as a candidate for corresponding to sup-10 ) (Fig.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003515,"myo-3, sup-3",A236T,K12F2.1,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00003515,"myo-3, sup-3",A23V,K12F2.1,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003515,"myo-3, sup-3",G200E,K12F2.1,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003515,"myo-3, sup-3",K170OPAL,K12F2.1,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00003515,"myo-3, sup-3",R131OCHRE,K12F2.1,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003930,"pat-3, epi-2",F226S,ZK1058.2,"Line 11356: We thank J. Hodgkin for the sup-9(e2655 ) and sup-9(e2661 ) mutants, C. Ceol for the sup-9(n3310 ) mutant, B. DeStasio for the sup-9(lr )lf mutants, B. Williams for supplying the pat-3::gfp plasmid, and A.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003930,"pat-3, epi-2",K170OPAL,ZK1058.2,"Line 11356: We thank J. Hodgkin for the sup-9(e2655 ) and sup-9(e2661 ) mutants, C. Ceol for the sup-9(n3310 ) mutant, B. DeStasio for the sup-9(lr )lf mutants, B. Williams for supplying the pat-3::gfp plasmid, and A.","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00003930,"pat-3, epi-2",Q126AMBER,ZK1058.2,"Line 11356: We thank J. Hodgkin for the sup-9(e2655 ) and sup-9(e2661 ) mutants, C. Ceol for the sup-9(n3310 ) mutant, B. DeStasio for the sup-9(lr )lf mutants, B. Williams for supplying the pat-3::gfp plasmid, and A.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003930,"pat-3, epi-2",T103I,ZK1058.2,"Line 11356: We thank J. Hodgkin for the sup-9(e2655 ) and sup-9(e2661 ) mutants, C. Ceol for the sup-9(n3310 ) mutant, B. DeStasio for the sup-9(lr )lf mutants, B. Williams for supplying the pat-3::gfp plasmid, and A.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00003930,"pat-3, epi-2",T236M,ZK1058.2,"Line 11356: We thank J. Hodgkin for the sup-9(e2655 ) and sup-9(e2661 ) mutants, C. Ceol for the sup-9(n3310 ) mutant, B. DeStasio for the sup-9(lr )lf mutants, B. Williams for supplying the pat-3::gfp plasmid, and A.","Line 11488: sup- 9, sup-10 , and unc-93 function in muscles To confirm their structure and muscle expression, we overex- pressed the sup-9 , sup-10 , and unc-93 cDNAs under the myo-3 Table 3. sup-9 altered-function mutations Allele Mutation Effect Isolation background Allele type Mutagen n1550 GCG to ACG A236T Wild-type gf EMS n3310 GCG to ACG A236T Wild-type gf EMS e2655 GCG to ACG A236T Wild-type gf EMS e2661 GCG to ACG A236T Wild-type gf EMS n2360 ACG to ATG T236M sup-9(n1550) Partial lf EMS n2361 ACG to ATG T236M sup-9(n1550) Partial lf EMS n2288 GGA to GAA G173E sup-9(n1550) Partial lf EMS n2359 GCA to ACA A174T sup-9(n1550) Partial lf EMS The sequence of the sup-9 coding region including intron exon boundaries was determined.",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19a,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19b,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19c,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19d,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19e,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19f,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19g,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19h,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19i,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19j,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19k,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19l,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",I61S,Y51A2D.19m,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00004830,"slo-1, nsy-3",R131OCHRE,Y51A2D.19m,"Line 11571: Mutants de- fective in several C. elegans voltage-gated K channels have been characterized, including the K v channels exp-2 (Davis et al., 1999) and egl-36 (Elkes et al., 1997; Johnstone et al., 1997), the HERG channel egl-2 (Weinshenker et al., 1999) and the large- conductance Ca 2 -activated channel slo-1 (Wang et al., 2001).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",A174T,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11438: Two other partial lf alleles, sup-9(n1550 n2288) and sup-9(n1550 n2359) , contain missense mutations affecting the third trans- membrane domain, G173E and A174T, respectively.",True Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",A236T,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,True Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",A23V,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",A74V,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",D203A,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",D203N,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",D278N,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11463: Continued Allele Mutation Effect Isolation background Mutagen Splice mutations n241 e AGgt to AGct Intron 1 Donor unc-93(e1500) DES n659 a AGgt to AGct Intron 1 Donor sup-18(n463); unc-93(e1500) EMS n180 e agAG to acAG Intron 1 Accept sup-10(n983) SPO n1028 a CGgt to CGat Intron 2 Donor sup-10(n983) EMS GAT to AAT D278N n2285 c TGgt to TGat Intron 3 Donor sup-9(n1550); sup-18(n1014) EMS n271 e AGgt to AGat Intron 4 Donor unc-93(e1500) EMS n1553 c AGgt to AGat Intron 4 Donor sup-10(n983) EMS n2175 c agGA to aaGA Intron 4 Accept sup-9(n1550) EMS n2174 c TGgt to TGat Intron 5 Donor sup-9(n1550) EMS n2279 c agAG to aaAG Intron 6 Accept sup-9(n1435); unc93(e1500) EMS n1026 a CGgt to CGat Intron 7 Donor sup-10(n983) EMS Insertion, deletion, and frame-shift mutations n1913 f C to GAT Codon 4 Fs unc-93(e1500) GR n1428 d Tc1 Insertion Codon 17 Fs unc-93(e1500) SPO n2287 c 155 bp Del.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",D58V,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",E181K,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",F109S,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",F226S,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G106E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G106R,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G121R,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G172E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G172R,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G173E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11438: Two other partial lf alleles, sup-9(n1550 n2288) and sup-9(n1550 n2359) , contain missense mutations affecting the third trans- membrane domain, G173E and A174T, respectively.",True Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G173R,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G200E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G202D,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G202S,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G22E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G230E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G230R,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",G95D,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",I61S,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",I94N,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",L122F,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",L20OCHRE,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",P101S,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",P119S,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Q126AMBER,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Q208OPAL,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Q216OPAL,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Q37AMBER,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Q42AMBER,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Q77AMBER,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",R131OCHRE,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",S235F,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",T103I,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",T195I,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",V242M,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",V41A,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",V44E,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",W165AMBER,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",W165OCHRE,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",W165R,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",W78AMBER,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",W78OCHRE,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006318,"sup-9, twk-23, twk-38",Y190F,F34D6.3,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006656,"twk-1, twk-7",D203A,F21C3.1,"Line 11572: While two-pore channels define the largest family of K chan - nels, mutations affecting only one gene in this family, twk-18 , have been reported (Kunkel et al., 2000).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006656,"twk-1, twk-7",D203N,F21C3.1,"Line 11572: While two-pore channels define the largest family of K chan - nels, mutations affecting only one gene in this family, twk-18 , have been reported (Kunkel et al., 2000).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006656,"twk-1, twk-7",L20OCHRE,F21C3.1,"Line 11572: While two-pore channels define the largest family of K chan - nels, mutations affecting only one gene in this family, twk-18 , have been reported (Kunkel et al., 2000).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006656,"twk-1, twk-7",V44E,F21C3.1,"Line 11572: While two-pore channels define the largest family of K chan - nels, mutations affecting only one gene in this family, twk-18 , have been reported (Kunkel et al., 2000).","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006745,unc-5,A236T,B0273.4d,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00006745,unc-5,A23V,B0273.4f,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,D203A,B0273.4c,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,D203N,B0273.4c,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,E88K,B0273.4d,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00006745,unc-5,E88K,B0273.4e,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00006745,unc-5,G202D,B0273.4f,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,G202S,B0273.4f,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,G95D,B0273.4d,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,I61S,B0273.4c,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006745,unc-5,I94N,B0273.4f,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,L20OCHRE,B0273.4d,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,Q37AMBER,B0273.4c,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,T103I,B0273.4a,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,T103I,B0273.4b,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,T103I,B0273.4c,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,V242M,B0273.4f,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006745,unc-5,V44E,B0273.4d,Line 11375: The unc-54 3fi untranslated region (UTR) from pPD95.77 was replaced with an 808 bp region of genomic sequence im- mediately following the stop codon of sup-9 by standard PCR and clon- ing techniques.,"Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006749,unc-9,K170OPAL,R12H7.1a,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00006749,unc-9,P119S,R12H7.1a,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006749,unc-9,V41A,R12H7.1b,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006749,unc-9,V44E,R12H7.1b,"Line 11328: Genetic studies of sup-9, unc-93, and sup-10 strongly suggest that these genes encode components of a multi-subunit protein complex that coordinates muscle contraction in Caenorhabditis elegans.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00006784,unc-49,D278N,T21C12.1o,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11463: Continued Allele Mutation Effect Isolation background Mutagen Splice mutations n241 e AGgt to AGct Intron 1 Donor unc-93(e1500) DES n659 a AGgt to AGct Intron 1 Donor sup-18(n463); unc-93(e1500) EMS n180 e agAG to acAG Intron 1 Accept sup-10(n983) SPO n1028 a CGgt to CGat Intron 2 Donor sup-10(n983) EMS GAT to AAT D278N n2285 c TGgt to TGat Intron 3 Donor sup-9(n1550); sup-18(n1014) EMS n271 e AGgt to AGat Intron 4 Donor unc-93(e1500) EMS n1553 c AGgt to AGat Intron 4 Donor sup-10(n983) EMS n2175 c agGA to aaGA Intron 4 Accept sup-9(n1550) EMS n2174 c TGgt to TGat Intron 5 Donor sup-9(n1550) EMS n2279 c agAG to aaAG Intron 6 Accept sup-9(n1435); unc93(e1500) EMS n1026 a CGgt to CGat Intron 7 Donor sup-10(n983) EMS Insertion, deletion, and frame-shift mutations n1913 f C to GAT Codon 4 Fs unc-93(e1500) GR n1428 d Tc1 Insertion Codon 17 Fs unc-93(e1500) SPO n2287 c 155 bp Del.",False Positive
WBPaper00006135,WBGene00006784,unc-49,E181K,T21C12.1m,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,F226S,T21C12.1o,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G106E,T21C12.1h,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G106R,T21C12.1h,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G121R,T21C12.1m,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G200E,T21C12.1c,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G200E,T21C12.1d,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G200E,T21C12.1e,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,G200E,T21C12.1k,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,I94N,T21C12.1h,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,I94N,T21C12.1i,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,I94N,T21C12.1m,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,K170OPAL,T21C12.1h,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1b,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1c,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1d,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1e,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1f,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1j,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,L122F,T21C12.1k,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,P119S,T21C12.1i,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Q99OPAL,T21C12.1i,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00006784,unc-49,S235F,T21C12.1b,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,S235F,T21C12.1f,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,T103I,T21C12.1h,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,T195I,T21C12.1o,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,T236M,T21C12.1f,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11488: sup- 9, sup-10 , and unc-93 function in muscles To confirm their structure and muscle expression, we overex- pressed the sup-9 , sup-10 , and unc-93 cDNAs under the myo-3 Table 3. sup-9 altered-function mutations Allele Mutation Effect Isolation background Allele type Mutagen n1550 GCG to ACG A236T Wild-type gf EMS n3310 GCG to ACG A236T Wild-type gf EMS e2655 GCG to ACG A236T Wild-type gf EMS e2661 GCG to ACG A236T Wild-type gf EMS n2360 ACG to ATG T236M sup-9(n1550) Partial lf EMS n2361 ACG to ATG T236M sup-9(n1550) Partial lf EMS n2288 GGA to GAA G173E sup-9(n1550) Partial lf EMS n2359 GCA to ACA A174T sup-9(n1550) Partial lf EMS The sequence of the sup-9 coding region including intron exon boundaries was determined.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Y190F,T21C12.1b,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Y190F,T21C12.1c,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Y190F,T21C12.1d,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Y190F,T21C12.1e,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Y190F,T21C12.1f,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006784,unc-49,Y190F,T21C12.1k,"Line 11533: Electrophysiological patch-clamp recordings of C. elegans muscles reveal that treatment of body- wall muscle cells with muscimol, a GABA Cl channel agonist, leads to hyperpolarization by an inward Cl flux that is depen - dent on the GABA receptor channel UNC-49 (Richmond and Jorgensen, 1999).","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,A236T,C01G10.11a,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00006808,unc-76,A236T,C01G10.11b,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00006808,unc-76,A236T,C01G10.11c,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00006808,unc-76,A236T,C01G10.11f,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.",Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00006808,unc-76,D278N,C01G10.11a,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11463: Continued Allele Mutation Effect Isolation background Mutagen Splice mutations n241 e AGgt to AGct Intron 1 Donor unc-93(e1500) DES n659 a AGgt to AGct Intron 1 Donor sup-18(n463); unc-93(e1500) EMS n180 e agAG to acAG Intron 1 Accept sup-10(n983) SPO n1028 a CGgt to CGat Intron 2 Donor sup-10(n983) EMS GAT to AAT D278N n2285 c TGgt to TGat Intron 3 Donor sup-9(n1550); sup-18(n1014) EMS n271 e AGgt to AGat Intron 4 Donor unc-93(e1500) EMS n1553 c AGgt to AGat Intron 4 Donor sup-10(n983) EMS n2175 c agGA to aaGA Intron 4 Accept sup-9(n1550) EMS n2174 c TGgt to TGat Intron 5 Donor sup-9(n1550) EMS n2279 c agAG to aaAG Intron 6 Accept sup-9(n1435); unc93(e1500) EMS n1026 a CGgt to CGat Intron 7 Donor sup-10(n983) EMS Insertion, deletion, and frame-shift mutations n1913 f C to GAT Codon 4 Fs unc-93(e1500) GR n1428 d Tc1 Insertion Codon 17 Fs unc-93(e1500) SPO n2287 c 155 bp Del.",False Positive
WBPaper00006135,WBGene00006808,unc-76,D278N,C01G10.11b,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11463: Continued Allele Mutation Effect Isolation background Mutagen Splice mutations n241 e AGgt to AGct Intron 1 Donor unc-93(e1500) DES n659 a AGgt to AGct Intron 1 Donor sup-18(n463); unc-93(e1500) EMS n180 e agAG to acAG Intron 1 Accept sup-10(n983) SPO n1028 a CGgt to CGat Intron 2 Donor sup-10(n983) EMS GAT to AAT D278N n2285 c TGgt to TGat Intron 3 Donor sup-9(n1550); sup-18(n1014) EMS n271 e AGgt to AGat Intron 4 Donor unc-93(e1500) EMS n1553 c AGgt to AGat Intron 4 Donor sup-10(n983) EMS n2175 c agGA to aaGA Intron 4 Accept sup-9(n1550) EMS n2174 c TGgt to TGat Intron 5 Donor sup-9(n1550) EMS n2279 c agAG to aaAG Intron 6 Accept sup-9(n1435); unc93(e1500) EMS n1026 a CGgt to CGat Intron 7 Donor sup-10(n983) EMS Insertion, deletion, and frame-shift mutations n1913 f C to GAT Codon 4 Fs unc-93(e1500) GR n1428 d Tc1 Insertion Codon 17 Fs unc-93(e1500) SPO n2287 c 155 bp Del.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G106E,C01G10.11a,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G106E,C01G10.11b,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G106E,C01G10.11f,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G106R,C01G10.11a,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G106R,C01G10.11b,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G106R,C01G10.11f,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G173E,C01G10.11d,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11438: Two other partial lf alleles, sup-9(n1550 n2288) and sup-9(n1550 n2359) , contain missense mutations affecting the third trans- membrane domain, G173E and A174T, respectively.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G173R,C01G10.11d,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,G323R,C01G10.11f,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11451: sup-10(n619) encodes a protein with a glutamate-to- lysine substitution in the predicted extracellular domain of SUP- 10, whereas a second missense mutation sup-10(n240) causes a glycine-to-arginine substitution at residue 323 at the beginning of the predicted intracellular domain (Table 4).",False Positive
WBPaper00006135,WBGene00006808,unc-76,I94N,C01G10.11c,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,I94N,C01G10.11e,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,L122F,C01G10.11d,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,L20OCHRE,C01G10.11c,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,P101S,C01G10.11d,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,Q77AMBER,C01G10.11e,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,Q99OPAL,C01G10.11c,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11491: Table 4. sup-10 mutations Allele Mutation Effect Isolation background Mutagen Loss-of-function mutations n1017 a TGG to TAG W19 Amber sup-10(n983) EMS n1008 a CAA to TAA Q99 Opal sup-10(n983) EMS n2297 b TGG to TGA W139 Ochre sup-9(n1550); sup-18(n1014) EMS n1626 a AAA to TAA K170 Opal sup-10(n983) Gamma n619 c GAG to AAG E88K unc-93(e1500) EMS n240 c GGG to AGG G323R unc-93(e1500) DES n1007 a agAT to aaAT Exon 3 Donor sup-10(n983) EMS n250 c TTgtto TTga Exon 5 Donor unc-93(e1500) Gamma n342 c TTgtto TTga Exon 5 Donor unc-93(e1500) NTG n3558 d 85 bp del Codon 16 Fs unc-93(e1500) UV-TMP n3564 d 99 bp del Codon 34 Fs unc-93(e1500) UV-TMP n183 c 53 bp del, Codon 128 Fs unc-93(e1500) SPO e2127 e Tc1 insertion Codon 103 Fs Wild type SPO n1468 a Tc1 insertion Codon 136 Fs sup-10(n983) SPO Gain-of-function mutations n983 a gf TGG to TAG W322 Amber Wild type EMS ThesequencesofbothDNAstrandsweredeterminedforeachmutant.Forsplicemutations,intronsequenceisrepresentedinlowercase,andexonsequenceinuppercase.EMS,Ethylmethanesulfonate;SPO,spontaneous;UV-TMP,ultraviolet and trimethylpsoralen; NTG, nitrosoguanidine; DES, diethyl sulfate.",False Positive
WBPaper00006135,WBGene00006808,unc-76,T103I,C01G10.11e,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,T195I,C01G10.11a,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,T195I,C01G10.11b,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,T195I,C01G10.11f,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00006808,unc-76,V41A,C01G10.11d,"Line 11383: Fire) or an unc-76 promoter vector (Bloom and Horvitz, 1997) to generate myo-3::sup-9 and unc-76::sup-9 , respectively.","Line 11430: The mutations V41A, V44E, D58V, I61S, and A74V cause changes in the M1-P1 linker, which has been shown to act as a dimerization domain in vitro in the human TWIK-1 two-pore channel (Lesage et al., 1996).",False Positive
WBPaper00006135,WBGene00007774,,A236T,C27C12.4,Line 11568: Mouse ET8 and human ET22 are more similar to the C. elegans predicted gene C27C12.4 than to UNC-93.,Line 11431: The sup-9(n1550) gf allele that leads to the rubberband Unc phenotype causes an A236T substitution in the fourth transmem- brane domain.,False Positive
WBPaper00006135,WBGene00007774,,D203A,C27C12.4,Line 11568: Mouse ET8 and human ET22 are more similar to the C. elegans predicted gene C27C12.4 than to UNC-93.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00007774,,D203N,C27C12.4,Line 11568: Mouse ET8 and human ET22 are more similar to the C. elegans predicted gene C27C12.4 than to UNC-93.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00007774,,G106E,C27C12.4,Line 11568: Mouse ET8 and human ET22 are more similar to the C. elegans predicted gene C27C12.4 than to UNC-93.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00007774,,G106R,C27C12.4,Line 11568: Mouse ET8 and human ET22 are more similar to the C. elegans predicted gene C27C12.4 than to UNC-93.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006135,WBGene00007774,,R131OCHRE,C27C12.4,Line 11568: Mouse ET8 and human ET22 are more similar to the C. elegans predicted gene C27C12.4 than to UNC-93.,"Line 11442: Neurosci., October 8, 2003 23(27):91339145 9135 Table 2. sup-9 loss-of-function mutations Allele Mutation Effect Isolation background Mutagen Nonsense mutations n345 e TTA to TGA L20 Ochre unc-93(e1500) NTG n292 e CAG to TAG Q37 Amber unc-93(e1500) SPO n668 a CAG to TAG Q42 Amber unc-93(e1500); sup-18(n463) EMS n1012 a CAG to TAG Q77 Amber sup-10(n983) EMS n2276 c TGG to TAG W78 Amber sup-9(n1435); unc-93(e1500) EMS n2292 c TGG to TAG W78 Amber sup-9(n1550); sup-18(n1014) EMS n1549 f TGG to TGA W78 Ochre sup-10(n983) EMS lr11 b CAG to TAG Q126 Amber unc-93(e1500) ENU n1023 a CGA to TGA R131 Ochre sup-10(n983) EMS n2357 c TGG to TGA W165 Ochre sup-9(n1550); sup-18(n1014) EMS n266 e TGG to TAG W165 Amber unc-93(e1500) EMS n1037 a CAA to TAA Q208 Opal sup-10(n983) EMS lr73 b CAA to TAA Q216 Opal unc-93(e1500) ENU lr57 b CAA to TAA Q216 Opal unc-93(e1500) ENU n186 e CAA to TAA Q216 Opal unc-93(e1500) EMS Missense mutations n2282 c ATG to ATA M1I sup-9(n1435); unc-93(e1500) EMS n213 e GGA to GAA G22E unc-93(e1500) EMS lr129 b GCA to GTA A23V unc-93(e1500) ENU n1472 f GTG to GCG V41A sup-10(n983) GR n233 e GTG to GAG V44E unc-93(e1500) DES n2291 c GAC to GTC D58V sup-9(n1550) EMS lr35 b ATT to AGT I61S unc-93(e1500) ENU n1025 a GCC to GTC A74V sup-10(n983) EMS n1016 a ATC to AAC I94N sup-10(n983) EMS n1020 a GGC to GAC G95D sup-10(n983) EMS n2354 c GGC to GAC G95D sup-9(n1550); sup-18(n1014) EMS n190 e CCA to TCA P101S unc-93(e1500) EMS n508 g CCA to TCA P101S sup-11(n406) ; unc-93(e1500) EMS n2353 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2356 c CCA to TCA P101S sup-9(n1550); sup-18(n1014) EMS n2347 c ACA to ATA T103I sup-9(n1550); sup-18(n1014) EMS n1009 a GGA to GAA G106E sup-10(n983) EMS n2351 c GGA to AGA G106R sup-9(n1550); sup-18(n1014) EMS lr45 b TTC to TCC F109S unc-93(e1500) ENU n2281 c CCA to TCA P119S sup-9(n1435); unc-93(e1500) EMS n2345 c CCA to TCA P119S sup-9(n1550); sup-18(n1014) EMS lr100 b GGA to AGA G121R unc-93(e1500) ENU n264 e CTT to TTT L122F unc-93(e1500) EMS lr38 b TGG to CGG W165R unc-93(e1500) ENU n2355 c GGA to AGA G172R sup-9(n1550); sup-18(n1014) EMS n219 e GGA to GAA G172E unc-93(e1500) UV n223 e GGA to AGA G172R unc-93(e1500) SPO n2294 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2296 c GGA to AGA G173R sup-9(n1550); sup-18(n1014) EMS n2350 c GAA to AAA E181K sup-9(n1550); sup-18(n1014) EMS n2352 c TAC to TTC Y190F sup-9(n1550); sup-18(n1014) EMS n2278 f ACT to ATT T195I sup-9(n1435) EMS n2343 c ACT to ATT T195I sup-9(n1550); sup-18(n1014) EMS n191 e GGA to GAA G200E unc-93(e1500) EMS n2286 c GGA to GAA G200E sup-9(n1550); sup-18(n1014) EMS n2283 c GGA to GAA G200E sup-9(n1435); unc-93(e1500) EMS n1469 f GGT to AGT G202S sup-10(n983) SPO n2344 c GGT to GAT G202D sup-9(n1550); sup-18(n1014) EMS lr1 b GAC to GCC D203A unc-93(e1500) ENU n2346 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n2349 c GAC to AAC D203N sup-9(n1550); sup-18(n1014) EMS n1557 f TTC to TCC F226S sup-10(n983) EMS n2348 c GGG to AGG G230R sup-9(n1550); sup-18(n1014) EMS n2176 c GGG to GAG G230E sup-9(n1550) EMS n189 e TCT to TTT S235F unc-93(e1500) EMS n2358 c TCT to TTT S235F sup-9(n1550); sup-18(n1014) EMS lr142 b GTG to ATG V242M unc-93(e1500) ENU 9136 J.",False Positive
WBPaper00006391,WBGene00000901,daf-5,E162K,W01G7.1,"Line 2088: We have studied the daf-5 gene, which, along with the daf-3 Smad gene, is antagonized by upstream receptors and receptor-regulated Smads.",Line 2215: This region is critically important for DAF-5 function; the sa310 mutation (E162K) has a phenotype as severe as putative Development 131 (2) Research article A DNA Rescued lin es W07G1 W0 2B8 0 / 2 F 01 D 5 F 49 F 2 W01G7 2 / 4 F 01 D 5 0 / 1 F 49 F 2 3 / 4 W01G7 2 / 2 faP4 d af -5 js P 306 unc -5 2 W01G7 W07G1 F49F2 W0 2 B8 F 01 D5 js P 306 8 .6 kb of W01G7 .,True Positive
WBPaper00006391,WBGene00000905,"daf-9, mig-8",E162K,T13C5.1a,"Line 2108: Genetic analysis places the TGF b pathway upstream of daf-12 (a gene encoding a nuclear hormone receptor) and daf-9 (a gene encoding a putative biosynthetic enzyme for a hormone that regulates DAF-12) (Thomas et al., 1993; Antebi et al., 1998; Gerisch et al., 2001; Jia et al., 2002).",Line 2215: This region is critically important for DAF-5 function; the sa310 mutation (E162K) has a phenotype as severe as putative Development 131 (2) Research article A DNA Rescued lin es W07G1 W0 2B8 0 / 2 F 01 D 5 F 49 F 2 W01G7 2 / 4 F 01 D 5 0 / 1 F 49 F 2 3 / 4 W01G7 2 / 2 faP4 d af -5 js P 306 unc -5 2 W01G7 W07G1 F49F2 W0 2 B8 F 01 D5 js P 306 8 .6 kb of W01G7 .,False Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",D281N,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",False Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",E449K,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",E453K,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",G524D,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",G524S,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",L482I,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).",Line 9336: The allele mu349 carries two changes; one causes a L482I missense mutation and the other is an insertion of a T after nucleotide 2601 that is predicted to generate a stop codon 114 bases downstream of the insertion site.,True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",R460W,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",S239L,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",S369N,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",T498I,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00000238,"bar-1, pvl-1, spy-1",V278G,C54D1.6,"Line 9334: We found six other mutations that introduce stop codons directly in the bar-1 reading frame: de6 (Q25STOP), mu350 (Q143STOP), sy324 (Q304STOP), mu236 (Q320 STOP), de7 (Q320 STOP), and ep479 (W711STOP).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",True Positive
WBPaper00024331,WBGene00003102,"mab-5, lin-21",L130F,C08C3.3,"Line 9443: Second, this result could indicate that the Wnt signaling pathway that regulates mab-5 expression in the Q L neuroblast is more sensitive to alterations in BAR-1 level or activity than the Wnt-mediated processes regulating Hox gene expression in hypodermal cells P3.p-P8.p and P12.","Line 9351: However, for both mu63 and mu349 , different changes were found than those reported previously (Maloof et al., 1999). mu63 was reported to cause an L130F substitution.",False Positive
WBPaper00024331,WBGene00003171,mec-7,L130F,ZK154.3,"Line 9357: Phenotypic analysis of bar-1 mutations We characterized the effects of these bar-1 mutations on three Wnt-mediated processes previously shown to be altered in bar-1(ga80) : vulval induction, migration of the Q L descendants, and P12 cell fate specification (Table 3) .To carry out this analysis and to facilitate isolation and back- crossing of the alleles (see Materials and methods), all of the bar-1 alleles are present in a genetic background containing the integrated transgenic array muIs35 , which contains a mec-7 D GFP reporter construct allowing observation of Q L progeny in live animals by fluorescence microscopy (Chal- fie, 1994).","Line 9351: However, for both mu63 and mu349 , different changes were found than those reported previously (Maloof et al., 1999). mu63 was reported to cause an L130F substitution.",False Positive
WBPaper00024331,WBGene00003842,oct-1,L482I,F52F12.1b,"Line 9426: We found several transcription factors that could potentially bind to these sequences, including CdxA, Oct-1, dl, SRY, HSF, NIT-2, GATA-1, and CRE-BP (L.N.",Line 9336: The allele mu349 carries two changes; one causes a L482I missense mutation and the other is an insertion of a T after nucleotide 2601 that is predicted to generate a stop codon 114 bases downstream of the insertion site.,False Positive
WBPaper00024331,WBGene00006943,wrm-1,R460W,B0336.1b,"Line 9380: The C. elegans genome encodes three h -catenin homologs, two of which, BAR-1 and WRM-1, act in canonical and non- canonical Wnt pathways, respectively (Herman, 2003; Kors- wagen, 2002).","Line 9341: The remaining 12 alleles cause missense mutations in BAR-1: ep451 (S239L), ep484 (V278G, D281N), ep466 (S369N), ep478 (E449K), ep487 (E449K), ep463 (E453K), ep461 (R460W), ep485 (T498I), ep460 (G524D), mu63 (G524D), ep486 (G524S), and mu349 Table 2 Tissue-specific rescue of bar-1 phenotypes Strain Percent underinduced Percentage with P12 defect N Average backup Range N wild type 0 0 200 2.52 F 0.64 2-4 100 bar-1(ga80) 63 86 110 1.15 F 0.67 0.5-3 100 bar-1(ga80) Ex[pDE204] 7 11 500 2.60 F 0.60 2-4 100 bar-1(ga80) Ex[VPCe::bar-1] 6 22 353 1.70 F 0.90 0.5-4 100 bar-1(ga80) Ex[VCNe::bar-1] 53 69 339 2.41 F 0.65 1-5 100 The first column indicates the strains assayed.",False Positive
WBPaper00024569,WBGene00002990,"lin-1, elk-1",A306T,C37F5.1b,"Line 5130: One possibility mouse, the Stomatin Related Olfactory protein (SRO) of is that these proteins interact with many other degenerin olfactory sensory neurons is associated with caveolin-1, proteins in C. elegans.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00002990,"lin-1, elk-1",A320V,C37F5.1a,"Line 5130: One possibility mouse, the Stomatin Related Olfactory protein (SRO) of is that these proteins interact with many other degenerin olfactory sensory neurons is associated with caveolin-1, proteins in C. elegans.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A204T,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A204T,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A204T,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A204T,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A207T,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,A207T,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,A207T,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,A207T,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4d,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4f,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4h,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4i,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4k,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4l,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4m,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A234V,F14D12.4o,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A296V,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A296V,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A296V,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A296V,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A304T,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A304T,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A304T,F14D12.4c,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A304T,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A304T,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4d,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4h,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4k,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4m,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A306T,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A320V,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A320V,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A320V,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A320V,F14D12.4k,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A320V,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,A325T,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A325T,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A325T,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,A325T,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,C387Y,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5069: In addition, we found that two missense cross the plasma membrane [16, 21], MEC-2 is likely to interact with the cytoplasmic and/or membrane span- mutations outside the stomatin-like region, R385H ( u26) and C387Y (u171), which virtually abolish touch sensitiv- ning regions of MEC-4.",True Positive
WBPaper00024569,WBGene00003166,mec-2,C387Y,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5069: In addition, we found that two missense cross the plasma membrane [16, 21], MEC-2 is likely to interact with the cytoplasmic and/or membrane span- mutations outside the stomatin-like region, R385H ( u26) and C387Y (u171), which virtually abolish touch sensitiv- ning regions of MEC-4.",True Positive
WBPaper00024569,WBGene00003166,mec-2,C387Y,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5069: In addition, we found that two missense cross the plasma membrane [16, 21], MEC-2 is likely to interact with the cytoplasmic and/or membrane span- mutations outside the stomatin-like region, R385H ( u26) and C387Y (u171), which virtually abolish touch sensitiv- ning regions of MEC-4.",True Positive
WBPaper00024569,WBGene00003166,mec-2,E297K,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E297K,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E297K,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E297K,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E299K,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,E299K,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,E299K,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,E299K,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,E314K,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E314K,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E314K,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,E314K,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,G243E,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,G243E,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,G243E,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,G243E,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P134S,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P134S,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P134S,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P134S,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357L,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5075: We found, however, that the stomatin-like region was insufficient; and P357L) found in the three missense mutations that most severely disrupted the MEC-2 punctate pattern the MEC-2-specific C terminus was also needed to im- munoprecipitate full-length MEC-2 (Figure 3E).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357L,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5075: We found, however, that the stomatin-like region was insufficient; and P357L) found in the three missense mutations that most severely disrupted the MEC-2 punctate pattern the MEC-2-specific C terminus was also needed to im- munoprecipitate full-length MEC-2 (Figure 3E).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357L,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5075: We found, however, that the stomatin-like region was insufficient; and P357L) found in the three missense mutations that most severely disrupted the MEC-2 punctate pattern the MEC-2-specific C terminus was also needed to im- munoprecipitate full-length MEC-2 (Figure 3E).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357L,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5075: We found, however, that the stomatin-like region was insufficient; and P357L) found in the three missense mutations that most severely disrupted the MEC-2 punctate pattern the MEC-2-specific C terminus was also needed to im- munoprecipitate full-length MEC-2 (Figure 3E).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357S,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357S,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357S,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,P357S,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,Q145R,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).",Line 5064: Further support for the importance of the stomatin-like region for MEC-2 activation comes from our finding that the MEC-2 (114-481) construct we used previously [11] had a Q145R mutation in the stomatin- like region.,False Positive
WBPaper00024569,WBGene00003166,mec-2,Q145R,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).",Line 5064: Further support for the importance of the stomatin-like region for MEC-2 activation comes from our finding that the MEC-2 (114-481) construct we used previously [11] had a Q145R mutation in the stomatin- like region.,False Positive
WBPaper00024569,WBGene00003166,mec-2,Q145R,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).",Line 5064: Further support for the importance of the stomatin-like region for MEC-2 activation comes from our finding that the MEC-2 (114-481) construct we used previously [11] had a Q145R mutation in the stomatin- like region.,False Positive
WBPaper00024569,WBGene00003166,mec-2,Q145R,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).",Line 5064: Further support for the importance of the stomatin-like region for MEC-2 activation comes from our finding that the MEC-2 (114-481) construct we used previously [11] had a Q145R mutation in the stomatin- like region.,False Positive
WBPaper00024569,WBGene00003166,mec-2,R184C,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,R184C,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,R184C,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,R184C,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",True Positive
WBPaper00024569,WBGene00003166,mec-2,R239H,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,R239H,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,R239H,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,R239H,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,R385H,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5069: In addition, we found that two missense cross the plasma membrane [16, 21], MEC-2 is likely to interact with the cytoplasmic and/or membrane span- mutations outside the stomatin-like region, R385H ( u26) and C387Y (u171), which virtually abolish touch sensitiv- ning regions of MEC-4.",False Positive
WBPaper00024569,WBGene00003166,mec-2,R385H,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5069: In addition, we found that two missense cross the plasma membrane [16, 21], MEC-2 is likely to interact with the cytoplasmic and/or membrane span- mutations outside the stomatin-like region, R385H ( u26) and C387Y (u171), which virtually abolish touch sensitiv- ning regions of MEC-4.",False Positive
WBPaper00024569,WBGene00003166,mec-2,R385H,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5069: In addition, we found that two missense cross the plasma membrane [16, 21], MEC-2 is likely to interact with the cytoplasmic and/or membrane span- mutations outside the stomatin-like region, R385H ( u26) and C387Y (u171), which virtually abolish touch sensitiv- ning regions of MEC-4.",False Positive
WBPaper00024569,WBGene00003166,mec-2,S200F,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,S200F,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,S200F,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,S200F,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,T246I,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,T246I,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,T246I,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,T246I,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003166,mec-2,V190M,F14D12.4a,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,V190M,F14D12.4b,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,V190M,F14D12.4e,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003166,mec-2,V190M,F14D12.4n,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",True Positive
WBPaper00024569,WBGene00003168,"mec-4, mec-13",E299K,T01C8.7,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003170,mec-6,V190M,W02D3.3,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003171,mec-7,A296V,ZK154.3,"Line 5186: mec-7 is a fi-tubulin gene required fi-integrin, an endogenous Xenopus oocyte membrane protein [47].","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003171,mec-7,P357L,ZK154.3,"Line 5186: mec-7 is a fi-tubulin gene required fi-integrin, an endogenous Xenopus oocyte membrane protein [47].","Line 5075: We found, however, that the stomatin-like region was insufficient; and P357L) found in the three missense mutations that most severely disrupted the MEC-2 punctate pattern the MEC-2-specific C terminus was also needed to im- munoprecipitate full-length MEC-2 (Figure 3E).",False Positive
WBPaper00024569,WBGene00003171,mec-7,P357S,ZK154.3,"Line 5186: mec-7 is a fi-tubulin gene required fi-integrin, an endogenous Xenopus oocyte membrane protein [47].","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003174,"mec-10, deg-2",A207T,F16F9.5,"Line 4986: Background: The response to gentle body touch in C. elegans requires a degenerin channel complex containing four proteins (MEC-2, MEC-4, MEC-6, and MEC-10).","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",False Positive
WBPaper00024569,WBGene00003889,"osm-9, nss-2",A296V,B0212.5,"Line 5222: OSM-9, a ture of the integral membrane protein stomatin.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003889,"osm-9, nss-2",A304T,B0212.5,"Line 5222: OSM-9, a ture of the integral membrane protein stomatin.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00003889,"osm-9, nss-2",E314K,B0212.5,"Line 5222: OSM-9, a ture of the integral membrane protein stomatin.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006061,stl-1,A234V,F30A10.5a,"Line 5109: Several punctate pattern, however, does require the other pro- teins of the degenerin complex, suggesting that it may stomatin-like proteins in C. elegans (STL-1 and STO-5; S.Z.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006061,stl-1,A234V,F30A10.5b,"Line 5109: Several punctate pattern, however, does require the other pro- teins of the degenerin complex, suggesting that it may stomatin-like proteins in C. elegans (STL-1 and STO-5; S.Z.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006067,sto-5,A204T,F41G4.3d,"Line 5109: Several punctate pattern, however, does require the other pro- teins of the degenerin complex, suggesting that it may stomatin-like proteins in C. elegans (STL-1 and STO-5; S.Z.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006067,sto-5,A207T,F41G4.3d,"Line 5109: Several punctate pattern, however, does require the other pro- teins of the degenerin complex, suggesting that it may stomatin-like proteins in C. elegans (STL-1 and STO-5; S.Z.","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",False Positive
WBPaper00024569,WBGene00006067,sto-5,A234V,F41G4.3b,"Line 5109: Several punctate pattern, however, does require the other pro- teins of the degenerin complex, suggesting that it may stomatin-like proteins in C. elegans (STL-1 and STO-5; S.Z.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006067,sto-5,A234V,F41G4.3d,"Line 5109: Several punctate pattern, however, does require the other pro- teins of the degenerin complex, suggesting that it may stomatin-like proteins in C. elegans (STL-1 and STO-5; S.Z.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006741,"unc-1, unc-102",A207T,K03E6.5a,"Line 5127: like genes [30] of which only mec-2, unc-24, and unc-1 pears to regulate glucose transport in red blood cells [36, 37].","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",False Positive
WBPaper00024569,WBGene00006741,"unc-1, unc-102",A234V,K03E6.5a,"Line 5127: like genes [30] of which only mec-2, unc-24, and unc-1 pears to regulate glucose transport in red blood cells [36, 37].","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006741,"unc-1, unc-102",P134S,K03E6.5b,"Line 5127: like genes [30] of which only mec-2, unc-24, and unc-1 pears to regulate glucose transport in red blood cells [36, 37].","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006741,"unc-1, unc-102",V190M,K03E6.5a,"Line 5127: like genes [30] of which only mec-2, unc-24, and unc-1 pears to regulate glucose transport in red blood cells [36, 37].","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006761,unc-24,A207T,F57H12.2,"Line 4994: A second stomatin-like protein, UNC-24, colocalizes with MEC-2 in vivo and coimmunoprecipitates with MEC-2 and MEC-4 in Xenopus oocytes; unc-24 enhances the touch insensitivity of temperature-sensitive alleles of mec-4 and mec-6.","Line 5074: This region stomatin-like region of MEC-2 would be sufficient to associate with MEC-2 when both proteins were ex- no longer bound GST-MEC-4(1-108) if the MEC-2 se- quence contained any of the changes (R184C, A207T, pressed (without MEC-4) in Xenopus oocytes.",False Positive
WBPaper00024569,WBGene00006761,unc-24,A306T,F57H12.2,"Line 4994: A second stomatin-like protein, UNC-24, colocalizes with MEC-2 in vivo and coimmunoprecipitates with MEC-2 and MEC-4 in Xenopus oocytes; unc-24 enhances the touch insensitivity of temperature-sensitive alleles of mec-4 and mec-6.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00024569,WBGene00006761,unc-24,E299K,F57H12.2,"Line 4994: A second stomatin-like protein, UNC-24, colocalizes with MEC-2 in vivo and coimmunoprecipitates with MEC-2 and MEC-4 in Xenopus oocytes; unc-24 enhances the touch insensitivity of temperature-sensitive alleles of mec-4 and mec-6.","Line 5082: Point Mutations in mec-2 Allele Nucleotide Change Amino Acid Change Type of Mutation Reference u96 G2754A - splice junction u226 G2758A - splice junction u37 G9567A W119* nonsense u90 G9567A W119* nonsense u274 C9610T P134S missense u153 G9762A - splice junction u232 C10324T R179* nonsense Huang et al., 1995 u64 C10339T R184C missense u224 G10357A V190M missense u306 C10388T S200F missense e75 G10399A A204T missense Gu et al., 1996 u284 G10399A A204T missense Gu et al., 1996 u28 G10408A A207T missense u16 C10423T R212* nonsense u277 C10423T R212* nonsense u1 G10447A - splice junction u227 C10540T A234V missense Huang et al., 1995 e1608 G10555A R239H missense Huang et al., 1995 u236 G10567A, A10572T G243E, K245* missense, nonsense u7 G10567A G243E missense Huang et al., 1995 u750 C10576T T246I missense Huang et al., 1995 e1524 C10623T Q262* nonsense Huang et al., 1995 u206 G10718A W272* nonsense u144 C10789T A296V missense u318 G10791A E297K missense e1514 G10797A E299K missense Huang et al., 1995 u243 G10812A A304T missense u24 G10818A A306T missense u217 G10888A E314K missense u233 C10891T Q315* nonsense e1084 C10903T R319* nonsense Huang et al., 1995 u157 C10903T R319* nonsense u328 C10903T R319* nonsense u311 C10907T A320V missense u43 C10922T A325T missense u130 C11067T P357L missense u132 C11066T P357S missense u26 G12856A R385H missense Gu et al., 1996 u171 G12862A C387Y missense u272 C13066T Q430* nonsense u79 G14284A - splice junction u169 C14298T Q453* nonsense u733 C14298T Q453* nonsense Gu et al., 1996 u8 C14358T Q473* nonsense Mutation positions are numbered according to the mec-2 genomic sequence (GenBank Accession U26736) and the full-length MEC-2 amino acid sequence (GenBank Accession Q27433, Huang et al., 1995).",False Positive
WBPaper00025193,WBGene00003515,"myo-3, sup-3",Q78L,K12F2.1,"Line 1315: Coelomocyte endocytosis was assayed using arIs37 (p myo-3::ssGFP ) or cdIs5 (p myo-3::ssDsRed2 ) 17,37 .",Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00003515,"myo-3, sup-3",V65D,K12F2.1,"Line 1315: Coelomocyte endocytosis was assayed using arIs37 (p myo-3::ssGFP ) or cdIs5 (p myo-3::ssDsRed2 ) 17,37 .",Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00004268,rab-5,Q78L,F26H9.6,"Line 1125: Consistent with the known catalytic function of Vps9 domains in Rab5 GDP/GTP exchange, we found that RME-6 binds specifically to Caenorhabditis elegans RAB-5 in the GDP-bound conformation, and rme-6 mutants have phenotypes that indicate low RAB-5 activity.",Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00004268,rab-5,S33N,F26H9.6,"Line 1125: Consistent with the known catalytic function of Vps9 domains in Rab5 GDP/GTP exchange, we found that RME-6 binds specifically to Caenorhabditis elegans RAB-5 in the GDP-bound conformation, and rme-6 mutants have phenotypes that indicate low RAB-5 activity.",Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00004271,rab-7,T23N,W03C9.3,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00004377,rme-6,C1017Y,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,True Positive
WBPaper00025193,WBGene00004377,rme-6,Q324*,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00004377,rme-6,Q610*,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00004377,rme-6,V65D,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,True Positive
WBPaper00025193,WBGene00004377,rme-6,W1079R,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,True Positive
WBPaper00025193,WBGene00004377,rme-6,W757*,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00004377,rme-6,W919*,F49E7.1a,Line 1123: Here we identify a new regulator of endocytosis called RME-6.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00004397,rol-6,S33N,T01B7.7,Line 1345: Rescue of the coelo- mocyte endocytosis defect of an rme-6(b1018);arIs37 strain was achieved by microinjection of a 7.2-kb PCR-amplified DNA fragment including the complete F49E7.1a gene (at 10 micro g ml 1 ) together with the dominant trans- genic marker rol-6(su1006) (pRF4; 100 micro g ml 1 ).,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00006741,"unc-1, unc-102",V65D,K03E6.5a,Line 1341: Tight linkage between rme-6 and unc-1 was shown by the following three-point mapping results: egl-17 (11 of 11) rme-6 (0 of 11) unc-1 ; and unc-1 (0 of 53) rme-6 (53 of 53) dpy-3 .,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00006843,unc-119,T23N,M142.1c,Line 1356: The resulting plasmid was introduced into rme-6(b1014); unc-119(ed3) by the microparticle bombardment together with a marker plasmid MM016B that contains the wild-type unc-119 gene 28 .,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00006843,unc-119,V65D,M142.1b,Line 1356: The resulting plasmid was introduced into rme-6(b1014); unc-119(ed3) by the microparticle bombardment together with a marker plasmid MM016B that contains the wild-type unc-119 gene 28 .,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00006845,"unc-122, ofm-1, cof-1",V65D,F11C3.2,"Line 1329: Transgenic strains constructed for this study are: pwIs2(GFP::rme-6) , pwIs169( p pie-1::GFP::rme-6) , pwIs20( p pie-1::GFP::rab- 5) , pwIs53( p pie-1::mRFP::chc-1) , pwIs31( p unc-122::GFP::rme-6) , pwIs167( p unc-122:: mRFP::chc-1) , pwIs177( p unc-122::mRFP::apt-4) , pwIs179( p unc-122::mRFP::eea-1) , pwEx81( p unc-122::mRFP::rme-6 ; GFP::chc-1) and pwEx82(rme-6::GFP) .",Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00006926,vit-2,T23N,C42D8.2,"Line 1314: Strains expressing transgenes in germline cells were grown at 25 degree C. Other strains were grown at 20 degree C. Transgenic strain bIs1 ( vit-2::GFP ) expressing a fusion of YP170, a yolk protein and GFP was used to monitor yolk uptake by oocytes 16 .",Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",Q324*,C48G7.3h,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",S33N,C48G7.3f,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",S33N,C48G7.3i,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",S33N,C48G7.3l,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1183: a b Bait Vector rme-6 Vector Vector rab-5 WT rab-5(Q78L) rab-5(S33N) rab-7 WT rab-7(T23N) rme-6 Prey + LeuGal / Leu GFPRME-6 GFP + S33N S33N S33N WT WT Q78L Q78L + + + + + + HARAB-5 IP:HA IB:GFP Total lysate IB:GFP IB:HA Figure 2 RME-6 physically interacts with RAB-5 S33N .,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",T293A,C48G7.3k,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,"Line 1347: Comparison of these sequences with the wild-type gene revealed a single sequence change for each mutant ( ar483 (T293A), b1014 (C1816T), ar474 (C3099T), ar476 (G3462A), b1018 (G3899A), ar471 (G3899A), b1019 ts(G4316A), ar477 (G4316A), ar511 (G4725A), ar507 (G5594A) and b1015 (T5980A); Fig.",False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",V65D,C48G7.3d,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",W757*,C48G7.3d,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00008183,"rin-1, tag-333",W919*,C48G7.3g,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00011696,eea-1,Q324*,T10G3.5a,"Line 1237: In coelomocytes we focused on two markers for plasma membrane clathin-coated pits: clathrin heavy chain (CHC-1) and fi- adaptin (APT-4), and two markers for early endosomes: EEA-1 and RAB-5 (Fig.",Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00011696,eea-1,V65D,T10G3.5a,"Line 1237: In coelomocytes we focused on two markers for plasma membrane clathin-coated pits: clathrin heavy chain (CHC-1) and fi- adaptin (APT-4), and two markers for early endosomes: EEA-1 and RAB-5 (Fig.",Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00011696,eea-1,V65D,T10G3.5b,"Line 1237: In coelomocytes we focused on two markers for plasma membrane clathin-coated pits: clathrin heavy chain (CHC-1) and fi- adaptin (APT-4), and two markers for early endosomes: EEA-1 and RAB-5 (Fig.",Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00025193,WBGene00017161,rabn-5,T293A,F01F1.4,"Line 1304: Interestingly, RME-6 seems not to interact with C. elegans Rabaptin-5 (RABN-5) in two-hybrid assays (our unpublished observation) or with EEA-1 in co-immunoprecipitation assays (Fig.","Line 1347: Comparison of these sequences with the wild-type gene revealed a single sequence change for each mutant ( ar483 (T293A), b1014 (C1816T), ar474 (C3099T), ar476 (G3462A), b1018 (G3899A), ar471 (G3899A), b1019 ts(G4316A), ar477 (G4316A), ar511 (G4725A), ar507 (G5594A) and b1015 (T5980A); Fig.",False Positive
WBPaper00025193,WBGene00021922,atg-3,V65D,Y55F3AM.4b,Line 1328: This mutation was followed through genetic crosses by PCR using the primers rabx5-F (5 -ATTCCCCCAGATTGTGTATG-3) and rabx5- R (5 -CCGGTGACGTGGAAGTTGGT-3 ).,Line 1168: ab cd e g h i f Wild type rme-6 rme-6(b1014) rme-6(ar507) DIC ssGFP YP170 GFP SP SP Cc Cc Body cavity 161 356 840 1093 1093 1 GAP Vps9 ar483 (V65D) ar474(Q610stop) ar476 (splice acceptor at codon 627) b1014 (Q324stop) ar511(W919stop) ar507 (C1017Y) b1015 (W1079R) b1019 ts/ar477 (splice acceptor at codon 801) b1014/ar471(W757stop) Ce.RME-6 Ce.C48G7.3 Hs.RME-6 Hs.Rin1 Ce.Rabex-5 Hs.Rabex-5 Sc.Vps9p Dm.RME-6 N2 b1014 (Q324stop ) - M r 132K RME-6 - * Figure 1 rme-6 mutant phenotypes and the predicted RME-6 protein.,False Positive
WBPaper00026908,WBGene00003166,mec-2,A713T,F14D12.4f,Line 15391: The MEC touch-transducing channel complex includes DEG/ENaC subunits MEC-4 (26) and MEC-10 (27) as well as stomatin-related MEC-2 (28) and paraoxonase-related MEC-6 (29).,"Line 15543: A and B, the MEC-4(A713T/A745T) channel is strongly temperature sensitive for induction of necrotic cell death.",False Positive
WBPaper00026908,WBGene00003166,mec-2,A713V,F14D12.4f,Line 15391: The MEC touch-transducing channel complex includes DEG/ENaC subunits MEC-4 (26) and MEC-10 (27) as well as stomatin-related MEC-2 (28) and paraoxonase-related MEC-6 (29).,Line 15414: One major suppressor class we isolated includes intragenic sec- ond site changes that maintain the channel hyperactivating mec-4 (d) substitution (A713V) but have a second site mec-4 mutation that oth- erwise disrupts channel activity.,False Positive
WBPaper00026908,WBGene00003166,mec-2,A745T,F14D12.4d,Line 15391: The MEC touch-transducing channel complex includes DEG/ENaC subunits MEC-4 (26) and MEC-10 (27) as well as stomatin-related MEC-2 (28) and paraoxonase-related MEC-6 (29).,"Line 15368: The bz2 mutation encodes substitution A745T, which is situated in the intracellular C-terminal domain of MEC-4.",False Positive
WBPaper00026908,WBGene00003166,mec-2,S635F,F14D12.4d,Line 15391: The MEC touch-transducing channel complex includes DEG/ENaC subunits MEC-4 (26) and MEC-10 (27) as well as stomatin-related MEC-2 (28) and paraoxonase-related MEC-6 (29).,"Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",A713T,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15543: A and B, the MEC-4(A713T/A745T) channel is strongly temperature sensitive for induction of necrotic cell death.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",A713V,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.",Line 15414: One major suppressor class we isolated includes intragenic sec- ond site changes that maintain the channel hyperactivating mec-4 (d) substitution (A713V) but have a second site mec-4 mutation that oth- erwise disrupts channel activity.,True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",A745T,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15368: The bz2 mutation encodes substitution A745T, which is situated in the intracellular C-terminal domain of MEC-4.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",C723Y,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",G716S,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",G717E,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",G720D,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",L728F,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",P643L,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",P655L,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",Q664*,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",R601C,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",R619K,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",S635F,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",S726F,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",T701I,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",T729I,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",True Positive
WBPaper00026908,WBGene00003168,"mec-4, mec-13",W658*,T01C8.7,"Line 15365: For example, C. elegans DEG/ENaC MEC-4 comprises the core subunit of a touch-transducing ion channel critical for mechanosensation that when hyperactivated by a mec-4(d) mutation induces necrosis of the sensory neurons in which it is expressed.","Line 15506: Allele Mutation site Base change Alteration Location bz149 2956 C-T R601C Extracellular bz183 3055 G-A R619K Extracellular bz195 3103 fi C S635F frameshift Extracellular bz133 3116 G-A 5 -AGGTRAG Extracellular bz134 3116 G-A 5 -AGGTRAG Extracellular bz143 3116 G-A 5 -AGGTRAG Extracellular bz94 3194 C-T P643L Extracellular bz104 3220 C-T P655L Extracellular bz112 3230 G-A W658Stop Extracellular bz150 3246 C-T Q664Stop Extracellular bz122 3349 G-A 3 -TTTCAGR Extracellular bz159 3406 C-T T701I Extracellular bz173 3590 G-A G716S Pore bz11 3593 G-A G717E Pore bz165 3602 G-A G720D Pore bz139 3611 G-A C723Y Pore bz45 3620 C-T S726F Pore bz101 3625 C-T L728F Pore bz184 3629 C-T T729I Pore bz8 3658 G-A L739E Pore bz179 3748 T-A stop769R, 7 AA extension C terminus bz2 3676 G-A A745T C terminus a The underlined nucleotide is changed to A causing loss of the splice site.",False Positive
WBPaper00027336,WBGene00000186,"ark-1, rok-1",D303N,C01C7.1a,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00000186,"ark-1, rok-1",D303N,C01C7.1b,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00000253,"bli-3, tag-31, duox-1",H832Y,F56C11.1,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001061,"dpl-1, mex-4, szy-10",G533R,T23G7.1,"Line 5324: Other class B synMuv proteins include DPL-1 and EFL-1, which are similar to mammalian DP and E2F pro- teins and, by analogy to their mammalian counterparts, likely function to target LIN-35 retinoblastoma (Rb) to DNA(C eol andH orvitz 2001).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001061,"dpl-1, mex-4, szy-10",S384I,T23G7.1,"Line 5324: Other class B synMuv proteins include DPL-1 and EFL-1, which are similar to mammalian DP and E2F pro- teins and, by analogy to their mammalian counterparts, likely function to target LIN-35 retinoblastoma (Rb) to DNA(C eol andH orvitz 2001).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001063,dpy-1,D305N,M01E10.2a,"Line 5338: LGII: lin-31(n301) , dpy-10(e128) , tra-2(q276) , rol-6(e187) , dpl- 1(n2994) (C eol and H orvitz 2001; T homas et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001063,dpy-1,P675L,M01E10.2a,"Line 5338: LGII: lin-31(n301) , dpy-10(e128) , tra-2(q276) , rol-6(e187) , dpl- 1(n2994) (C eol and H orvitz 2001; T homas et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001063,dpy-1,S720L,M01E10.2a,"Line 5338: LGII: lin-31(n301) , dpy-10(e128) , tra-2(q276) , rol-6(e187) , dpl- 1(n2994) (C eol and H orvitz 2001; T homas et al .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00001067,dpy-5,E174K,F27C1.8,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001067,dpy-5,G229E,F27C1.8,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001068,dpy-6,E174K,F16F9.2,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00001068,dpy-6,S720L,F16F9.2,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00001161,"efl-1, mex-2",G341R,Y102A5C.18,"Line 5324: Other class B synMuv proteins include DPL-1 and EFL-1, which are similar to mammalian DP and E2F pro- teins and, by analogy to their mammalian counterparts, likely function to target LIN-35 retinoblastoma (Rb) to DNA(C eol andH orvitz 2001).","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00001515,"gap-1, suv-1, sli-5",S305L,T24C12.2,"Line 5343: LGX: egl-17(e1313) , sli-1(sy143) , aex-3(ad418) , unc-1(e1598 n1201) (E. C. P ark and H. R. H orvitz , unpublished results), dpy- 3(e27) , gap-1(ga133) (H ajnal et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00001515,"gap-1, suv-1, sli-5",S384I,T24C12.2,"Line 5343: LGX: egl-17(e1313) , sli-1(sy143) , aex-3(ad418) , unc-1(e1598 n1201) (E. C. P ark and H. R. H orvitz , unpublished results), dpy- 3(e27) , gap-1(ga133) (H ajnal et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002299,"let-23, kin-7",G533R,ZK1067.1c,"Line 5305: In addition to let-60 Ras, this pathway includes the receptor tyrosine kinase let-23 , the SH2/SH3 adap- tor sem-5 , and the MAP kinase mpk-1 , all of which are Sequence data from this article have been deposited with the EMBL/ GenBank Data Libraries under accession nos.","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002299,"let-23, kin-7",H284P,ZK1067.1b,"Line 5305: In addition to let-60 Ras, this pathway includes the receptor tyrosine kinase let-23 , the SH2/SH3 adap- tor sem-5 , and the MAP kinase mpk-1 , all of which are Sequence data from this article have been deposited with the EMBL/ GenBank Data Libraries under accession nos.","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002299,"let-23, kin-7",P675L,ZK1067.1b,"Line 5305: In addition to let-60 Ras, this pathway includes the receptor tyrosine kinase let-23 , the SH2/SH3 adap- tor sem-5 , and the MAP kinase mpk-1 , all of which are Sequence data from this article have been deposited with the EMBL/ GenBank Data Libraries under accession nos.","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002299,"let-23, kin-7",S309N,ZK1067.1d,"Line 5305: In addition to let-60 Ras, this pathway includes the receptor tyrosine kinase let-23 , the SH2/SH3 adap- tor sem-5 , and the MAP kinase mpk-1 , all of which are Sequence data from this article have been deposited with the EMBL/ GenBank Data Libraries under accession nos.","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00002990,"lin-1, elk-1",S309N,C37F5.1b,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00002990,"lin-1, elk-1",S384I,C37F5.1b,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",E424K,F36H1.4a,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",H284P,F36H1.4b,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",H284P,F36H1.4e,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",S305L,F36H1.4e,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",S309N,F36H1.4b,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",S309N,F36H1.4e,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",S384I,F36H1.4a,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",S384I,F36H1.4d,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002992,"lin-3, let-94, sli-4",S384I,F36H1.4e,Line 5300: The homeobox gene lin-39 is expressed in the midbody and regulates the sequential steps of fusion and vulval cell-fate specification of the P n .p cells in this region (C lark et al .,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002998,lin-9,A242V,ZK637.7b,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00002998,lin-9,D303N,ZK637.7a,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00002998,lin-9,D305N,ZK637.7b,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00002998,lin-9,G341R,ZK637.7b,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00002998,lin-9,S305L,ZK637.7a,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00003020,lin-35,A555V,C32F10.2,"Line 5278: The class B synMuv genes include lin-35, a homolog of the retinoblastoma (Rb) tumor suppressor gene, as well as homologs of genes that function with Rb in transcriptional regulation.","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00003020,lin-35,S309N,C32F10.2,"Line 5278: The class B synMuv genes include lin-35, a homolog of the retinoblastoma (Rb) tumor suppressor gene, as well as homologs of genes that function with Rb in transcriptional regulation.","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00003021,lin-36,A242V,F44B9.6,"Line 5340: LGIII: dpy-17(e164) , lon-1(e185) , lin-13(n770) (F erguson and Horvitz 1989), lin-37(n758) , lin-36(n766) , unc-36(e251) , lin-9(n112) , unc-32(e189) , lin-52(n771) (F erguson and Horvitz 1989), and dpy-18(e364) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00003021,lin-36,E424K,F44B9.6,"Line 5340: LGIII: dpy-17(e164) , lon-1(e185) , lin-13(n770) (F erguson and Horvitz 1989), lin-37(n758) , lin-36(n766) , unc-36(e251) , lin-9(n112) , unc-32(e189) , lin-52(n771) (F erguson and Horvitz 1989), and dpy-18(e364) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00003021,lin-36,H284P,F44B9.6,"Line 5340: LGIII: dpy-17(e164) , lon-1(e185) , lin-13(n770) (F erguson and Horvitz 1989), lin-37(n758) , lin-36(n766) , unc-36(e251) , lin-9(n112) , unc-32(e189) , lin-52(n771) (F erguson and Horvitz 1989), and dpy-18(e364) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00003036,"lin-53, rba-2",E174K,K07A1.12,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00003036,"lin-53, rba-2",S384I,K07A1.12,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",True Positive
WBPaper00027336,WBGene00003037,lin-54,S309N,JC8.6a,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00003037,lin-54,S309N,JC8.6b,"Line 5327: Other class B synMuv proteins also are components of this complex (M. M. H arrison and H. R. H orvitz , unpublished observations), and complexes purified from Drosophila extracts containing DP, E2F, and Rb homologs contain homologs of the synMuv proteins LIN-9, LIN-37, LIN- 52, LIN-53 RbAp48, LIN-54, and LIN-61 (K orenjak et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00003167,mec-3,D303N,F01D4.6a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00003167,mec-3,E174K,F01D4.6d,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00003167,mec-3,H284P,F01D4.6a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00003218,"mep-1, gei-2",A555V,M04B2.1,Line 5362: mep-1/Df animals were con- structed by mating Df/nT1; 1 /nT1 males with dpy-20 mep-1; lin- 15A(n767) hermaphrodites and scoring non-Dpy cross-progeny.,"Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00003218,"mep-1, gei-2",S305L,M04B2.1,Line 5362: mep-1/Df animals were con- structed by mating Df/nT1; 1 /nT1 males with dpy-20 mep-1; lin- 15A(n767) hermaphrodites and scoring non-Dpy cross-progeny.,"Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00003218,"mep-1, gei-2",S309N,M04B2.1,Line 5362: mep-1/Df animals were con- structed by mating Df/nT1; 1 /nT1 males with dpy-20 mep-1; lin- 15A(n767) hermaphrodites and scoring non-Dpy cross-progeny.,"Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",True Positive
WBPaper00027336,WBGene00003401,"mpk-1, sur-1",A242V,F43C1.2b,"Line 5305: In addition to let-60 Ras, this pathway includes the receptor tyrosine kinase let-23 , the SH2/SH3 adap- tor sem-5 , and the MAP kinase mpk-1 , all of which are Sequence data from this article have been deposited with the EMBL/ GenBank Data Libraries under accession nos.","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004397,rol-6,G229E,T01B7.7,"Line 5338: LGII: lin-31(n301) , dpy-10(e128) , tra-2(q276) , rol-6(e187) , dpl- 1(n2994) (C eol and H orvitz 2001; T homas et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004743,scm-1,A242V,M01D7.2a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004743,scm-1,H284P,M01D7.2a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004829,sli-1,D303N,M02A10.3b,"Line 5343: LGX: egl-17(e1313) , sli-1(sy143) , aex-3(ad418) , unc-1(e1598 n1201) (E. C. P ark and H. R. H orvitz , unpublished results), dpy- 3(e27) , gap-1(ga133) (H ajnal et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004829,sli-1,D303N,M02A10.3c,"Line 5343: LGX: egl-17(e1313) , sli-1(sy143) , aex-3(ad418) , unc-1(e1598 n1201) (E. C. P ark and H. R. H orvitz , unpublished results), dpy- 3(e27) , gap-1(ga133) (H ajnal et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004829,sli-1,S305L,M02A10.3a,"Line 5343: LGX: egl-17(e1313) , sli-1(sy143) , aex-3(ad418) , unc-1(e1598 n1201) (E. C. P ark and H. R. H orvitz , unpublished results), dpy- 3(e27) , gap-1(ga133) (H ajnal et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",True Positive
WBPaper00027336,WBGene00004969,"spe-15, hum-3",E174K,F47G6.4b,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004969,"spe-15, hum-3",G533R,F47G6.4b,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004969,"spe-15, hum-3",H284P,F47G6.4a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00004969,"spe-15, hum-3",S305L,F47G6.4a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00004969,"spe-15, hum-3",S309N,F47G6.4a,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00004969,"spe-15, hum-3",S309N,F47G6.4c,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006741,"unc-1, unc-102",A242V,K03E6.5b,"Line 5343: LGX: egl-17(e1313) , sli-1(sy143) , aex-3(ad418) , unc-1(e1598 n1201) (E. C. P ark and H. R. H orvitz , unpublished results), dpy- 3(e27) , gap-1(ga133) (H ajnal et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,A242V,T02C5.5j,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,A242V,T02C5.5k,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,A242V,T02C5.5l,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,A242V,T02C5.5m,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,E174K,T02C5.5f,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,E174K,T02C5.5g,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,E174K,T02C5.5h,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,E174K,T02C5.5i,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,E174K,T02C5.5o,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,E424K,T02C5.5q,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,G341R,T02C5.5f,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006742,unc-2,G341R,T02C5.5g,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006742,unc-2,G341R,T02C5.5h,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006742,unc-2,G341R,T02C5.5i,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006742,unc-2,G533R,T02C5.5a,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,G533R,T02C5.5c,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,S384I,T02C5.5p,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006742,unc-2,S925F,T02C5.5o,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006745,unc-5,A242V,B0273.4d,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006745,unc-5,E424K,B0273.4d,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006745,unc-5,G341R,B0273.4a,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006745,unc-5,G341R,B0273.4b,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006745,unc-5,G533R,B0273.4a,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006745,unc-5,G533R,B0273.4b,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006745,unc-5,S305L,B0273.4d,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006745,unc-5,S305L,B0273.4e,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006745,unc-5,S309N,B0273.4c,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006745,unc-5,T807S,B0273.4a,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006745,unc-5,T807S,B0273.4c,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006749,unc-9,G229E,R12H7.1a,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006750,"unc-10, rim-1",S925F,T10A3.1d,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006750,"unc-10, rim-1",S925F,T10A3.1f,"Line 5344: 1997), unc-2(e55) , lon- 2(e678) , unc-10(e102) , dpy-6(e14) , unc-9(e101) , unc-3(e151) , lin-15B(n744) , lin-15A(n767) , and lin-15AB(n765) .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,A555V,ZK524.2j,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,D303N,ZK524.2f,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,D303N,ZK524.2i,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,G1006S,ZK524.2a,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,G533R,ZK524.2a,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,G533R,ZK524.2d,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,G533R,ZK524.2e,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,S305L,ZK524.2k,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006752,unc-13,S384I,ZK524.2f,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,S384I,ZK524.2i,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,T807S,ZK524.2d,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006752,unc-13,T807S,ZK524.2f,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",D303N,ZK617.1a,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",D303N,ZK617.1b,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",D303N,ZK617.1f,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",D303N,ZK617.1g,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",D303N,ZK617.1h,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",D303N,ZK617.1i,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1a,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1b,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1e,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1f,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1g,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1h,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E174K,ZK617.1i,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",E424K,ZK617.1e,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",G229E,ZK617.1a,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",G229E,ZK617.1b,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",G229E,ZK617.1f,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",G229E,ZK617.1g,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",G229E,ZK617.1h,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",G229E,ZK617.1i,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1a,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1b,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1c,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1f,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1g,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1h,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S384I,ZK617.1i,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S720L,ZK617.1b,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S720L,ZK617.1e,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S720L,ZK617.1f,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S720L,ZK617.1h,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S720L,ZK617.1i,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S925F,ZK617.1h,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006759,"unc-22, twitchin",S925F,ZK617.1i,"Line 5341: S tern and H. R. H orvitz , un- published results), dpy-20(e1282) , unc-22(e66) , dpy-26(n198) , ark-1(sy247) (H opper et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006805,"unc-73, let-509",A555V,F55C7.7e,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006805,"unc-73, let-509",A555V,F55C7.7h,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00006805,"unc-73, let-509",S309N,F55C7.7a,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006805,"unc-73, let-509",S309N,F55C7.7b,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006805,"unc-73, let-509",S309N,F55C7.7f,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00006805,"unc-73, let-509",S309N,F55C7.7i,"Line 5337: We also used strains containing the following mutations: LGI: bli-3(e767) , lin-17(n677) , unc-11(e47) , unc-73(e936) , lin- 44(n1792) , unc-38(x20) , dpy-5(e61) , lin-35(n745) , unc-13(e1091) , lin-53(n833) (F erguson and H orvitz 1989), and unc- 54(e1092) (D ibb et al .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00007029,mys-1,E174K,VC5.4,"Line 5434: These tests defined five new synMuv loci: lin-65 , lin(n3628) , mep-1 , mys-1 , and trr-1 .","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00007029,mys-1,G341R,VC5.4,"Line 5434: These tests defined five new synMuv loci: lin-65 , lin(n3628) , mep-1 , mys-1 , and trr-1 .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",True Positive
WBPaper00027336,WBGene00007030,epc-1,S720L,Y111B2A.11,"Line 5633: Furthermore, many of the cloned synMuv genes, including the class A gene lin-15A , the class B gene lin-35 Rb, the class C genes trr-1 and epc-1 , and ark-1 and sli-1 , encode the sole C. elegans member of their respective gene families.",Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,False Positive
WBPaper00027336,WBGene00013006,lin-38,S305L,Y48E1B.7,"Line 5339: 2003), let-23(sy10, sy97) , unc-4(e120) , unc-53(n569) , mex-1(it9) , rol- 1(e91) , and lin-38(n751) .","Line 5612: These possibilities include: (1) Two sets of genes encode similar sets of pro- teins with corresponding proteins of each set control- ling the same biochemical activity, and hence each set controls the same biological process; (2) two sets of genes encode distinct sets of proteins with each set controlling distinct biochemical activities but the same biological process; and (3) two sets of genes encode distinct sets of TABLE 8 (Continued) Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation lin-53(n3622) AAG/ gtatgtgt AAG/atatgtgt Exon 1 donor lin-53(n3623) T GG TAG W337amber lin-65(n3441) TG GTGA W534amber lin-65(n3541) TG GTGA W534amber lin-65(n3543) T CG TTG S720L Unknown mep-1(n3680) A GT AAT S309N Unknown mep-1(n3702) CAG TAG Q706amber mep-1(n3703) CTT/ gtaagttt CTT/ataagttt Exon 3 donor mys-1(n3681) i GGA AGA G341R Acetyltransferase sli-1(n3538) T CA TTA S305L SH2 sli-1(n3544) ttttcca g/AAA ttttccaa/AAA Exon 6 acceptor sli-1(n3683) tttttta g/GAT ttttttaa/GAT Exon 4 acceptor trr-1(n3630) j TGG TAG W2064amber trr-1(n3637) j CAG TAG Q3444amber trr-1(n3704) j CAA TAA Q694ochre trr-1(n3708) j CGA TGA R1248opal trr-1(n3709) j CGA TGA R2550opal trr-1(n3712) j TGG TAG W2505amber The synMuv proteins described are limited to those for which we obtained mutant allele sequence; this is not a comprehensive listing of synMuv proteins.",False Positive
WBPaper00027336,WBGene00022142,,E174K,Y71G12B.2,"Line 5465: Most of the new mutations interacted synthetically with class A and class C but not with class B mutations, TABLE 2 Three- and four-factor crosses Gene Genotype of heterozygote Phenotype of selected recombinants Genotype of selected recombinants (with respect to unselected markers) lin-65 1 lin-65 1 /bli-3 1 lin-17; lin-15A(n767) Lin-17 9/19 lin-65/ 1 bli-3 1 lin-65/ 1 spe-15 1 ; lin-15A(n767) Muv 10/18 spe-15/ 1 1 lin-65 lin-17/spe-15 11 ; lin-15A(n767) Lin-17 11/11 spe-15/ 1 bli-3 11 1 lin-65 1 / 1 Y73E7.2 Y71G12B.2 Y71G12B.17 1 Y71G12B.18; lin-15A(n767) Muv 4/30 Y73E7.2/ 1 Muv 2/30 Y71G12B.2/ 1 Muv 1/30 Y71G12B.17/ 1 Muv 0/30 Y71G12B.18/ 1 1 lin-65 11 1 lin-17/Y71G12B.17 1 Y71G12B.18 Y71G12B.27 M01D7.2 1 ; lin-15A(n767) Lin-17 17/23 M01D7.2/ 1 Lin-17 18/23 Y71G12B.27/ 1 Lin-17 21/23 Y71G12B.18/ 1 Lin-17 23/23 Y71G12B.17/ 1 lin(n3542) 11 lin(n3542) lin-15A(n767)/unc-10 dpy-6 1 lin-15A(n767) Unc 8/8 lin(n3542)/ 1 1 lin(n3542) 1 lin-15A(n767)/dpy-6 1 unc-9 lin-15A(n767) Unc 4/40 lin(n3542)/ 1 lin(n3628) lin(n3628) 11 / 1 dpy-5 unc-13; lin-15A(n767) Dpy 0/6 lin(n3628)/ 1 Unc 6/6 lin(n3628)/ 1 1 lin(n3628) 1 /unc-11 1 dpy-5; lin-15A(n767) Unc 1/11 lin(n3628)/ 1 Dpy 5/11 lin(n3628)/ 1 unc-11 11 lin(n3628)/ 1 unc-73 lin-44 1 ; lin-15A(n767) Muv 3/9 unc-73 lin-44/ 11 11 lin(n3628) dpy-5/unc-73 lin-44 11 ; lin-15A(n767) Muv 0/21 unc-73 lin-44/ 11 lin(n3628) 1 dpy-5/ 1 unc-38 1 ; lin-15A(n767) Muv 3/7 unc-38/ 1 unc-11 lin(n3628) 1 / 11 unc-38; lin-15A(n767) Muv 0/9 unc-38/ 1 mep-1 1 mep-1 1 /unc-5 1 dpy-20; lin-15A(n767) Unc 56/57 mep-1/ 1 Dpy 2/61 mep-1/ 1 mep-1 11 / 1 dpy-20 unc-30; lin-15A(n767) Dpy 0/51 mep-1/ 1 Unc 58/58 mep-1/ 1 11 mep-1 1 /unc-24 mec-3 1 dpy-20; lin-15A(n767) Unc Mec 10/12 mep-1/ 1 Unc 17/17 mep-1/ 1 Mec Dpy 0/8 mep-1/ 1 Dpy 2/8 mep-1/ 1 1 mep-1 dpy-20 1 /lin-3 11 unc-22; lin-15A(n767) Dpy 5/5 lin-3/ 1 Vul 3/10 mep-1/ 1 11 mep-1 1 /mec-3 sem-3 1 dpy-20; lin-15A(n767) Mec 17/17 mep-1/ 1 Dpy 6/13 mep-1/ 1 mys-1 1 mys-1 1 /unc-46 1 dpy-11; lin-15A Unc 3/7 mys-1/ 1 Dpy 7/11 mys-1/ 1 trr-1 1 rol-6 1 trr-1/dpy-10 1 unc-4 1 ; lin-15A(n767) Rol 3/14 unc-4/ 1 Dpy 3/3 trr-1/ 1 Unc 0/8 trr-1/ 1 1 trr-1 1 /dpy-10 1 rol-1; lin-15A(n767) Rol 9/20 trr-1/ 1 11 trr-1/dpy-10 unc-53 1 ; lin-15A(n767) Unc 0/17 trr-1/ 1 1 trr-1 1 /unc-53 1 rol-1; lin-15A(n767) Unc 7/10 trr-1/ 1 Rol 7/10 trr-1/ 1 1 trr-1 1 rol-1/unc-4 1 mex-1 1 ; lin-15A(n767) Rol 12/14 mex-1/ 1 Three- and four-factor crosses were performed using standard methods (B renner 1974).","Line 5605: Mutation Wild-type sequence Mutant sequence Substitution, splice site change, or aberration Domain affected by missense mutation B. Allele sequences dpl-1(n3643) d TA TTAA Y341ochre GGC CGC G533R Unknown e-1(n3639) e CAA TAA Q175ochre let-418(n3536) C CT CTT P675L Helicase/ATPase let-418(n3626) GGT AGT G1006S Helicase/ATPase let-418(n3629) T CC TTC S925F Helicase/ATPase let-418(n3634) T GG TAG W1128amber let-418(n3635) CAG TAG Q1594amber let-418(n3636) ACT TCT T807S Helicase/ATPase TG GTGA W1329opal let-418(n3719) T GG TAG W295amber lin-9(n3631) CAA TAA LIN-9L: Q594ochre LIN-9S: Q592ochre lin-9(n3675) GAT AAT LIN-9L: D305N Unknown LIN-9S: D303N Unknown lin-9(n3767) CAG TAG LIN-9L: Q509amber LIN-9S: Q507amber lin-13(n3642) CAT TAT H832Y Zn finger lin-13(n3673) CAG TAG Q1988amber lin-13(n3674) CGA TGA R1250opal lin-13(n3726) G GA GAA G229E Unknown lin-35(n3763) f GCA GTA A555V Pocket TTG AAA AAG TTG AAA AAA G K594 frameshift and truncation after 611 a.a. lin-36(n3671) C AT CCT H284P C/H-rich region GAA AAA E424K Unknown lin-36(n3672) CAG TAG Q467amber lin-36(n3765) g GCT GTT A242V C/H-rich region lin-52(n3718) h CAG TAG Q31amber lin-53(n3448) A GT ATT S384I WD repeat lin-53(n3521) GAA AAA E174K WD repeat ( continued ) 722 C. J. Ceol et al .",False Positive
WBPaper00027336,WBGene00022149,lin-65,S720L,Y71G12B.9a,Line 5282: We also describe the molecular characterization of the class B synMuv gene lin-65.,Line 5499: lin- 65(n3543) contains a missense mutation that changes a polar serine residue to a nonpolar leucine (S720L).,True Positive
WBPaper00027659,WBGene00001130,"dyn-1, dyn1",I401F,C02C6.1a,"Line 20886: We identified 14 loss-of-function alleles of the C. elegans dynamin gene, dyn-1, that are defective in the removal of apoptotic cells.","Line 20935: With the exception of en9 (I401F), all remaining alleles of dyn-1 bear missense mutations in the GTPase domain essential for the func- tion of mammalian and Drosophila dynamins (reviewed by Hinshaw, 2000 )(Figure 1A).",True Positive
WBPaper00027659,WBGene00001130,"dyn-1, dyn1",I401F,C02C6.1b,"Line 20886: We identified 14 loss-of-function alleles of the C. elegans dynamin gene, dyn-1, that are defective in the removal of apoptotic cells.","Line 20935: With the exception of en9 (I401F), all remaining alleles of dyn-1 bear missense mutations in the GTPase domain essential for the func- tion of mammalian and Drosophila dynamins (reviewed by Hinshaw, 2000 )(Figure 1A).",True Positive
WBPaper00027659,WBGene00004373,rme-1,I401F,W06H8.1g,"Line 21000: Dynamin Regulates the Removal of Apoptotic Cells 747 observedin rme-1 , -2 ,or -8 mutants(Figure3D).Thus,en- docytosis mediatedby rme-1 , -2 ,and -8 doesnot appear to play a major role in the removal of apoptotic cells.","Line 20935: With the exception of en9 (I401F), all remaining alleles of dyn-1 bear missense mutations in the GTPase domain essential for the func- tion of mammalian and Drosophila dynamins (reviewed by Hinshaw, 2000 )(Figure 1A).",False Positive
WBPaper00027659,WBGene00004373,rme-1,I401F,W06H8.1h,"Line 21000: Dynamin Regulates the Removal of Apoptotic Cells 747 observedin rme-1 , -2 ,or -8 mutants(Figure3D).Thus,en- docytosis mediatedby rme-1 , -2 ,and -8 doesnot appear to play a major role in the removal of apoptotic cells.","Line 20935: With the exception of en9 (I401F), all remaining alleles of dyn-1 bear missense mutations in the GTPase domain essential for the func- tion of mammalian and Drosophila dynamins (reviewed by Hinshaw, 2000 )(Figure 1A).",False Positive
WBPaper00027748,WBGene00000103,akt-2,D181E,F28H6.1a,"Line 19138: In C. elegans this pathway includes 38 insulin-like proteins [9,27], an insulin/IGF-1-receptorlike molecule (DAF-2 [7]), PI 3-kinase catalytic (AGE-1 [28]) and adaptor (AAP-1 [29]) subunits, a phosphoinositide-dependent kinase (PDK-1 [30]), two Akt/protein kinase B (PKB) homologs (AKT-1 and AKT-2 [31]), and a serum- and glucocorticoid- inducible kinase homolog (SGK-1 [32]) (see later).","Line 19373: Interestingly, the PTPN1/ PTP1B H214A mutation reduces K m approximately 5-fold, and the D181E and Q262A mutations reduce K m approx- imately 10-fold each [86].",False Positive
WBPaper00027748,WBGene00000103,akt-2,D181E,F28H6.1b,"Line 19138: In C. elegans this pathway includes 38 insulin-like proteins [9,27], an insulin/IGF-1-receptorlike molecule (DAF-2 [7]), PI 3-kinase catalytic (AGE-1 [28]) and adaptor (AAP-1 [29]) subunits, a phosphoinositide-dependent kinase (PDK-1 [30]), two Akt/protein kinase B (PKB) homologs (AKT-1 and AKT-2 [31]), and a serum- and glucocorticoid- inducible kinase homolog (SGK-1 [32]) (see later).","Line 19373: Interestingly, the PTPN1/ PTP1B H214A mutation reduces K m approximately 5-fold, and the D181E and Q262A mutations reduce K m approx- imately 10-fold each [86].",False Positive
WBPaper00027748,WBGene00000899,daf-3,D181E,F25E2.5a,"Line 19155: The major targets of DAF-7/TGF- b signaling are the SMAD4 tumor suppressor homolog DAF-3 [55] and its binding partner DAF-5/SNO [56,57].","Line 19373: Interestingly, the PTPN1/ PTP1B H214A mutation reduces K m approximately 5-fold, and the D181E and Q262A mutations reduce K m approx- imately 10-fold each [86].",False Positive
WBPaper00027748,WBGene00000899,daf-3,D181E,F25E2.5d,"Line 19155: The major targets of DAF-7/TGF- b signaling are the SMAD4 tumor suppressor homolog DAF-3 [55] and its binding partner DAF-5/SNO [56,57].","Line 19373: Interestingly, the PTPN1/ PTP1B H214A mutation reduces K m approximately 5-fold, and the D181E and Q262A mutations reduce K m approx- imately 10-fold each [86].",False Positive
WBPaper00027748,WBGene00004789,"sgk-1, tag-74",H214A,W10G6.2a,"Line 19138: In C. elegans this pathway includes 38 insulin-like proteins [9,27], an insulin/IGF-1-receptorlike molecule (DAF-2 [7]), PI 3-kinase catalytic (AGE-1 [28]) and adaptor (AAP-1 [29]) subunits, a phosphoinositide-dependent kinase (PDK-1 [30]), two Akt/protein kinase B (PKB) homologs (AKT-1 and AKT-2 [31]), and a serum- and glucocorticoid- inducible kinase homolog (SGK-1 [32]) (see later).","Line 19373: Interestingly, the PTPN1/ PTP1B H214A mutation reduces K m approximately 5-fold, and the D181E and Q262A mutations reduce K m approx- imately 10-fold each [86].",False Positive
WBPaper00027748,WBGene00010671,eak-7,Q262A,K08E7.1,"Line 19347: Notably, one (or more) of the four eak genes that remain to be cloned (eak-1, eak-2, eak-3, and eak-7) may encode such a molecule.","Line 19373: Interestingly, the PTPN1/ PTP1B H214A mutation reduces K m approximately 5-fold, and the D181E and Q262A mutations reduce K m approx- imately 10-fold each [86].",False Positive
WBPaper00028727,WBGene00000517,cki-2,A139V,T05A6.2b,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00000517,cki-2,R85Q,T05A6.2b,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00001049,dog-1,G243A,F33H2.1,"Line 1174: M03C11.2 A gene name has not yet been assigned for this locus (indi- cated by * in Table 1), but the gene is a member of the DEAD helicase family related to DOG-1.","Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00002033,htp-2,A139V,Y73B6BL.2,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00002033,htp-2,D17N,Y73B6BL.2,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00002033,htp-2,G263R,Y73B6BL.2,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00002033,htp-2,R85Q,Y73B6BL.2,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00002033,htp-2,T222I,Y73B6BL.2,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00002034,htp-3,D17N,F57C9.5,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00003161,"mdf-2, mad-2",D65N,Y69A2AR.30a,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00003161,"mdf-2, mad-2",D65N,Y69A2AR.30b,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",True Positive
WBPaper00028727,WBGene00003161,"mdf-2, mad-2",G49A,Y69A2AR.30a,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00003161,"mdf-2, mad-2",G49A,Y69A2AR.30b,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00003161,"mdf-2, mad-2",G49A,Y69A2AR.30c,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00003214,mel-32,T222I,C05D11.11a,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00006745,unc-5,C756T,B0273.4c,Line 1042: A case in point is the molecular analysis of unc-52 mutations and intragenic suppressor alleles [35].,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00006745,unc-5,G345A,B0273.4e,Line 1042: A case in point is the molecular analysis of unc-52 mutations and intragenic suppressor alleles [35].,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00006745,unc-5,G345A,B0273.4f,Line 1042: A case in point is the molecular analysis of unc-52 mutations and intragenic suppressor alleles [35].,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00006745,unc-5,T222I,B0273.4f,Line 1042: A case in point is the molecular analysis of unc-52 mutations and intragenic suppressor alleles [35].,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00008140,"xpf-1, him-9",A139V,C47D12.8,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00008140,"xpf-1, him-9",G49A,C47D12.8,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00010839,chl-1,C520T,M03C11.2,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00028727,WBGene00016602,mus-81,R85Q,C43E11.2b,Line 1020: strains 3 Mis- sense 3 Null 3 Silent 3 Total *C05C10.5Hypothetical protein 788 1175 0 0 2 1 3 mel-32 C05D11.11Serine hydroxyl-methyl-transferase160015001614127 mus-81 C43E11.2Endonuclease MUS812530117110437 xpf-1 C47D12.8Structure-specific endonuclease ERCC1-XPF9112145200538 *F25H2.13Helicase of the DEAD superfamily4985149910549 htp-3 F57C9.5HIM-3 paralogue25981452115510 *M03C11.2Helicase of the DEAD superfamily5943149010415 cki-2 T05A6.2Hypothetical protein155515690071210 mdf-2 Y69A2AR.30Spindle assembly checkpoint protein4461146610156 htp-2 Y73B6BL.2HIM-3 paralogue protein 21199145100516 Totals 14225 42 2 27 71 * Gene name not assigned 1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.,"Line 1075: Although 10- fold pools might be possible in C. elegans given that the genome size of this organism is slightly smaller than Ara- bidopsis , the construction of libraries for screening in 96 or mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding htp-2 Y73B6BL.2 CN750 vc14 C507T A139V htp-2 Y73B6BL.2 CN50 vc22 C756T T222I htp-2 Y73B6BL.2 CN1271 vc29 C712T S207= htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q htp-2 Y73B6BL.2 CN574 vc5 G49A D17N htp-2 Y73B6BL.2 CN901 vc6 G878A G263R One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature.",False Positive
WBPaper00030864,WBGene00004440,rpl-26,K36M,F28C6.7a,"Line 18411: Three independent samples of each genotype were prepared, and levels of lin-3 and rpl-26 were quantified from each biological replicate.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00004440,rpl-26,K36M,F28C6.7b,"Line 18411: Three independent samples of each genotype were prepared, and levels of lin-3 and rpl-26 were quantified from each biological replicate.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00004440,rpl-26,K36M,F28C6.7c,"Line 18411: Three independent samples of each genotype were prepared, and levels of lin-3 and rpl-26 were quantified from each biological replicate.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00004782,set-2,K36M,C26E6.9a,"Line 18421: Deletion or RNAi of some genes encoding proteins with SET domains causes gross abnormalities, including synthetic multivulva and suppression of synthetic multivulva phenotypes Allele Phenotype oras a single % multivulva in combination with Gene RNAi* mutant lin-15A(n767) lin-15B(n744) lin-15AB(n765) blmp-1 tm548 WT 0 (196) 0 (188) 100 (99) lin-59 sa489 WT 0 (188) 0 (102) 100 (143) mes-2 bn11 Mes 0 (233) 0 (258) 1 (194) mes-4 bn73 Mes 0 (140) 0 (130) 7 (224) met-1 n4337 WT 81 (469) 0 (216) 100 (206) met-2 n4256 WT 100 (350) 0 (349) 100 (273) set-1 n4617 Emb, LvlNA NA NA set-2 n4589 WT 0 (291) 1 (134) 100 (281) set-3 n4948 WT 0 (194) 0 (142) 100 (116) set-4 n4600 WT 0 (361) 0 (236) 99 (202) set-5 ok1568 WT 0 (170) 0 (157) 100 (104) set-6 tm1611 WT 0 (151) 0 (139) 100 (111) ttll-12 RNAi WT 0 (186) 0 (215) 100 (116) set-8 tm2113 WT 0 (122) 0 (130) 100 (131) set-9 n4949 WT 0 (171) 0 (151) 100 (91) set-10 RNAi WT 0 (211) 0 (149) 100 (36) set-11 n4488 WT 0 (473) 0 (275) 100 (241) set-12 n4442 WT 0 (380) 0 (204) 100 (262) set-13 n5012 WT 0 (119) 0 (136) 100 (104) set-14 RNAi WT 0 (222) 0 (219) 100 (140) set-15 RNAi WT 0 (75) 0 (102) 100 (97) set-16 n4526 Lvl NA NA NA set-17 n5017 WT 0 (147) 0 (104) 100 (146) set-18 gk334 WT 1 (171) 0 (161) 100 (143) set-19 ok1813 WT 0 (163) 0 (101) 100 (111) set-20 RNAi WT 0 (211) 0 (195) 100 (147) set-21 RNAi WT 0 (235) 0 (176) 100 (113) set-22 n5015 WT 0 (125) 0 (130) 100 (120) set-23 n4496 Emb NA NA NA set-24 n4909 WT 0 (151) 0 (96) 100 (103) set-25 n5021 WT 0 (183) 0 (117) 100 (170) set-26 RNAi WT 0 (227) 0 (159) 100 (90) set-27 RNAi WT 0 (123) 0 (139) 100 (123) set-28 n4953 WT 0 (144) 0 (99) 100 (128) set-29 RNAi WT 0 (163) 0 (132) 100 (107) set-30 gk315 WT 0 (150) 0 (132) 100 (180) set-31 ok1482 WT 0 (190) 0 (206) 100 (158) set-32 ok1457 WT 0 (174) 0 (241) 100 (166) Shading denotes phenotypes that differ from that of the wild type.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00004782,set-2,K36M,C26E6.9c,"Line 18421: Deletion or RNAi of some genes encoding proteins with SET domains causes gross abnormalities, including synthetic multivulva and suppression of synthetic multivulva phenotypes Allele Phenotype oras a single % multivulva in combination with Gene RNAi* mutant lin-15A(n767) lin-15B(n744) lin-15AB(n765) blmp-1 tm548 WT 0 (196) 0 (188) 100 (99) lin-59 sa489 WT 0 (188) 0 (102) 100 (143) mes-2 bn11 Mes 0 (233) 0 (258) 1 (194) mes-4 bn73 Mes 0 (140) 0 (130) 7 (224) met-1 n4337 WT 81 (469) 0 (216) 100 (206) met-2 n4256 WT 100 (350) 0 (349) 100 (273) set-1 n4617 Emb, LvlNA NA NA set-2 n4589 WT 0 (291) 1 (134) 100 (281) set-3 n4948 WT 0 (194) 0 (142) 100 (116) set-4 n4600 WT 0 (361) 0 (236) 99 (202) set-5 ok1568 WT 0 (170) 0 (157) 100 (104) set-6 tm1611 WT 0 (151) 0 (139) 100 (111) ttll-12 RNAi WT 0 (186) 0 (215) 100 (116) set-8 tm2113 WT 0 (122) 0 (130) 100 (131) set-9 n4949 WT 0 (171) 0 (151) 100 (91) set-10 RNAi WT 0 (211) 0 (149) 100 (36) set-11 n4488 WT 0 (473) 0 (275) 100 (241) set-12 n4442 WT 0 (380) 0 (204) 100 (262) set-13 n5012 WT 0 (119) 0 (136) 100 (104) set-14 RNAi WT 0 (222) 0 (219) 100 (140) set-15 RNAi WT 0 (75) 0 (102) 100 (97) set-16 n4526 Lvl NA NA NA set-17 n5017 WT 0 (147) 0 (104) 100 (146) set-18 gk334 WT 1 (171) 0 (161) 100 (143) set-19 ok1813 WT 0 (163) 0 (101) 100 (111) set-20 RNAi WT 0 (211) 0 (195) 100 (147) set-21 RNAi WT 0 (235) 0 (176) 100 (113) set-22 n5015 WT 0 (125) 0 (130) 100 (120) set-23 n4496 Emb NA NA NA set-24 n4909 WT 0 (151) 0 (96) 100 (103) set-25 n5021 WT 0 (183) 0 (117) 100 (170) set-26 RNAi WT 0 (227) 0 (159) 100 (90) set-27 RNAi WT 0 (123) 0 (139) 100 (123) set-28 n4953 WT 0 (144) 0 (99) 100 (128) set-29 RNAi WT 0 (163) 0 (132) 100 (107) set-30 gk315 WT 0 (150) 0 (132) 100 (180) set-31 ok1482 WT 0 (190) 0 (206) 100 (158) set-32 ok1457 WT 0 (174) 0 (241) 100 (166) Shading denotes phenotypes that differ from that of the wild type.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00008405,"ttll-12, set-7",K36M,D2013.9,"Line 18421: Deletion or RNAi of some genes encoding proteins with SET domains causes gross abnormalities, including synthetic multivulva and suppression of synthetic multivulva phenotypes Allele Phenotype oras a single % multivulva in combination with Gene RNAi* mutant lin-15A(n767) lin-15B(n744) lin-15AB(n765) blmp-1 tm548 WT 0 (196) 0 (188) 100 (99) lin-59 sa489 WT 0 (188) 0 (102) 100 (143) mes-2 bn11 Mes 0 (233) 0 (258) 1 (194) mes-4 bn73 Mes 0 (140) 0 (130) 7 (224) met-1 n4337 WT 81 (469) 0 (216) 100 (206) met-2 n4256 WT 100 (350) 0 (349) 100 (273) set-1 n4617 Emb, LvlNA NA NA set-2 n4589 WT 0 (291) 1 (134) 100 (281) set-3 n4948 WT 0 (194) 0 (142) 100 (116) set-4 n4600 WT 0 (361) 0 (236) 99 (202) set-5 ok1568 WT 0 (170) 0 (157) 100 (104) set-6 tm1611 WT 0 (151) 0 (139) 100 (111) ttll-12 RNAi WT 0 (186) 0 (215) 100 (116) set-8 tm2113 WT 0 (122) 0 (130) 100 (131) set-9 n4949 WT 0 (171) 0 (151) 100 (91) set-10 RNAi WT 0 (211) 0 (149) 100 (36) set-11 n4488 WT 0 (473) 0 (275) 100 (241) set-12 n4442 WT 0 (380) 0 (204) 100 (262) set-13 n5012 WT 0 (119) 0 (136) 100 (104) set-14 RNAi WT 0 (222) 0 (219) 100 (140) set-15 RNAi WT 0 (75) 0 (102) 100 (97) set-16 n4526 Lvl NA NA NA set-17 n5017 WT 0 (147) 0 (104) 100 (146) set-18 gk334 WT 1 (171) 0 (161) 100 (143) set-19 ok1813 WT 0 (163) 0 (101) 100 (111) set-20 RNAi WT 0 (211) 0 (195) 100 (147) set-21 RNAi WT 0 (235) 0 (176) 100 (113) set-22 n5015 WT 0 (125) 0 (130) 100 (120) set-23 n4496 Emb NA NA NA set-24 n4909 WT 0 (151) 0 (96) 100 (103) set-25 n5021 WT 0 (183) 0 (117) 100 (170) set-26 RNAi WT 0 (227) 0 (159) 100 (90) set-27 RNAi WT 0 (123) 0 (139) 100 (123) set-28 n4953 WT 0 (144) 0 (99) 100 (128) set-29 RNAi WT 0 (163) 0 (132) 100 (107) set-30 gk315 WT 0 (150) 0 (132) 100 (180) set-31 ok1482 WT 0 (190) 0 (206) 100 (158) set-32 ok1457 WT 0 (174) 0 (241) 100 (166) Shading denotes phenotypes that differ from that of the wild type.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00016603,met-1,K36M,C43E11.3a,Line 18324: We surveyed all 38 putative HMT genes in C. elegans and identified met-1 and met-2 as negative regulators of vulval cell-fate specification.,"Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00016603,met-1,K36M,C43E11.3b,Line 18324: We surveyed all 38 putative HMT genes in C. elegans and identified met-1 and met-2 as negative regulators of vulval cell-fate specification.,"Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030864,WBGene00020006,set-15,K36M,R11E3.4,"Line 18421: Deletion or RNAi of some genes encoding proteins with SET domains causes gross abnormalities, including synthetic multivulva and suppression of synthetic multivulva phenotypes Allele Phenotype oras a single % multivulva in combination with Gene RNAi* mutant lin-15A(n767) lin-15B(n744) lin-15AB(n765) blmp-1 tm548 WT 0 (196) 0 (188) 100 (99) lin-59 sa489 WT 0 (188) 0 (102) 100 (143) mes-2 bn11 Mes 0 (233) 0 (258) 1 (194) mes-4 bn73 Mes 0 (140) 0 (130) 7 (224) met-1 n4337 WT 81 (469) 0 (216) 100 (206) met-2 n4256 WT 100 (350) 0 (349) 100 (273) set-1 n4617 Emb, LvlNA NA NA set-2 n4589 WT 0 (291) 1 (134) 100 (281) set-3 n4948 WT 0 (194) 0 (142) 100 (116) set-4 n4600 WT 0 (361) 0 (236) 99 (202) set-5 ok1568 WT 0 (170) 0 (157) 100 (104) set-6 tm1611 WT 0 (151) 0 (139) 100 (111) ttll-12 RNAi WT 0 (186) 0 (215) 100 (116) set-8 tm2113 WT 0 (122) 0 (130) 100 (131) set-9 n4949 WT 0 (171) 0 (151) 100 (91) set-10 RNAi WT 0 (211) 0 (149) 100 (36) set-11 n4488 WT 0 (473) 0 (275) 100 (241) set-12 n4442 WT 0 (380) 0 (204) 100 (262) set-13 n5012 WT 0 (119) 0 (136) 100 (104) set-14 RNAi WT 0 (222) 0 (219) 100 (140) set-15 RNAi WT 0 (75) 0 (102) 100 (97) set-16 n4526 Lvl NA NA NA set-17 n5017 WT 0 (147) 0 (104) 100 (146) set-18 gk334 WT 1 (171) 0 (161) 100 (143) set-19 ok1813 WT 0 (163) 0 (101) 100 (111) set-20 RNAi WT 0 (211) 0 (195) 100 (147) set-21 RNAi WT 0 (235) 0 (176) 100 (113) set-22 n5015 WT 0 (125) 0 (130) 100 (120) set-23 n4496 Emb NA NA NA set-24 n4909 WT 0 (151) 0 (96) 100 (103) set-25 n5021 WT 0 (183) 0 (117) 100 (170) set-26 RNAi WT 0 (227) 0 (159) 100 (90) set-27 RNAi WT 0 (123) 0 (139) 100 (123) set-28 n4953 WT 0 (144) 0 (99) 100 (128) set-29 RNAi WT 0 (163) 0 (132) 100 (107) set-30 gk315 WT 0 (150) 0 (132) 100 (180) set-31 ok1482 WT 0 (190) 0 (206) 100 (158) set-32 ok1457 WT 0 (174) 0 (241) 100 (166) Shading denotes phenotypes that differ from that of the wild type.","Line 18371: Our results suggest that in C. elegans ,the trimethylation of histone H3 lysine 36 by MET-1/Set2 promotes a transcriptional repression cascade mediated by a NuRD-like complex and by the trimethylation of histone H3K9 by a SETDB1-like HMT.",False Positive
WBPaper00030973,WBGene00000483,"che-1, tax-1, tax-5",D233G,C55B7.12b,"Line 729: Upon reanalyzing the che-1(ot73) sequence we found the molecular lesion to be a D233G change, rather than an earlier frameshift, as previ- ously reported (C hang et al .","Line 729: Upon reanalyzing the che-1(ot73) sequence we found the molecular lesion to be a D233G change, rather than an earlier frameshift, as previ- ously reported (C hang et al .",True Positive
WBPaper00030973,WBGene00006743,unc-3,D233G,Y16B4A.1,"Line 742: On the basis of their physical interactions in other systems as well as genetic interaction tests, we proposed that the COG-1 and UNC-37 proteins directly interact to control the postmitotic adoption of terminal ASEL and ASER fates (C hang et al .","Line 729: Upon reanalyzing the che-1(ot73) sequence we found the molecular lesion to be a D233G change, rather than an earlier frameshift, as previ- ously reported (C hang et al .",False Positive
WBPaper00032509,WBGene00002981,"lgg-2, atg-8.2",P71L,ZK593.6b,"Line 23234: When the formation of PGL granules was examined in other autophagy mutants, we found that loss of function of compo- nents involved in the two ubiquitin-like pathways, including atg-4.1 , atg-3 , lgg-3/atg12 , atg-7 , and lgg-2/atg8 , caused accu- mulation of PGL granules (Figures 1L1O and Table S1).","Line 23388: GST-tagged full-length or truncated SEPA-1 immobilized on glutathione Sepharose beads was incubated with His-SEPA-1, His-SEPA-1 (P71L), or His-SEPA-1 fragment (39160).",False Positive
WBPaper00032509,WBGene00004945,sop-2,S12A,C50E10.4a,Line 23485: Anti-SOP-2 monoclonal antibody was used for control IP.,Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00004945,sop-2,S12A,C50E10.4b,Line 23485: Anti-SOP-2 monoclonal antibody was used for control IP.,Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00006745,unc-5,S12A,B0273.4a,"Line 23235: PGL granules were also found in unc-51 , atg-18 , and vps-16 mutant embryos (Figure 1P and Table S1), which encode components of the Atg1 kinase complex, the retrieval complex, and the complex required for autophagosome/lysosome fusion, respec- tively.",Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00006745,unc-5,S12A,B0273.4b,"Line 23235: PGL granules were also found in unc-51 , atg-18 , and vps-16 mutant embryos (Figure 1P and Table S1), which encode components of the Atg1 kinase complex, the retrieval complex, and the complex required for autophagosome/lysosome fusion, respec- tively.",Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00006745,unc-5,S12A,B0273.4c,"Line 23235: PGL granules were also found in unc-51 , atg-18 , and vps-16 mutant embryos (Figure 1P and Table S1), which encode components of the Atg1 kinase complex, the retrieval complex, and the complex required for autophagosome/lysosome fusion, respec- tively.",Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00009696,,S12A,F44F1.4,Line 23397: F44F1.4 was expressed only in a few cells in the head region.,Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00010808,sepa-1,P71L,M01E5.6,"Line 23188: The activity of sepa-1 is required for the degradation of these P granule components and for their accumulation into aggregates, termed PGL granules, in autophagy mutants.","Line 23388: GST-tagged full-length or truncated SEPA-1 immobilized on glutathione Sepharose beads was incubated with His-SEPA-1, His-SEPA-1 (P71L), or His-SEPA-1 fragment (39160).",True Positive
WBPaper00032509,WBGene00013595,atg-4.1,P71L,Y87G2A.3a,"Line 23234: When the formation of PGL granules was examined in other autophagy mutants, we found that loss of function of compo- nents involved in the two ubiquitin-like pathways, including atg-4.1 , atg-3 , lgg-3/atg12 , atg-7 , and lgg-2/atg8 , caused accu- mulation of PGL granules (Figures 1L1O and Table S1).","Line 23388: GST-tagged full-length or truncated SEPA-1 immobilized on glutathione Sepharose beads was incubated with His-SEPA-1, His-SEPA-1 (P71L), or His-SEPA-1 fragment (39160).",False Positive
WBPaper00032509,WBGene00018294,"atg-18, tag-283, atgr-18",S12A,F41E6.13a,"Line 23235: PGL granules were also found in unc-51 , atg-18 , and vps-16 mutant embryos (Figure 1P and Table S1), which encode components of the Atg1 kinase complex, the retrieval complex, and the complex required for autophagosome/lysosome fusion, respec- tively.",Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00032509,WBGene00018294,"atg-18, tag-283, atgr-18",S12A,F41E6.13b,"Line 23235: PGL granules were also found in unc-51 , atg-18 , and vps-16 mutant embryos (Figure 1P and Table S1), which encode components of the Atg1 kinase complex, the retrieval complex, and the complex required for autophagosome/lysosome fusion, respec- tively.",Line 23378: Phylogenetic analysis grouped the SEPA-1 family members into three major sub- groups (Figure S12A).,False Positive
WBPaper00035548,WBGene00000042,acr-2,V309M,K11G12.2,Line 2633: The mutation is in the pore domain of the ACR-2 acetylcholine receptor subunit and is identical to a hyperactivating mutation in the muscle receptor of patients with myasthenia gravis.,"Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",True Positive
WBPaper00035548,WBGene00000043,acr-3,V309M,K11G12.7,"Line 2636: Expression of these subunits in Xenopus oocytes demonstrates that the functional receptor is comprised of three alpha-subunits, UNC-38, UNC-63 and ACR-12, and two non-alpha-subunits, ACR-2 and ACR-3.","Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",False Positive
WBPaper00035548,WBGene00000044,acr-5,V309M,K03F8.2,"Line 2850: Last, we tested mutations in other neuronally expressed acetylcholine receptor subunits, including acr-5 , acr-9 , acr-14 , and acr-19 , and found that none of them suppressed acr- 2(n2420gf) (Figure 6B and unpublished data).","Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",False Positive
WBPaper00035548,WBGene00000051,acr-12,V309M,R01E6.4a,"Line 2636: Expression of these subunits in Xenopus oocytes demonstrates that the functional receptor is comprised of three alpha-subunits, UNC-38, UNC-63 and ACR-12, and two non-alpha-subunits, ACR-2 and ACR-3.","Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",False Positive
WBPaper00035548,WBGene00000058,acr-19,V309M,C31H5.3b,"Line 2850: Last, we tested mutations in other neuronally expressed acetylcholine receptor subunits, including acr-5 , acr-9 , acr-14 , and acr-19 , and found that none of them suppressed acr- 2(n2420gf) (Figure 6B and unpublished data).","Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",False Positive
WBPaper00035548,WBGene00001070,dpy-8,V13M,C31H2.2,"Line 2984: Further three- factor mapping placed n2420 between dpy-8 and unc-6 : from n2420/dpy-8 unc-6 heterozygotes, 18/19 Dpy non-Unc segregated n2420 , and 1/18 Unc non-Dpy segregated n2420 .","Line 2961: The ACR-2R receptor includes all five subunits. (B) The ACR-2(V13M)R receptor shows high sensitivity to acetylcholine and an increased sensitivity to DMPP, and weakly responds to levamisole and choline.",False Positive
WBPaper00035548,WBGene00001612,"glr-1, not-3",V13M,C06E1.4,Line 2725: Coexpression with reporter genes for GABAergic neurons and interneurons con- firmed that the acr-2 transcriptional reporters were not expressed in the ventral cord GABAergic motor neurons or in the interneurons expressing glr-1 or nmr-1 (Figure 3B).,"Line 2961: The ACR-2R receptor includes all five subunits. (B) The ACR-2(V13M)R receptor shows high sensitivity to acetylcholine and an increased sensitivity to DMPP, and weakly responds to levamisole and choline.",False Positive
WBPaper00035548,WBGene00003774,nmr-1,V309M,F07F6.6,Line 2725: Coexpression with reporter genes for GABAergic neurons and interneurons con- firmed that the acr-2 transcriptional reporters were not expressed in the ventral cord GABAergic motor neurons or in the interneurons expressing glr-1 or nmr-1 (Figure 3B).,"Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",False Positive
WBPaper00035548,WBGene00006797,"unc-63, lev-7, tmr-3",V309M,Y110A7A.3,"Line 2636: Expression of these subunits in Xenopus oocytes demonstrates that the functional receptor is comprised of three alpha-subunits, UNC-38, UNC-63 and ACR-12, and two non-alpha-subunits, ACR-2 and ACR-3.","Line 2694: The mutation in n2420 results in a valine 309 to methionine substitution, which is at the 13 9 position in the pore-forming TM2 domain of the ACR-2 subunit (TM2 numbering scheme as in [19]) (Figure 1D).",False Positive
WBPaper00036086,WBGene00000223,atf-7,P58S,C07G2.2a,"Line 7260: Using single nucleotide polymorphism (SNP)-based mapping [25,26], we narrowed the region containing the qd22 mutation to a 250 kb region of the left arm of LG III, where we identified a C R T missense mutation causing a P58S change in the open reading frame defined by the gene atf-7 , encoding a basic-region leucine zipper (bZIP) domain-containing protein (Figure 2A).","Line 7260: Using single nucleotide polymorphism (SNP)-based mapping [25,26], we narrowed the region containing the qd22 mutation to a 250 kb region of the left arm of LG III, where we identified a C R T missense mutation causing a P58S change in the open reading frame defined by the gene atf-7 , encoding a basic-region leucine zipper (bZIP) domain-containing protein (Figure 2A).",True Positive
WBPaper00036086,WBGene00000223,atf-7,P58S,C07G2.2b,"Line 7260: Using single nucleotide polymorphism (SNP)-based mapping [25,26], we narrowed the region containing the qd22 mutation to a 250 kb region of the left arm of LG III, where we identified a C R T missense mutation causing a P58S change in the open reading frame defined by the gene atf-7 , encoding a basic-region leucine zipper (bZIP) domain-containing protein (Figure 2A).","Line 7260: Using single nucleotide polymorphism (SNP)-based mapping [25,26], we narrowed the region containing the qd22 mutation to a 250 kb region of the left arm of LG III, where we identified a C R T missense mutation causing a P58S change in the open reading frame defined by the gene atf-7 , encoding a basic-region leucine zipper (bZIP) domain-containing protein (Figure 2A).",True Positive
WBPaper00036086,WBGene00000223,atf-7,P58S,C07G2.2d,"Line 7260: Using single nucleotide polymorphism (SNP)-based mapping [25,26], we narrowed the region containing the qd22 mutation to a 250 kb region of the left arm of LG III, where we identified a C R T missense mutation causing a P58S change in the open reading frame defined by the gene atf-7 , encoding a basic-region leucine zipper (bZIP) domain-containing protein (Figure 2A).","Line 7260: Using single nucleotide polymorphism (SNP)-based mapping [25,26], we narrowed the region containing the qd22 mutation to a 250 kb region of the left arm of LG III, where we identified a C R T missense mutation causing a P58S change in the open reading frame defined by the gene atf-7 , encoding a basic-region leucine zipper (bZIP) domain-containing protein (Figure 2A).",False Positive
WBPaper00036086,WBGene00003807,"npr-1, bor-1",R221K,C39E6.6,"Line 7450: In order to facilitate interpretation of the pathogen killing assays with recombinants, a strain carrying the qd22 mutation (without the agIs219 transgene) and the CB4856-derived allele of npr-1 , 215F, was utilized for crossing with CB4856 because of the enhanced susceptibility conferred by the 215F allele of npr-1 relative to the Bristol N2 background [44,45] in which qd22 was initially isolated.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00003822,"nsy-1, esp-8, ask-1, xts-1, srf-6",G440E,F59A6.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00003822,"nsy-1, esp-8, ask-1, xts-1, srf-6",G673E,F59A6.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00003822,"nsy-1, esp-8, ask-1, xts-1, srf-6",G793R,F59A6.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00003822,"nsy-1, esp-8, ask-1, xts-1, srf-6",P867L,F59A6.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00003822,"nsy-1, esp-8, ask-1, xts-1, srf-6",R221K,F59A6.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00004055,pmk-1,C173Y,B0218.3,"Line 7267: Previously, we have established that a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK) pathway regulates immunity in C. elegans , establishing the conservation of key innate immune signaling pathways of mammals in the immune response of C. elegans .",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004055,pmk-1,D161N,B0218.3,"Line 7267: Previously, we have established that a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK) pathway regulates immunity in C. elegans , establishing the conservation of key innate immune signaling pathways of mammals in the immune response of C. elegans .",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004055,pmk-1,L296F,B0218.3,"Line 7267: Previously, we have established that a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK) pathway regulates immunity in C. elegans , establishing the conservation of key innate immune signaling pathways of mammals in the immune response of C. elegans .",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004055,pmk-1,M209I,B0218.3,"Line 7267: Previously, we have established that a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK) pathway regulates immunity in C. elegans , establishing the conservation of key innate immune signaling pathways of mammals in the immune response of C. elegans .",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004758,"sek-1, esp-2",E220K,R03G5.2,"Line 7288: Furthermore, we found that atf-7(qd22 qd130) also suppressed the pathogen susceptibility (Figure 3D and Figure S15) and diminished agIs219 GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4) mutant.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004758,"sek-1, esp-2",G199D,R03G5.2,"Line 7288: Furthermore, we found that atf-7(qd22 qd130) also suppressed the pathogen susceptibility (Figure 3D and Figure S15) and diminished agIs219 GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4) mutant.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004758,"sek-1, esp-2",G212R,R03G5.2,"Line 7288: Furthermore, we found that atf-7(qd22 qd130) also suppressed the pathogen susceptibility (Figure 3D and Figure S15) and diminished agIs219 GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4) mutant.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004758,"sek-1, esp-2",M217I,R03G5.2,"Line 7288: Furthermore, we found that atf-7(qd22 qd130) also suppressed the pathogen susceptibility (Figure 3D and Figure S15) and diminished agIs219 GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4) mutant.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004758,"sek-1, esp-2",R221K,R03G5.2,"Line 7288: Furthermore, we found that atf-7(qd22 qd130) also suppressed the pathogen susceptibility (Figure 3D and Figure S15) and diminished agIs219 GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4) mutant.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004758,"sek-1, esp-2",S103N,R03G5.2,"Line 7288: Furthermore, we found that atf-7(qd22 qd130) also suppressed the pathogen susceptibility (Figure 3D and Figure S15) and diminished agIs219 GFP reporter expression (Figure 3C) phenotypes of the sek-1(km4) mutant.",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,True Positive
WBPaper00036086,WBGene00004804,"skn-1, sow-1, xrep-3, skinhead",G199D,T19E7.2d,"Line 7347: The PMK-1 pathway regulates the response to arsenite and oxidative stress through regulation of the transcription factor SKN-1 [29,30].",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00004804,"skn-1, sow-1, xrep-3, skinhead",L296F,T19E7.2a,"Line 7347: The PMK-1 pathway regulates the response to arsenite and oxidative stress through regulation of the transcription factor SKN-1 [29,30].",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00004804,"skn-1, sow-1, xrep-3, skinhead",R221K,T19E7.2b,"Line 7347: The PMK-1 pathway regulates the response to arsenite and oxidative stress through regulation of the transcription factor SKN-1 [29,30].",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00004804,"skn-1, sow-1, xrep-3, skinhead",S103N,T19E7.2d,"Line 7347: The PMK-1 pathway regulates the response to arsenite and oxidative stress through regulation of the transcription factor SKN-1 [29,30].",Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",A451V,F13B10.1b,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",L296F,F13B10.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",L296F,F13B10.1c,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",L296F,F13B10.1f,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",L296F,F13B10.1g,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",M217I,F13B10.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",M217I,F13B10.1c,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",M217I,F13B10.1f,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",M217I,F13B10.1g,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",P460L,F13B10.1b,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",S103N,F13B10.1a,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036086,WBGene00006575,"tir-1, nsy-2",S103N,F13B10.1g,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,Line 7293: Gene Allele Mutation nsy-1 qd1 Not identified nsy-1 qd3 Q256* nsy-1 qd6 W391* nsy-1 qd8 G440E nsy-1 qd23 W514* nsy-1 qd25 W157* nsy-1 qd29 Q426* nsy-1 qd31 P867L nsy-1 qd38 G793R nsy-1 qd41 451 bp deletion with 2 bp insertion nsy-1 qd44 Not identified nsy-1 qd50 Splice site nsy-1 qd52 Not identified nsy-1 qd55 G673E sek-1 qd12 R221K sek-1 qd14 S103N sek-1 qd24 M217I sek-1 qd26 E220K sek-1 qd37 G199D sek-1 qd39 W123* sek-1 qd60 G5R sek-1 qd65 G212R pmk-1 qd9 L296F pmk-1 qd11 D161N pmk-1 qd13 M209I pmk-1 qd15 W353* pmk-1 qd20 C173Y pmk-1 qd47 W29* pmk-1 qd49 Not identified tir-1 qd2 A451V tir-1 qd66 Q278* tir-1 qd67 P460L atf-7 qd22 P58S Mutations in tir-1 are in reference to gene model F13B10.1b .,False Positive
WBPaper00036485,WBGene00001579,gex-2,L667F,F56A11.1,"Line 22122: In a forward genetic screen for muscle arm Developmental Cell 18 , 961-972, June 15, 2010 2010 Elsevier Inc. 961 development defective (Madd) mutants, we isolated new alleles of unc-40 , unc-73 , and gex-2 (Alexander et al., 2009).","Line 22173: To further investigate the role of MADD-2s C-terminal domains, we recreated the tr101 (I530N) and tr64 (L667F) missense mutations in the FNIII and B30.2 domains of the MADD-2::CFP fusion protein, respectively.",False Positive
WBPaper00036485,WBGene00001863,"him-4, cpg-14",G774R,F15G9.4a,"Line 22213: (A) MADD- 2::CFP is expressed from the him-4 promoter from an extrachromosomal transgenic (Ex) array, whereas UNC- 40::YFP is expressed from the him-4 promoter from the trIs34 integrated transgenic array (Alexander et al., 2009).",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,False Positive
WBPaper00036485,WBGene00001863,"him-4, cpg-14",G774R,F15G9.4b,"Line 22213: (A) MADD- 2::CFP is expressed from the him-4 promoter from an extrachromosomal transgenic (Ex) array, whereas UNC- 40::YFP is expressed from the him-4 promoter from the trIs34 integrated transgenic array (Alexander et al., 2009).",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,False Positive
WBPaper00036485,WBGene00001863,"him-4, cpg-14",G774R,F15G9.4d,"Line 22213: (A) MADD- 2::CFP is expressed from the him-4 promoter from an extrachromosomal transgenic (Ex) array, whereas UNC- 40::YFP is expressed from the him-4 promoter from the trIs34 integrated transgenic array (Alexander et al., 2009).",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,False Positive
WBPaper00036485,WBGene00003515,"myo-3, sup-3",L667F,K12F2.1,Line 22152: (D and E) A madd-2(tr103) mutant rescued by a transgenic array expressing a genomic version of madd-2 tagged with GFP (D) (see Figure S1) and by muscle-specific expression of MADD- 2A::CFP from the pan-muscle promoter myo-3 (E).,"Line 22173: To further investigate the role of MADD-2s C-terminal domains, we recreated the tr101 (I530N) and tr64 (L667F) missense mutations in the FNIII and B30.2 domains of the MADD-2::CFP fusion protein, respectively.",False Positive
WBPaper00036485,WBGene00004854,slt-1,G774R,F40E10.4,"Line 22197: We found that the HSN axon guidance defects of both unc-40 null animals and madd-2 null mutants can be enhanced by a mutation in slt-1 , which encodes a component of a parallel pathway.",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,False Positive
WBPaper00036485,WBGene00006745,unc-5,G774R,B0273.4a,"Line 22106: For example, unc-5 , unc-6 , and unc-40 mutants were isolated in the first C .",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,False Positive
WBPaper00036485,WBGene00006745,unc-5,G774R,B0273.4d,"Line 22106: For example, unc-5 , unc-6 , and unc-40 mutants were isolated in the first C .",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,False Positive
WBPaper00036485,WBGene00006745,unc-5,L667F,B0273.4e,"Line 22106: For example, unc-5 , unc-6 , and unc-40 mutants were isolated in the first C .","Line 22173: To further investigate the role of MADD-2s C-terminal domains, we recreated the tr101 (I530N) and tr64 (L667F) missense mutations in the FNIII and B30.2 domains of the MADD-2::CFP fusion protein, respectively.",False Positive
WBPaper00036485,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",G774R,T19B4.7,"Line 22094: Through a screen for muscle arm development defective (Madd) mutants, we previously discovered that the UNC-40/DCC guidance receptor directs muscle arm extension through the Rho-GEF UNC-73.",Line 22279: unc-40(ev546) was a kind gift from Joe Culotti. We found that ev546 carries a G774R missense mutation in the fourth fibronectin type III domain of UNC-40.,True Positive
WBPaper00036485,WBGene00006805,"unc-73, let-509",C10S,F55C7.7d,"Line 22094: Through a screen for muscle arm development defective (Madd) mutants, we previously discovered that the UNC-40/DCC guidance receptor directs muscle arm extension through the Rho-GEF UNC-73.","Line 22160: In an otherwise wild-type background, the expression of MADD-2A( D R) or MADD-2A(C7S, C10S) induced muscle arm extension defects (Figure 4) and did not enhance the Madd phenotype of a madd-2(tr103) null mutant (Table S2).",False Positive
WBPaper00036485,WBGene00016539,"madd-2, rax-1, trim-9",C10S,C39F7.2a,"Line 22095: Here, we describe a gene identified through our mutant screen called madd-2, and show that it functions in an UNC-40 pathway.","Line 22160: In an otherwise wild-type background, the expression of MADD-2A( D R) or MADD-2A(C7S, C10S) induced muscle arm extension defects (Figure 4) and did not enhance the Madd phenotype of a madd-2(tr103) null mutant (Table S2).",False Positive
WBPaper00036485,WBGene00016539,"madd-2, rax-1, trim-9",C10S,C39F7.2b,"Line 22095: Here, we describe a gene identified through our mutant screen called madd-2, and show that it functions in an UNC-40 pathway.","Line 22160: In an otherwise wild-type background, the expression of MADD-2A( D R) or MADD-2A(C7S, C10S) induced muscle arm extension defects (Figure 4) and did not enhance the Madd phenotype of a madd-2(tr103) null mutant (Table S2).",False Positive
WBPaper00036485,WBGene00016539,"madd-2, rax-1, trim-9",L667F,C39F7.2a,"Line 22095: Here, we describe a gene identified through our mutant screen called madd-2, and show that it functions in an UNC-40 pathway.","Line 22173: To further investigate the role of MADD-2s C-terminal domains, we recreated the tr101 (I530N) and tr64 (L667F) missense mutations in the FNIII and B30.2 domains of the MADD-2::CFP fusion protein, respectively.",True Positive
WBPaper00038214,WBGene00001017,dnc-1,L452P,ZK593.5a,"Line 12502: We isolated two dnc-1 alleles, or404 ts and or676 ts, and two new dnc-4 alleles, or618 ts and or633 ts.",Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,True Positive
WBPaper00038214,WBGene00001017,dnc-1,L452P,ZK593.5c,"Line 12502: We isolated two dnc-1 alleles, or404 ts and or676 ts, and two new dnc-4 alleles, or618 ts and or633 ts.",Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,False Positive
WBPaper00038214,WBGene00001017,dnc-1,L452P,ZK593.5d,"Line 12502: We isolated two dnc-1 alleles, or404 ts and or676 ts, and two new dnc-4 alleles, or618 ts and or633 ts.",Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,False Positive
WBPaper00038214,WBGene00001017,dnc-1,V1247L,ZK593.5a,"Line 12502: We isolated two dnc-1 alleles, or404 ts and or676 ts, and two new dnc-4 alleles, or618 ts and or633 ts.",Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,False Positive
WBPaper00038214,WBGene00002991,lin-2,C71Y,F17E5.1a,"Line 12465: Results Over the past several years, using chemical mutagenesis of egg- laying defective lin-2(-) mutants with either ethyl methanesulfonate or ethyl nitrosourea, we have isolated conditional mutations in multiple essential C. elegans genes that already had been characterized using either mutant alleles or RNAi to reduce gene function.",Line 12582: We found that par-2(or373 ts) contained a cysteine to tyrosine change at codon 71 (Fig.,False Positive
WBPaper00038214,WBGene00002991,lin-2,L452P,F17E5.1a,"Line 12465: Results Over the past several years, using chemical mutagenesis of egg- laying defective lin-2(-) mutants with either ethyl methanesulfonate or ethyl nitrosourea, we have isolated conditional mutations in multiple essential C. elegans genes that already had been characterized using either mutant alleles or RNAi to reduce gene function.",Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,False Positive
WBPaper00038214,WBGene00003048,lit-1,L452P,W06F12.1a,"Line 12568: Gene Allele Potentially Fast-acting 1 dnc-1 or404 Yes dnc-1 or676 Unclear 3 dnc-4 or618 Yes dnc-4 or633 Yes lit-1 or393 Not tested mei-1 2 or642 Yes mei-1 2 or646 Yes mex-1 or286 Not tested par-2 2 or373 Yes par-2 2 or539 Yes par-2 2 or640 Yes plk-1 or683 Unclear 3 rsa-1 or598 Yes spd-2 or293 Yes spd-2 or493 Unclear 4 spd-2 or454 Unclear 4 spd-2 or655 Unclear 3 sur-6 or550 Unclear 3 tba-1 or594 Yes tbb-2 or600 No zyg-1 2 or278 No zyg-1 2 or297 Yes zyg-1 2 or409 Yes zyg-1 2 or1018 No 1 We determined if an allele was potentially fast-acting in the following manner: We mounted embryos produced at 15 u C on microscope slides and immediately made time-lapse videomicrographs at a room maintained at 24 u C. If defects similar to those observed after long temperature shifts were found in at least 20% of the embryos and if there was little embryonic lethality at 15 u C, we conclude that the allele may be fast-acting.",Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,False Positive
WBPaper00038214,WBGene00003183,mei-1,K202Q,T01G9.5a,Line 12516: mei-1/ Katanin mutants The meiotic spindles in the oocytes of most animals are smaller than mitotic spindles.,Line 12539: The mutation in each changes a highly conserved lysine to glutamine at codon 202 and causes fast- inactivation of MEI-1 function (Fig.,False Positive
WBPaper00038214,WBGene00003183,mei-1,K202Q,T01G9.5b,Line 12516: mei-1/ Katanin mutants The meiotic spindles in the oocytes of most animals are smaller than mitotic spindles.,Line 12539: The mutation in each changes a highly conserved lysine to glutamine at codon 202 and causes fast- inactivation of MEI-1 function (Fig.,False Positive
WBPaper00038214,WBGene00003917,par-2,C71Y,F58B6.3a,"Line 12568: Gene Allele Potentially Fast-acting 1 dnc-1 or404 Yes dnc-1 or676 Unclear 3 dnc-4 or618 Yes dnc-4 or633 Yes lit-1 or393 Not tested mei-1 2 or642 Yes mei-1 2 or646 Yes mex-1 or286 Not tested par-2 2 or373 Yes par-2 2 or539 Yes par-2 2 or640 Yes plk-1 or683 Unclear 3 rsa-1 or598 Yes spd-2 or293 Yes spd-2 or493 Unclear 4 spd-2 or454 Unclear 4 spd-2 or655 Unclear 3 sur-6 or550 Unclear 3 tba-1 or594 Yes tbb-2 or600 No zyg-1 2 or278 No zyg-1 2 or297 Yes zyg-1 2 or409 Yes zyg-1 2 or1018 No 1 We determined if an allele was potentially fast-acting in the following manner: We mounted embryos produced at 15 u C on microscope slides and immediately made time-lapse videomicrographs at a room maintained at 24 u C. If defects similar to those observed after long temperature shifts were found in at least 20% of the embryos and if there was little embryonic lethality at 15 u C, we conclude that the allele may be fast-acting.",Line 12582: We found that par-2(or373 ts) contained a cysteine to tyrosine change at codon 71 (Fig.,True Positive
WBPaper00038214,WBGene00003917,par-2,K202Q,F58B6.3a,"Line 12568: Gene Allele Potentially Fast-acting 1 dnc-1 or404 Yes dnc-1 or676 Unclear 3 dnc-4 or618 Yes dnc-4 or633 Yes lit-1 or393 Not tested mei-1 2 or642 Yes mei-1 2 or646 Yes mex-1 or286 Not tested par-2 2 or373 Yes par-2 2 or539 Yes par-2 2 or640 Yes plk-1 or683 Unclear 3 rsa-1 or598 Yes spd-2 or293 Yes spd-2 or493 Unclear 4 spd-2 or454 Unclear 4 spd-2 or655 Unclear 3 sur-6 or550 Unclear 3 tba-1 or594 Yes tbb-2 or600 No zyg-1 2 or278 No zyg-1 2 or297 Yes zyg-1 2 or409 Yes zyg-1 2 or1018 No 1 We determined if an allele was potentially fast-acting in the following manner: We mounted embryos produced at 15 u C on microscope slides and immediately made time-lapse videomicrographs at a room maintained at 24 u C. If defects similar to those observed after long temperature shifts were found in at least 20% of the embryos and if there was little embryonic lethality at 15 u C, we conclude that the allele may be fast-acting.",Line 12539: The mutation in each changes a highly conserved lysine to glutamine at codon 202 and causes fast- inactivation of MEI-1 function (Fig.,False Positive
WBPaper00038214,WBGene00006352,sur-6,C71Y,F26E4.1,"Line 12487: SUR-6 is the B 9 subunit in C. elegans and has known functions during embryonic and vulval development [36,37].",Line 12582: We found that par-2(or373 ts) contained a cysteine to tyrosine change at codon 71 (Fig.,False Positive
WBPaper00038214,WBGene00006352,sur-6,W140R,F26E4.1,"Line 12487: SUR-6 is the B 9 subunit in C. elegans and has known functions during embryonic and vulval development [36,37].","Line 12491: In genetic crosses, sur-6(or550 ts ) failed to complement sur-6(sv30) (data not shown). The amino acid alteration in sur-6(or550 ts ) changes a highly conserved tryptophan to arginine at position 140 (Fig.",True Positive
WBPaper00038214,WBGene00006988,zyg-1,L452P,F59E12.2,Line 12550: zyg-1 mutants ZYG-1 is a polo-related kinase homologous to vertebrate SAK/ PLK4 [52] that localizes to centrioles and is required for centriole duplication [53].,Line 12512: dnc-1(or676 ts ) has two changes: one at position 452 (leucine to proline) and the other at position 1247 (valine to leucine).,False Positive
WBPaper00038214,WBGene00016124,dnc-4,C71Y,C26B2.1,"Line 12502: We isolated two dnc-1 alleles, or404 ts and or676 ts, and two new dnc-4 alleles, or618 ts and or633 ts.",Line 12582: We found that par-2(or373 ts) contained a cysteine to tyrosine change at codon 71 (Fig.,False Positive
WBPaper00038214,WBGene00016124,dnc-4,V359G,C26B2.1,"Line 12502: We isolated two dnc-1 alleles, or404 ts and or676 ts, and two new dnc-4 alleles, or618 ts and or633 ts.",Line 12513: dnc-4(or618 ts ) substitutes valine for a glycine at position 359 and dnc-4(or633 ts ) has an altered splice donor site after the first exon (G to A) at nucleotide 604 in the unspliced RNA molecule.,True Positive
WBPaper00040140,WBGene00000123,"ama-1, rpb-1",A363V,F36A4.7,Line 1939: Mutations in the Caenorhabditis elegans RNA polymerase II AMA-1/RPB-1 subunit that cause alpha-amanitin resistance and/or developmental defects were isolated previously.,"Line 2006: n Table 1 Summary of a -amanitin - resistant and hypomorphic ama-1 mutations Strain a Allele DNA Mutation AA Change Corresponding S. cerevisiae AA Location in Structure b Terminal Phenotype c 20 25 N2 N. M. d DR680 e m118 3893 g / a 777 C / Y 764 C Funnel, near a -amanitin binding site Adult (F) Adult (F) DR786 e m322 3481 g / a 739 R / H 726 R Funnel, near a -amanitin binding site Adult (F) Adult (F) DR1099 e m118 3893g / a 777 C / Y 764 C Funnel, near a -amanitin binding site Adult (F) Adult (ME) m526 3917 g / a 785 G / E 772 G Funnel, near a -amanitin binding site DR731 f m118 3893g / a 777 C / Y 764 C Adult (F) Adult (ME) m251 1719 c / t 363 A / V 355 G Active site, a -helix 8, between rpb1/2 DR730 f m118 3893g / a 777 C / Y 764 C Adult (F) Adult (ME) m238 6623 g / a 1406 G / R 1388 G Cleft, loop DR892 f m118 3893 g / a 777 C / Y 764 C Adult (ME) Mid larval arrest m396 6414 c / t 1336 S / F 1318 T Cleft, b -sheet 44, between rpb1/5 DR682 f m118 3893g / a 777 C / Y 764 C Cleft (trigger loop), b -sheet 36 Mid larval to adult (ME) arrest Mid larval arrest m235 5210 g / a 1086 G / E 1073 G DR683 f m118 3893g / a 777 C / Y 764 C Adult (ST) L1 larval arrest m236 5105 a / t 1051 N / I 1038 T Foot, b -sheet 35 DR811 g m118 3893g / a 777 C / Y 764 C L1 larval arrest L1 larval arrest m332 4168 g / a 869 V / M 856 T Cleft, a -helix 24 DR880 g m118 3893g / a 777 C / Y 764 C L1 larval arrest L1 larval arrest m370 3171 g / a 636 G / R 623 G Pore 1, b -sheet 17 DR976 h m118 3893g / a 777 C / Y 764 C Adult (F) Adult (F) m370 3171 g / a 636 G / R 623 G m417 3502 c / t 746 A / V 733 A Funnel, b -sheet 21 DR877 g m118 3893g / a 777 C / Y 764 C L1 larval arrest L1 larval arrest m367 5282 g / a 1110 G / E 1097 G Cleft (trigger loop), b -sheet 37 DR966 i m118 3893g / a 777 C / Y 764 C Adult (F) Adult (F) m367 N. M. d m414 N. M. d Numbering of the DNA sequence is from the genomic sequence, beginning at the translation start site.",True Positive
WBPaper00040140,WBGene00003992,pgl-1,R739H,ZK381.4b,"Line 1973: To assay gastrulation, embryos were probed using rabbit anti-PGL-1, which labels the primordial germ cells Z2/Z3 ,and DAPI to stainDNA as previously described (Schaner et al.","Line 1981: We also identi ed a novel C. elegans a -amanitin - resistant mutation, ama-1 (m322 ), as an R739H substitution (Table 1).",False Positive
WBPaper00041364,WBGene00000068,"acy-1, sgs-1",G473R,F17C8.1,"Line 13182: To generate C-terminal GFP fusions to ACY-1, ACY-2 ,and ACY-3 ,weusedfosmids WRM067dG12, WRM0638bH07 ,and WRM0618cF11 ,respec- tively.","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000099,"air-2, let-603, stu-7, cyk-6",E272*,B0207.4,"Line 13094: 2006), the localization of the AIR-2 Aurora B protein kinase to chromatin (Govindan et al.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",A665T,K04F10.4e,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4a,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4b,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4c,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4d,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4e,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4f,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4g,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4h,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4i,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G331R,K04F10.4j,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4a,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4b,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4c,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4d,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4e,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4f,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4g,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4h,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4i,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000254,"bli-4, let-77, kpc-4",G473R,K04F10.4j,"Line 13139: The following rearrangements, de ciencies, duplications, and extrachromosomal arrays were used: hT2 [dpy-18(h662) ; bli-4(e937)] (I; III), hT2[bli-4(e937 )let-?","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",False Positive
WBPaper00041364,WBGene00000418,ced-4,Y29*,C35D10.9a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00000418,ced-4,Y29*,C35D10.9b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00000441,ceh-18,S12A,ZC64.3b,"Line 13160: inx-22(tm1661) , ceh-18(mg57) ,and vab-1(dx31) do not suppress acy-4(lf) sterility (Govindan et al.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00000441,ceh-18,S12B,ZC64.3b,"Line 13160: inx-22(tm1661) , ceh-18(mg57) ,and vab-1(dx31) do not suppress acy-4(lf) sterility (Govindan et al.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00001067,dpy-5,E272*,F27C1.8,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00001320,ent-1,E272*,ZK809.4a,"Line 13444: The spr genes encode multiple chromatin-modifying components that might constitute a C. elegans CoREST- like complex, similar to mammalian CoREST ( core pressor for element-1 - s ilencing t ranscription factor; reviewed by Lakowski et al.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00001413,fem-3,Y284*,C01F6.4a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13437: Previously isolated spr-5 mutations, the strong loss-of-function allele, by134 (Y284stop) (Eimer et al.",False Positive
WBPaper00041364,WBGene00001413,fem-3,Y29*,C01F6.4c,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00001481,"fog-1, cpb-4",E272*,Y54E10A.4c,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00001481,"fog-1, cpb-4",G331R,Y54E10A.4c,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00001481,"fog-1, cpb-4",W177*,Y54E10A.4c,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00001482,fog-2,W148*,Y113G7B.5a,"Line 13138: C. elegans Meiotic Maturation Signaling 907 (ok1806) , unc-68(e540) , oma-2(te51) , spr-1(gk734) , unc-23 (e25) , fog-2(oz40) ,and fog-2(q71) ; LGX: spr-3(by108) and spr-3(ok2525) .","Line 13306: sacy-1(tn1385) also strongly suppressed the self-sterility of fog-2(q71) (Table 3), another strong loss-of-function fog-2 mutation (W148stop; Clifford et al.",False Positive
WBPaper00041364,WBGene00001482,fog-2,W148*,Y113G7B.5b,"Line 13138: C. elegans Meiotic Maturation Signaling 907 (ok1806) , unc-68(e540) , oma-2(te51) , spr-1(gk734) , unc-23 (e25) , fog-2(oz40) ,and fog-2(q71) ; LGX: spr-3(by108) and spr-3(ok2525) .","Line 13306: sacy-1(tn1385) also strongly suppressed the self-sterility of fog-2(q71) (Table 3), another strong loss-of-function fog-2 mutation (W148stop; Clifford et al.",False Positive
WBPaper00041364,WBGene00001482,fog-2,Y284*,Y113G7B.5a,"Line 13138: C. elegans Meiotic Maturation Signaling 907 (ok1806) , unc-68(e540) , oma-2(te51) , spr-1(gk734) , unc-23 (e25) , fog-2(oz40) ,and fog-2(q71) ; LGX: spr-3(by108) and spr-3(ok2525) .","Line 13437: Previously isolated spr-5 mutations, the strong loss-of-function allele, by134 (Y284stop) (Eimer et al.",False Positive
WBPaper00041364,WBGene00001482,fog-2,Y284*,Y113G7B.5b,"Line 13138: C. elegans Meiotic Maturation Signaling 907 (ok1806) , unc-68(e540) , oma-2(te51) , spr-1(gk734) , unc-23 (e25) , fog-2(oz40) ,and fog-2(q71) ; LGX: spr-3(by108) and spr-3(ok2525) .","Line 13437: Previously isolated spr-5 mutations, the strong loss-of-function allele, by134 (Y284stop) (Eimer et al.",False Positive
WBPaper00041364,WBGene00001482,fog-2,Y29*,Y113G7B.5a,"Line 13138: C. elegans Meiotic Maturation Signaling 907 (ok1806) , unc-68(e540) , oma-2(te51) , spr-1(gk734) , unc-23 (e25) , fog-2(oz40) ,and fog-2(q71) ; LGX: spr-3(by108) and spr-3(ok2525) .","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00001482,fog-2,Y29*,Y113G7B.5b,"Line 13138: C. elegans Meiotic Maturation Signaling 907 (ok1806) , unc-68(e540) , oma-2(te51) , spr-1(gk734) , unc-23 (e25) , fog-2(oz40) ,and fog-2(q71) ; LGX: spr-3(by108) and spr-3(ok2525) .","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00001595,gld-1,S12A,T23G11.3,Line 13326: Biochemical studies estab- lished that FOG-2 can form a ternary complex with the KH- domain proteinGLD-1 and the 3 9 -UTR of tra-2 (Clifford et al.,"Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00001595,gld-1,S12B,T23G11.3,Line 13326: Biochemical studies estab- lished that FOG-2 can form a ternary complex with the KH- domain proteinGLD-1 and the 3 9 -UTR of tra-2 (Clifford et al.,Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00002123,"inx-1, opu-1, pcr55",Y29*,C16E9.4a,"Line 13605: The gonadal sheath cells inhibit meiotic maturation in part via gap-junctional communication involving the innexins INX-8 and INX-9 in the gonadal sheath cells (T. Starich and D. Greenstein, unpublished data) and INX-14 and INX-22 in oocytes (Govindan et al.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00002123,"inx-1, opu-1, pcr55",Y29*,C16E9.4b,"Line 13605: The gonadal sheath cells inhibit meiotic maturation in part via gap-junctional communication involving the innexins INX-8 and INX-9 in the gonadal sheath cells (T. Starich and D. Greenstein, unpublished data) and INX-14 and INX-22 in oocytes (Govindan et al.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00002130,"inx-8, opu-8",S12A,ZK792.2,"Line 13605: The gonadal sheath cells inhibit meiotic maturation in part via gap-junctional communication involving the innexins INX-8 and INX-9 in the gonadal sheath cells (T. Starich and D. Greenstein, unpublished data) and INX-14 and INX-22 in oocytes (Govindan et al.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00002130,"inx-8, opu-8",S12B,ZK792.2,"Line 13605: The gonadal sheath cells inhibit meiotic maturation in part via gap-junctional communication involving the innexins INX-8 and INX-9 in the gonadal sheath cells (T. Starich and D. Greenstein, unpublished data) and INX-14 and INX-22 in oocytes (Govindan et al.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00002131,"inx-9, opu-9",S12A,ZK792.3,"Line 13605: The gonadal sheath cells inhibit meiotic maturation in part via gap-junctional communication involving the innexins INX-8 and INX-9 in the gonadal sheath cells (T. Starich and D. Greenstein, unpublished data) and INX-14 and INX-22 in oocytes (Govindan et al.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00002131,"inx-9, opu-9",S12B,ZK792.3,"Line 13605: The gonadal sheath cells inhibit meiotic maturation in part via gap-junctional communication involving the innexins INX-8 and INX-9 in the gonadal sheath cells (T. Starich and D. Greenstein, unpublished data) and INX-14 and INX-22 in oocytes (Govindan et al.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00002189,kin-1,G331R,ZK909.2a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00002189,kin-1,G331R,ZK909.2b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00002189,kin-1,Y29*,ZK909.2h,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00002189,kin-1,Y29*,ZK909.2j,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00002190,kin-2,E272*,R07E4.6c,"Line 13212: In C. elegans ,the catalytic and regulatory subunits of PKA are encoded by kin-1 and kin-2 , respectively (Gross et al.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00002190,kin-2,S12A,R07E4.6c,"Line 13212: In C. elegans ,the catalytic and regulatory subunits of PKA are encoded by kin-1 and kin-2 , respectively (Gross et al.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00002190,kin-2,S12B,R07E4.6c,"Line 13212: In C. elegans ,the catalytic and regulatory subunits of PKA are encoded by kin-1 and kin-2 , respectively (Gross et al.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00002190,kin-2,W177*,R07E4.6b,"Line 13212: In C. elegans ,the catalytic and regulatory subunits of PKA are encoded by kin-1 and kin-2 , respectively (Gross et al.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00002990,"lin-1, elk-1",S12A,C37F5.1b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00002990,"lin-1, elk-1",S12B,C37F5.1b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00002992,"lin-3, let-94, sli-4",E272*,F36H1.4b,"Line 13582: The SynMuv genes establish a necessary precondition for vulval induction by repressing ectopic transcription of lin-3 , which encodes the anchor cell signal (Cui et al.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00003020,lin-35,E272*,C32F10.2,Line 13583: SynMuv B genes de ne a chromatin regulatory path- way involving the Rb retinoblastoma ortholog LIN-35 (Lu and Horvitz 1998).,"Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00003020,lin-35,S12A,C32F10.2,Line 13583: SynMuv B genes de ne a chromatin regulatory path- way involving the Rb retinoblastoma ortholog LIN-35 (Lu and Horvitz 1998).,"Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00003020,lin-35,S12B,C32F10.2,Line 13583: SynMuv B genes de ne a chromatin regulatory path- way involving the Rb retinoblastoma ortholog LIN-35 (Lu and Horvitz 1998).,Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00003777,nmy-2,G331R,F20G4.3,"Line 13097: In this regard, MSP might function in part by promoting the phosphorylation of the MLC-4 regulatory light chain of NMY-2 nonmuscle my- osin (Nadarajan et al.","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00003864,"oma-1, moe-1",E272*,C09G9.6,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00003906,paf-1,G331R,W03G9.6,Line 13362: 1993) and ced-4 encodes an Apaf-1 - like protein (Yuan and Horvitz 1992).,"Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00003906,paf-1,W148*,W03G9.6,Line 13362: 1993) and ced-4 encodes an Apaf-1 - like protein (Yuan and Horvitz 1992).,"Line 13306: sacy-1(tn1385) also strongly suppressed the self-sterility of fog-2(q71) (Table 3), another strong loss-of-function fog-2 mutation (W148stop; Clifford et al.",False Positive
WBPaper00041364,WBGene00004397,rol-6,G331R,T01B7.7,Line 13183: Fusion constructs were injected into the wild type with rol-6(su1006d) as co-injection marker.,"Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00004397,rol-6,Y29*,T01B7.7,Line 13183: Fusion constructs were injected into the wild type with rol-6(su1006d) as co-injection marker.,"Line 13292: sacy-1 functions in the hermaphrodite sperm-to-oocyte switch We serendipitously found that sacy-1(tn1385) strongly sup- presses the self-sterility caused by fog-2(oz40) (Table 3), a strong loss-of-function mutation (Y29stop) in fog-2 , which Figure 3 Molecular identi cation of Sacy mutations in pde-6 , twk-1 , and CoREST genes.",False Positive
WBPaper00041364,WBGene00004510,"rrf-3, fer-15",G331R,F10B5.7,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",False Positive
WBPaper00041364,WBGene00004769,"sel-12, sum-1",E272*,F35H12.3,Line 13442: spr-5 and other spr genes were originally identi ed as suppressors of the sel-12 presenilin mutant egg-laying defect (Wen et al.,"Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00005007,spr-2,E272*,C27B7.1a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00005007,spr-2,E272*,C27B7.1b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00005009,spr-4,E272*,C09H6.1a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00005009,spr-4,E272*,C09H6.1b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00005010,spr-5,A665T,Y40B1B.6,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00005010,spr-5,G533R,Y40B1B.6,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13264: tn1385 results in a G533R substitution in motif VI, which contributes to ATP binding and hydrolysis (Linder 2006).",False Positive
WBPaper00041364,WBGene00005010,spr-5,Y284*,Y40B1B.6,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13437: Previously isolated spr-5 mutations, the strong loss-of-function allele, by134 (Y284stop) (Eimer et al.",False Positive
WBPaper00041364,WBGene00006594,"tom-1, tag-23, tomo-1",A665T,M01A10.2a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006594,"tom-1, tag-23, tomo-1",A665T,M01A10.2e,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006594,"tom-1, tag-23, tomo-1",A665T,M01A10.2f,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006594,"tom-1, tag-23, tomo-1",A665T,M01A10.2g,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006594,"tom-1, tag-23, tomo-1",A665T,M01A10.2h,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006594,"tom-1, tag-23, tomo-1",A665T,M01A10.2i,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006605,tra-2,E272*,C15F1.3c,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006656,"twk-1, twk-7",E272*,F21C3.1,Line 13055: Modulatory factors include multiple subunits of a CoREST-like complex and the TWK-1 two-pore potassium channel.,"Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006656,"twk-1, twk-7",W177*,F21C3.1,Line 13055: Modulatory factors include multiple subunits of a CoREST-like complex and the TWK-1 two-pore potassium channel.,"Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006656,"twk-1, twk-7",W330*,F21C3.1,Line 13055: Modulatory factors include multiple subunits of a CoREST-like complex and the TWK-1 two-pore potassium channel.,"Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006751,"unc-11, let-581",E272*,C32E8.10a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006751,"unc-11, let-581",E272*,C32E8.10b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006751,"unc-11, let-581",E272*,C32E8.10c,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006751,"unc-11, let-581",E272*,C32E8.10d,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006751,"unc-11, let-581",E272*,C32E8.10e,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006751,"unc-11, let-581",E272*,C32E8.10h,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006752,unc-13,A665T,ZK524.2e,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006752,unc-13,A665T,ZK524.2f,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006752,unc-13,A665T,ZK524.2g,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006752,unc-13,A665T,ZK524.2i,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00006752,unc-13,E272*,ZK524.2a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006752,unc-13,E272*,ZK524.2d,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006752,unc-13,E272*,ZK524.2e,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006752,unc-13,G533R,ZK524.2a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13264: tn1385 results in a G533R substitution in motif VI, which contributes to ATP binding and hydrolysis (Linder 2006).",False Positive
WBPaper00041364,WBGene00006752,unc-13,G533R,ZK524.2d,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13264: tn1385 results in a G533R substitution in motif VI, which contributes to ATP binding and hydrolysis (Linder 2006).",False Positive
WBPaper00041364,WBGene00006752,unc-13,G533R,ZK524.2e,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13264: tn1385 results in a G533R substitution in motif VI, which contributes to ATP binding and hydrolysis (Linder 2006).",False Positive
WBPaper00041364,WBGene00006752,unc-13,S12A,ZK524.2b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006752,unc-13,S12A,ZK524.2g,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006752,unc-13,S12B,ZK524.2b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006752,unc-13,S12B,ZK524.2g,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",E272*,ZK617.1e,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12A,ZK617.1a,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12A,ZK617.1b,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12A,ZK617.1f,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12A,ZK617.1g,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12A,ZK617.1h,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12A,ZK617.1i,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.","Line 13510: TWK-1 has several human homologs, including TREK-1 and TREK-2 (Figure S12A).",False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12B,ZK617.1a,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12B,ZK617.1b,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12B,ZK617.1f,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12B,ZK617.1g,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12B,ZK617.1h,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00006759,"unc-22, twitchin",S12B,ZK617.1i,"Line 13148: The three pde-6 alleles failed to complement for this property, but exhibited normal RNAi responses with unc-22 and pos-1 triggers.",Line 13518: We observed that TWK-1 D C284::GFP could mediate function for both oocyte maturation and motility (Figure S12B).,False Positive
WBPaper00041364,WBGene00019245,sacy-1,G331R,H27M09.1,"Line 13053: sacy-1, which encodes a highly conserved DEAD-box helicase, is an essential germline factor that negatively regulates meiotic maturation.","Line 13266: tn1440 results in G331R in motif Ib, which contrib- utes to RNA binding (Schutz et al , 2010).",True Positive
WBPaper00041364,WBGene00019245,sacy-1,G473R,H27M09.1,"Line 13053: sacy-1, which encodes a highly conserved DEAD-box helicase, is an essential germline factor that negatively regulates meiotic maturation.","Line 13267: tn1391 results in G473R in a region between motifs IV and V, which is surface exposed in the crystal structure of the human ortholog DDX41 (Schutz et al.",True Positive
WBPaper00041364,WBGene00019245,sacy-1,G533R,H27M09.1,"Line 13053: sacy-1, which encodes a highly conserved DEAD-box helicase, is an essential germline factor that negatively regulates meiotic maturation.","Line 13264: tn1385 results in a G533R substitution in motif VI, which contributes to ATP binding and hydrolysis (Linder 2006).",True Positive
WBPaper00041364,WBGene00021463,zeel-1,A665T,Y39G10AR.5,"Line 13153: In addi- tion, more than half of Sacy mutations localize to LGI and thus the documented incompatibility between Bristol and Hawaiian strains caused by the peel-1/zeel-1 system (Seidel et al.","Line 13438: 2011), and ar197 (A665T) (Jarriault and Greenwald 2002), also suppress acy-4(ok1806) sterility and fail to complement tn1394 for suppression.",False Positive
WBPaper00041364,WBGene00022389,pde-6,E272*,Y95B8A.10a,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041364,WBGene00022389,pde-6,E272*,Y95B8A.10b,"Line 13126: In addition, the following mutations were used: LGI: pde-6(ok3410) , gsa-1(pk75) , fog-1(e2121) , dpy-5 (e61) , tom-1(ok188) , tom-1(ok2437) , tom-1(ok285) , tom-1 (tm4724) , let-605(h312) , dpy-14(e188) , sacy-1(tm5503) , unc- 15(e1402) , unc-13(e450) , unc-13(e1091) , pbrm-1(gk1195 ) , rrf- 1(pk1417) , spr-4(by105) , fog-3(q470) , lin-11(n566) , spr-5 (ar197) , spr-5(by134) , kin-1(ok338) , and uev-1(ok2610) ; LG II: tra-2(e2020) and rrf-3(pk1426) ;LGIII: ced-4(n1162) , unc-32(e189) ,and unc-119(ed3) ;LGIV: unc-33(mn407) , unc- 24(e138) , oma-1(zu405te33) , spr-2(ar199) , spr-2(ar211) , spr-2(tm4802) , fem-3 (e1996) , fem-3(q20) , him-8(tm611) , dpy-20(e1282) ,and ced-3(n717) ;LGV: unc-46(e177) , acy-4 Figure 1 kin-1 is required in the gonadal sheath cells for oocyte meiotic maturation.","Line 13477: tn1398 and tn1403 introduce stop codons after the fourth trans- membrane domain (W330stop and E272stop, respectively) and tn1397 introduces a stop codon after the second trans- membrane domain (Figure 3; W177stop).",False Positive
WBPaper00041467,WBGene00000390,cdc-42,G124D,R07G3.1,"Line 744: The mammalian homolog of SID-3, activated cdc-42-associated kinase (ACK), acts in many signaling pathways that respond to environmental changes and is known to directly associate with endocytic vesicles, which have been implicated in dsRNA transport.","Line 800: 1 C , compare Left and 100 micro m 1kb TYROSINE KINASE SH3 CRIB qt18 (splice acceptor) qt32 (G124D) qt38 (R353Q) tm342 ) * qt28 (R254 ) * qt16 ( ) * qt37 (W300 ) * qt31 (W310 ) * qt40 (R353 ) * qt29 (Q411 ) * qt27 (Q659 ) * qt36 (Q815 ) * qt14 ) * B A 30 60 0 % unsilenced SID-3 - - - DsRed sid-3(-) wild type * * genetic background proteins expressed wild type sid-3(-) C sid-3(-); qtEx [DsRedsid-3(+)] sid-3(-); qtEx [DsRed] D silenced bwm cells silenced bwm cells silenced bwm cells silenced bwm cells silenced pharynx 200 aa TYROSINE KINASESH3 CRIB E C. elegans C. briggsae D. melanogaster H. sapiens GH wild type sid-1( Q154 ) ark-1(n3701) ark-1( Q528 ) * * 50 100 % dumpy dpy-7 RNAi 25 12.5 0 TNK1 ACK DPR-2DACK H. s D. m % identity C. e SID-3 C. e ARK-1 0.2 H.s ACK H.s TNK1 D.m DACK D.m DPR2 C.e SID-3 C.e ARK-1 F Fig.",False Positive
WBPaper00041467,WBGene00002207,"sid-3, kin-25",G124D,B0302.1a,"Line 741: Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA.","Line 800: 1 C , compare Left and 100 micro m 1kb TYROSINE KINASE SH3 CRIB qt18 (splice acceptor) qt32 (G124D) qt38 (R353Q) tm342 ) * qt28 (R254 ) * qt16 ( ) * qt37 (W300 ) * qt31 (W310 ) * qt40 (R353 ) * qt29 (Q411 ) * qt27 (Q659 ) * qt36 (Q815 ) * qt14 ) * B A 30 60 0 % unsilenced SID-3 - - - DsRed sid-3(-) wild type * * genetic background proteins expressed wild type sid-3(-) C sid-3(-); qtEx [DsRedsid-3(+)] sid-3(-); qtEx [DsRed] D silenced bwm cells silenced bwm cells silenced bwm cells silenced bwm cells silenced pharynx 200 aa TYROSINE KINASESH3 CRIB E C. elegans C. briggsae D. melanogaster H. sapiens GH wild type sid-1( Q154 ) ark-1(n3701) ark-1( Q528 ) * * 50 100 % dumpy dpy-7 RNAi 25 12.5 0 TNK1 ACK DPR-2DACK H. s D. m % identity C. e SID-3 C. e ARK-1 0.2 H.s ACK H.s TNK1 D.m DACK D.m DPR2 C.e SID-3 C.e ARK-1 F Fig.",True Positive
WBPaper00041467,WBGene00002207,"sid-3, kin-25",G124D,B0302.1b,"Line 741: Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA.","Line 800: 1 C , compare Left and 100 micro m 1kb TYROSINE KINASE SH3 CRIB qt18 (splice acceptor) qt32 (G124D) qt38 (R353Q) tm342 ) * qt28 (R254 ) * qt16 ( ) * qt37 (W300 ) * qt31 (W310 ) * qt40 (R353 ) * qt29 (Q411 ) * qt27 (Q659 ) * qt36 (Q815 ) * qt14 ) * B A 30 60 0 % unsilenced SID-3 - - - DsRed sid-3(-) wild type * * genetic background proteins expressed wild type sid-3(-) C sid-3(-); qtEx [DsRedsid-3(+)] sid-3(-); qtEx [DsRed] D silenced bwm cells silenced bwm cells silenced bwm cells silenced bwm cells silenced pharynx 200 aa TYROSINE KINASESH3 CRIB E C. elegans C. briggsae D. melanogaster H. sapiens GH wild type sid-1( Q154 ) ark-1(n3701) ark-1( Q528 ) * * 50 100 % dumpy dpy-7 RNAi 25 12.5 0 TNK1 ACK DPR-2DACK H. s D. m % identity C. e SID-3 C. e ARK-1 0.2 H.s ACK H.s TNK1 D.m DACK D.m DPR2 C.e SID-3 C.e ARK-1 F Fig.",True Positive
WBPaper00041467,WBGene00002207,"sid-3, kin-25",K139A,B0302.1a,"Line 741: Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA.","Line 836: Speci cally, we transformed sid-3 mutant animals with constructs that express either wild-type SID-3 or a SID-3(K139A) mutant protein.",False Positive
WBPaper00041467,WBGene00002207,"sid-3, kin-25",K139A,B0302.1b,"Line 741: Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA.","Line 836: Speci cally, we transformed sid-3 mutant animals with constructs that express either wild-type SID-3 or a SID-3(K139A) mutant protein.",False Positive
WBPaper00041467,WBGene00002207,"sid-3, kin-25",R353Q,B0302.1a,"Line 741: Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA.","Line 800: 1 C , compare Left and 100 micro m 1kb TYROSINE KINASE SH3 CRIB qt18 (splice acceptor) qt32 (G124D) qt38 (R353Q) tm342 ) * qt28 (R254 ) * qt16 ( ) * qt37 (W300 ) * qt31 (W310 ) * qt40 (R353 ) * qt29 (Q411 ) * qt27 (Q659 ) * qt36 (Q815 ) * qt14 ) * B A 30 60 0 % unsilenced SID-3 - - - DsRed sid-3(-) wild type * * genetic background proteins expressed wild type sid-3(-) C sid-3(-); qtEx [DsRedsid-3(+)] sid-3(-); qtEx [DsRed] D silenced bwm cells silenced bwm cells silenced bwm cells silenced bwm cells silenced pharynx 200 aa TYROSINE KINASESH3 CRIB E C. elegans C. briggsae D. melanogaster H. sapiens GH wild type sid-1( Q154 ) ark-1(n3701) ark-1( Q528 ) * * 50 100 % dumpy dpy-7 RNAi 25 12.5 0 TNK1 ACK DPR-2DACK H. s D. m % identity C. e SID-3 C. e ARK-1 0.2 H.s ACK H.s TNK1 D.m DACK D.m DPR2 C.e SID-3 C.e ARK-1 F Fig.",False Positive
WBPaper00041467,WBGene00002207,"sid-3, kin-25",R353Q,B0302.1b,"Line 741: Here, we identify systemic RNAi defective-3 (SID-3) as a conserved tyrosine kinase required for the efficient import of dsRNA.","Line 800: 1 C , compare Left and 100 micro m 1kb TYROSINE KINASE SH3 CRIB qt18 (splice acceptor) qt32 (G124D) qt38 (R353Q) tm342 ) * qt28 (R254 ) * qt16 ( ) * qt37 (W300 ) * qt31 (W310 ) * qt40 (R353 ) * qt29 (Q411 ) * qt27 (Q659 ) * qt36 (Q815 ) * qt14 ) * B A 30 60 0 % unsilenced SID-3 - - - DsRed sid-3(-) wild type * * genetic background proteins expressed wild type sid-3(-) C sid-3(-); qtEx [DsRedsid-3(+)] sid-3(-); qtEx [DsRed] D silenced bwm cells silenced bwm cells silenced bwm cells silenced bwm cells silenced pharynx 200 aa TYROSINE KINASESH3 CRIB E C. elegans C. briggsae D. melanogaster H. sapiens GH wild type sid-1( Q154 ) ark-1(n3701) ark-1( Q528 ) * * 50 100 % dumpy dpy-7 RNAi 25 12.5 0 TNK1 ACK DPR-2DACK H. s D. m % identity C. e SID-3 C. e ARK-1 0.2 H.s ACK H.s TNK1 D.m DACK D.m DPR2 C.e SID-3 C.e ARK-1 F Fig.",False Positive
WBPaper00041467,WBGene00006743,unc-3,K139A,Y16B4A.1,Line 780: This mapping placed sid-3 to the right of the visible marker unc-3 on the X chromosome (Fig.,"Line 836: Speci cally, we transformed sid-3 mutant animals with constructs that express either wild-type SID-3 or a SID-3(K139A) mutant protein.",False Positive
WBPaper00044537,WBGene00001284,"emb-30, apc-4",L221F,F54C8.3,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00001511,"fzy-1, cdc-20",D434N,ZK177.6,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00002079,"xpo-2, imb-5",S273N,Y48G1A.5a,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00002079,"xpo-2, imb-5",S679L,Y48G1A.5a,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00002169,isw-1,S273N,F37A4.8,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003133,"mat-2, apc-1, pod-3, evl-22",L74F,W10C6.1,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003133,"mat-2, apc-1, pod-3, evl-22",V1208M,W10C6.1,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,K196R,F49E11.1a,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24395: Lower panel shows Coomassie blue - stained MBP::MBK-2 used in the assay to control for loading. KD is MBK-2(K196R) with a mutation in the ATP binding site.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,K196R,F49E11.1i,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24395: Lower panel shows Coomassie blue - stained MBP::MBK-2 used in the assay to control for loading. KD is MBK-2(K196R) with a mutation in the ATP binding site.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,K196R,F49E11.1m,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24395: Lower panel shows Coomassie blue - stained MBP::MBK-2 used in the assay to control for loading. KD is MBK-2(K196R) with a mutation in the ATP binding site.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,L283F,F49E11.1a,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,L283F,F49E11.1i,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,L283F,F49E11.1m,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,L353F,F49E11.1a,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,L353F,F49E11.1e,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,L353F,F49E11.1i,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,L353F,F49E11.1m,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,L74F,F49E11.1a,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,L74F,F49E11.1i,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,L74F,F49E11.1m,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,R433C,F49E11.1a,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,R433C,F49E11.1i,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,R433C,F49E11.1m,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,S273N,F49E11.1f,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,V311I,F49E11.1a,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,V311I,F49E11.1h,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,V311I,F49E11.1i,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,V311I,F49E11.1l,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,V311I,F49E11.1m,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00003150,mbk-2,V87M,F49E11.1b,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,V87M,F49E11.1c,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,V87M,F49E11.1g,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003150,mbk-2,V87M,F49E11.1k,"Line 24154: Using RNA-mediated interference to test candidate loci identified by WGS/SNP mapping, we identified 10 extragenic and six intragenic suppressors of mbk-2, a DYRK family kinase required for the transition from oocyte to zygote.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00003993,pgl-2,L283F,B0523.3,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00004042,"plk-1, plc1",L74F,C14B9.4,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00004042,"plk-1, plc1",V87M,C14B9.4,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00006734,ufd-2,L283F,T05H10.5b,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00006734,ufd-2,L353F,T05H10.5b,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00006734,ufd-2,R433C,T05H10.5c,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00007574,,V311I,C14B1.3,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00009507,"mus-101, emb-10, zyg-2",S273N,F37D6.1,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00011275,psf-1,V87M,R53.6,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00013443,"such-1, som-2",L17F,Y66D12A.17,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00013443,"such-1, som-2",V311I,Y66D12A.17,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00013849,,D434N,ZC84.6,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00017751,,L283F,F23F12.3,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00017751,,R433C,F23F12.3,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00017778,"nono-1, psf-1",G544S,F25B5.7a,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00017778,"nono-1, psf-1",L221F,F25B5.7c,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00017778,"nono-1, psf-1",L353F,F25B5.7a,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00017778,"nono-1, psf-1",L353F,F25B5.7d,"Line 24240: RNAi experiments: RNAi experiments were performed using feeding clones from the OpenBiosystem library (B0523.3, C03H5.4, C40H1.2, F25B5.7, F37A4.8, F46F5.11, F54C8.3, T05H10.5, T24H7.5, W08F4.8, Y48G1A.5, ZK1307.8, ZK177.6) or from the Arhinger library (C14B1.3, C14B9.4, F13H8.7, F23F12.3, F33G12.6, F37D6.1, R10F2.6, W10C6.1, ZC84.6), except for the such-1 RNAi clone, which was made by am- plifying a 0.9-kb such-1 cDNA fragment using primers CGTGAGC AACTGTGATGCTC and TTAAATAAACATCCACGTGCATGG.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00019997,,G544S,R10F2.6,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00019997,,R433C,R10F2.6,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00020784,tat-4,G544S,T24H7.5a,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,True Positive
WBPaper00044537,WBGene00020784,tat-4,L353F,T24H7.5a,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00020784,tat-4,V87M,T24H7.5a,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00021097,cdc-37,L221F,W08F4.8a,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00021097,cdc-37,L353F,W08F4.8b,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00021097,cdc-37,V87M,W08F4.8a,"Line 24222: 90% 3% (n = 790) e Semi-dominant ax2002 III 2.9 - 12.0 M R10F2.6 82.61% 0% (n = 520) C14B1.3 80.00% 0% (n = 510) psf-1 100% 0% (n = 550) psf-1 93.33%, 0% (n = 550) F23F12.3 77.78% 0% (n = 530) isw-1 85.71% 0% (n = 580) plk-1 78.05% 3% (n = 790) e ZC84.6 81.63% 0% (n = 510) ZC84.6 91.18% 0% (n = 510) ax2001 II 0 - 1.0 M C03H5.4 87.50% 0% (n = 500) cdc-37 78.57% 0% (n = 520) F46F5.11 84.21% 0% (n = 500) ax2009 II 4.9 - 11.6 M tat-4 95.00% 0% (n = 550) upb-1 77.78% 0% (n = 600) ufd-2 83.33% 0% (n = 500) a Interval of low Hawaiian SNP frequency in F2 recombinants as determined by WGS.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00021463,zeel-1,L17F,Y39G10AR.5,"Line 24418: Despite back- crossing mbk-2(dd5) six times into CB4856, mbk-2(dd5) Hw still retained primarily non-Hawaiian SNPs on most of LG IV (0 - 15.8 Mb out of 17.5 Mb), where mbk-2 resides, and on LG I (1.5 - 12.8 Mb out of 15 Mb), where the peel-1-zeel-1 N2/Hw incompatibility locus resides (Seidel et al.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00021463,zeel-1,L74F,Y39G10AR.5,"Line 24418: Despite back- crossing mbk-2(dd5) six times into CB4856, mbk-2(dd5) Hw still retained primarily non-Hawaiian SNPs on most of LG IV (0 - 15.8 Mb out of 17.5 Mb), where mbk-2 resides, and on LG I (1.5 - 12.8 Mb out of 15 Mb), where the peel-1-zeel-1 N2/Hw incompatibility locus resides (Seidel et al.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00044537,WBGene00077563,peel-1,L17F,Y39G10AR.25,"Line 24418: Despite back- crossing mbk-2(dd5) six times into CB4856, mbk-2(dd5) Hw still retained primarily non-Hawaiian SNPs on most of LG IV (0 - 15.8 Mb out of 17.5 Mb), where mbk-2 resides, and on LG I (1.5 - 12.8 Mb out of 15 Mb), where the peel-1-zeel-1 N2/Hw incompatibility locus resides (Seidel et al.",Line 24305: n Table 2 Summary of suppressors Gene Description a Allele Mutation Conservation b Domain % Hatch c mbk-2 Intragenic ax2004 R433C Identical Kinase 97% (n = 290) mbk-2 Intragenic ax2005 L283F No Kinase 56% (n = 300) mbk-2 Intragenic ax2006 L353F Identical Kinase 47% (n = 340) mbk-2 Intragenic ax2007 V311I Identical Kinase 39% (n = 240) cdc-37 Hsp90 co-chaperone ax2001 L221F Identical Hsp90 binding 68% (n = 250) tat-4 Lipid fl ippase ax2009 G544S Weak Intracellular loop 47% (n = 260) plk-1 Polo kinase ax2008 L74F Strong Kinase 48% (n = 130) plk-1 Polo kinase ax2002 V87M Strong Kinase 39% (n = 150) fzy-1 APC regulator ax2014 D434N Strong WD40 37% (n = 300) such-1 APC subunit ax2010 L17F No 39% (n = 230) emb-30 APC subunit ax2003 Splice site 35% (n = 260) mat-2 APC subunit ax2012 V1208M Strong 23% (n = 260) mus-101 DNA replication ax2011 S273N No BRCT 49% (n = 150) xpo-2 Mitotic importin ax2013 S679L Strong Nuclear transport 41% (n = 280) a Abbreviated description as obtained from Wormbase WS239.,False Positive
WBPaper00045172,WBGene00000367,cca-1,G1735R,C54D2.5a,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00000367,cca-1,M1778I,C54D2.5c,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00000367,cca-1,R1845C,C54D2.5c,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00002173,"itr-1, lfe-1, dec-4",R1845C,F33D4.2d,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006616,trp-4,A1064V,Y71A12B.4,"Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1525R,T02C5.5j,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1525R,T02C5.5k,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1525R,T02C5.5l,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1525R,T02C5.5m,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1525R,T02C5.5p,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1735R,T02C5.5f,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1735R,T02C5.5g,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1735R,T02C5.5h,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1735R,T02C5.5i,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,G1735R,T02C5.5p,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,R1845C,T02C5.5o,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006742,unc-2,R1845C,T02C5.5p,"Line 719: Consistent with a role for membrane depolarization and voltage-gated calcium channel (VGCC) activation in our model, we observed partial suppression of trp-4(d) degeneration in knockdown experiments of some ( cca-1 ) but not other ( egl-19 and unc-2 ) VGCC -subunits (M. Doitsidou and A. Nagarajan, unpublished data).","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5i,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5j,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5k,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5l,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5m,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5n,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5o,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",A1064V,K11C4.5p,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 633: Specifically, trp-4(ot749) results in an alanine to valine substi- tution (A1064V) of a highly conserved alanine of the 21st ankyrin repeat, trp-4(ot756) in a substitution of a highly con- served glycine (G1735R) in the pore-forming region, trp- 4(ot755) in a proline to leucine substitution (P1749L) between the pore-forming region and the sixth transmembrane domain, and trp-4(ot757) carries two mutations in the cytosolic C-terminal tail of TRP-4 (R1845C fiL1876H).",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5a,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5b,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5c,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5d,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5e,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5f,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5g,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00045172,WBGene00006801,"unc-68, ryr-1, kra-1",M1778I,K11C4.5h,"Line 684: Progressive Degeneration of Dopaminergic Neurons C Calreticulin mutants ER Ca 2+ channel mutants G D on trp-4(d) degeneration Calnexin mutants E A B EGTACALB1 expression cnx-1 trp-4(d) trp-4(d);cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm ns 0 2 4 6 otIs259[dat-1::gfp] ns *** *** trp-4(d) trp-4(d);crt-1 trp-4(d);crt-1;cnx-1 0 2 4 6 vtIs1[dat-1::gfp] Mean # of head DA neurons/worm itr-1 trp-4(d) trp-4(d);itr-1 trp-4(d) trp-4(d);unc-68 otIs259[dat-1::gfp] RNAi against ER Ca 2+ channels F wild type trp-4(d);crt-1(ok948) trp-4(d) trp-4(d);crt-1(bz29) 0 2 4 6 otIs259[dat-1::gfp] Mean # of head DA neurons/worm *** *** Corrected cell fluorescence 10 5 wild type crt-1 wild type crt-1 Mean # of head DA neurons/worm trp-4(d) + Empty Vector trp-4(d) +itr-1 RNAi trp-4(d)+crt-1 RNAi trp-4(d) +unc-68 RNAi trp-4(d)+itr-1,unc-68 RNAi 0.0 0.5 1.0 1.5 2.0 *** ** Larval 1 stageLarval 4 stage Mean # of head DA neurons/worm 0 2 4 6 wild type +10mM EGTA trp-4(d) trp-4(d) +10mM EGTA *** *** vtIs1[dat-1::gfp] wild type trp-4(d) trp-4(d) +Pdat-1::CALB1 trp-4(d) +Pdat-1::MDH-1 0 2 4 6 Mean # of head DA neurons/worm *** ** ** Line 1 High C Line 1 High C Line 2 Low C Line 2 Low C Line 3 Low C Line 3 Low C vtIs1[dat-1::gfp] on trp-4 expression CEPD proximal CEPD distal 0 2 4 6 8 ns ns CEPV proximal CEPD proximal 0.0 0.5 1.0 1.5 2.0 2.5 ns ns Ptrp-4::gfp Pdat-1::GFP-TRP-4 Dantrolene wild type +10 micro M trp-4(d) +0 micro M trp-4(d) +10 micro M 0 2 4 6 ** vtIs1[dat-1::gfp] Mean # of head DA neurons/worm *** * 0 2 4 6 I H trp-4(d) trp-4(d);crt-1(ok948) trp-4(d) +100micro M BAPTA-AM trp-4(d);crt-1(ok948) +100micro M BAPTA-AM Mean # of head DA neurons/worm 0 2 4 6 *** ** ** otIs259[dat-1::gfp] BAPTA-AM on calreticulin mutants Dantrolene on calreticulin mutants trp-4(d) trp-4(d);crt-1(bz29) trp-4(d) + 10micro M Dantrolene trp-4(d);crt-1(bz29) + 10micro M Dantrolene Mean # of head DA neurons/worm otIs259[dat-1::gfp] 0 2 4 6 ** *** *** vtIs1[dat-1 Figure 4.","Line 651: In addition to dopaminergic neurons, a degeneration phenotype was observed in other trp- B TRP-4 Channel # of variants on the right arm of CHRI A 42 27 1 ot477 ot337 Ca2+/Na+/K+/other cations Ankyrin repeats NH2 COOH TM4 M1778I substitution TRP4 KLLFGIYMMVTLIVLINLLIAMMSDTYQ dNOMPC KIVFGIYMLVSVVVLINLLIAMMSDTYQ zTRPN1 KMVFGVYLVVTFIVLINLLIAMMSDTYQ 1757 1784 TM6 D C trp-4 intragenic revertants retrieved in ot337 suppression screen 7000 8000 9000 10000 11000 12000 13000 14000 ot337 (M1778I) ot753 (W1575*) ot756 (G1735R) ot758 ot745 ot744 ot754 (splice site) ot746, ot747 (splice site) 0 4000 6000 ot743 ot752 (G1525R) ot751 (Q1229*) ot755 (P1749L) ot748 (splice site) ot750 (splice site) ot749 (A1064V) ot757 (R1845C and L1876H) 5000 0 100 200 300 400 Mean velocity(um/s) * Bacteria - - - + + + + wild type trp-4(d) (ot337) cat-2 ( e1112) trp-4_lf (ot753) - E Basal slowing response in trp-4(ot337) mutants TM1TM2TM3 TM5TM6 C EPV C EPD ADE PD E Ma le tail 0.0 0.2 0.4 0.6 0.8 1.0 Proportion of head dopaminergic neurons trp-4(ot337) vtIs1[dat-1::gfp] Overexpression of trp-4(d) in DA neurons wild type Ex[dat-1::trp-4(d)] Line 1 Ex[dat-1::trp-4(d)] Line 2 Figure 2.",False Positive
WBPaper00046810,WBGene00000063,act-1,E100K,T04C12.6,"Line 4927: The primers used to detect the cDNAs of sma-6 and act-1 are: sma-6 , MLF-34 and MLF-44; act-1 , NMA-163 and NMA-164.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000269,bre-4,G109E,Y73E7A.7b,"Line 4860: The following mutations and integrated transgenes were used: Linkage group I (LG I): drag- 1(jj4) , arIs37(secreted CC :: gfp) , bre-4(ok3167) , bre-5(ye17); LG II: sma-6(e1482) , pod-2(ye60) , cgt-3(ok2877)/mIn1[mIs14 dpy-10(e128)] , jjIs2437[CXTim50 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000269,bre-4,G259E,Y73E7A.7a,"Line 4860: The following mutations and integrated transgenes were used: Linkage group I (LG I): drag- 1(jj4) , arIs37(secreted CC :: gfp) , bre-4(ok3167) , bre-5(ye17); LG II: sma-6(e1482) , pod-2(ye60) , cgt-3(ok2877)/mIn1[mIs14 dpy-10(e128)] , jjIs2437[CXTim50 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000270,bre-5,S169F,T12G3.8a,"Line 4778: *** p 100 tsp-21(jj77) [20 degree C] and [22 degree C] 100% 0% > 100 lin-12(n676n930ts) [20 degree C] 99.0% 1.0% 279 lin-12(n676n930ts); tsp-21(jj77) [20 degree C] 93.0% 7.0% *** 356 lin-12(n676n930ts) [22 degree C] 86.0% 14.0% 326 lin-12(n676n930ts); tsp-21(jj77) [22 degree C] 64.4% 35.6% *** 623 *** p 100 bre-5 (ye17) [20 degree C] 0% 92.50% 7.50% 106 cgt-3(ok2877) [22 degree C] 0% 84.50% 15.50% 97 lin-12(n676n930ts) [22 degree C] 0% 91.96% 8.04% 87 cgt-3(ok2877); lin-12(n676n930ts) [22 degree C] 0% 66.10% 33.90% 109 doi:10.1371/journal.pgen.1005221.t008 Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 18 / 33 examination of the position of the M-derived CCs in cgt-3(ok2877);sma-9(cc604) and bre-5 (ye17);sma-9(cc604) mutants showed that a majority of the double mutant animals have their M-derived CCs located on the dorsal side (S3 Table), indicating a suppression rather than a re- versal of polarity.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R261K,R13A5.1a,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R261K,R13A5.1b,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R261K,R13A5.1d,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R261K,R13A5.1e,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R67W,R13A5.1a,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R67W,R13A5.1b,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R67W,R13A5.1d,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",R67W,R13A5.1e,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",S169F,R13A5.1a,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",S169F,R13A5.1b,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",S169F,R13A5.1d,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000846,"cup-5, muc-1",S169F,R13A5.1e,"Line 4716: l Corresponding genes were identi ed via a combination of linkage analysis (linkage to cup-5(ar465) III, sma-9(cc604) X ), snip-SNP mapping [86], and complementation tests based on the Susm phenotype, with the following alleles: dbl-1(wk70) , sma-6(e1482) , daf-4(m63) , sma-2(e502) , sma-3(e491) , sma- 4(e729) , lon-2(e678) , and lon-1(e185) .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000897,daf-1,K265E,F29C4.1a,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000897,daf-1,K265E,F29C4.1b,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000897,daf-1,R67W,F29C4.1a,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000897,daf-1,R67W,F29C4.1b,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000900,daf-4,A434T,C05D2.1c,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00000900,daf-4,A586T,C05D2.1a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00000900,daf-4,K265E,C05D2.1a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000900,daf-4,K265E,C05D2.1d,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000900,daf-4,M484I,C05D2.1a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00000900,daf-4,P643S,C05D2.1e,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000900,daf-4,Q628*,C05D2.1e,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000903,daf-7,G19E,B0412.2,Line 4968: tsp-21(jj77) has no effect on the Daf-c phenotypes of daf-1 and daf-7 mutants.,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000936,"dbl-1, cet-1",E100K,T25F10.2,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00000936,"dbl-1, cet-1",W278*,T25F10.2,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00001250,elt-2,V236E,C33D3.1,"Line 4776: tsp-21 allele Transgene Tissue of transgene expression Relative body length WT None None 1.11 plus/minus 0.006 *** (n = 34) tsp-21(jj77) None None 1.00 plus/minus 0.007 (n = 30) tsp-21(jj77) tsp-21p :: tsp-21 cDNA Hypodermis, intestine, pharynx 1.13 plus/minus 0.010 *** (n = 34) tsp-21(jj77) rol-6p :: tsp-21 cDNA Hypodermis 1.17 plus/minus 0.006 *** (n = 34) tsp-21(jj77) elt-3p :: tsp-21 cDNA Hypodermis 1.08 plus/minus 0.008 *** (n = 72) tsp-21(jj77) myo-2p :: tsp-21 cDNA Pharynx 1.00 plus/minus 0.012 (n = 32) tsp-21(jj77) elt-2p :: tsp-21 cDNA Intestine 1.01 plus/minus 0.010 (n = 40) Body length was normalized to that of tsp-21(jj77) mutants.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00001251,elt-3,G259E,K02B9.4b,"Line 4776: tsp-21 allele Transgene Tissue of transgene expression Relative body length WT None None 1.11 plus/minus 0.006 *** (n = 34) tsp-21(jj77) None None 1.00 plus/minus 0.007 (n = 30) tsp-21(jj77) tsp-21p :: tsp-21 cDNA Hypodermis, intestine, pharynx 1.13 plus/minus 0.010 *** (n = 34) tsp-21(jj77) rol-6p :: tsp-21 cDNA Hypodermis 1.17 plus/minus 0.006 *** (n = 34) tsp-21(jj77) elt-3p :: tsp-21 cDNA Hypodermis 1.08 plus/minus 0.008 *** (n = 72) tsp-21(jj77) myo-2p :: tsp-21 cDNA Pharynx 1.00 plus/minus 0.012 (n = 32) tsp-21(jj77) elt-2p :: tsp-21 cDNA Intestine 1.01 plus/minus 0.010 (n = 40) Body length was normalized to that of tsp-21(jj77) mutants.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00001251,elt-3,V236E,K02B9.4b,"Line 4776: tsp-21 allele Transgene Tissue of transgene expression Relative body length WT None None 1.11 plus/minus 0.006 *** (n = 34) tsp-21(jj77) None None 1.00 plus/minus 0.007 (n = 30) tsp-21(jj77) tsp-21p :: tsp-21 cDNA Hypodermis, intestine, pharynx 1.13 plus/minus 0.010 *** (n = 34) tsp-21(jj77) rol-6p :: tsp-21 cDNA Hypodermis 1.17 plus/minus 0.006 *** (n = 34) tsp-21(jj77) elt-3p :: tsp-21 cDNA Hypodermis 1.08 plus/minus 0.008 *** (n = 72) tsp-21(jj77) myo-2p :: tsp-21 cDNA Pharynx 1.00 plus/minus 0.012 (n = 32) tsp-21(jj77) elt-2p :: tsp-21 cDNA Intestine 1.01 plus/minus 0.010 (n = 40) Body length was normalized to that of tsp-21(jj77) mutants.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00001815,"hmt-1, haf-5",G19E,W09D6.6,"Line 4950: Growth was monitored for 2 - 9 days at 30 degree C. The plasmids KAT-1-Cub-PLV, NubG-KAT-1 (in pNX33 vector) and KAT-1-NubG (in pXN21 vector) [42], HMT-1-Cub-PLV and HMT-1-NubG (in pXN21 vector) [46] were kindly provided by Sungjin Kim (Cornell University) and used as specificity controls.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003001,lin-12,G109E,R107.8,"Line 4673: Finally, we provide evidence that like TSP-12 and TSP-14, which have been previously shown to function in promoting LIN-12/ Notch signaling [28], TSP-21 also appears to function in LIN-12/Notch signaling in a cell type- specific manner.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003055,lon-1,W197*,F48E8.1a,"Line 4681: Intriguingly, we isolated lon-1(jj67) as a sma-9 suppressor and showed that an existing, strong loss-of-function allele, lon-1(e185) , also suppresses the sma-9 Fig 2.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003055,lon-1,W197*,F48E8.1b,"Line 4681: Intriguingly, we isolated lon-1(jj67) as a sma-9 suppressor and showed that an existing, strong loss-of-function allele, lon-1(e185) , also suppresses the sma-9 Fig 2.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003055,lon-1,W197*,F48E8.1c,"Line 4681: Intriguingly, we isolated lon-1(jj67) as a sma-9 suppressor and showed that an existing, strong loss-of-function allele, lon-1(e185) , also suppresses the sma-9 Fig 2.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003514,myo-2,R261K,T18D3.4,"Line 4776: tsp-21 allele Transgene Tissue of transgene expression Relative body length WT None None 1.11 plus/minus 0.006 *** (n = 34) tsp-21(jj77) None None 1.00 plus/minus 0.007 (n = 30) tsp-21(jj77) tsp-21p :: tsp-21 cDNA Hypodermis, intestine, pharynx 1.13 plus/minus 0.010 *** (n = 34) tsp-21(jj77) rol-6p :: tsp-21 cDNA Hypodermis 1.17 plus/minus 0.006 *** (n = 34) tsp-21(jj77) elt-3p :: tsp-21 cDNA Hypodermis 1.08 plus/minus 0.008 *** (n = 72) tsp-21(jj77) myo-2p :: tsp-21 cDNA Pharynx 1.00 plus/minus 0.012 (n = 32) tsp-21(jj77) elt-2p :: tsp-21 cDNA Intestine 1.01 plus/minus 0.010 (n = 40) Body length was normalized to that of tsp-21(jj77) mutants.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003514,myo-2,S169F,T18D3.4,"Line 4776: tsp-21 allele Transgene Tissue of transgene expression Relative body length WT None None 1.11 plus/minus 0.006 *** (n = 34) tsp-21(jj77) None None 1.00 plus/minus 0.007 (n = 30) tsp-21(jj77) tsp-21p :: tsp-21 cDNA Hypodermis, intestine, pharynx 1.13 plus/minus 0.010 *** (n = 34) tsp-21(jj77) rol-6p :: tsp-21 cDNA Hypodermis 1.17 plus/minus 0.006 *** (n = 34) tsp-21(jj77) elt-3p :: tsp-21 cDNA Hypodermis 1.08 plus/minus 0.008 *** (n = 72) tsp-21(jj77) myo-2p :: tsp-21 cDNA Pharynx 1.00 plus/minus 0.012 (n = 32) tsp-21(jj77) elt-2p :: tsp-21 cDNA Intestine 1.01 plus/minus 0.010 (n = 40) Body length was normalized to that of tsp-21(jj77) mutants.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003919,par-4,G361R,Y59A8B.14a,"Line 4951: NubG fusions for PAR-4, a protein unexpected to interact with any of the proteins tested, was included as an- other control for specificity of the interactions.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00003919,par-4,R67W,Y59A8B.14b,"Line 4951: NubG fusions for PAR-4, a protein unexpected to interact with any of the proteins tested, was included as an- other control for specificity of the interactions.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004076,"pod-2, phi-47",A434T,W09B6.1c,"Line 4860: The following mutations and integrated transgenes were used: Linkage group I (LG I): drag- 1(jj4) , arIs37(secreted CC :: gfp) , bre-4(ok3167) , bre-5(ye17); LG II: sma-6(e1482) , pod-2(ye60) , cgt-3(ok2877)/mIn1[mIs14 dpy-10(e128)] , jjIs2437[CXTim50 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004076,"pod-2, phi-47",G361R,W09B6.1c,"Line 4860: The following mutations and integrated transgenes were used: Linkage group I (LG I): drag- 1(jj4) , arIs37(secreted CC :: gfp) , bre-4(ok3167) , bre-5(ye17); LG II: sma-6(e1482) , pod-2(ye60) , cgt-3(ok2877)/mIn1[mIs14 dpy-10(e128)] , jjIs2437[CXTim50 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004397,rol-6,G109E,T01B7.7,"Line 4776: tsp-21 allele Transgene Tissue of transgene expression Relative body length WT None None 1.11 plus/minus 0.006 *** (n = 34) tsp-21(jj77) None None 1.00 plus/minus 0.007 (n = 30) tsp-21(jj77) tsp-21p :: tsp-21 cDNA Hypodermis, intestine, pharynx 1.13 plus/minus 0.010 *** (n = 34) tsp-21(jj77) rol-6p :: tsp-21 cDNA Hypodermis 1.17 plus/minus 0.006 *** (n = 34) tsp-21(jj77) elt-3p :: tsp-21 cDNA Hypodermis 1.08 plus/minus 0.008 *** (n = 72) tsp-21(jj77) myo-2p :: tsp-21 cDNA Pharynx 1.00 plus/minus 0.012 (n = 32) tsp-21(jj77) elt-2p :: tsp-21 cDNA Intestine 1.01 plus/minus 0.010 (n = 40) Body length was normalized to that of tsp-21(jj77) mutants.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",Q261*,R31.1c,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",Q261*,R31.1f,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",R67W,R31.1b,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",R67W,R31.1d,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",S3330L,R31.1a,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",S3330L,R31.1b,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",S3330L,R31.1d,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004855,"sma-1, sma-7, sma1",S3330L,R31.1e,"Line 4675: Here we show that null mutations in unc-129 , which encodes a TGF -like molecule important for axon guidance [29], or null mutations in genes that regulate body size but do not function in the Sma/Mab pathway, such as the -spectrin gene sma-1 [30], or the cuticle colla- gen gene lon-3 [31, 32], do not suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004856,"sma-2, cem-1",C62Y,ZK370.2a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004856,"sma-2, cem-1",E100K,ZK370.2a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004856,"sma-2, cem-1",G109E,ZK370.2b,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004856,"sma-2, cem-1",G19E,ZK370.2a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004856,"sma-2, cem-1",R67W,ZK370.2a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004857,sma-3,G259E,R13F6.9,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004857,sma-3,K265E,R13F6.9,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004857,sma-3,Q261*,R13F6.9,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004857,sma-3,S169F,R13F6.9,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004857,sma-3,W197*,R13F6.9,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004858,sma-4,R261K,R12B2.1a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004858,sma-4,S169F,R12B2.1a,"Line 4640: The Sma/Mab pathway includes a BMP-like molecule DBL-1 [13, 14], the type I receptor SMA-6 [15], the type II re- ceptor DAF-4 [16], the R-Smads SMA-2 and SMA-3, and the Co-Smad SMA-4 [17].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00004860,sma-6,R67W,C32D5.2,"Line 4604: TSP-12 and TSP-14 can also associate with SMA-6, the type I receptor of the Sma/Mab pathway.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004860,sma-6,W112*,C32D5.2,"Line 4604: TSP-12 and TSP-14 can also associate with SMA-6, the type I receptor of the Sma/Mab pathway.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004860,sma-6,W328*,C32D5.2,"Line 4604: TSP-12 and TSP-14 can also associate with SMA-6, the type I receptor of the Sma/Mab pathway.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004862,sma-9,A586T,T05A10.1i,Line 4651: This dorsoventral asymmetry is regulated by the schnurri homolog sma-9 [19].,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004862,sma-9,A586T,T05A10.1j,Line 4651: This dorsoventral asymmetry is regulated by the schnurri homolog sma-9 [19].,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004862,sma-9,Q593*,T05A10.1a,Line 4651: This dorsoventral asymmetry is regulated by the schnurri homolog sma-9 [19].,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004862,sma-9,S169F,T05A10.1h,Line 4651: This dorsoventral asymmetry is regulated by the schnurri homolog sma-9 [19].,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00004862,sma-9,V236E,T05A10.1c,Line 4651: This dorsoventral asymmetry is regulated by the schnurri homolog sma-9 [19].,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006308,"sul-1, tag-37",A586T,K09C4.8,"Line 4728: 1(RNAi) sma-9(cc604) 0% (n = 150) sul-1(RNAi) sma-9(cc604) 0% (n = 70) tsp-21(tm6269) 100% (n = 483) sma-9(RNAi) 4.4% (n = 635) tsp-21(tm6269) sma-9(RNAi) 98.9% (n = 603) tsp-21(jj77) 100% (n > 100) tsp-21(jj77) sma-9(cc604) 85% (n = 517) tsp-21(jj77) sma-9(cc604); jjEx[tsp-21p :: tsp-21 genomic :: tsp-21 3 UTR] 2.5% (n = 82) tsp-21(jj77) sma-9(cc604); jjIs[tsp-21p :: tsp-21 genomic :: gfp :: tsp-21 3 UTR] 5% (n = 120) tsp-21(jj77) sma-9(cc604); jjEx[hlh-8p :: tsp-21cDNA] 4% (n = 385) doi:10.1371/journal.pgen.1005221.t003 Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 10 / 33 Fig 4. tsp-21 encodes a conserved tetraspanin protein of the C6a group.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006640,tsp-14,R261K,F39C12.3b,"Line 4603: We further showed that TSP-21 can associate with itself and with two additional tetraspanins, TSP-12 and TSP-14, which also promote Sma/Mab signaling.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,A586T,B0273.4f,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,G109E,B0273.4e,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,G259E,B0273.4a,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,G259E,B0273.4b,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,G259E,B0273.4f,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,Q628*,B0273.4a,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,R261K,B0273.4f,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,S169F,B0273.4a,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,S169F,B0273.4b,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006745,unc-5,S169F,B0273.4f,Line 4913: Plasmid constructs and transgenic lines sma-6 reporter and rescuing constructs pJKL840: sma-6p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1048: sma-6(jj69)p :: nls :: rfp :: lacZ :: unc-54 3 UTR pJKL1060: sma-6p :: sma-6 rescuing construct tsp-21 reporter constructs pJKL1005: 5kb tsp-21p :: tsp-21 genomic ORF :: 1 .,"Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006751,"unc-11, let-581",M484I,C32E8.10h,"Line 4920: Generating TSP-21::GFP using CRISPR technology The following mix of plasmid DNAs was injected into the N2 gravid adults: (1) a Cas9 expres- sion plasmid pDD162 [91], (2) a tsp-21 -specific sgRNA plasmid pZL10, which has GAAACT- GACACGGTAGAAGATGG replacing the unc-119 sgRNA in plasmid 46169 [92], (3) the homologous repair template pZL11: 5kb tsp-21p :: tsp-21 genomic ORF (sgRNA target site modi- fied) :: gfp :: 1 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006751,"unc-11, let-581",Q628*,C32E8.10c,"Line 4920: Generating TSP-21::GFP using CRISPR technology The following mix of plasmid DNAs was injected into the N2 gravid adults: (1) a Cas9 expres- sion plasmid pDD162 [91], (2) a tsp-21 -specific sgRNA plasmid pZL10, which has GAAACT- GACACGGTAGAAGATGG replacing the unc-119 sgRNA in plasmid 46169 [92], (3) the homologous repair template pZL11: 5kb tsp-21p :: tsp-21 genomic ORF (sgRNA target site modi- fied) :: gfp :: 1 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006751,"unc-11, let-581",Q628*,C32E8.10d,"Line 4920: Generating TSP-21::GFP using CRISPR technology The following mix of plasmid DNAs was injected into the N2 gravid adults: (1) a Cas9 expres- sion plasmid pDD162 [91], (2) a tsp-21 -specific sgRNA plasmid pZL10, which has GAAACT- GACACGGTAGAAGATGG replacing the unc-119 sgRNA in plasmid 46169 [92], (3) the homologous repair template pZL11: 5kb tsp-21p :: tsp-21 genomic ORF (sgRNA target site modi- fied) :: gfp :: 1 .","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",G259E,T19B4.7,"Line 4654: Using this sma-9 M lineage suppression phenotype (Fig 1A and 1C and 1E), we have recently identified two new modulators of the Sma/Mab pathway, the RGM protein DRAG-1 and the DCC/neogenin homolog UNC-40, which directly associate with each other to positively regulate Sma/Mab signaling [21, 22, Fig 2A].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",Q628*,T19B4.7,"Line 4654: Using this sma-9 M lineage suppression phenotype (Fig 1A and 1C and 1E), we have recently identified two new modulators of the Sma/Mab pathway, the RGM protein DRAG-1 and the DCC/neogenin homolog UNC-40, which directly associate with each other to positively regulate Sma/Mab signaling [21, 22, Fig 2A].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",R677C,T19B4.7,"Line 4654: Using this sma-9 M lineage suppression phenotype (Fig 1A and 1C and 1E), we have recently identified two new modulators of the Sma/Mab pathway, the RGM protein DRAG-1 and the DCC/neogenin homolog UNC-40, which directly associate with each other to positively regulate Sma/Mab signaling [21, 22, Fig 2A].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",V236E,T19B4.7,"Line 4654: Using this sma-9 M lineage suppression phenotype (Fig 1A and 1C and 1E), we have recently identified two new modulators of the Sma/Mab pathway, the RGM protein DRAG-1 and the DCC/neogenin homolog UNC-40, which directly associate with each other to positively regulate Sma/Mab signaling [21, 22, Fig 2A].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00006776,"unc-40, unc-91, madd-1, madd-40",W278*,T19B4.7,"Line 4654: Using this sma-9 M lineage suppression phenotype (Fig 1A and 1C and 1E), we have recently identified two new modulators of the Sma/Mab pathway, the RGM protein DRAG-1 and the DCC/neogenin homolog UNC-40, which directly associate with each other to positively regulate Sma/Mab signaling [21, 22, Fig 2A].","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00007103,crm-1,E100K,B0024.14f,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00007103,crm-1,G259E,B0024.14f,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00007103,crm-1,K265E,B0024.14f,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00007103,crm-1,Q261*,B0024.14a,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00007103,crm-1,Q261*,B0024.14d,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00007103,crm-1,V236E,B0024.14b,"Line 4687: *** p 100) c 2.67% (n = 225) sma-3(e491) 100% (n > 100) c 24.7% (n = 348) sma-4(e729) 100% (n = 61) c 21.5% (n = 177) lon-2(e678) 88% (n = 305) c 2.61% (n = 115) drag-1(jj4) 98.5% (n = 201) d 0 (n = 39) unc-40(e1430) 88.7% (n = 150) e ND lon-1(e185) 33.5% (n = 54) 7.44% (n = 121) sma-10(wk89) 48.9% (n = 534) ND sma-10(ok2224) 57.5% (n = 569) ND crm-1(tm2218) 0(n > 100) ND crm-1(RNAi) crm-1 (tm2218) 0(n > 200) ND daf-1(m40) 0(n > 100) c ND unc-129(ev554) 0(n > 100) ND unc-129(ev566) 0(n > 100) ND sma-1(ru18) 0(n > 100) ND lon-3(ct417) 0(n > 100) ND let-381(RNAi) f 7.0% (n = 143) g - let-381(RNAi); sma-3(jj3) f 6.9% (n = 144) g - Suppression was scored based on the re-appearance of M-derived CCs, which are missing in sma-9(cc604) mutant.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00016558,pks-1,A586T,C41A3.1a,"Line 4900: These included C41A3.1, K09C4.8 and C17G1.8.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00016558,pks-1,A586T,C41A3.1b,"Line 4900: These included C41A3.1, K09C4.8 and C17G1.8.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00016558,pks-1,G361R,C41A3.1a,"Line 4900: These included C41A3.1, K09C4.8 and C17G1.8.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00016558,pks-1,G361R,C41A3.1b,"Line 4900: These included C41A3.1, K09C4.8 and C17G1.8.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00016558,pks-1,Q628*,C41A3.1a,"Line 4900: These included C41A3.1, K09C4.8 and C17G1.8.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00016558,pks-1,Q628*,C41A3.1b,"Line 4900: These included C41A3.1, K09C4.8 and C17G1.8.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00019127,cgt-3,R261K,F59G1.1a,"Line 4778: *** p 100 tsp-21(jj77) [20 degree C] and [22 degree C] 100% 0% > 100 lin-12(n676n930ts) [20 degree C] 99.0% 1.0% 279 lin-12(n676n930ts); tsp-21(jj77) [20 degree C] 93.0% 7.0% *** 356 lin-12(n676n930ts) [22 degree C] 86.0% 14.0% 326 lin-12(n676n930ts); tsp-21(jj77) [22 degree C] 64.4% 35.6% *** 623 *** p 100 bre-5 (ye17) [20 degree C] 0% 92.50% 7.50% 106 cgt-3(ok2877) [22 degree C] 0% 84.50% 15.50% 97 lin-12(n676n930ts) [22 degree C] 0% 91.96% 8.04% 87 cgt-3(ok2877); lin-12(n676n930ts) [22 degree C] 0% 66.10% 33.90% 109 doi:10.1371/journal.pgen.1005221.t008 Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 18 / 33 examination of the position of the M-derived CCs in cgt-3(ok2877);sma-9(cc604) and bre-5 (ye17);sma-9(cc604) mutants showed that a majority of the double mutant animals have their M-derived CCs located on the dorsal side (S3 Table), indicating a suppression rather than a re- versal of polarity.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00019127,cgt-3,R67W,F59G1.1a,"Line 4778: *** p 100 tsp-21(jj77) [20 degree C] and [22 degree C] 100% 0% > 100 lin-12(n676n930ts) [20 degree C] 99.0% 1.0% 279 lin-12(n676n930ts); tsp-21(jj77) [20 degree C] 93.0% 7.0% *** 356 lin-12(n676n930ts) [22 degree C] 86.0% 14.0% 326 lin-12(n676n930ts); tsp-21(jj77) [22 degree C] 64.4% 35.6% *** 623 *** p 100 bre-5 (ye17) [20 degree C] 0% 92.50% 7.50% 106 cgt-3(ok2877) [22 degree C] 0% 84.50% 15.50% 97 lin-12(n676n930ts) [22 degree C] 0% 91.96% 8.04% 87 cgt-3(ok2877); lin-12(n676n930ts) [22 degree C] 0% 66.10% 33.90% 109 doi:10.1371/journal.pgen.1005221.t008 Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 18 / 33 examination of the position of the M-derived CCs in cgt-3(ok2877);sma-9(cc604) and bre-5 (ye17);sma-9(cc604) mutants showed that a majority of the double mutant animals have their M-derived CCs located on the dorsal side (S3 Table), indicating a suppression rather than a re- versal of polarity.","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00020649,sma-10,A434T,T21D12.9a,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,A434T,T21D12.9c,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,G361R,T21D12.9a,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,G361R,T21D12.9c,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,P643S,T21D12.9a,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,P643S,T21D12.9c,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,Q593*,T21D12.9a,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00020649,sma-10,Q593*,T21D12.9c,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00020649,sma-10,W462*,T21D12.9a,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00020649,sma-10,W462*,T21D12.9c,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00020649,sma-10,Y665N,T21D12.9a,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00020649,sma-10,Y665N,T21D12.9c,"Line 4677: In contrast, two deletion alleles of sma-10 , which encodes a conserved, leucine-rich repeats- and immuno- globulin (Ig)-like domain (LRIG)-containing transmembrane protein that promotes Sma/Mab signaling in regulating body size [34, Fig 2A], do suppress the M lineage phenotype of sma-9(0) mutants (Table 1).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00023491,tsp-21,C62Y,C17G1.8,"Line 4723: 3) A DNA fragment containing the genomic sequence of tsp-21 (5kb upstream, entire coding region in- cluding introns, and 1.7kb downstream sequences for C17G1.8 in pJKL1005, Fig 4B) rescued the Susm phenotype of jj77 (Table 3).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",False Positive
WBPaper00046810,WBGene00023491,tsp-21,G109E,C17G1.8,"Line 4723: 3) A DNA fragment containing the genomic sequence of tsp-21 (5kb upstream, entire coding region in- cluding introns, and 1.7kb downstream sequences for C17G1.8 in pJKL1005, Fig 4B) rescued the Susm phenotype of jj77 (Table 3).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00046810,WBGene00023491,tsp-21,V236E,C17G1.8,"Line 4723: 3) A DNA fragment containing the genomic sequence of tsp-21 (5kb upstream, entire coding region in- cluding introns, and 1.7kb downstream sequences for C17G1.8 in pJKL1005, Fig 4B) rescued the Susm phenotype of jj77 (Table 3).","Line 4698: Gene LG Protein Allele Degree of suppression when homozygous a Degree of suppression when heterozygous b Molecular lesion p dbl-1 V BMP ligand jj54 l 100% (n = 803) 23.3% (n = 103) W278Stop (TGG to TGA) sma-6 II Type I receptor jj1 c 100% (n = 109) ND W328Stop (TGG to TAG) jj69 l , n , q 94.8% (n = 173) 2% (n = 50) G to A at -1,886bp jj76 l 98.7% (n = 394) 18.99% (n = 79) W112Stop (TGG to TAG) daf-4 III Type II receptor jj50 m 86% (n = 384) 2.63% (n = 38) A586T (GCA to ACA) jj52 m 88% (n = 338) 1.14% (n = 88) A586T (GCA to ACA) jj53 l 87% (n = 162) ND M484I (ATG to ATA) sma-2 III R-SMAD jj5 m 82.2% (n = 225) 15.2% (n = 79) G19E (GGA to GAA) jj6 l 71% (n = 100) ND G19E (GGA to GAA) jj64 l 71.2% (n = 139) 3.6% (n = 111) R67W (CGG to TGG) jj66 l 87% (n-710) ND C62Y (TGC to TAC) jj72 l 96.7% (n = 62) 10% (n = 60) E100K (GAA to AAA) sma-3 III R-SMAD jj3 c 100% (n = 100) ND Intron 9 splice donor T to A Truncation after amino acid 318 i jj55 l 100% (n = 703) 12.5% (n = 128) K265E (AAA to GAA) jj63 l 72% (n = 271) ND W349Stop (TGG to TAG) jj74 l 94.1% (n = 239) ND G259E (GGA to GAA) jj75 l 100% (n = 173) ND Q261Stop (CAG to TAG) jj82 l 96.9% (n = 449) 10.94% (n = 64) G259E (GGA to GAA) sma-4 III Co-SMAD jj51 l 100% (n = 1662) 24.49% (n = 49) S169F (TCT to TTT) jj56 100% (n = 623) 15.58% (n = 321) Intron 3 splice donor G to A Truncation after amino acid 155 i jj70 m , o 97.5% (n = 80) 12.1% (n = 149) S3330L (TCA to TTA) jj79 l 56.2% (n = 539) 15.67% (n = 134) R261K (AGA to AAA) lon-2 X Glypican jj61 n 82.3% (n = 124) ND 11,781bp deletion after exon 8, Truncation after amino acid 390 j drag-1 I RGM jj4 d 98.5% (N = 201) 0% (n = 39) Intron 1 splice donor G to A Truncation after amino acid 16 k unc- 40 I DCC/ neogenin jj2 m 63.3% (n = 128) 24.55% (n = 110) R677C (CGT to TGT) jj7 m 63% (n = 50) 2.48% (n = 121) R677C (CGT to TGT) jj59 e 73.3% (n = 195) 0 (n = 83) Q628Stop (CAA to TAA) sma- 10 IV LRIG jj49 n 66% (n = 607) 4.26% (n = 47) G361R (GGA to AGA) jj57 n 95% (n = 1156) 23.19% (n = 111) Intron 8 splice donor T to A Truncation after amino acid 442 i jj62 n 82.8% (n = 134) ND W462Stop (TGG to TGA) jj71 n 70.2% (n = 228) ND Q593Stop (CAA to TAA) jj73 n 88% (n = 188) 5.85% (n = 205) A434T (GCA to ACA) jj78 n 97.1% (n = 615) 12.8% (n = 211) P643S (CCA to TCA) jj83 n 66.2% (n = 757) 7.29% (n = 96) Y665N (TAT to AAT) lon-1 III CRISP jj67 l 66.8% (n = 190) ND W197Stop (TGG to TGA) tsp-21 X Tetraspanin jj60 m 89.8% (n = 98) 1.04% (n = 96) G109E (GGA to GAA) jj77 m 99.5% (n = 643) ND V236E (GTA to GAA) and 84bp deletion of intron 6 into exon 7, 6bp (ATCTCT) insertion 13AA deletion + 2AA insertion i ( Continued ) Tetraspanins Promote BMP Signaling PLOS Genetics  DOI:10.1371/journal.pgen.1005221 May 15, 2015 7/33 Mutations in the membrane protein tetraspanin-21 (TSP-21) are novel sma-9 suppressors We performed whole genome sequencing (WGS) of the novel complementation group that in- cludes jj60 and jj77 to identify the corresponding gene.",True Positive
WBPaper00047026,WBGene00000067,act-5,A97T,T25C8.2,Line 6378: Both mutants were resistant to all nine wact-11-family members 11111111111111111111111111111110111011101110111011101110111011101110111011101110111101111011110111101111011110111101111011110111101111011110111101111011110111110111011101110111010101101101101111101110110110110 1010101011011001100110011001100110011001100110011001100110011001100110011000100010001000100010001000100010001000100010001000100010001000100010001000100010001000 1000100010001000100010011001001001001000100010010100101001010010111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100 11100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011001010001000100110010001100010001100011000110001100011 000110001100011000110001100011000110001100011000110001100010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000 10000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000 Group 1 ( n=102) Group 2 (n =67) Group 3 (n =106) C. elegans C. oncophora H. contortus D. rerio HEK cells Genetic screen outcome 275 129 116 59 76 Lethal Non-lethal Resistant mutants obtained Resistant mutants not obtained Genetic screen was not performed Pairwise similarity > 0.55 Group 1 molecule ( n=102) Group 2 molecule ( n=67) Group 3 molecule ( n=106) wact-11 structural family Mutants obtained (n=6) Mutants not obtained (n=33) wact-11 wact-12 wact-125 wact-127 wact-399 wact- 400 wact- 568 wact-406 wact-52 Screen not performed ( n =236) C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18C19 Figure 2  Nematode selectivity and structural proling of the 275 C. elegans -lethal molecules.,Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00047026,WBGene00000067,act-5,T66I,T25C8.2,Line 6378: Both mutants were resistant to all nine wact-11-family members 11111111111111111111111111111110111011101110111011101110111011101110111011101110111101111011110111101111011110111101111011110111101111011110111101111011110111110111011101110111010101101101101111101110110110110 1010101011011001100110011001100110011001100110011001100110011001100110011000100010001000100010001000100010001000100010001000100010001000100010001000100010001000 1000100010001000100010011001001001001000100010010100101001010010111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100 11100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011100111001110011001010001000100110010001100010001100011000110001100011 000110001100011000110001100011000110001100011000110001100010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000 10000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000100001000010000 Group 1 ( n=102) Group 2 (n =67) Group 3 (n =106) C. elegans C. oncophora H. contortus D. rerio HEK cells Genetic screen outcome 275 129 116 59 76 Lethal Non-lethal Resistant mutants obtained Resistant mutants not obtained Genetic screen was not performed Pairwise similarity > 0.55 Group 1 molecule ( n=102) Group 2 molecule ( n=67) Group 3 molecule ( n=106) wact-11 structural family Mutants obtained (n=6) Mutants not obtained (n=33) wact-11 wact-12 wact-125 wact-127 wact-399 wact- 400 wact- 568 wact-406 wact-52 Screen not performed ( n =236) C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18C19 Figure 2  Nematode selectivity and structural proling of the 275 C. elegans -lethal molecules.,Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00047026,WBGene00000962,"dhc-1, let-354, spd-4",G77D,T21E12.4b,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00047026,WBGene00000962,"dhc-1, let-354, spd-4",H146Y,T21E12.4a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",C78Y,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",F136S,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",G133E,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",G71E,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",G71E,T07C4.7b,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",G77D,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",G77D,T07C4.7b,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",R74K,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00003225,"mev-1, cyt-1, sdhc-1",T66I,T07C4.7a,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00006433,"sdhb-1, tag-55",H146Y,F42A8.2,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00006433,"sdhb-1, tag-55",I260N,F42A8.2,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00006433,"sdhb-1, tag-55",P145L,F42A8.2,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00006433,"sdhb-1, tag-55",P211L,F42A8.2,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00009353,sdhd-1,A97T,F33A8.5,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00009353,sdhd-1,D95N,F33A8.5,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,True Positive
WBPaper00047026,WBGene00009353,sdhd-1,H84Q,F33A8.5,"Line 6392: Ten strains had missense mutations in sdhb-1 , a different set of 16 strains had a missense mutation in sdhc-1 (otherwise known as mev-1), six other strains had missense mutations in sdhd-1 and one remaining strain had no commonly mutated gene (Table 1).",Line 6416: Number of strains C. elegans mutated gene C. elegans residue change Ascaris suum orthologous residue Human orthologous residue 1 sdhb-1 P145L P127 P131 2 sdhb-1 H146Y H128 H132 6 sdhb-1 P211L P193 P207 1 sdhb-1 I260N I242 I246 3 sdhc-1 T66I T81 P64 1 sdhc-1 G71E G86 I69 8 sdhc-1 R74K R89 R72 1 sdhc-1 G77D G92 G75 1 sdhc-1 C78Y C93 I76 1 sdhc-1 G133E G148 G131 1 sdhc-1 F136S F151 H134 1 sdhd-1 H84Q H95 H98 4 sdhd-1 D95N D106 D109 1 sdhd-1 A97T G108 V111 1?,False Positive
WBPaper00048712,WBGene00003166,mec-2,A713T,F14D12.4f,"Line 16397: A total of 10 ng cRNA of mec-4(d) , mec-2 ,and mec-10 ;1 ng mec-6 ;and 1ngcRNA of mec-19 were injected to oocytes unless noted (oocytes were a gift of Dr. Jian Yang and were obtained from frogs from Xenopus I, Dexter, MI, or Nasco, Fort Atkinson, WI).",Line 16342: The mec-4(d) mutation e1611 (producing an A713T substitution) re- sults in constitutive channel activation and thus neurodegeneration (Driscoll and Chal e 1991; Brown et al.,False Positive
WBPaper00048712,WBGene00003168,"mec-4, mec-13",A713T,T01C8.7,Line 16316: The Caenorhabditis elegans DEG/ENaC proteins MEC-4 and MEC-10 transduce gentle touch in the six touch receptor neurons .,Line 16342: The mec-4(d) mutation e1611 (producing an A713T substitution) re- sults in constitutive channel activation and thus neurodegeneration (Driscoll and Chal e 1991; Brown et al.,False Positive
WBPaper00048884,WBGene00001651,gon-2,C707Y,T01H8.5d,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.",Line 24573: identified the C707Y allele [42] and Lainez et al.,False Positive
WBPaper00048884,WBGene00001651,gon-2,D1000Y,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24571: These mutations affect residues immediately downstream of dx65/ dx148 (Fig 3), converting a moderately conserved glutamate to lysine ( dx116 , E996K) and a non-conserved aspartate to tyrosine (D1000Y).",True Positive
WBPaper00048884,WBGene00001651,gon-2,D1033N,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.",Line 24572: These affect a highly conserved acidic residue ( dx96 D1033N) and a non-conserved acidic residue ( dx150 E1050K) within a region that is important for TRPM6 activity (Fig 4).,True Positive
WBPaper00048884,WBGene00001651,gon-2,E1050K,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.",Line 24572: These affect a highly conserved acidic residue ( dx96 D1033N) and a non-conserved acidic residue ( dx150 E1050K) within a region that is important for TRPM6 activity (Fig 4).,True Positive
WBPaper00048884,WBGene00001651,gon-2,E1050K,T01H8.5c,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.",Line 24572: These affect a highly conserved acidic residue ( dx96 D1033N) and a non-conserved acidic residue ( dx150 E1050K) within a region that is important for TRPM6 activity (Fig 4).,False Positive
WBPaper00048884,WBGene00001651,gon-2,E996K,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24571: These mutations affect residues immediately downstream of dx65/ dx148 (Fig 3), converting a moderately conserved glutamate to lysine ( dx116 , E996K) and a non-conserved aspartate to tyrosine (D1000Y).",True Positive
WBPaper00048884,WBGene00001651,gon-2,K991E,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24550: Consistent with the idea that this area is preferentially affected, dx148 (K991Q) and dx65 (K991E) cause different alterations to a Novel Alleles of a TRPM Channel PLOS ONE  DOI:10.1371/journal.pone.0143445 November 25, 2015 4/16 Fig 1.",False Positive
WBPaper00048884,WBGene00001651,gon-2,K991Q,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24550: Consistent with the idea that this area is preferentially affected, dx148 (K991Q) and dx65 (K991E) cause different alterations to a Novel Alleles of a TRPM Channel PLOS ONE  DOI:10.1371/journal.pone.0143445 November 25, 2015 4/16 Fig 1.",True Positive
WBPaper00048884,WBGene00001651,gon-2,L1075P,T01H8.5e,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24646: found that the Brugada Syndrome L1075P allele of TRPM4 resulted in an increase in the amount of protein present on cell surface, suggesting a defect in endocytic trafficking [61].",False Positive
WBPaper00048884,WBGene00001651,gon-2,L708P,T01H8.5e,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.",Line 24574: identified the L708P allele [43] in patients with hypomagnesemia and secondary hypercalcemia (HSH).,False Positive
WBPaper00048884,WBGene00001651,gon-2,S141L,T01H8.5a,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24564: For example, the S141L mutation in human TRPM6 affects one of these ankyrin repeats and pre- vents channel subunit assembly, thus leading to hereditary Mg 2+ deficiency [39].",False Positive
WBPaper00048884,WBGene00001651,gon-2,S141L,T01H8.5b,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24564: For example, the S141L mutation in human TRPM6 affects one of these ankyrin repeats and pre- vents channel subunit assembly, thus leading to hereditary Mg 2+ deficiency [39].",False Positive
WBPaper00048884,WBGene00001651,gon-2,S141L,T01H8.5d,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24564: For example, the S141L mutation in human TRPM6 affects one of these ankyrin repeats and pre- vents channel subunit assembly, thus leading to hereditary Mg 2+ deficiency [39].",False Positive
WBPaper00048884,WBGene00001795,"gtl-1, tag-33",K991E,C05C12.3,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24550: Consistent with the idea that this area is preferentially affected, dx148 (K991Q) and dx65 (K991E) cause different alterations to a Novel Alleles of a TRPM Channel PLOS ONE  DOI:10.1371/journal.pone.0143445 November 25, 2015 4/16 Fig 1.",False Positive
WBPaper00048884,WBGene00001795,"gtl-1, tag-33",K991Q,C05C12.3,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.","Line 24550: Consistent with the idea that this area is preferentially affected, dx148 (K991Q) and dx65 (K991E) cause different alterations to a Novel Alleles of a TRPM Channel PLOS ONE  DOI:10.1371/journal.pone.0143445 November 25, 2015 4/16 Fig 1.",False Positive
WBPaper00048884,WBGene00001796,gtl-2,C707Y,F54D1.5,"Line 24466: The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7.",Line 24573: identified the C707Y allele [42] and Lainez et al.,False Positive
WBPaper00048884,WBGene00006752,unc-13,E1050K,ZK524.2b,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,Line 24572: These affect a highly conserved acidic residue ( dx96 D1033N) and a non-conserved acidic residue ( dx150 E1050K) within a region that is important for TRPM6 activity (Fig 4).,False Positive
WBPaper00048884,WBGene00006752,unc-13,E1050K,ZK524.2d,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,Line 24572: These affect a highly conserved acidic residue ( dx96 D1033N) and a non-conserved acidic residue ( dx150 E1050K) within a region that is important for TRPM6 activity (Fig 4).,False Positive
WBPaper00048884,WBGene00006752,unc-13,E996K,ZK524.2a,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24571: These mutations affect residues immediately downstream of dx65/ dx148 (Fig 3), converting a moderately conserved glutamate to lysine ( dx116 , E996K) and a non-conserved aspartate to tyrosine (D1000Y).",False Positive
WBPaper00048884,WBGene00006752,unc-13,E996K,ZK524.2j,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24571: These mutations affect residues immediately downstream of dx65/ dx148 (Fig 3), converting a moderately conserved glutamate to lysine ( dx116 , E996K) and a non-conserved aspartate to tyrosine (D1000Y).",False Positive
WBPaper00048884,WBGene00006752,unc-13,K991E,ZK524.2b,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24550: Consistent with the idea that this area is preferentially affected, dx148 (K991Q) and dx65 (K991E) cause different alterations to a Novel Alleles of a TRPM Channel PLOS ONE  DOI:10.1371/journal.pone.0143445 November 25, 2015 4/16 Fig 1.",False Positive
WBPaper00048884,WBGene00006752,unc-13,K991Q,ZK524.2b,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24550: Consistent with the idea that this area is preferentially affected, dx148 (K991Q) and dx65 (K991E) cause different alterations to a Novel Alleles of a TRPM Channel PLOS ONE  DOI:10.1371/journal.pone.0143445 November 25, 2015 4/16 Fig 1.",False Positive
WBPaper00048884,WBGene00006752,unc-13,L1075P,ZK524.2e,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24646: found that the Brugada Syndrome L1075P allele of TRPM4 resulted in an increase in the amount of protein present on cell surface, suggesting a defect in endocytic trafficking [61].",False Positive
WBPaper00048884,WBGene00006752,unc-13,L1075P,ZK524.2g,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24646: found that the Brugada Syndrome L1075P allele of TRPM4 resulted in an increase in the amount of protein present on cell surface, suggesting a defect in endocytic trafficking [61].",False Positive
WBPaper00048884,WBGene00006752,unc-13,L1075P,ZK524.2i,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24646: found that the Brugada Syndrome L1075P allele of TRPM4 resulted in an increase in the amount of protein present on cell surface, suggesting a defect in endocytic trafficking [61].",False Positive
WBPaper00048884,WBGene00006752,unc-13,L1143P,ZK524.2k,Line 24511: Strains The following strains were used: CB4856 Wild type Hawaiian; LX929 vsIs48[Punc-17::gfp] X; EJ556 gon-2(q388dx60) unc-29(e1072) I; EJ557 gon-2(q388dx65) unc-29(e1072) I; EJ652 unc- 13(e51) gon-2(dx87) I; EJ720 gon-2(q388dx96) unc-29(e1072) I; EJ922 gon-2(q388dx116) unc-29(e1072) I; EJ959 gon-2(q388dx99) unc-29(e1072) I; EJ1021 gon-2(q388dx148); gem-1 (bc364) I; EJ1110 gon-2(q388) I; EJ1173 vsIs48[Punc-17::gfp] N2/CB4856 hybrid X; EJ1190 gon-2(q388); vsIs48[Punc-17::gfp]; EJ1191 gon-2(q388dx146); gem-1(bc364) I; EJ1192 unc-13 (e51) gon-2(ok465)/unc-13(e51) lin-11(n566) I; EJ1193 gon-2(q388dx146); gem-1(bc364) I.,"Line 24596: This region of the protein is notable for multiple reasons. identified the L1143P mutation of TRPM6 in a patient with HSH [43], and found that while the mutation severely impairs channel activity, it does not affect expression and/or trafficking.",False Positive
WBPaper00048884,WBGene00008214,gem-1,S141L,C49F8.2,"Line 24503: We have performed extensive genetic screens for mutations that suppress the gonadogenesis defect of gon-2(q388ts) mutants, and these resulted in the identification two new loci, gem-1 [34] and gem-4 [35].","Line 24564: For example, the S141L mutation in human TRPM6 affects one of these ankyrin repeats and pre- vents channel subunit assembly, thus leading to hereditary Mg 2+ deficiency [39].",False Positive
WBPaper00049625,WBGene00008205,"sams-1, drop-4",A42V,C49F5.1,"Line 2245: Class IV mutant drop-4 is cloned as sams-1 and, different to the other three classes, is ACS-22-independent and hydrolysis-resistant.",Line 2514: The extremely large LDs resemble those in a previously reported mutant sams-1 (Li et al. drop-4(ssd206) does not complement a deletion mutant sams-1(ok2946) and bears a missense mutation Ala42Val at the SAMS-1 protein level.,True Positive
WBPaper00049977,WBGene00004503,rpt-3,D261N,F23F12.6,"Line 22360: Results The aspartic protease DDI-1 and ERAD factors are required for transcriptional responses to proteasome disruption The proteasome subunit gene rpt-3 is upregulated in a skn-1 -dependent manner in response to pro- teasome disruption ( Li et al., 2011 ).","Line 22468: We used CRISPR/Cas9 mutagenesis to generate a protease dead mutant containing two amino acid substitutions at conserved residues of the catalytic motif, includ- ing the aspartic acid residue that forms the active site (D261N, G263A).",False Positive
WBPaper00049977,WBGene00004505,rpt-5,D261N,F56H1.4,Line 22376: We examined activation of rpt-3::gfp in ERAD and ddi-1 mutant animals following disruption of proteasome function by RNAi of the essential proteasome subunit rpt-5.,"Line 22468: We used CRISPR/Cas9 mutagenesis to generate a protease dead mutant containing two amino acid substitutions at conserved residues of the catalytic motif, includ- ing the aspartic acid residue that forms the active site (D261N, G263A).",False Positive
WBPaper00049977,WBGene00015308,"ddi-1, vsm-1",D261N,C01G5.6,"Line 22313: Genes required for SKN-1 activation encode regulators of ER traffic, a peptide N-glycanase, and DDI-1, a conserved aspartic protease.","Line 22468: We used CRISPR/Cas9 mutagenesis to generate a protease dead mutant containing two amino acid substitutions at conserved residues of the catalytic motif, includ- ing the aspartic acid residue that forms the active site (D261N, G263A).",False Positive
WBPaper00049977,WBGene00015308,"ddi-1, vsm-1",G263A,C01G5.6,"Line 22313: Genes required for SKN-1 activation encode regulators of ER traffic, a peptide N-glycanase, and DDI-1, a conserved aspartic protease.","Line 22468: We used CRISPR/Cas9 mutagenesis to generate a protease dead mutant containing two amino acid substitutions at conserved residues of the catalytic motif, includ- ing the aspartic acid residue that forms the active site (D261N, G263A).",False Positive
WBPaper00050743,WBGene00003514,myo-2,L307F,T18D3.4,"Line 24894: At least 15 male cross progeny (lacking the nT1[qIs51] myo-2::GFP balancer), were examined for the bright and enlarged P-granule phenotype.","Line 24733: sam5 contains a G to A point mutation that introduces an early stop codon in exon 10 of drh-3, while in sam2 a C to T missense substitution (Leu307Phe) was discovered in exon 5 of the same gene.",False Positive
WBPaper00050743,WBGene00008400,"drh-3, ekl-3",L307F,D2005.5,"Line 24680: In a forward screen to identify mutants with abnormal P granules, ten alleles were recovered with a csr-1 P-granule phenotype, eight of which con- tain mutations in known components of the CSR-1 complex (csr-1, ego-1, ekl-1, and drh-3).","Line 24733: sam5 contains a G to A point mutation that introduces an early stop codon in exon 10 of drh-3, while in sam2 a C to T missense substitution (Leu307Phe) was discovered in exon 5 of the same gene.",True Positive
WBPaper00050743,WBGene00017641,csr-1,L307F,F20D12.1b,"Line 24723: To determine if alleles mapping to chromosome IV contain mutations in csr-1/F20D12.1,  complementation tests were performed with csr-1(fj54).","Line 24733: sam5 contains a G to A point mutation that introduces an early stop codon in exon 10 of drh-3, while in sam2 a C to T missense substitution (Leu307Phe) was discovered in exon 5 of the same gene.",False Positive
WBPaper00051175,WBGene00000042,acr-2,G477E,K11G12.2,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000042,acr-2,P177S,K11G12.2,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00000042,acr-2,V309M,K11G12.2,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25225: 4 Corresponding authors: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093. A V309M gain-of-function mutation in the second TM domain of the ACR-2 subunit causes elevated cholinergic activity.",False Positive
WBPaper00051175,WBGene00000043,acr-3,C151Y,K11G12.7,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25292: Of particular note, for UNC-63, animals harboring the C151Y mutationare resistant to levamisole (Lewis et al.",False Positive
WBPaper00051175,WBGene00000043,acr-3,G121R,K11G12.7,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000043,acr-3,P111L,K11G12.7,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000043,acr-3,P159L,K11G12.7,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.",Line 25350: (B) Protein diagrams illustrating known and new alleles of unc-38 . P159L was previously isolated in a levamisole resistance screen (Garcia et al.,False Positive
WBPaper00051175,WBGene00000043,acr-3,P159S,K11G12.7,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000043,acr-3,V309M,K11G12.7,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25225: 4 Corresponding authors: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093. A V309M gain-of-function mutation in the second TM domain of the ACR-2 subunit causes elevated cholinergic activity.",False Positive
WBPaper00051175,WBGene00000051,acr-12,V309M,R01E6.4a,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25225: 4 Corresponding authors: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093. A V309M gain-of-function mutation in the second TM domain of the ACR-2 subunit causes elevated cholinergic activity.",False Positive
WBPaper00051175,WBGene00000140,anc-1,G321R,ZK973.6c,"Line 25259: For mapping the unc-63(ju815) allele, CZ24017 (Table S2 )was outcrossed to N2, and linkage of the ju815 mutation to chromosome I was determined based on cosegregation of the suppression effect with the unc-63 SNPandaSNPin anc-1(I) , 1.36 map units from the unc-63 ( I ) locus (Table S1).","Line 25290: The M150I mutation in UNC-63 ( ju860 ) and the G321R or P494H mutation in UNC-38 ( ju852 , ju857 ) showed disparate distribution throughout the receptors (Figure 1, A and B).",False Positive
WBPaper00051175,WBGene00000140,anc-1,G477E,ZK973.6c,"Line 25259: For mapping the unc-63(ju815) allele, CZ24017 (Table S2 )was outcrossed to N2, and linkage of the ju815 mutation to chromosome I was determined based on cosegregation of the suppression effect with the unc-63 SNPandaSNPin anc-1(I) , 1.36 map units from the unc-63 ( I ) locus (Table S1).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000140,anc-1,P159L,ZK973.6c,"Line 25259: For mapping the unc-63(ju815) allele, CZ24017 (Table S2 )was outcrossed to N2, and linkage of the ju815 mutation to chromosome I was determined based on cosegregation of the suppression effect with the unc-63 SNPandaSNPin anc-1(I) , 1.36 map units from the unc-63 ( I ) locus (Table S1).",Line 25350: (B) Protein diagrams illustrating known and new alleles of unc-38 . P159L was previously isolated in a levamisole resistance screen (Garcia et al.,False Positive
WBPaper00051175,WBGene00000140,anc-1,P159S,ZK973.6c,"Line 25259: For mapping the unc-63(ju815) allele, CZ24017 (Table S2 )was outcrossed to N2, and linkage of the ju815 mutation to chromosome I was determined based on cosegregation of the suppression effect with the unc-63 SNPandaSNPin anc-1(I) , 1.36 map units from the unc-63 ( I ) locus (Table S1).","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000140,anc-1,P267L,ZK973.6a,"Line 25259: For mapping the unc-63(ju815) allele, CZ24017 (Table S2 )was outcrossed to N2, and linkage of the ju815 mutation to chromosome I was determined based on cosegregation of the suppression effect with the unc-63 SNPandaSNPin anc-1(I) , 1.36 map units from the unc-63 ( I ) locus (Table S1).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00000140,anc-1,V309M,ZK973.6c,"Line 25259: For mapping the unc-63(ju815) allele, CZ24017 (Table S2 )was outcrossed to N2, and linkage of the ju815 mutation to chromosome I was determined based on cosegregation of the suppression effect with the unc-63 SNPandaSNPin anc-1(I) , 1.36 map units from the unc-63 ( I ) locus (Table S1).","Line 25225: 4 Corresponding authors: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093. A V309M gain-of-function mutation in the second TM domain of the ACR-2 subunit causes elevated cholinergic activity.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",G121R,F47D12.1a,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",G121R,F47D12.1b,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",G121R,F47D12.1c,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",G121R,F47D12.1d,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P111L,F47D12.1a,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P111L,F47D12.1b,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P111L,F47D12.1c,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P111L,F47D12.1d,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P267L,F47D12.1a,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P267L,F47D12.1b,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001518,"gar-2, acm-2",P267L,F47D12.1c,"Line 25427: To test this, we examined gar-2 , which is also expressed in the cholinergic motorneurons and is thought to inhibit circuit activity through Go a signaling (Dittman and Kaplan 2008).","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001519,"gar-3, acm-3, gar-3a",K130I,Y40H4A.1a,"Line 25421: The activity-induced SPHK-1::GFP expression required a G-protein signaling pathway in- volving the muscarinic receptor gene gar-3 , the guanine exchanger factor Trio unc-73 , and a calmodulin-like calcium binding protein calm-1 (Chan et al.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001519,"gar-3, acm-3, gar-3a",K130I,Y40H4A.1b,"Line 25421: The activity-induced SPHK-1::GFP expression required a G-protein signaling pathway in- volving the muscarinic receptor gene gar-3 , the guanine exchanger factor Trio unc-73 , and a calmodulin-like calcium binding protein calm-1 (Chan et al.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00001519,"gar-3, acm-3, gar-3a",S398F,Y40H4A.1a,"Line 25421: The activity-induced SPHK-1::GFP expression required a G-protein signaling pathway in- volving the muscarinic receptor gene gar-3 , the guanine exchanger factor Trio unc-73 , and a calmodulin-like calcium binding protein calm-1 (Chan et al.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00001796,gtl-2,G321R,F54D1.5,Line 25282: Two loss-of- function mutations affected the TRPM channel gtl-2 (Stawicki et al.,"Line 25290: The M150I mutation in UNC-63 ( ju860 ) and the G321R or P494H mutation in UNC-38 ( ju852 , ju857 ) showed disparate distribution throughout the receptors (Figure 1, A and B).",False Positive
WBPaper00051175,WBGene00001796,gtl-2,G524R,F54D1.5,Line 25282: Two loss-of- function mutations affected the TRPM channel gtl-2 (Stawicki et al.,"Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00001796,gtl-2,S398F,F54D1.5,Line 25282: Two loss-of- function mutations affected the TRPM channel gtl-2 (Stawicki et al.,"Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00002043,hyl-1,P267L,C09G4.1c,Line 25447: The hyl-1 and lagr-1 mutations are small deletions that disrupt the catalytic domains of these proteins (Deng et al.,"Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006752,unc-13,G477E,ZK524.2k,"Line 25231: Additional suppressors of the acr-2(gf) convulsion phenotype de ned a divalent cation transient receptor potential channel subfamily M (TRPM) that modulates locomotor circuit via ion homeostasis, and a novel mu- tation in unc-13 that affects synaptic transmission through positional docking of synaptic vesicles (Stawicki et al.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006752,unc-13,P415S,ZK524.2j,"Line 25231: Additional suppressors of the acr-2(gf) convulsion phenotype de ned a divalent cation transient receptor potential channel subfamily M (TRPM) that modulates locomotor circuit via ion homeostasis, and a novel mu- tation in unc-13 that affects synaptic transmission through positional docking of synaptic vesicles (Stawicki et al.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00006752,unc-13,P494H,ZK524.2j,"Line 25231: Additional suppressors of the acr-2(gf) convulsion phenotype de ned a divalent cation transient receptor potential channel subfamily M (TRPM) that modulates locomotor circuit via ion homeostasis, and a novel mu- tation in unc-13 that affects synaptic transmission through positional docking of synaptic vesicles (Stawicki et al.","Line 25290: The M150I mutation in UNC-63 ( ju860 ) and the G321R or P494H mutation in UNC-38 ( ju852 , ju857 ) showed disparate distribution throughout the receptors (Figure 1, A and B).",False Positive
WBPaper00051175,WBGene00006752,unc-13,S398F,ZK524.2h,"Line 25231: Additional suppressors of the acr-2(gf) convulsion phenotype de ned a divalent cation transient receptor potential channel subfamily M (TRPM) that modulates locomotor circuit via ion homeostasis, and a novel mu- tation in unc-13 that affects synaptic transmission through positional docking of synaptic vesicles (Stawicki et al.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00006756,unc-17,G121R,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006756,unc-17,G477E,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006756,unc-17,G524R,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00006756,unc-17,P267L,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006756,unc-17,P415S,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",True Positive
WBPaper00051175,WBGene00006756,unc-17,S398F,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",True Positive
WBPaper00051175,WBGene00006756,unc-17,Y400N,ZC416.8a,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25328: The new alleles of unc-17 map to the region around TM11, which contains one previously reported partial loss-of-function mutation, Y400N, isolated in aldicarb resistance screens (Figure 2C) (Zhu et al.",False Positive
WBPaper00051175,WBGene00006777,"unc-41, tcf-1, apt-10",G121R,C27H6.1c,"Line 25311: The ju873 mutation affects unc-41 ,the C. elegans Stoned B homo- log, which is generally agreed to function in synaptic vesicle recycling (Walther et al.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",C151Y,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25292: Of particular note, for UNC-63, animals harboring the C151Y mutationare resistant to levamisole (Lewis et al.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",C294Y,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",True Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",G121R,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",K130I,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",M150I,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25290: The M150I mutation in UNC-63 ( ju860 ) and the G321R or P494H mutation in UNC-38 ( ju852 , ju857 ) showed disparate distribution throughout the receptors (Figure 1, A and B).",True Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",P111L,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",P159L,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.",Line 25350: (B) Protein diagrams illustrating known and new alleles of unc-38 . P159L was previously isolated in a levamisole resistance screen (Garcia et al.,False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",P159S,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25344: New alleles isolated in the acr-2(gf) suppressor screen are indicated with a ju allele number. G121R, K130I, and P159S were previously iso- lated through an acr-2(gf) screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",S398F,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00006797,"unc-63, lev-7, tmr-3",V309M,Y110A7A.3,"Line 25199: The cholinergic motor neurons express an ACR-2-containing pentameric acetylcholine receptor (ACR-2R) comprised of ACR-2, ACR-3, ACR-12, UNC-38, and UNC-63 subunits.","Line 25225: 4 Corresponding authors: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093. A V309M gain-of-function mutation in the second TM domain of the ACR-2 subunit causes elevated cholinergic activity.",False Positive
WBPaper00051175,WBGene00006805,"unc-73, let-509",P177S,F55C7.7c,"Line 25421: The activity-induced SPHK-1::GFP expression required a G-protein signaling pathway in- volving the muscarinic receptor gene gar-3 , the guanine exchanger factor Trio unc-73 , and a calmodulin-like calcium binding protein calm-1 (Chan et al.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00006805,"unc-73, let-509",P177S,F55C7.7g,"Line 25421: The activity-induced SPHK-1::GFP expression required a G-protein signaling pathway in- volving the muscarinic receptor gene gar-3 , the guanine exchanger factor Trio unc-73 , and a calmodulin-like calcium binding protein calm-1 (Chan et al.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00007918,"sphk-1, tag-274",G321R,C34C6.5a,"Line 25204: We further defined a role for the sphingosine kinase, sphk-1, in cholinergic neuron activity, independent of previously known signaling pathways.","Line 25290: The M150I mutation in UNC-63 ( ju860 ) and the G321R or P494H mutation in UNC-38 ( ju852 , ju857 ) showed disparate distribution throughout the receptors (Figure 1, A and B).",False Positive
WBPaper00051175,WBGene00007918,"sphk-1, tag-274",P111L,C34C6.5a,"Line 25204: We further defined a role for the sphingosine kinase, sphk-1, in cholinergic neuron activity, independent of previously known signaling pathways.","Line 25352: 2001), and P111L, P267L, and G477E were previously iso- lated in an acr-2(gf) suppressor screen (Jospin et al.",False Positive
WBPaper00051175,WBGene00007918,"sphk-1, tag-274",P177S,C34C6.5a,"Line 25204: We further defined a role for the sphingosine kinase, sphk-1, in cholinergic neuron activity, independent of previously known signaling pathways.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",True Positive
WBPaper00051175,WBGene00007918,"sphk-1, tag-274",V309M,C34C6.5b,"Line 25204: We further defined a role for the sphingosine kinase, sphk-1, in cholinergic neuron activity, independent of previously known signaling pathways.","Line 25225: 4 Corresponding authors: University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093. A V309M gain-of-function mutation in the second TM domain of the ACR-2 subunit causes elevated cholinergic activity.",False Positive
WBPaper00051175,WBGene00020051,mfsd-6,G421E,R13A5.9,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051175,WBGene00020051,mfsd-6,G524R,R13A5.9,"Line 25203: A majority of these suppressor mutations affect genes that play critical roles in synaptic transmission, including two novel mutations in the vesicular acetylcholine transporter unc-17 In addition, we identified a role for a conserved major facilitator superfamily domain family protein mfsd-6 in regulating neural circuit activity.","Line 25320: unc-31(ju818) causes a premature termination in all n Table 1 acr-2(gf) suppressors Gene Allele Nucleotide Change a Amino Acid Change b AChR subunits unc-38 ju852 cCc/cAc P494H unc-38 ju857 Gga/Aga G321R unc-63 ju860 atG/atA M150I unc-63 ju815 tGt/tAt C294Y Synaptic genes unc-31 ju818 Cga/Tga R1180 fl sphk-1 ju831 Cca/Tca P177S unc-17 ju840 tCc/tTc S398F unc-17 ju854 Ccc/Tcc P415S unc-41 ju873 ctG/ctA Q91 fl unc-13 ju874 atttcaGcttccttg/ atttcaActtccttg Splice site: intron 26/exon 27 mfsd-6 ju833 Gga/Aga G524R mfsd-6 ju866 gGa/gAa G421E mfsd-6 ju870 ttG/ttA Q76 fl Unidenti ed ju807 (II) ju863 (II) AChR, acetylcholine receptor.",False Positive
WBPaper00051394,WBGene00000962,"dhc-1, let-354, spd-4",P262L,T21E12.4a,"Line 88: ju1279 converts a conserved proline residue to leucine (P262L) in the N-terminal region 1 of the tail domain of DHC-1 (Fig 2A and S2 Fig), which is responsible for dynein homodimerization and acts as a scaffold for subunit assembly [22].","Line 88: ju1279 converts a conserved proline residue to leucine (P262L) in the N-terminal region 1 of the tail domain of DHC-1 (Fig 2A and S2 Fig), which is responsible for dynein homodimerization and acts as a scaffold for subunit assembly [22].",True Positive
WBPaper00051394,WBGene00000962,"dhc-1, let-354, spd-4",S285F,T21E12.4a,"Line 88: ju1279 converts a conserved proline residue to leucine (P262L) in the N-terminal region 1 of the tail domain of DHC-1 (Fig 2A and S2 Fig), which is responsible for dynein homodimerization and acts as a scaffold for subunit assembly [22].","Line 71: The last missense mutation, ju962 (S285F), was in the intermediate domain of α-tubulin, reported to be necessary for binding of the MT stabilizing drug, taxol (Fig 1D and S1 Fig) [15].",False Positive
WBPaper00051394,WBGene00001008,dlk-1,K115A,F33E2.2a,"Line 76: tbb- 2 (ju1535) partially suppressed the behavioral and synapse remodeling defects of tba-1(gf)dlk- 1(0) (S1 Table and Fig 1D), and such suppression was rescued by transgenic expression of wild type TBB-2 in tba-1(gf)dlk-1(0); tbb-2(ju1535) animals (Fig 1F).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00001008,dlk-1,K115A,F33E2.2b,"Line 76: tbb- 2 (ju1535) partially suppressed the behavioral and synapse remodeling defects of tba-1(gf)dlk- 1(0) (S1 Table and Fig 1D), and such suppression was rescued by transgenic expression of wild type TBB-2 in tba-1(gf)dlk-1(0); tbb-2(ju1535) animals (Fig 1F).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00001008,dlk-1,K115A,F33E2.2c,"Line 76: tbb- 2 (ju1535) partially suppressed the behavioral and synapse remodeling defects of tba-1(gf)dlk- 1(0) (S1 Table and Fig 1D), and such suppression was rescued by transgenic expression of wild type TBB-2 in tba-1(gf)dlk-1(0); tbb-2(ju1535) animals (Fig 1F).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00001008,dlk-1,V229I,F33E2.2d,"Line 76: tbb- 2 (ju1535) partially suppressed the behavioral and synapse remodeling defects of tba-1(gf)dlk- 1(0) (S1 Table and Fig 1D), and such suppression was rescued by transgenic expression of wild type TBB-2 in tba-1(gf)dlk-1(0); tbb-2(ju1535) animals (Fig 1F).","Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).",False Positive
WBPaper00051394,WBGene00001456,flp-13,S138L,F33D4.3,Line 111: (B) Representative images of DD synapses along the DNC (Pflp-13-SNB-1::GFP (juIs137)) in adult animals.,"Line 70: Another missense muta- tion, ju965 (S138L), was close to the GTP binding pocket of α-tubulin [15] (S1 Fig).",False Positive
WBPaper00051394,WBGene00003515,"myo-3, sup-3",S138L,K12F2.1,"Line 160: As a control, expression of TTBK-3 from a muscle specific promoter (myo-3) failed to do so (Fig 4B and 4C), supporting the conclusion that TTBK-3 is required in DD neurons.","Line 70: Another missense muta- tion, ju965 (S138L), was close to the GTP binding pocket of α-tubulin [15] (S1 Fig).",False Positive
WBPaper00051394,WBGene00003515,"myo-3, sup-3",V229I,K12F2.1,"Line 160: As a control, expression of TTBK-3 from a muscle specific promoter (myo-3) failed to do so (Fig 4B and 4C), supporting the conclusion that TTBK-3 is required in DD neurons.","Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).",False Positive
WBPaper00051394,WBGene00006528,tba-1,A419T,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 69: Two missense mutations (ju973 (L426F) and ju987 (A419T)) were in H12 of the C-terminal domain, and could possibly have reversed the MAP binding defects caused by tba-1(gf)(S1 Fig).",True Positive
WBPaper00051394,WBGene00006528,tba-1,D209A,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00006528,tba-1,G414R,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,True Positive
WBPaper00051394,WBGene00006528,tba-1,K115A,F26E4.8b,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00006528,tba-1,L426F,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 69: Two missense mutations (ju973 (L426F) and ju987 (A419T)) were in H12 of the C-terminal domain, and could possibly have reversed the MAP binding defects caused by tba-1(gf)(S1 Fig).",True Positive
WBPaper00051394,WBGene00006528,tba-1,P305S,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 75: We mapped the suppressor ju1535 to β-tubulin tbb-2, causing a conserved Proline305 to Serine change (P305S) in the intermediate domain, which lies in the internal surface of the MT polymer (S1 Fig).",False Positive
WBPaper00051394,WBGene00006528,tba-1,S138L,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 70: Another missense muta- tion, ju965 (S138L), was close to the GTP binding pocket of α-tubulin [15] (S1 Fig).",True Positive
WBPaper00051394,WBGene00006528,tba-1,S285F,F26E4.8a,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 71: The last missense mutation, ju962 (S285F), was in the intermediate domain of α-tubulin, reported to be necessary for binding of the MT stabilizing drug, taxol (Fig 1D and S1 Fig) [15].",True Positive
WBPaper00051394,WBGene00006537,"tbb-2, rot-2",D209A,C36E8.5,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00006537,"tbb-2, rot-2",P305S,C36E8.5,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 75: We mapped the suppressor ju1535 to β-tubulin tbb-2, causing a conserved Proline305 to Serine change (P305S) in the intermediate domain, which lies in the internal surface of the MT polymer (S1 Fig).",True Positive
WBPaper00051394,WBGene00006537,"tbb-2, rot-2",S138L,C36E8.5,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 70: Another missense muta- tion, ju965 (S138L), was close to the GTP binding pocket of α-tubulin [15] (S1 Fig).",False Positive
WBPaper00051394,WBGene00006537,"tbb-2, rot-2",V229I,C36E8.5,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,"Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).",False Positive
WBPaper00051394,WBGene00006762,unc-25,G414R,Y37D8A.23a,Line 115: (E) Quantification of synaptic puncta in the DNC (Punc-25-SNB-1::GFP (juIs1)) of adult animals.,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,False Positive
WBPaper00051394,WBGene00006762,unc-25,G414R,Y37D8A.23b,Line 115: (E) Quantification of synaptic puncta in the DNC (Punc-25-SNB-1::GFP (juIs1)) of adult animals.,Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,False Positive
WBPaper00051394,WBGene00006762,unc-25,S138L,Y37D8A.23c,Line 115: (E) Quantification of synaptic puncta in the DNC (Punc-25-SNB-1::GFP (juIs1)) of adult animals.,"Line 70: Another missense muta- tion, ju965 (S138L), was close to the GTP binding pocket of α-tubulin [15] (S1 Fig).",False Positive
WBPaper00051394,WBGene00006762,unc-25,S285F,Y37D8A.23c,Line 115: (E) Quantification of synaptic puncta in the DNC (Punc-25-SNB-1::GFP (juIs1)) of adult animals.,"Line 71: The last missense mutation, ju962 (S285F), was in the intermediate domain of α-tubulin, reported to be necessary for binding of the MT stabilizing drug, taxol (Fig 1D and S1 Fig) [15].",False Positive
WBPaper00051394,WBGene00009324,ttbk-3,D209A,F32B6.10a,"Line 136: The kinase TTBK-3 acts cell autonomously in DD neuron remodeling  We mapped another suppressor mutation of tba-1(gf)dlk-1(0), ju978, to the kinase ttbk-3 (F32B6.10) (S1 Table and Fig 4A).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00009324,ttbk-3,D209A,F32B6.10b,"Line 136: The kinase TTBK-3 acts cell autonomously in DD neuron remodeling  We mapped another suppressor mutation of tba-1(gf)dlk-1(0), ju978, to the kinase ttbk-3 (F32B6.10) (S1 Table and Fig 4A).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00009324,ttbk-3,K115A,F32B6.10a,"Line 136: The kinase TTBK-3 acts cell autonomously in DD neuron remodeling  We mapped another suppressor mutation of tba-1(gf)dlk-1(0), ju978, to the kinase ttbk-3 (F32B6.10) (S1 Table and Fig 4A).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00009324,ttbk-3,K115A,F32B6.10b,"Line 136: The kinase TTBK-3 acts cell autonomously in DD neuron remodeling  We mapped another suppressor mutation of tba-1(gf)dlk-1(0), ju978, to the kinase ttbk-3 (F32B6.10) (S1 Table and Fig 4A).",Line 153: Overexpressing kinase-dead versions of TTBK-3 (K115A or D209A) [39] failed to rescue tba-1(gf)dlk-1(0); ttbk-3(ju978) (Fig 4D).,False Positive
WBPaper00051394,WBGene00009324,ttbk-3,V229I,F32B6.10a,"Line 136: The kinase TTBK-3 acts cell autonomously in DD neuron remodeling  We mapped another suppressor mutation of tba-1(gf)dlk-1(0), ju978, to the kinase ttbk-3 (F32B6.10) (S1 Table and Fig 4A).","Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).",False Positive
WBPaper00051394,WBGene00009324,ttbk-3,V229I,F32B6.10b,"Line 136: The kinase TTBK-3 acts cell autonomously in DD neuron remodeling  We mapped another suppressor mutation of tba-1(gf)dlk-1(0), ju978, to the kinase ttbk-3 (F32B6.10) (S1 Table and Fig 4A).","Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).",False Positive
WBPaper00051394,WBGene00011283,ttbk-7,G414R,R90.1,"Line 164: We also tested a null allele of ttbk-7 (R90.1), the closest homolog of mammalian TTBK1/2 (65% sequence identity), which also failed to  PLOS Genetics  https://doi.org/10.1371/journal.pgen.1006844 June 21, 2017  10 / 20  Cellular mechanisms of neural circuit rewiring  Fig 4.",Line 59: Intragenic mutations of tba-1 and a novel mutation of tbb-2 ameliorate the activity of tba-1(gf)  tba-1(gf)alters a conserved glycine residue to arginine (G414R) in the C-terminal H11-12 loop of α-tubulin (S1 Fig) [14].,False Positive
WBPaper00051394,WBGene00016124,dnc-4,V229I,C26B2.1,"Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).","Line 97: Another suppressor, ju993, changed valine 229 to isoleucine in the C. elegans p62 subunit of  dynactin DNC-4 (Fig 2D).",True Positive
